Research

Items from Faculty of Science > Pharmacy & Pharmacology

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Creators | Date | Item Type | No Grouping
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Number of items at this level: 2601.

A

Abbate, F., Winum, J.-Y., Potter, B. V. L., Casini, A., Montero, J.-L., Scozzafava, A. and Supuran, C. T., 2004. Carbonic anhydrase inhibitors : X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorganic & Medicinal Chemistry Letters, 14 (1), pp. 231-234.

Abbate, S., Longhi, G., Castiglioni, E., Lebon, F., Wood, P. M., Woo, L. W. L. and Potter, B. V. L., 2009. Determination of the absolute configuration of aromatase and dual aromatase-sulfatase inhibitors by vibrational and electronic circular dichroism spectra analysis. Chirality, 21 (9), pp. 802-808.

Abbate, V., Hider, R. C., Pourzand, C. and Reelfs, O., 2013. Mitochondia-targeted iron chelators for the monitoring and adjustment of cellular labile iron pools. In: Fifth Congress of the International BioIron Society (IBIS), 2013-04-13 - 2013-04-17, London.

Abdallah, A. M., Renzoni, E. A., Anevlavis, S., Lagan, A. L., Munkonge, F. M., Fonseca, C., Black, C. M., Briggs, D., Wells, A. U., Marshall, S. E., McHugh, N., du Bois, R. M. and Welsh, K. I., 2006. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. International journal of immunogenetics, 33 (3), pp. 155-161.

Abdullah, N., Jordan, N. J., Kolios, G. and Collins, A. J., 2003. Chemokine expression in gastric mucosa from patients with gastritis is related more with the inflammation than with the helicobacter pylori infection. Gut, 52 (Suppl VI), A152.

Abla, N., Geiser, L., Mirgaldi, M., Naik, A., Veuthey, J. L., Guy, R. H. and Kalia, Y. N., 2005. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility. Journal of Pharmaceutical Sciences, 94 (12), pp. 2667-2675.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2005. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. Journal of Controlled Release, 108, pp. 319-330.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2005. Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharmaceutical Research, 22 (12), pp. 2069-2078.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2006. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharmaceutical Research, 23 (8), pp. 1842-1849.

Abla, N., Raik, A., Guy, R. H. and Kalia, Y. N., 2005. Iontophoresis: clinical applications and future challenges. In: Smith, E. W. and Maibach, H. I., eds. Percutaneous Penetration Enhancers, 2nd ed. Vol. 2nd Edition. Boca Raton, Florida: CRC Press, pp. 177-219.

Acharya, K. R. and Lloyd, M. D., 2005. The advantages and limitations of protein crystal structures. Trends in Pharmacological Sciences, 26 (1), pp. 10-14.

Adjimatera, N., Blagbrough, I. S. and Pourzand, C., 2005. Monitoring formulation and intracellular delivery of plasmids by lipopolyamines. Abstracts of Papers of the American Chemical Society, 229, U211-U211.

Adjimatera, N., Kral, T., Hof, M. and Blagbrough, I. S., 2006. Lipopolyamine-mediated single nanoparticle formation of calf thymus DNA analyzed by fluorescence correlation spectroscopy. Pharmaceutical Research, 23 (7), pp. 1564-1573.

Adjimatera, N., Neal, A. P. and Blagbrough, I. S., 2005. Fluorescence techniques in non-viral gene therapy. In: Hof, M., Hutterer, R. and Fidler, V., eds. Fluorescence Spectroscopy in Biology: Advanced Methods and their Applications to Membranes, Proteins, DNA, and Cells. Vol. 3. Heidelberg: Springer-Verlag, pp. 201-228. (Springer Series on Fluorescence)

Adjimatera, N., Neal, A. P. and Blagbrough, I. S., 2005. Sensing DNA nanocomplex delivery by fluorescent probes. Abstracts of Papers of the American Chemical Society, 229, U140-U140.

Adjimatera, N., Neal, A. P., Pourzand, C. and Blagbrough, I. S., 2005. Fluorescent lipopolyamines: A new class of molecular probes in non-viral gene therapy. Abstracts of Papers of the American Chemical Society, 229, U117-U117.

Adjimatera, N., Pourzand, C. and Blagbrough, I. S., 2005. Synthesis and biological testing of lipopolyamine N2,N3-dioleoylspermine: Self-assembly of a nanopharmaceutical for plasmid delivery. Abstracts of Papers of the American Chemical Society, 229, U234-U234.

Adkins, C. E., Wissing, F., Potter, B. V. L. and Taylor, C. W., 2000. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A. Biochemical Journal, 352, pp. 929-933.

Agbor, T.A., Demma, Z., Mrsny, R.J., Castillo, A., Boll, E.J. and Mccormick, B.A., 2014. The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs SalmonellaTyphimurium-induced neutrophil transepithelial migration. Cellular Microbiology

Ahmed, O. A. A., Adjimatera, N., Pourzand, C. and Blagbrough, I. S., 2005. N4,N9-dioleoyl spermine is a novel nonviral lipopolyamine vector for plasmid DNA formulation. Pharmaceutical Research, 22 (6), pp. 972-980.

Ahmed, O. A. A. and Blagbrough, I. S., 2006. Formulation and delivery of p-EGFP DNA condensed by a synthetic lipospermine. Journal of Pharmacy and Pharmacology, 58, A63-A63.

Ahmed, O. A. A., Pourzand, C. and Blagbrough, I. S., 2006. Varying the unsaturation in N4,N9-dioctadecanoyl spermines: Nonviral lipopolyamine vectors for more efficient plasmid DNA formulation. Pharmaceutical Research, 23 (1), pp. 31-40.

Ahrens, B., Davidson, M. G., Forsyth, V. T., Mahon, M. F., Johnson, A. L., Mason, S. A., Price, R. D. and Raithby, P. R., 2001. Neutron diffraction study of a phenol-nitroxide radical adduct: A structural model for hydrogen atom abstraction by peroxyl radicals from vitamin E and related phenolic antioxidants. Journal of the American Chemical Society, 123 (37), pp. 9164-9165.

Akasaka, T., Balasas, T., Russell, L. J., Sugimoto, K. J., Majid, A., Walewska, R., Karran, E. L., Brown, D. G., Cain, K., Harder, L., Gesk, S., Martin-Subero, J. I., Atherton, M. G., Brüggemann, M., Calasanz, M. J., Davies, T., Haas, O. A., Hagemeijer, A., Kempski, H., Lessard, M., Lillington, D. M., Moore, S., Nguyen-Khac, F., Radford-Weiss, I., Schoch, C., Struski, S., Talley, P., Welham, M. J., Worley, H., Strefford, J. C., Harrison, C. J., Siebert, R. and Dyer, M. J. S., 2007. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood, 109 (8), pp. 3451-3461.

Akkaya, Ö., İşsever Öztürk, S., Bolhuis, A. and Gümüşel, F., 2012. Mutations in the translation initiation region of the pac gene resulting in increased levels of activity of penicillin G acylase. World Journal of Microbiology and Biotechnology, 28 (5), pp. 2159-2164.

Al-Heresh, A. M., Proctor, J., Jones, S. M., Dixey, J., Cox, B., Welsh, K. and McHugh, N., 2002. Tumour necrosis factor‐α polymorphism and the HLA‐Cw*0602 allele in psoriatic arthritis. Rheumatology, 41 (5), pp. 525-530.

Al-Qenaei, A., Yiakouvaki, A., Hall, N. D. and Pourzand, C., 2007. The role of lysosomal labile iron pool in differential sensitivity of Jurkat T cell lines to hydrogen peroxide. American Journal of Hematology, 82 (6), p. 565.

Al-Qenaei, A., 2008. The role of iron in rheumatoid arthritis. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Al-Qenaei, A., Yiakouvaki, A., Reelfs, O., Santambrogio, P., Levi, S., Hall, N. D., Tyrrell, R. M. and Pourzand, C., 2014. Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide. Free Radical Biology and Medicine, 68, pp. 87-100.

Al-Shukaily, A., Lyndon, G. J., Baugh, J. A. and Hall, N. D., 2003. Oxidative stress as a pro-inflammatory modulator of T cell-monocyte interactions. Inflammation Research, 52 (Suppl 2), S148.

Alam, J., Igarashi, K., Immenshuh, S., Shibabara, S. and Tyrrell, R. M., 2004. Regulation of the heme oxygenase 1 gene: recent advances and highlights from the international conference (Uppsala, 2003) on heme oxygenase. Antioxidants & Redox Signaling, 6 (5), pp. 924-933.

Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D. and Guy, R. H., 2001. Effect of ethanol and isopropyl myristate on the bioavailability of topical terbinafine in human stratum corneum, in vivo. International Journal of Pharmaceutics, 219, pp. 11-19.

Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D. and Guy, R. H., 2001. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. Journal of Controlled Release, 71, pp. 319-327.

Alberti, I., Kalia, Y. N., Naik, A. and Guy, R. H., 2001. Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo , in man. Pharmaceutical Research, 18 (10), pp. 1472-1475.

Alhusein, N., Blagbrough, I. S. and De Bank, P. A., 2012. Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate). Drug Delivery and Translational Research, 2 (6), pp. 477-488.

Alhusein, N., Blagbrough, I. S. and De Bank, P. A., 2013. Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline. Drug Delivery and Translational Research, 3 (6), pp. 542-550.

Alhusein, N., De Bank, P. A., Blagbrough, I. S. and Bolhuis, A., 2013. Killing bacteria within biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre matrices of polycaprolactone and poly(ethylene-co-vinyl acetate). Drug Delivery and Translational Research, 3 (6), pp. 531-541.

Ali Khan, M., Wood, P.J., Lamb-Guhren, N.M., Caggiano, L., Kociok-Köhn, G., Tosh, D. and Lewis, S.E., 2014. The enone motif of (+)-grandifloracin is not essential for 'anti-austerity' antiproliferative activity. Bioorganic & Medicinal Chemistry Letters, 24 (13), pp. 2815-2819.

Ali-Hassan, S., 2012. The Development of Biological Therapeutics. Thesis (Master of Philosophy (MPhil)). University of Bath.

Allan, G. M., Bubert, C., Vicker, N., Smith, A., Tutill, H. J., Purohit, A., Reed, M. J. and Potter, B. V. L., 2006. Novel, potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology, 248 (1), pp. 204-207.

Allan, G. M., Lawrence, H. R., Cornet, J., Bubert, C., Fischer, D. S., Vicker, N., Smith, A., Tutill, H. J., Purohit, A., Day, J. M., Mahon, M. F., Reed, M. J. and Potter, B. V. L., 2006. Modification of estrone at the 6, 16, and 17 positions : novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry, 49 (4), pp. 1325-1345.

Allan, G. M., Vicker, N., Lawrence, H. R., Tutill, H. J., Day, J. M., Huchet, M., Ferrandis, E., Reed, M. J., Purohit, A. and Potter, B. V. L., 2008. Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1 : templates for design. Bioorganic and Medicinal Chemistry, 16 (8), pp. 4438-4456.

Allen, T., Iftinca, M., Cole, W. C. and Plane, F., 2002. Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. The Journal of Physiology, 545 (3), pp. 975-986.

Allwood, M. B., Cannan, B., van Aalten, D. M. F. and Eggleston, I. M., 2007. Efficient synthesis of 1,3,7-substituted xanthines by a safety-catch protection strategy. Tetrahedron, 63, pp. 12294-12302.

Altroff, H., Van der Walle, C. F., Asselin, J., Fairless, R., Campbell, I. D. and Mardon, H. J., 2001. The eighth FIII domain of human fibronectin promotes integrin α 5 β 1 binding via stabilization of the ninth FIII domain. Journal of Biological Chemistry, 276 (42), pp. 38885-38892.

Alvarez-Figueroa, M. J., Delgado-Charro, M. B. and Blanco-Méndez, J., 2001. Passive and iontophoretic transdermal penetration of methotrexate. International Journal of Pharmaceutics, 212, pp. 101-107.

Alvarez-Román, R., Barré, G., Guy, R. H. and Fessi, H., 2001. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. European Journal of Pharmaceutics and Biopharmaceutics, 52, pp. 191-195.

Alvarez-Román, R., Merino, G., Kalia, Y. N., Naik, A. and Guy, R. H., 2003. Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. Journal of Pharmaceutical Sciences, 92 (6), pp. 1138-1146.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Fessi, H. and Guy, R. H., 2004. Visualization of skin penetration using confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics, 58, pp. 301-316.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H. and Fessi, H., 2004. Enhancement of topical delivery from biodegradable nanoparticles. Pharmaceutical Research, 21 (10), pp. 1818-1825.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H. and Fessi, H., 2004. Skin penetration and distribution of polymeric nanoparticles. Journal of Controlled Release, 99, pp. 53-62.

Amadesi, S., Grant, A. D., Cottrell, G. S., Vaksman, N., Poole, D. P., Rozengurt, E. and Bunnett, N. W., 2009. Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2. The Journal of Comparative Neurology, 516 (2), pp. 141-156.

Amaya, M. F., Watts, A. G., Damager, I., Wehenkel, A., Nguyen, T., Buschiazzo, A., Paris, G., Frasch, A. C., Withers, S. G. and Alzari, P. M., 2004. Structural insights into the catalytic mechanism of trypanosoma cruzi trans-sialidase. Structure, 12 (5), pp. 775-784.

Andersen, O. A., Dixon, M. J., Eggleston, I. M. and van Aalten, D. M. F., 2005. Natural product family 18 chitinase inhibitors. Natural Product Reports, 22, pp. 563-579.

Andersen, O. A., Nathubhai, A., Dixon, M. J., Eggleston, I. M. and van Aalten, D. M. F., 2008. Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin. Chemistry & Biology, 15 (3), pp. 295-301.

Anderson, H., Bartley, E., Davison, A. M., Haines, S. L. and Rogers, P. J., 2002. Patients' experiences of over-the-counter treatments for irritable bowel syndrome. International Journal of Pharmacy Practice, 10 ((Suppl)), R21.

Anderson, N. J., Robinson, E. S. J., Husbands, S. M., Delagrange, P., Nutt, D. J. and Hudson, A. L., 2003. Characterization of [3H]Harmane Binding to Rat Whole Brain Membranes. Annals of the New York Academy of Sciences, 1009 (1), pp. 175-179.

Anderson, N. J., Tyacke, R. J., Husbands, S. M., Nutt, D. J., Hudson, A. L. and Robinson, E. S. J., 2006. In vitro and ex vivo distribution of [ 3 H]harmane, an endogenous β-carboline, in rat brain. Neuropharmacology, 50, pp. 269-276.

Angell, K. L., Kreshka, M. A., McCoy, R., Donnelly, P., Turner-Cobb, J. M., Graddy, K., Kraemer, H. C. and Koopman, C., 2007. Psychosocial intervention for rural women with breast cancer. Journal of General Internal Medicine, 18 (7), pp. 499-507.

Anto, B., James, K.L., Barlow, D., Brinklow, N., Oborne, C.A. and Whittlesea, C., 2013. Exploratory study to identify the process used by pharmacy staff to verify the accuracy of dispensed medicines. International Journal of Pharmacy Practice, 21 (4), pp. 233-242.

Apel, M., Uebe, S., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Pasutto, F., Ekici, A. B., McManus, R., Ho, P., Bruce, I. N., Ryan, A. W., Behrens, F., Böhm, B., Traupe, H., Lohmann, J., Gieger, C., Wichmann, H.-E., Padyukov, L., Fitzgerald, O., Alenius, G.-M., McHugh, N. J., Novelli, G., Burkhardt, H., Barton, A., Reis, A. and Hüffmeier, U., 2013. Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis. Arthritis & Rheumatism, 65 (5), pp. 1224-1231.

Ariza, A., Vickers, T. J., Greig, N., Armour, K. A., Dixon, M. J., Eggleston, I. M., Fairlamb, A. H. and Bond, C. S., 2006. Specificity of the trypanothione-dependent Leishmania major glyoxalase 1: structure and biochemical comparison with the human enzyme. Molecular Microbiology, 59 (4), pp. 1239-1248.

Armas, J. B., Dantas, J., Mendonça, D., Farto, R., Ribeiro, M., Herrero-Beaumont, G., Gouveia, J. and McHugh, N. J., 2000. Anticardiolipin and antinuclear antibodies in cancer patients--a case control study. Clinical and Experimental Rheumatology, 18 (2), pp. 227-232.

Armas, J. B., Davies, J., Davis, M., Lovell, C. and McHugh, N., 1992. Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum. Clinical and Experimental Rheumatology, 10 (2), pp. 177-180.

Aroun, A., 2010. A Comparative study of the antiproliferative activity of iron chelators PIH, SIH and their light-activated caged derivatives in skin cells. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Aroun, A., Zhong, J. L., Tyrrell, R. M. and Pourzand, C., 2012. Iron, oxidative stress and the example of solar ultraviolet A radiation. Photochemical & Photobiological Sciences, 11 (1), pp. 118-134.

Arrowsmith, R. L., Waghorn, P. A., Jones, M. W., Bauman, A., Brayshaw, S. K., Hu, Z. Y., Kociok-Kohn, G., Mindt, T. L., Tyrrell, R. M., Botchway, S. W., Dilworth, J. R. and Pascu, S. I., 2011. Fluorescent gallium and indium bis(thiosemicarbazonates) and their radiolabelled analogues: Synthesis, structures and cellular confocal fluorescence imaging investigations. Dalton Transactions, 40 (23), pp. 6238-6252.

Arrowsmith, R. L., Zeglis, B. M., Viola-Villegas, N., Divilov, V., Jones, M., Waghorn, P. A., Phillips, F. L., Mindt, T. L., Eggleston, I. M., Botchway, S. W., Dilworth, J. R., Aigbirhio, F. I., Lewis, J. S. and Pascu, S. I., 2011. Fluorescent copper(II), gallium(III) and indium(III) bis(thiosemicarbazonates) : Radiolabeling, cellular confocal fluorescence and PET imaging studies. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S59.

Arumugam, R. and McHugh, N. J., 2012. Mortality and causes of death in psoriatic arthritis. Journal of Rheumatology, Supplement 89, pp. 32-35.

Ashamu, G. A., Galione, A. and Potter, B. V. L., 1995. Chemoenzymatic synthesis of analogues of the second messenger candidate cyclic adenosine 5′-diphosphate ribose. Journal of the Chemical Society, Chemical Communications, 1995 (13), pp. 1359-1360.

Ashamu, G. A., Sethi, J. K., Galione, A. and Potter, B. V. L., 1997. Roles for adenosine ribose hydroxyl groups in cyclic adenosine 5‘-diphosphate ribose-mediated Ca2+ release. Biochemistry, 36 (31), pp. 9509-9517.

Astoul, E., Edmunds, C., Cantrell, D. A. and Ward, S. G., 2001. PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends in Immunology, 22 (9), pp. 490-496.

Auner, B. G., O'Neill, M. A. A., Valenta, C. and Hadgraft, J., 2005. Interaction of phloretin and 6-ketocholestanol with DPPC-liposomes as phospholipid model membranes. International Journal of Pharmaceutics, 294, pp. 149-155.

B

Babu, K. S., Woodcock, D. A., Smith, S. E., Staniforth, J. N., Holgate, S. T. and Conway, J. H., 2003. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. European Respiratory Journal, 21 (6), pp. 1046-1049.

Bailey, C., Henderson, G. and Kelly, E., 2008. Functional selectivity in GPCR desensitization. Fundamental & Clinical Pharmacology, 22, p. 7.

Bailey, C. P., 2007. Morphine tolerance: getting hooked. The Biochemist, 29, pp. 12-15.

Bailey, C. P. and Connor, M., 2005. Opioids: cellular mechanisms of tolerance and physical dependence. Current Opinion in Pharmacology, 5 (1), pp. 60-68.

Bailey, C. P., Couch, D., Johnson, E., Griffiths, K., Kelly, E. and Henderson, G., 2003. μ-Opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. Journal of Neuroscience, 23 (33), pp. 10515-10520.

Bailey, C. P., Kelly, E. and Henderson, G., 2004. Protein kinase C activation enhances morphine-induced rapid desensitization of μ-opioid receptors in mature rat locus ceruleus neurons. Molecular Pharmacology, 66 (6), pp. 1592-1598.

Bailey, C. P., Maubach, K. A. and Jones, R. S. G., 2004. Neurokinin-1 receptors in the rat nucleus tractus solitarius: pre- and postsynaptic modulation of glutamate and GABA release. Neuroscience, 127, pp. 467-479.

Bailey, C. P., O'Callaghan, M. J., Croft, A. P., Manley, S. J. and Little, H. J., 2001. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology, 41, pp. 989-999.

Bailey, C. P., Smith, F. L., Kelly, E., Dewey, W. L. and Henderson, G., 2006. How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance? Trends in Pharmacological Sciences, 27 (11), pp. 558-565.

Bailey, C. P., Trejos, J. A., Schanne, F. A. X. and Stanton, P. K., 2003. Pairing elevation of [cyclic GMP] with inhibition of PKA produces long-term depression of glutamate release from isolated rat hippocampal presynaptic terminals. European Journal of Neuroscience, 17, pp. 903-908.

Bailey, C. P., Llorente, J., Gabra, B. H., Smith, F. L., Dewey, W. L., Kelly, E. and Henderson, G., 2009. Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. European Journal of Neuroscience, 29 (2), pp. 307-318.

Bailey, C. P., Nicholls, R. E., Zhang, X. L., Zhou, Z. Y., Muller, W., Kandel, E. R. and Stanton, P. K., 2008. Gαi2 inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses. Learning and Memory, 15 (4), pp. 261-270.

Bailey, C. P., Oldfield, S., Llorente, J., Caunt, C. J., Teschemacher, A., Roberts, L., McArdle, C., Smith, F., Dewey, W., Kelly, E. and Henderson, G., 2009. Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of µ-opioid receptors in mature brain neurons. British Journal of Pharmacology, 158 (1), pp. 157-164.

Bailey, H. V., Heaton, W., Vicker, N. and Potter, B. V. L., 2006. Rapid microwave-assisted reductive amination of ketones with anilines. Synlett, 2006 (15), pp. 2444-2448.

Bailey, H. V., 2007. Drug design and novel anti-cancer therapeutics: inhibitors of 17β [beta] hydroxysteroid dehydrogenase type 3. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.

Bailey, S. J., Dhillon, A., Woodhall, G. L. and Jones, R. S. G., 2004. Lamina-specific differences in GABAB autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology, 46, pp. 31-42.

Bailey, S. J., Ravier, M. A. and Rutter, G. A., 2007. Glucose-dependent regulation of γ-Aminobutyric Acid (GABAA) receptor expression in mouse pancreatic islet α-cells. Diabetes, 56 (2), pp. 320-327.

Bailey, S. J., Stocksley, M. A., Buckel, A., Young, C. and Slater, C. R., 2003. Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats. Journal of Neuroscience, 23 (6), pp. 2102-2111.

Bailey, S. J. and Toth, M., 2004. Variability in the benzodiazepine response of serotonin 5-HT 1A receptor null mice displaying anxiety-lie phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA A receptors. Journal of Neuroscience, 24 (28), pp. 6343-6351.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl,naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Bailey, V. C., Fortt, S. M., Summerhill, R. J., Galione, A. and Potter, B. V.l., 1996. Cyclic aristeromycin diphosphate ribose : a potent and poorly hydrolysable Ca2+-mobilising mimic of cyclic adenosine diphosphate ribose. FEBS Letters, 379 (3), pp. 227-230.

Bailey, V. C., Sethi, J. K., Fortt, S. M., Galione, A. and Potter, B. V. L., 1997. 7-Deaza cyclic adenosine 5′-diphosphate ribose : first example of a Ca2+-mobilizing partial agonist related to cyclic adenosine 5′-diphosphate ribose. Chemistry & Biology, 4 (1), pp. 51-61.

Bailey, V. C., Sethi, J. K., Galione, A. and Potter, B. V. L., 1997. Synthesis of 7-deaza-8-bromo cyclic adenosine 5′-diphosphate ribose : the first hydrolysis resistant antagonist at the cADPR receptor. Chemical Communications, 1997 (7), pp. 695-696.

Ball, A. L., Chambers, K. A., Hewinson, M., Navaratnarajah, S., Samrin, L., Thomas, N., Tyler, A. E. H., Wall, A. J. and Lloyd, M. D., 2008. A microtitre plate assay for measuring glycosidase activity. Journal of Enzyme Inhibition and Medicinal Chemistry, 23 (1), pp. 131-135.

Ball, J., Archer, S. and Ward, S., 2014. Forthcoming. PI3K inhibitors as potential therapeutics for autoimmune disease. Drug Discovery Today

Ballard, K. D., Seaman, H. E., de Vries, C. S. and Wright, J. T., 2008. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study - Part 1. BJOG : An International Journal Of Obstetrics & Gynaecology, 115 (11), pp. 1382-1391.

Banks, J., Shaw, A. and Weiss, M. C., 2007. The community pharmacy and discursive complexity: A qualitative study of interaction between counter assistants and customers. Health and Social Care in the Community, 15 (4), pp. 313-321.

Banks, J., Shaw, A. and Weiss, M. C., 2005. Walking a line between health care and sales: The role of the medicines counter assistant. Pharmaceutical Journal, 274 (7349), pp. 586-589.

Baptist, M., Braksator, E., Bailey, C., Kelly, E. and Henderson, G., 2008. Mu-opioid receptor internalisation : Studies using a pHluorin tag. Fundamental & Clinical Pharmacology, 22, p. 60.

Baraldi, E., Carugo, K. D., Hyvönen, M., Surdo, P. L., Riley, A. M., Potter, B. V. L., O’Brien, R., Ladbury, J. E. and Saraste, M., 1999. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure, 7 (4), pp. 449-460.

Barral, S., Haynes, C., Stone, M. and Gordon, D., 2006. LRTae: improving statistical power for genetic association with case/control data when phenotype and/or genotype misclassification errors are present. Bmc Genetics, 7.

Barrett, C. M. L., Ray, N., Thomas, J. D., Robinson, C. and Bolhuis, A., 2003. Quantitative export of a reporter protein, GFP, by the twin-arginine translocation pathway in Escherichia coli. Biochemical and Biophysical Research Communications, 304 (2), pp. 279-284.

Barrington, S. L., Carroll, R., Hewitson, M., Munangatire, B., Rogers, P. J. and Wood, S. M., 2003. Use of diphenhydramine as a non-prescription hypnotic: patients' experiences. International Journal of Pharmacy Practice, 11, R25.

Bartlett, T. E., Bannister, N. J., Collett, V. J., Dargan, S. L., Massey, P. V., Bortolotto, Z. A., Fitzjohn, S. M., Bashir, Z. I., Collingridge, G. L. and Lodge, D., 2007. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology, 52 (1), pp. 60-70.

Bartrum, H. E., Adams, H., Caggiano, L. and Jackson, R. F. W., 2008. Synthesis of β2-homophenylalanine derivatives by Negishi cross-coupling reactions. Tetrahedron, 64 (17), pp. 3701-3712.

Bashir, Z. I. and Massey, P. V., 2006. Long-term potentiation & long-term depression. In: Selzer, M., Clarke, L., Cohen, P., Duncan, P. and Gage, F., eds. Textbook of Neural Repair and Rehabillitation: Neural Repair and Plasticity. Vol. 1. New York: Cambridge University Press, pp. 60-78.

Basu-Modak, S., Ali, D., Gordon, M., Polte, T., Yiakouvaki, A., Pourzand, C., Rice-Evans, C. and Tyrrell, R. M., 2006. Suppression of UVA-mediated release of labile iron by epicatechin - A link to lysosomal protection. Free Radical Biology and Medicine, 41 (8), pp. 1197-1204.

Basu-Modak, S., Gordon, M. J., Dobson, L. H., Spencer, J. P. E., Rice-Evans, C. and Tyrrell, R. M., 2003. Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. Free Radical Biology and Medicine, 35 (8), pp. 910-921.

Basu-Modak, S. and Tyrrell, R. M., 2001. Modulation of gene expression by solar ultraviolet radiation. In: Giacomoni, P. U., ed. Sun Protection in Man. Elsevier Science B.V., pp. 303-320.

Batchelor, H.K., Fotaki, N. and Klein, S., 2014. Paediatric oral biopharmaceutics : Key considerations and current challenges. Advanced Drug Delivery Reviews, 73, pp. 102-126.

Batt, M. E., Jaques, R. and Stone, M., 2004. Preparticipation examination (screening): Practical issues as determined by sport - A United Kingdom perspective. Clinical Journal of Sport Medicine, 14 (3), pp. 178-182.

Baxter, K., Weiss, M. C. and LeGrand, J., 2007. Collaborative commissioning of secondary care services by Primary Care Trusts. Public Money & Management, 27 (3), pp. 207-214.

Baxter, K., Weiss, M. C. and Grand, J. L., 2008. The dynamics of commissioning across organisational and clinical boundaries. Journal of Health Organization and Management, 22 (2), pp. 111-128.

Bayoumi, S. A. L., Rowan, M. G., Beeching, J. R. and Blagbrough, I. S., 2008. Investigation of biosynthetic pathways to hydroxycoumarins during post-harvest physiological deterioration in cassava roots by using stable isotope labelling. ChemBiochem, 9 (18), pp. 3013-3022.

Bayoumi, S. A. L., Rowan, M. G., Blagbrough, I. S. and Beeching, J. R., 2008. Biosynthesis of scopoletin and scopolin in cassava roots during post-harvest physiological deterioration: The E-Z-isomerisation stage. Phytochemistry, 69 (17), pp. 2928-2936.

Bayoumi, S. A. L., Rowan, M. G., Beeching, J. R. and Blagbrough, I. S., 2010. Constituents and secondary metabolite natural products in fresh and deteriorated cassava roots. Phytochemistry, 71 (5-6), pp. 598-604.

Bayoumi, S. A. L. H., 2008. Molecular genetic analysis of secondary metabolite biosynthesis in cassava as an economic and nutritious plant. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Beale, N. and Taylor, G., 2005. Where there's smoke ... there's council tax valuation band A. British Journal of General Practice, 55 (512), pp. 233-234.

Beard, J. D., Burbridge, D. J., Moskalenko, A. V., Dudko, O., Yarova, P. L., Smirnov, S. V. and Gordeev, S. N., 2009. An atomic force microscope nanoscalpel for nanolithography and biological applications. Nanotechnology, 20 (44), 445302.

Beard, J. D., Gordeev, S. N. and Guy, R. H., 2011. AFM nanotools for surgery of biological Cells. Journal of Physics: Conference Series, 286 (1), 012003.

Beard, J. D., Guy, R. H. and Gordeev, S. N., 2013. Mechanical tomography of human corneocytes with a nanoneedle. Journal Of Investigative Dermatology, 133 (6), pp. 1565-1571.

Beauchard, A., Phillips, V. A., Lloyd, M. D. and Threadgill, M. D., 2009. Synthesis of 2-(4-carboxybutenyl)- and 2-(4-carboxybutynyl)-cyclopentene-1-carboxamides. Tetrahedron, 65 (39), pp. 8176-8184.

Beauchard, A., Twum, E. A., Lloyd, M. D. and Threadgill, M. D., 2011. S-2-Amino-4-cyanobutanoic acid (β-cyanomethyl-L-Ala) as an atom-efficient solubilising synthon for L-glutamine. Tetrahedron Letters, 52 (41), pp. 5311-5314.

Beecroft, M. D., Marchant, J. S., Riley, A. M., Van Straten, N. C. R., Van Der Marel, G. A., Van Boom, J. H., Potter, B. V. L. and Taylor, C. W., 1999. Acyclophostin : a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy. Molecular Pharmacology, 55 (1), pp. 109-117.

Beezer, A. E., Hills, A. K., O'Neill, M. A. A., Morris, A. C., Kierstan, K. T. E., Deal, R. M., Waters, L. J., Hadgraft, J., Mitchell, J. C., Connor, J. A., Orchard, J. E., Willson, R. J., Hofelich, T. C., Beaudin, J., Wolf, G., Baitalow, F., Gaisford, S., Lane, R. A., Buckton, G., Phipps, M. A., Winneke, R. A., Schmitt, E. A., Hansen, L. D., O'Sullivan, D. and Parmar, M. K., 2001. The imidazole catalysed hydrolysis of triacetin: an inter- and intra-laboratory development of a test reaction for isothermal heat conduction microcalorimeters used for determination of both thermodynamic and kinetic parameters. Thermochimica Acta, 380, pp. 13-17.

Beezer, A. E., Morris, A. C., O'Neill, M. A. A., Willson, R. J., Hills, A. K., Mitchell, J. C. and Connor, J. A., 2001. Direct determination of equilibrium thermodynamic and kinetic parameters from isothermal heat conduction microcalorimetry. Journal of Physical Chemistry B, 105, pp. 1212-1215.

Beezer, A. E., O'Neill, M. A. A., Urakami, K., Connor, J. A. and Tetteh, J., 2004. Pharmaceutical microcalorimetry: recent advances in the study of solid state materials. Thermochimica Acta, 420, pp. 19-22.

Begat, P., Morton, D. A. V., Staniforth, J. N. and Price, R., 2004. The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics. Pharmaceutical Research, 21 (10), pp. 1826-1833.

Begat, P., Young, P. M., Edge, S., Kaerger, J. S. and Price, R., 2003. The effect of mechanical processing on surface stability of pharmaceutical powders: Visualization by atomic force microscopy. Journal of Pharmaceutical Sciences, 92 (3), pp. 611-620.

Begat, P., Morton, D. A. V., Shur, J., Kippax, P., Staniforth, J. N. and Price, R., 2009. The role of force control agents in high-dose dry powder inhaler formulations. Journal of Pharmaceutical Sciences, 98 (8), pp. 2770-2783.

Begat, P., Morton, D. A. V., Staniforth, J. N. and Price, R., 2004. The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy. Pharmaceutical Research, 21 (9), pp. 1591-1597.

Belevych, A. E., Beck, R., Tammaro, P., Poston, L. and Smirnov, S. V., 2002. Developmental changes in the functional characteristics and expression of voltage-gated K + channel currents in rat aortic myocytes. Cardiovascular Research, 54 (1), pp. 152-161.

Beleznai, T., Takano, H., Hamill, C., Yarova, P., Douglas, G., Channon, K. and Dora, K., 2011. Enhanced K+-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE -/- mice. Cardiovascular Research, 92 (2), pp. 199-208.

Beleznai, T. Z., Yarova, P. L., Yuill, K. H. and Dora, K. A., 2011. Smooth Muscle Ca(2+)-Activated and Voltage-Gated K(+) Channels Modulate Conducted Dilation in Rat Isolated Small Mesenteric Arteries. Microcirculation, 18 (6), pp. 487-500.

Belsey, N. A., Cordery, S. F., Bunge, A. L. and Guy, R. H., 2011. Assessment of dermal exposure to pesticide residues during re-entry. Environmental Science & Technology, 45 (10), pp. 4609-4615.

Belsey, N. A., Garrett, N. L., Contreras-Rojas, L. R., Pickup-Gerlaugh, A. J., Price, G. J., Moger, J. and Guy, R. H., 2014. Evaluation of drug delivery to intact and porated skin by coherent Raman scattering and fluorescence microscopies. Journal of Controlled Release, 174 (28), pp. 37-42.

Bennett, J. H., Carter, D. H., Alavi, A. L., Beresford, J. N. and Walsh, S., 2001. Patterns of integrin expression in a human mandibular explant model of osteoblast differentiation. Archives of Oral Biology, 46 (3), pp. 229-238.

Benzeval, I., Bowen, C. R., Guy, R. H. and Delgado-Charro, M. B., 2013. Effects of iontophoresis, hydration, and permeation enhancers on human nail plate: Infrared and impedance spectroscopy assessment. Pharmaceutical Research, 30 (6), pp. 1652-1662.

Berg, I., Potter, B. V. L., Mayr, G. W. and Guse, A. H., 2000. Nicotinic acid adenine dinucleotide phosphate (NAADP+) is an essential regulator of T-lymphocyte Ca2+-signaling. The Journal of Cell Biology (JCB), 150 (3), pp. 581-588.

Berridge, M. J. and Potter, B. V. L., 1990. Inositol trisphosphate analogues induce different oscillatory patterns in Xenopus oocytes. Cell Regulation, 1 (9), pp. 675-681.

Betteridge, Z. E., Gunawardena, H., Chinoy, H., North, J., Ollier, W. E. R., Cooper, R. G. and McHugh, N. J., 2009. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Annals of the Rheumatic Diseases, 68 (10), pp. 1621-1625.

Betteridge, Z., Chinoy, H., Vencovsky, J., Cooper, R. G. and McHugh, N. J., 2011. Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients. Rheumatology, 50 (Supplement 3), pp. 105-106.

Betteridge, Z., Gunawardena, H., North, J., Slinn, J. and McHugh, N. J., 2007. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology, 46 (6), pp. 1005-1008.

Betteridge, Z., Gunawardena, H., North, J., Slinn, J. and McHugh, N. J., 2007. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis & Rheumatism, 56 (9), pp. 3132-3137.

Betteridge, Z. E., Gunawardena, H. and McHugh, N. J., 2011. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Research & Therapy, 13 (2), 209.

Betteridge, Z. E., Gunawardena, H. and McHugh, N. J., 2009. Pathogenic mechanisms of disease in myositis: autoantigens as clues. Current Opinion in Rheumatology, 21 (6), pp. 604-9.

Bhalla, N., Di Lorenzo, M., Pula, G. and Estrela, P. M. D., 2014. Novel tools for protein phosphorylation analysis based on proton release detection. In: 24th Anniversary World Congress on Biosensors, 2014-05-27 - 2014-05-30, Melbourne.

Bhalla, N., Di Lorenzo, M., Pula, G. and Estrela, P., 2014. Protein phosphorylation analysis based on proton release detection : potential tools for drug discovery. Biosensors and Bioelectronics, 54, pp. 109-114.

Bhaskaran-Nair Harikumar, K., Hardman, R., Aranjani, J.M., Vimala Raveendran, V. and Thejass, P., 2014. Immunomodulatory activity of complementary and alternative medicines. Evidence-based Complementary and Alternative Medicine, 2014, 765107.

Bittner, B., McIntyre, C., Tian, H., Tang, K., Shah, N., Phuapradit, W., Ahmed, H., Chokshi, H., Infeld, M., Fotaki, N., Ma, H., Portron, A., Jordan, P. and Schmidt, J., 2012. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC). Die Pharmazie - An International Journal of Pharmaceutical Sciences, 67 (3), pp. 233-241.

Black, S. J., Jones, C. and Junk, P. C., 2004. The molecular structure of [2Me2N(Me)]}2]. Main Group Metal Chemistry, 24 (7), pp. 453-454.

Black, S. L., Chauvignac, C., Grundt, P., Miller, C. N., Wood, S., Traynor, J. R., Lewis, J. W. and Husbands, S. M., 2003. Guanidino N-substituted and N,N-disubstituted derivatives of the k -opioid antagonist GNTI. Journal of Medicinal Chemistry, 46, pp. 5505-5511.

Black, S. L., Jales, A. R., Brandt, W., Lewis, J. W. and Husbands, S. M., 2003. The role of the side chain in determining relative δ- and k -affinity in C5'-substituted analogues of naltrindole. Journal of Medicinal Chemistry, 46, pp. 314-317.

Blagbrough, I. S., Adjimatera, N., Ahmed, O. A. A., Neal, A. P. and Pourzand, C. A., 2004. Spermine and lipopolyamines as gene delivery agents. In: Beadle, D. J., Mellor, I. R. and Usherwood, P. N. R., eds. Neurotox '03: Neurotoxicological targets from Functional Genomics and Proteomics. Society of Chemical Industry, pp. 147-159. (Functional Genomics and Proteomics)

Blagbrough, I. S., Adjimatera, N., Neal, A. P. and Haworth, I. S., 2004. Fluorescence techniques in non-viral gene therapy: Using spermine and lipopolyamines as DNA delivery agents. Abstracts of Papers of the American Chemical Society, 227, U34-U34.

Blagbrough, I. S. and Geall, A. J., 2003. Acidity of basic polyamines: pKa studies of symmetrical and unsymmetrical polyamines and their conjugates compared with their DNA binding. Abstracts of Papers of the American Chemical Society, 225, U199-U199.

Blagbrough, I. S. and Geall, A. J., 2002. Synthesis and DNA binding of steroid lipopolyamine conjugates: PKA studies of polyammonium ion ligands. Abstracts of Papers of the American Chemical Society, 224, U40-U40.

Blagbrough, I. S., Geall, A. J. and Al-Hadithi, D., 2001. Sar of bile acid polyamine conjugates in binding and condensation of DNA. Abstracts of Papers of the American Chemical Society, 221, U58-U58.

Blagbrough, I. S., Geall, A. J. and Neal, A. P., 2002. Design and synthesis of unsymmetrical polyamine spermidine and spermine conjugates with potential in DNA binding and non-viral gene therapy studies. Abstracts of Papers of the American Chemical Society, 224, U43-U43.

Blagbrough, I. S., Geall, A. J. and Neal, A. P., 2003. Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy. Biochemical Society Transactions, 31 (2), pp. 397-406.

Blagbrough, I. S., Geall, A. J., Taylor, R. J., Earll, M. E. and Eaton, M. W., 2001. Synthesis, DNA binding, and pK(a) studies of cholesterol-polyamine carbamates. Abstracts of Papers of the American Chemical Society, 221, U58-U58.

Blagbrough, I. S., Haworth, I. S., Taylor, S. and Carrington, S., 2001. Synthesis and DNA binding studies of 9-anthracenyl and 9-acridinyl-polyamine conjugates: Ligands designed with two discrete binding modes. Abstracts of Papers of the American Chemical Society, 221, U61-U62.

Blagbrough, I. S. and Metwally, A. A., 2013. siRNA and Gene Formulation for Efficient Gene Therapy. In: Molina, F. M., ed. Gene Therapy: Tools and Potential Applications. InTech.

Blagbrough, I. S. and Neal, A. P., 2002. Design and synthesis of fluorescent steroidal lipopolyamine conjugates for monitoring gene delivery. In: Matsoukas, J. and Mavromoustakos, T., eds. Drug Discovery and Design: Medical Aspects. Vol. 55. Amsterdam: IOS Press, pp. 64-75. (Biomedical and Health Research)

Blagbrough, I. S., Al-Hadithi, D. and Geall, A. J., 2000. Cheno-, urso- and deoxycholic acid spermine conjugates: Relative binding affinities for calf thymus DNA. Tetrahedron, 56 (21), pp. 3439-3447.

Blagbrough, I. S., Bayoumi, S. A. L., Rowan, M. G. and Beeching, J. R., 2010. Cassava: an appraisal of its phytochemistry and its biotechnological prospects. Phytochemistry, 71 (17-18), pp. 1940-1951.

Blagbrough, I. S., Elmasry, M. S., Woodman, T. J., Saleh, H. M. and Kheir, A. A., 2009. Quantitative determination of mebeverine HCl by NMR chemical shift migration. Tetrahedron, 65 (25), pp. 4930-4936.

Blagbrough, I. S., Geall, A. J. and David, S. A., 2000. Lipopolyamines incorporating the tetraamine spermine, bound to an alkyl chain, sequester bacterial lipopolysaccharide. Bioorganic & Medicinal Chemistry Letters, 10 (17), pp. 1959-1962.

Blagbrough, I. S., Metwally, A. A. and Ghonaim, H. M., 2012. Asymmetrical N4,N9-Diacyl Spermines: SAR Studies of Nonviral Lipopolyamine Vectors for Efficient siRNA Delivery with Silencing of EGFP Reporter Gene. Molecular Pharmaceutics, 9 (7), pp. 1853-1861.

Blagbrough, I. S. and Zara, C., 2009. Animal Models for Target Diseases in Gene Therapy - using DNA and siRNA Delivery Strategies. Pharmaceutical Research, 26 (1), pp. 1-18.

Blagbrough, I. S., Coates, P. A., Hardick, D. J., Lewis, T., Rowan, M. G., Wonnacott, S. and Potter, B. V. L., 1994. Acylation of lycoctonine : semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Letters, 35 (46), pp. 8705-8708.

Blagbrough, I. S., Hardick, D. J., Wonnacott, S. and Potter, B. V. L., 1994. Regioselective demethylation of aconitine. Tetrahedron Letters, 35 (20), pp. 3367-3370.

Blake, D. R., McCabe, C., Haigh, R. and Mapp, P. I., 2001. Neurogenic inflammation, pain and joint disease. Inflammation Research, 50, S157.

Blake, D. R., Robson, P., Ho, M., Jubb, R. W. and McCabe, C. S., 2005. Preliminary assessment of the efficacy, tolerability and safety of a cannabis base medicine in the treatment of pain caused by rheumatoid arthritis. Rheumatology, 45 (1), pp. 50-52.

Blake, D. R. and Taylor, G. J., 2003. An Iconoclastic Approach to Pharmacodynamics in Model Systems: Their Relevance to Humans: Introduction to Part 3. In: Winyard, P. G. and Willoughby, D. A., eds. Inflammation Protocols. Vol. 225. Springer, pp. 263-268. (Methods in Molecular Biology)

Blake, D. R. and Taylor, G. J., 2003. An iconoclastic approach to pharmacodynamics in model systems: their relevance to humans. Methods in Molecular Biology, 225, pp. 263-268.

Blake, K. V., De Vries, C. S., Arlett, P., Kurz, X. and Fitt, H., 2012. Increasing scientific standards, independence and transparency in post-authorisation studies: The role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiology and Drug Safety, 21 (7), pp. 690-696.

Blazer, L. L., Roman, D. L., Chung, A., Larsen, M. J., Greedy, B. M., Husbands, S. M. and Neubig, R. R., 2010. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Molecular Pharmacology, 78 (3), pp. 524-533.

Blazer, L. L., Zhang, H. M., Casey, E. M., Husbands, S. M. and Neubig, R. R., 2011. A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins. Biochemistry, 50 (15), pp. 3181-3192.

Bloomfield, K., John, N., McGrogan, A., Jones, R. and De Vries, C., 2010. Co-Prescribing of medications with anticholinergicproperties to those using cholinesterase inhibitors fordementia. Pharmacoepidemiology and Drug Safety, 19 (S1), 112.

Blunt, M.D. and Ward, S.G., 2012. Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system : Success, disappointment, and new opportunities. Frontiers in Immunology, 3, 226.

Blunt, M. D. and Ward, S. G., 2012. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. Current Opinion in Pharmacology, 12 (4), pp. 444-451.

Boardman, A., Schlindwein, F. S., Rocha, A. P. and Leite, A., 2002. A study on the optimum order of autoregressive models for heart rate variability. Physiological Measurement, 23 (2), pp. 325-336.

Boardman, A., Schlindwein, F. S., Thakor, N. V., Kimura, T. and Geocadin, R. G., 2002. Detection of asphyxia using heart rate variability. Medical and Biological Engineering and Computing, 40 (6), pp. 618-624.

Bochmann, M., Lancaster, S. J., Hannant, M. D., Rodriguez, A., Schormann, M., Walker, D. A. and Woodman, T. J., 2003. Role of B(C 6 F 5 ) 3 in catalyst activation, anion formation, and as C 6 F 5 transfer agent. Pure and Applied Chemistry, 75 (9), pp. 1183-1195.

Bojarová, P., Denehy, E., Walker, I., Loft, K., De Souza, D. P., Woo, L. W. L., Potter, B. V. L., McConville, M. J. and Williams, S. J., 2008. Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa Arylsulfatase by Aryl Sulfamates. ChemBiochem, 9 (4), pp. 613-623.

Boleij, A., Muytjens, C. M. J., Bukhari, S. I., Cayet, N., Glaser, P., Hermans, P. W. M., Swinkels, D. W., Bolhuis, A. and Tjalsma, H., 2011. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. Journal of Infectious Diseases, 203 (8), pp. 1101-1109.

Bolhuis, A., 2004. Early transport: Protein secretion pathways in Archaea. The Biochemist, 26 (3), pp. 16-18.

Bolhuis, A., 2002. Protein transport in the halophilic archaeon Halobacterium sp NRC 1: a major role for the Twin Arginine translocation pathway? Microbiology, 148 (11), pp. 3335-3345.

Bolhuis, A., 2004. The archaeal Sec-dependent protein translocation pathway. Philosophical Transactions of the Royal Society B, 359, pp. 919-927.

Bolhuis, A., Mathers, J. E., Thomas, J. D., Barrett, C. L. and Robinson, C., 2001. TatB and TatC form a functional and structural unit of the twin arginine translocase from Escherichia coli. Journal of Biological Chemistry, 276 (23), pp. 20213-20219.

Bolhuis, A., Kwan, D. and Thomas, J.R., 2010. Halophilic adaptations of proteins. In: Ortendhal, V. and Salchow, H., eds. Ribosomal Proteins and Protein Engineering. Nova Science, pp. 143-174. (Protein Science and Engineering)

Bolhuis, A. and Aldrich-Wright, J. R., 2014. Forthcoming. DNA as a target for antimicrobials. Bioorganic Chemistry

Bolhuis, A., Bogsch, E. G. and Robinson, C., 2000. Subunit interactions in the twin-arginine translocase complex of Escherichia coli. FEBS Letters, 472 (1), pp. 88-92.

Bolhuis, A., Hand, L., Marshall, J. E., Richards, A. D., Rodger, A. and Aldrich-Wright, J., 2011. Antimicrobial activity of ruthenium-based intercalators. European Journal of Pharmaceutical Sciences, 42 (4), pp. 313-317.

Bolhuis, A., Koetje, E., Dubois, J. Y., Vehmaanpera, J., Venema, G., Bron, S. and van Dijl, J. M., 2000. Did the mitochondrial processing peptidase evolve from a eubacterial regulator of gene expression? Molecular Biology and Evolution, 17 (1), pp. 198-201.

Bolhuis, A., Kwan, D. and Thomas, J. R., 2008. Halophilic adaptation of proteins. In: Siddiqui, K. S. and Thomas, T., eds. Protein Adaptation in Extremophiles. New York: Nova Science, pp. 71-104. (Molecular Anatomy and Physiology of Proteins)

Bolhuis, A. and Richards, A. D., 2011. Development of metal complexes as potential antimicrobials. In: Aldrich-Wright, J., ed. Metallointercalators: Synthesis and Techniques to Probe Their Interactions with Biomolecules. New York: Springer, pp. 373-388.

Bonander, N., Darby, R. A. J., Grgic, L., Bora, N., Wen, J., Brogna, S., Poyner, D. R., O'Neill, M. A. A. and Bill, R. M., 2009. Altering the ribosomal subunit ratio in yeast maximizes recombinant protein yield. Microbial Cell Factories, 8, 10.

Bond, C., Smith, E. and Garland, C. J., 2004. Survey of P13-kinase RNA expression in the rat. British Journal of Pharmacology, 2 (2), 80P.

Bone, H. K., Damiano, T., Bartlett, S., Perry, A., Letchford, J., Ripoli, Y. S., Nelson, A. S. and Welham, M. J., 2009. Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chemistry & Biology, 16 (1), pp. 15-27.

Bone, H. K., Nelson, A. S., Goldring, C. E., Tosh, D. and Welham, M. J., 2011. A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. Journal of Cell Science, 124 (12), pp. 1992-2000.

Bone, H. K. and Welham, M. J., 2007. Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. Journal of Cell Science, 120 (10), pp. 1752-1762.

Bonnesen, C., Eggleston, I. M. and Hayes, J. D., 2001. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Research, 61, pp. 6120-6130.

Bonser, J., Walker, J., Purohit, A., Reed, M. J., Potter, B. V. L., Willis, D. S., Franks, S. and Mason, H. D., 2000. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. The Journal of Endocrinology, 167 (3), pp. 465-471.

Borissow, C. N., Black, S. J., Paul, M., Tovey, S. C., Dedos, S. G., Taylor, C. W. and Potter, B. V. L., 2005. Adenophostin A and analogues modified at the adenine moiety: synthesis, conformational analysis and biological activity. Organic and Biomolecular Chemistry, 3, pp. 245-252.

Bouissou, C., Begat, P., van der Walle, C. and Price, R., 2005. Study of the surface mobility of PLGA microspheres using high-resolution topography measurements with the atomic force microscope. Journal of Controlled Release, 101 (1-3), pp. 290-292.

Bouissou, C., Potter, U., Altroff, H., Mardon, H. and van der Walle, C., 2004. Controlled release of the fibronectin central cell binding domain from polymeric microspheres. Journal of Controlled Release, 95 (3), pp. 557-566.

Bouissou, C., Rouse, J. J., Price, R. and van der Walle, C. F., 2006. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharmaceutical Research, 23 (6), pp. 1295-1305.

Bouissou, C. C., Sylvestre, J.-P., Guy, R. H. and Delgado-Charro, M. B., 2009. Reverse iontophoresis of amino acids: identification and separation of stratum corneum and subdermal sources in vitro. Pharmaceutical Research, 26 (12), pp. 2630-2638.

Bourre, L., Giuntini, F., Eggleston, I. M., Wilson, M. and MacRobert, A. J., 2008. 5-aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy. Molecular Cancer Therapeutics, 7 (6), pp. 1720-1729.

Bourre, L., Giuntini, F., Eggleston, I. M., Wilson, M. and MacRobert, A. J., 2009. Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism. British Journal of Cancer, 100 (5), pp. 723-731.

Bourre, L., Giuntini, F., Eggleston, I. M., Mosse, C. A., MacRobert, A. J. and Wilson, M., 2010. Effective photoinactivation of Gram-positive and Gram-negative bacterial strains using an HIV-1 Tat peptide-porphyrin conjugate. Photochemical & Photobiological Sciences, 9 (12), pp. 1613-1620.

Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R. B., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Griffiths, C. E. M., Bruce, I. N., Worthington, J. and Barton, A., 2011. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases, 70 (6), pp. 1016-1019.

Bowes, J., Flynn, E., Ho, P., Aly, B., Morgan, A. W., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Bruce, I. N. and Barton, A., 2010. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Annals of the Rheumatic Diseases, 69 (12), pp. 2199-2203.

Bowes, J., Ho, P., Flynn, E., Ali, F., Marzo-Ortega, H., Coates, L. C., Warren, R. B., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Bruce, I. N. and Barton, A., 2011. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases, 71, pp. 1350-1354.

Bowes, J., Orozco, G., Flynn, E., Ho, P., Brier, R., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Bruce, I. N. and Barton, A., 2011. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Annals of the Rheumatic Diseases, 70 (9), pp. 1641-1644.

Bowes, J., Ho, P., Flynn, E., Salah, S., McHugh, N. J., Fitzgerald, O., Packham, J., Morgan, A. W., Helliwell, P. S., Bruce, I. N. and Barton, A., 2012. Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility. Annals of the Rheumatic Diseases, 71, pp. 313-314.

Box, K., Comer, J., Mole, J., Taylor, R., Karki, S., Price, R. and Fotaki, N., 2012. Forthcoming. Small scale assays for studying dissolution and precipitation of pharmaceutical cocrystals. AAPS Journal

Boyce, V., Beaton, D., Govinda, R. A., Maetzel, A. M., Inman, R. D., Lapp, V. and Stone, M. A., 2007. The MCID for response to TNF blockers varies widely depending on the method chosen to calculate the MCID. Rheumatology, 46, I57-I57.

Bramananthan, N., Carmona, M., Lowe, J.P., Mahon, M.F., Poulten, R.C. and Whittlesey, M.K., 2014. Rh-FHF and Rh-F complexes containing small N-alkyl substituted six-membered ring N-heterocyclic carbenes. Organometallics, 33 (8), pp. 1986-1995.

Brambilla, G., Ganderton, D., Garzia, R., Lewis, D., Meakin, B. and Ventura, P., 1999. Modulation of aerosol clouds produced by pressurised inhalation aerosols. International Journal of Pharmaceutics, 186 (1), pp. 53-61.

Braun, J., Cook, R., Landewe, R., Gladman, D. D., Inman, R. D., Maksymowych, W., Mease, P., Davis, J., Van der Heijde, D., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., Khan, M., O'Shea, F. D., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M., Taylor, W. and Veale, D., 2006. Inspire lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis (SpA). Annals of the Rheumatic Diseases, 65, p. 208.

Braun, J., McHugh, N. J., Singh, A., Wajdula, J. S. and Sato, R., 2007. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly. Rheumatology, 46 (6), pp. 999-1004.

Brayden, D. J. and Mrsny, R. J., 2011. Oral peptide delivery: Prioritizing the leading technologies. Therapeutic Delivery, 2 (12), pp. 1567-1573.

Breuer, E., Karaman, R., Goldblum, A., Gibson, D., Leader, H., Potter, B. V. L. and Cummins, J. H., 1988. α-Oxyiminophosphonates : chemical and physical properties. Reactions, theoretical calculations, and X-ray crystal structures of (E) and (Z)-dimethyl α-hydroxyiminobenzylphosphonates. Journal of the Chemical Society, Perkin Transactions 1, 1988 (11), pp. 3047-3057.

Brimson, J. M., 2010. The Pharmacology of the Sigma-1 Receptor. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Brimson, J. M., Brown, C. A. and Safrany, S. T., 2011. Antagonists show GTP-sensitive high affinity binding to the sigma-1 receptor. British Journal of Pharmacology, 164 (2B), pp. 772-780.

Britten, N. and Weiss, M. C., 2004. What is concordance? In: Bond, C., ed. Concordance: A Partnership in Medicine-taking. London: Pharmaceutical Press, pp. 9-28.

Britton, R. and Scott, J., 2006. Community pharmacy services to drug misusers in the south west of England - results of the 2003-2004 postal survey. International Journal of Pharmacy Practice, 14, pp. 235-241.

Britton, R. and Scott, J., 2005. Pharmacy based needle exchange in the South West of England - cause for concern? In: 16th International Conference in the Reduction of Drug Related Harm, 2005-03-20 - 2005-03-24, Waterfront, Belfast.

Bromley, S. E., de Vries, C. S. and Farmer, R. D. T., 2004. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database. BJOG : An International Journal Of Obstetrics & Gynaecology, 111 (4), pp. 369-376.

Bromley, S. E., de Vries, C. S., Thomas, D. and Farmer, R. D. T., 2005. Hormone replacement therapy and risk of acute myocardial infarction: a review of the literature. Drug Safety, 28 (6), pp. 473-493.

Brophy, S., Taylor, G., Blake, D. R. and Calin, A., 2003. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis and iritis. Journal of Rheumatology, 30 (9), pp. 2054-2058.

Brown, L., Joseph, L., Crosbie, P., Landberg, G., Barber, P., Lindsay, M. and Booton, R., 2012. RNA from FFPE tissue is suitable for exon array analysis if extracted utilizing a robust protocol which incorporates laser capture microdissection. Lung Cancer, 75 (Supplement 1), S4.

Brown, M. R. W. and Kornberg, A., 2004. Inorganic polyphosphate in the origin and survival of species. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490, 101 (46), pp. 16085-16087.

Brown, M. R. W. and Smith, A. W., 2001. Dormancy and persistence in chronic infection: role of the general stress response in resistance to chemotherapy - J Antimicrob Chemother 2001; 48 : 141-142. Journal of Antimicrobial Chemotherapy, 48 (1), pp. 141-142.

Brown, M. R. W., Smith, A. W., Barker, J., Humphrey, T. J. and Dixon, B., 2002. E-coli O157 persistence in the environment. Microbiology, 148, pp. 1-2.

Brown, M. R. W., Smith, A. W., O'Flaherty, V., Moran, P., Lens, P. and Stoodley, P., 2002. Resistance of medical biofilms. In: Biofilms in medicine, industry and environmental biotechnology. London: IWA Publishing.

Brown, M. R. W., Smith, A. W., Wilson, M. and Devine, D., 2003. Antimicrobiol agents and biofilms. In: Medical implications of biofilms. Cambridge: Cambridge University Press, pp. 36-58.

Brown, R. S., Dowden, J., Moreau, C. and Potter, B. V. L., 2002. A concise route to tiazofurin. Tetrahedron Letters, 43 (37), pp. 6561-6562.

Brown, S., James, J., Pauling, J. D., Shipley, J. A., Korenodwych, E. and McHugh, N. J., 2010. Vacuum assisted closure therapy : A novel treatment for refractory digital ulceration in systemic sclerosis. Clinical and Experimental Rheumatology, 28 (2 Supp 58), S162-S163.

Bubert, C., Woo, L. W. L., Sutcliffe, O. B., Mahon, M. F., Chander, S. K., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile : SAR, crystal structures, in vitro and in vivo activities. ChemMedChem, 3 (11), pp. 1708-1730.

Buckley, C., Cavill, C., Taylor, G., Kay, H., Waldron, N., Korendowych, E. and McHugh, N. J., 2010. Mortality in psoriatic arthritis: a single-center study from the UK. Journal of Rheumatology, 37 (10), pp. 2141-2144.

Bunge, A. L., Touraille, G. D., Marty, J. P. and Guy, R. H., 2005. Modeling dermal absorption from soils and powders using stratum corneum tape-stripping in vivo. In: Riviere, J. E., ed. Dermal Absorption Models in Toxicology and Pharmacology. Boca Raton, Florida: CRC Press, pp. 191-212.

Bunnett, N. W. and Cottrell, G. S., 2010. Trafficking and signaling of G protein-coupled receptors in the nervous system : Implications for disease and therapy. CNS & Neurological Disorders-Drug Targets, 9 (5), pp. 539-556.

Buranaphalin, S., 2009. Pharmaceutical Analysis of Polyamines and Aminoglycosides. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Burgess, S. E., O'Neill, M. A. A., Beezer, A. E., Hadgraft, J. and Gaisford, S., 2005. Thermodynamics of membrane transport and implications for dermal delivery. Journal of Drug Delivery Science and Technology, 15 (4), pp. 325-327.

Burton, E., Harrigan, E., Mok, Y., Scott, J. and Yahie, U., 2003. Results of a 2003 national survey on paraphernalia supply from UK needle exchange agencies. In: Society for the Study of Addiction Annual Symposium,, 2003-01-01, Leeds.

Buscemi, G., Miller, P. W., Kealey, S., Gee, A. D., Long, N. J., Passchier, J. and Vilar, R., 2011. Rapid carbonylative coupling reactions using palladium(I) dimers: applications to (CO)-C-11-radiolabelling for the synthesis of PET tracers. Organic and Biomolecular Chemistry, 9 (9), pp. 3499-3503.

Busteed, S., Bennett, M. W., Molloy, C., Houston, A., Stone, M. A., Shanahan, F., Molloy, M. G. and O'Connell, J., 2006. Bcl-x(L) expression in vivo in rheumatoid synovium. Clinical Rheumatology, 25 (6), pp. 789-793.

Byron, P. R., Peart, J. and Staniforth, J. N., 1997. Aerosol electrostatics I: properties of fine powders before and after aerosolization by dry powder inhalers. Pharmaceutical Research, 14 (6), pp. 698-705.

Byrum, J., Jordan, S., Safrany, S. T. and Rodgers, W., 2004. Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP 6 inhibits Ku mobility. Nucleic Acids Research, 32, pp. 2776-2784.

C

Cabana Montenegro, S., Delgado-Charro, M. B. and Fotaki, N., 2012. Development and evaluation of age appropriate pellet formulations for an antiepileptic drug. In: 4th Conference of the European Paediatric Formulation Initiative (EuPFI) 2012, 2012-09-19 - 2012-09-20, Prague.

Caggiano, L., 2005. Silicon-mediated transformations of functional groups (Book review). Applied Organometallic Chemistry, 19 (5), p. 699.

Caggiano, L., Castoldi, D., Beumer, R., Bayon, P., Telser, J. and Gennari, C., 2003. Effects of allylic and homoallylic substituents on the ring closing metatheses reaction used to synthesise simplified eleuthesides. Tetrahedron Letters, 44, pp. 7913-7919.

Caggiano, L., Davies, J., Fox, D. J., Moody, D. C. and Warren, S., 2003. A novel silica catalysed stereoselective cyclic carbamate and carbonate rearrangement. Chemical Communications, 14, pp. 1650-1651.

Caggiano, L., Davies, J., Fox, D. J., Moody, D. C. and Warren, S., 2003. Stereoselective substituted pyrrolidine and cyclic ether synthesis by PhS migration. Chemical Communications, 14, pp. 1648-1649.

Caggiano, L., Fox, D. J., House, D., Jones, Z. A., Kerr, F. and Warren, S., 2002. Asymmetric synthesis of tetrahydrofurans by competitive [1,2]-phenylsulfanyl (PhS) migrations under thermodynamic control. Journal of the Chemical Society - Perkin Transcriptions 1, 23, pp. 2634-2645.

Caggiano, L., Fox, D. J., House, D., Jones, Z. A., Kerr, F. and Warren, S., 2002. Asymmetric synthesis of tetrahydropyrans with competitive [1,2]-phenylsulfanyl (PhS) migrations. Journal of the Chemical Society - Perkin Transcriptions 1, 23, pp. 2646-2651.

Caggiano, L., Fox, D. J. and Warren, S., 2002. Silica gel catalysed generation of episulfonium ions: a mild method for the synthesis of heterocycles. Chemical Communications

Caggiano, L., Jackson, R. F. W., Meijer, A. J. H. M., Pickup, B. T. and Wilkinson, K. A., 2008. Ionisation of the zinc/iodine bond of alkylzinc iodides in dimethylformamide from theory and experiment. Chemistry - A European Journal, 14 (29), p. 8798.

Cai, L., Threadgill, M. D., Wang, Y. L. and Li, M., 2009. Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells. Pathology & Oncology Research, 15 (3), pp. 323-328.

Callis, D. J., Thomas, N. F., Pearson, D. P. J. and Potter, B. V. L., 1996. A tandem Horner−Emmons olefination−conjugate addition approach to the synthesis of 1,5-disubstituted-6-azabicyclo[3.2.1]octanes based on the AE ring structure of the norditerpenoid alkaloid methyllycaconitine. Journal of Organic Chemistry, 61 (14), pp. 4634-4640.

Cameron, L. and Thompson, A. S., 2000. Determination of the structural role of the linking moieties in the DNA binding of adozelesin. Biochemistry, 39 (17), pp. 5004-5012.

Cami-Kobeci, G., Neale, A. P., Bradbury, F. A., Purington, L. C., Aceto, M. D., Harris, L. S., Lewis, J. W., Traynor, J. R. and Husbands, S. M., 2009. Mixed κ/μ Opioid Receptor Agonists: The 6β-Naltrexamines. Journal of Medicinal Chemistry, 52 (6), pp. 1546-1552.

Cami-Kobeci, G., Polgar, W. E., Khroyan, T. V., Toll, L. and Husbands, S. M., 2011. Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine. Journal of Medicinal Chemistry, 54 (19), pp. 6531-6537.

Cami-Kobeci, G., Polgar, W. E., Khroyan, T. V., Toll, L. and Husbands, S. M., 2011. Universal opioid receptor ligands - buprenorphine and related orvinols. Pharmacological Reports, 63 (1), p. 210.

Campbell, C., 2008. Poly(lactide-co-glycolide) devices for drug delivery. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Campbell, C. S. J., Contreras-Rojas, L. R., Delgado-Charro, B. and Guy, R. H., 2012. Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. Journal of Controlled Release, 162 (1), pp. 201-207.

Cantaert, T., Stone, M., ter Borg, M., de Vries, N., Wilson, A., Tak, P. and Baeten, D., 2008. A functional variant of TIR-domain-containing adaptor protein (TIRAP) is not associated with spondyloarthritis. Clinical Immunology, 127, S85-S85.

Cantaert, T., Stone, M. A., ter Borg, M., Mogg, R., De Vries, N., Wilson, A. G., Tak, P. P. and Baeten, D., 2008. A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. Annals of the Rheumatic Diseases, 67 (5), pp. 720-722.

Cantrill, J., Morris, C. and Weiss, M. C., 2006. How patients perceive minor illness and factors influencing seeing a doctor. Primary Health Care Research and Development, 7 (2), pp. 157-164.

Cao, J., Husbands, S. M., Kopajtic, T., Katz, J. L. and Newman, A. H., 2001. [(3- cis -3,5-dimethyl-1-piperazinyl)alkyl-bis-(4'-fluorophenyl)amine analogs as novel probes for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters, 11, pp. 3169-3173.

Cao, J., Kulkarni, S. S., Husbands, S. M., Bowen, W. D., Williams, W., Kopajtic, T., Katz, J. L., George, C. and Newman, A. H., 2003. Dual probles for the dopamine transporter and σ1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amyl analogues as potential cocaine-abuse therapeutic agents. Journal of Medicinal Chemistry, 46, pp. 2589-2598.

Carmichael, C., Lalani, M., Poon, L. M., Scott, J., Laaksonen, R., Rogers, P. and Scott, J., 2011. What do community pharmacists really think of the electronic prescription service (EPS)? International Journal of Pharmacy Practice, 19 (Suppl 2), p. 86.

Carr-Bains, S., Nightingale, A. L. and Ballard, K. D., 2011. Patients' experiences and satisfaction with out-of-hours GP home visiting provided by a GP cooperative. Family Practice, 28 (1), pp. 88-92.

Carrillo-Marquez, T., Caggiano, L., Jackson, R. F. W., Graboswka, U., Rae, A. and Tozer, M. J., 2005. New routes to b-cycloalkylalanine derivatives using serine-derived organozinc reagents. Organic and Biomolecular Chemistry, 3, pp. 4117-4123.

Carter, E., Lau, C. Y., Tosh, D., Ward, S. G. and Mrsny, R. J., 2013. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro : Implications for continued therapeutic use. European Journal of Pharmaceutics and Biopharmaceutics, 85 (1), pp. 12-19.

Cartwright, J. L., Safrany, S. T., Dixon, L. K., Darzynkiewicz, J., Stepenski, J., Burke, R. and McLennan, A. G., 2002. The g5R (D250) gene of African swine fever virus encodes a Nudix hydrolase that preferentially degrades diphosphoinositol polyphosphates. Journal of Virology, 76, pp. 1415-1421.

Carvajal, M. T. and Staniforth, J. N., 2006. Interactions of water with the surfaces of crystal polymorphs. International Journal of Pharmaceutics, 307 (2), pp. 216-224.

Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.

Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Characterization of BU09059 : A novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience, 5 (3), pp. 177-184.

Castoldi, D., Caggiano, L., Bayon, P., Costa, A. M., Cappella, P., Sharon, O. and Gennari, C., 2005. Synthesis of novel, simplified, C-7 substituted eleutheside analogues with potent microtubule-stabilizing activity. Tetrahedron, 61, pp. 2123-2139.

Castoldi, D., Caggiano, L., Panigada, L., Sharon, O., Costa, A. M. and Gennari, C., 2005. A formal total synthesis of eleutherobin through an unprecedented kinetically controlled ring-closing-metathesis reaction of a densely functionalized diene. Angewandte Chemie-International Edition, 44, pp. 588-591.

Castoldi, D., Caggiano, L., Panigada, L., Sharon, O., Costa, A. M. and Gennari, C., 2006. A formal total synthesis of eleutherobin using the ring-closing metathesis (RCM) reaction of a densely functionalized diene as the key step: investigation of the unusual kinetically controlled RCM stereochemistry. Chemistry, 12, pp. 51-62.

Cattaruzza, F., Cottrell, G., Vaksman, N. and Bunnett, N. W., 2009. Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation. British Journal of Pharmacology, 156 (5), pp. 730-739.

Challiss, R. A. J., Smith, S. M., Potter, B. V. L. and Nahorski, S. R., 1991. D-[35S(U)]Inositol 1,4,5-trisphosphorothioate, a novel radioligand for the inositol 1,4,5-trisphosphate receptor Complex binding to rat cerebellar membranes. FEBS Letters, 281 (1-2), pp. 101-104.

Challiss, R. A. J., Willcocks, A. L., Mulloy, B., Potter, B. V. L. and Nahorski, S. R., 1991. Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochemical Journal, 274 (3), pp. 861-867.

Chamberlain, S., 2009. Functional role of kainate receptors in the rat entorhinal cortex. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Chamberlain, S. E. L., Jane, D. E. and Jones, R. S. G., 2012. Pre- and post-synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex. Hippocampus, 22 (3), pp. 555-576.

Chamberlain, S. E. L., Yang, J. and Jones, R. S. G., 2008. The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex. Neural Plasticity, 2008, 872456.

Chan, C. C., Inrig, T., Molloy, C. B., Stone, M. A. and Derzko-Dzulynsky, L., 2012. Prevalence of inflammatory back pain in a cohort of patients with anterior uveitis. American Journal of Ophthalmology, 153 (6), pp. 1025-1030.

Chan, M. T., Owen, P., Dunphy, J., Cox, B., Carmichael, C., Korendowych, E. and McHugh, N. J., 2008. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. Journal of Rheumatology, 35 (1), pp. 77-83.

Chander, S. K., Foster, P. A., Leese, M. P., Newman, S. P., Potter, B. V. L., Purohit, A. and Reed, M. J., 2007. In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. British Journal of Cancer, 96 (9), pp. 1368-1376.

Chander, S. K., Purohit, A., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2004. The role of steroid suophatase in regulating the oestrogenicity of oestrogen sulphamates. Biochemical and Biophysical Research Communications, 322 (1), pp. 217-222.

Chandran, V., Gottlieb, A., Cook, R. J., Duffin, K. C., Garg, A., Helliwell, P., Kavanaugh, A., Krueger, G. G., Langley, R. G., Lynde, C., Mchugh, N. J., Mease, P., Olivieri, I., Rahman, P., Rosen, C. F., Salvarani, C., Thaci, D., Toloza, S. M. A., Wong, M. Y. W., Zhou, Q. M. and Gladman, D. D., 2009. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis & Rheumatism, 61 (9), pp. 1235-1242.

Changya, L., Gallacher, D. V., Irvine, R. F., Potter, B. V. L. and Petersen, O. H., 1989. Inositol 1,3,4,5-tetrakisphosphate is essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused mouse lacrimal acinar cells. Journal of Membrane Biology, 109 (1), pp. 85-93.

Chapman, C. A., Jones, R. S. G. and Jung, M., 2008. Neuronal plasticity in the entorhinal cortex. Neural Plasticity, 2008, 314785.

Chapman, C.J. and Frost, C.G., 2003. Synthesis of functionalised phenylalanines using rhodium catalysis in water. Advanced Synthesis & Catalysis, 345 (3), pp. 353-355.

Chapman, C.J. and Frost, C.G., 2007. Tandem and domino catalytic strategies for enantioselective synthesis. Synthesis, 2007 (1), pp. 1-21.

Chapman, C.J., Frost, C.G., Hartley, J.P. and Whittle, A.J., 2001. Efficient aromatic and heteroatom acylations using catalytic indium complexes with lithium perchlorate. Tetrahedron Letters, 42 (5), pp. 773-775.

Chapman, C.J., Frost, C.G., Matsuno, A. and Willis, M. C., 2007. Site-selective modification of peptides using rhodium and palladium catalysis : Complementary electrophilic and nucleophilic arylation. Chemical Communications, 2007 (38), pp. 3903-3905.

Chapman, C.J., Wadsworth, K.J. and Frost, C.G., 2003. Enantioselective rhodium-catalysed addition of boronic acids using C-symmetric aryl diphosphite ligands. Journal of Organometallic Chemistry, 680 (1-2), pp. 206-211.

Chapman, C. J., Frost, C. G., Gill-Carey, M. P., Kociok-Kohn, G., Mahon, M. F., Weller, A. S. and Willis, M. C., 2003. Diphosphine mono-sulfides: readily available chiral monophosphines. Tetrahedron: Asymmetry, 14 (6), pp. 705-710.

Chapman, C. J., Frost, C. G. and Mahon, M. F., 2006. Structure and reactivity of new phosphine ligands containing the hemi-labile sulfone moiety. Dalton Transactions, 2006 (18), pp. 2251-2262.

Chappell, F., Crampton, R., Miles, R. and Rogers, P., 2009. Exploring the views of community pharmacists and potential patients on the reclassification of azithromycin from POM to P for the treatment of chlamydial infection. International Journal of Pharmacy Practice, 17 (Supplement 2), B6-B7.

Charlton, R. A., Neville, A.J., Jordan, S., Pierini, A., Damase-Michel, C., Klungsøyr, K., Nybo Andersen, A.-M., Hansen, A.V., Gini, R., Bos, J.H.J., Puccini, A., Hurault-Delarue, C., Brooks, C.J., De Jong-Van Den Berg, L.T.W. and De Vries, C., 2014. Forthcoming. Healthcare databases in europe for studying medicine use and safety during pregnancy. Pharmacoepidemiology and Drug Safety

Charlton, R., 2012. The general practice research database as an alternative to registries for studying drug safety in pregnancy : Anticonvulsants as a case study. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Charlton, R., Cunnington, M., Weil, J. and de Vries, C. S., 2009. Regarding the need, or lack thereof, of a comparator group for pregnancy registries. Birth Defects Research Part A: Clinical and Molecular Teratology, 85 (9), p. 808.

Charlton, R., Snowball, J., Bloomfield, K. and De Vries, C., 2012. Colorectal cancer incidence on the General Practice Research Database. Pharmacoepidemiology and Drug Safety, 21 (7), pp. 775-783.

Charlton, R., Weil, J., Curmington, M. and de Vries, C. S., 2008. The general practice research database as a pregnancy registry system : Anticonvulsants as an example. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), 362.

Charlton, R. A., Cunnington, M. C., de Vries, C. S. and Weil, J. G., 2008. Data resources for investigating drug exposure during pregnancy and associated outcomes: The General Practice Research Database(GPRD) as an alternative to pregnancy registries. Drug Safety, 31 (1), pp. 39-51.

Charlton, R. A., Hutchison, A., Davis, K. J. and De Vries, C. S., 2013. Asthma management in pregnancy. PLoS ONE, 8 (4), e60247.

Charlton, R. A., Snowball, J. M., Bloomfield, K. and De Vries, C. S., 2011. Macrogol laxatives and colorectal cancer risk. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S270-S271.

Charlton, R. A., Weil, J. G., Cunnington, M. C., Ray, S. and de Vries, C. S., 2011. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance anticonvulsants and the risk of major congenital malformations. Drug Safety, 34 (2), pp. 157-171.

Charlton, R. A., Weil, J. G., Snowball, J. M., Cunnington, M. C. and de Vries, C. S., 2009. Can the General Practice Research Database identify a known teratogenic association? Pharmacoepidemiology and Drug Safety, 18 (Supplement 1), S12.

Charlton, R. A., Weil, J. G., Cunnington, M. C. and de Vries, C., 2010. Identifying major congenital malformations in the UK general practice research database (GPRD): A study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD. Drug Safety, 33 (9), pp. 741-750.

Charlton, R. A., Snowball, J. M., Bloomfield, K. and De Vries, C. S., 2013. Colorectal cancer risk reduction following macrogol exposure : A cohort and nested case control study in the UK. PLoS ONE, 8 (12), e83203.

Chatterjee, P. K., Chatterjee, B. E., Pederson, H., Sivarajah, A., McDonald, M. C., Mota-Filipe, H., Brown, P. A. J., Stewart, K. N., Cuzzocrea, S., Threadgill, M. D. and Thiemermann, C., 2004. 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion. Kidney International, 65 (2), pp. 499-509.

Chauvignac, C., Miller, C. N., Srivastava, S. K., Lewis, J. W., Husbands, S. M. and Traynor, J. R., 2005. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective k -opioid receptor antagonist. Journal of Medicinal Chemistry, 48, pp. 1676-1679.

Chen, M.-H., Cui, S.-X., Cheng, Y.-N., Sun, L.-R., Li, Q.-B., Xu, W.-F., Ward, S. G., Tang, W. and Qu, X.-J., 2008. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anti-Cancer Drugs, 19 (10), pp. 957-965.

Chilton, L., Smirnov, S. V., Loutzenhiser, K., Wang, X. and Loutzenhiser, R., 2011. Segment-specific differences in the inward rectifier K+ current along the renal interlobular artery. Cardiovascular Research, 92 (1), pp. 169-177.

Chilvers, E. R., Challiss, R. J., Willcocks, A. L., Potter, B. V. L., Barnes, P. J. and Nahorski, S. R., 1990. Characterisation of stereospecific binding sites for inositol 1,4,5-trisphosphate in airway smooth muscle. British Journal of Pharmacology, 99 (2), pp. 297-302.

Chinoy, H., Platt, H., Lamb, J. A., Betteridge, Z., Gunawardena, H., Fertig, N., Varsani, H., Davidson, J., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. R. and Cooper, R. G., 2008. The Protein Tyrosine Phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British caucasian patients. Arthritis & Rheumatism, 58 (10), pp. 3247-3254.

Chinoy, H., Li, C. K.-C., Platt, H., Fertig, N., Varsani, H., Gunawardena, H., Betteridge, Z., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. R., Cooper, R. G. and , U. A. O. M. I. C. a. U. J. D. R. G., 2012. Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology, 51 (5), pp. 794-799.

Chinoy, H., Payne, D., Poulton, K. V., Fertig, N., Betteridge, Z., Gunawardena, H., Davidson, J. E., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. and Cooper, R. G., 2009. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology, 48 (10), pp. 1213-7.

Chiu, C. P. C., Watts, A. G., Lairson, L. L., Gilbert, M., Lim, D., Wakarchuk, W. W., Withers, S. G. and Strynadka, N. C. J., 2004. Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog. Nature Structural and Molecular Biology, 11 (2), pp. 163-170.

Chryssanthopoulou, C. C., Turner-Cobb, J. M. and Lucas, A., 2005. Childcare as a stabilizing influence on HPA axis functioning: a reevaluation of maternal occupational patterns and familial relations. Developmental Psychobiology, 47 (4), pp. 354-368.

Ciupa, A., De Bank, P. A. and Caggiano, L., 2013. Multicellular aggregation of maltol-modified cells triggered by Fe3+ ions. Chemical Communications, 49 (86), pp. 10148-10150.

Ciupa, A., De Bank, P. A., Mahon, M. F., Wood, P. J. and Caggiano, L., 2013. Synthesis and antiproliferative activity of some 3-(pyrid-2-yl)-pyrazolines. MedChemComm, 4 (6), pp. 956-961.

Ciupa, A., Griffiths, N. J., Light, S. K., Wood, P. J. and Caggiano, L., 2011. Design, synthesis and antiproliferative activity of urocanic-chalcone hybrid derivatives. MedChemComm, 2 (10), pp. 1011-1015.

Ciupa, A., Mahon, M., De Bank, P. and Caggiano, L., 2012. Simple pyrazoline and pyrazole “turn on” fluorescent sensors selective for Cd2+ and Zn2+ in MeCN. Organic and Biomolecular Chemistry, 10 (44), pp. 8753-8757.

Clark, E. A., Crennell, S., Upadhyay, A., Zozulya, A. V., Mackay, J. D., Svergun, D. I., Bagby, S. and van den Elsen, J. M. H., 2011. A structural basis for Staphylococcal complement subversion : X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3d. Molecular Immunology, 48 (4), pp. 452-462.

Clarke, M. J., Tobyn, M. J. and Staniforth, J., 2000. Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol. Journal of Pharmaceutical Sciences, 89 (9), pp. 1160-1169.

Clayburgh, D. R., Barrett, T. A., Tang, Y., Meddings, J. B., Van Eldik, L. J., Watterson, D. M., Clarke, L. L., Mrsny, R. J. and Turner, J. R., 2005. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induce diarrhea in vivo. Journal of Clinical Investigation, 115 (10), pp. 2702-2715.

Clayson, J., Jales, A. R., Tyacke, R. J., Hudson, A. L., Nutt, D. J., Lewis, J. W. and Husbands, S. M., 2001. Selective δ-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorganic & Medicinal Chemistry Letters, 11, pp. 939-943.

Cleland, J. L., Daugherty, A. and Mrsny, R., 2001. Emerging protein delivery methods. Current Opinion in Biotechnology, 12, pp. 212-219.

Coates, L., Pauling, J., Pomeroy, E., Richardson, J., Gay, L., Mogg, R. and Stone, M., 2007. Validation study to assess responsiveness of the INSPIRE method for the evaluation of lateral spinal bending. Annals of the Rheumatic Diseases, 66 (Suppl II), p. 615.

Coates, L. C., Aslam, T., Al Balushi, F., Burden, A. D., Burden-The, E., Caperon, A. R., Cerio, R., Chattopadhyay, C., Chinoy, H., Goodfield, M. J. D., Kay, L., Kelly, S., Kirkham, B. W., Lovell, C. R., Marzo-Ortega, H., Murphy, R., Reynolds, N. J., Smith, C. H., Warren, R. B., Waxman, R., Wilson, H. E., Helliwell, P. S. and McHugh, N., 2013. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). British Journal of Dermatology, 168 (4), pp. 802-807.

Coates, L.C., Tillett, W., Chandler, D., Helliwell, P.S., Korendowych, E., Kyle, S., McInnes, I.B., Oliver, S., Ormerod, A., Smith, C., Symmons, D., Waldron, N. and McHugh, N.J., 2013. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology, 52 (10), pp. 1754-1757.

Coates, L. C., Fitzgerald, O., Mease, P. J., Gladman, D. D., Strand, V., Goel, N., Campbell, I., Krueger, G., McHugh, N. J. and Helliwell, P. S., 2014. Development of a Disease Activity and Responder Index for Psoriatic Arthritis -- Report of the Psoriatic Arthritis Module at OMERACT 11. The Journal of Rheumatology, 41 (4), pp. 782-791.

Coates, L. C., Walsh, J., Haroon, M., Fitzgerald, O., Aslam, T., Al Balushi, F., Burden, A. D., Burden-Teh, E., Caperon, A. R., Cerio, R., Chattopadhyay, C., Chinoy, H., Goodfield, M. J. D., Kay, L., Kelly, S., Kirkham, B. W., Lovell, C. R., Marzo-Ortega, H., McHugh, N., Murphy, R., Reynolds, N. J., Smith, C. H., Stewart, E. J. C., Warren, R. B., Waxman, R., Wilson, H. E. and Helliwell, P. S., 2014. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care and Research

Coates, L. C., Fitzgerald, O., Gladman, D. D., McHugh, N., Mease, P., Strand, V. and Helliwell, P. S., 2013. Brief report : Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis and Rheumatism, 65 (6), pp. 1504-1509.

Coates, P. A., Blagbrough, I. S., Hardick, D. J., Rowan, M. G., Wonnacott, S. and Potter, B. V. L., 1994. Rapid and efficient isolation of the nicotinic receptor antagonist methyllycaconitine from delphinium : assignment of the methylsuccinimide absolute stereochemistry as S. Tetrahedron Letters, 35 (46), pp. 8701-8704.

Coates, P. A., Blagbrough, I. S., Lewis, T., Potter, B. V. L. and Rowan, M. G., 1995. An HPLC assay for the norditerpenoid alkaloid methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist. Journal of Pharmaceutical and Biomedical Analysis, 13 (12), pp. 1541-1544.

Coates, P. A., Blagbrough, I. S., Rowan, M. G., Pearson, D. P. J., Lewis, T. and Potter, B. V. L., 1996. Preliminary synthetic studies of methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist : rapid syntheses of AE-bicyclic analogues. Journal of Pharmacy and Pharmacology, 48 (2), pp. 210-213.

Coates, P. A., Blagbrough, I. S., Rowan, M. G., Potter, B. V. L., Pearson, D. P. J. and Lewis, T., 1994. Rapid and efficient entry to substituted 2-succinimidobenzoate-3-azabicyclo[3.3.1]nonanes : AE-bicyclic analogues of methyllycaconitine. Tetrahedron Letters, 35 (46), pp. 8709-8712.

Colleypriest, B. J., Palmer, R. M., Ward, S. G. and Tosh, D., 2009. Cdx genes, inflammation and the pathogenesis of Barrett's metaplasia. Trends in Molecular Medicine, 15 (7), pp. 313-322.

Colleypriest, B. J., Ward, S. G. and Tosh, D., 2009. How does inflammation cause Barrett's metaplasia? Current Opinion in Pharmacology, 9 (6), pp. 721-726.

Collins, A. R., Gedik, C., Wood, S., White, A., Dubois, J., Duez, P., Rees, J. F., Legall, R., Degand, L., Loft, S., Jensen, A., Poulsen, H., Weimann, A., Jensen, B. R., Cadet, J., Douki, T., Ravanat, J. L., Faure, H., Tripier, M., Morel, I., Sergent, O., Cillard, P., Morin, B., Epe, B., Phoa, N., Hartwig, A., Pelzer, A., Dolara, P., Casalini, C., Guglielmi, F., Luceri, C., Kasai, H., Kido, R., Olinski, R., Bialkowski, K., Durackova, Z., Hlincikova, L., Korytar, P., Dusinska, M., Mislanova, C., Vina, J., Lloret, A., Moller, L., Hofer, T., Gremaud, E., Fay, L., Stadler, R., Eakins, J., Pognan, F., O'Brien, J., Elliott, R., Astley, S., Bailley, A., Herbert, K., Chauhan, D., Kelly, F., Dunster, C., Lunec, J., Podmore, I., Patel, P., Johnson, S., Evans, M., Tyrrell, R., Gordon, M., Wild, C., Hardie, L., Smith, E. and Escodd, [N. V.], 2002. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/8-oxo-7,8-dihydro-2 '-deoxyguanosine in DNA. Free Radical Research, 36 (3), pp. 239-245.

Collins, C. A., Fry, F. H., Holme, A. L., Yiakouvaki, A., Al-Qenaei, A., Pourzand, C. A. and Jacob, C., 2005. Towards multifunctional antioxidants: synthesis, electrochemistry, in vitro and cell culture evaluation of compounds with ligand/catalytic properties. Organic and Biomolecular Chemistry, 3, pp. 1541-1546.

Collins, G. T., Newman, A. H., Grundt, P., Rice, K. C., Husbands, S. M., Chauvignac, C., Chen, J., Wang, S. and Woods, J. H., 2007. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology

Collins, G. T., Truccone, A., Haji-Abdi, F., Newman, A. H., Grundt, P., Rice, K. C., Husbands, S. M., Greedy, B. M., Enguehard-Gueiffier, C., Gueiffier, A., Chen, J., Wang, S., Katz, J. L., Grandy, D. K., Sunahara, R. K. and Woods, J. H., 2009. Proerectile Effects of Dopamine D2-Like Agonists Are Mediated by the D3 Receptor in Rats and Mice. Journal of Pharmacology and Experimental Therapeutics, 329 (1), pp. 210-217.

Collins, L., Lowe, J.P., Mahon, M.F., Poulten, R.C. and Whittlesey, M.K., 2014. Copper diamidocarbene complexes : Characterization of monomeric to tetrameric species. Inorganic Chemistry, 53 (5), pp. 2699-2707.

Connolly, B. A., Potter, B. V. L., Eckstein, F., Pingoud, A. and Grotjahn, L., 1984. Synthesis and characterization of an octanucleotide containing the EcoRI recognition sequence with a phosphorothioate group at the cleavage site. Biochemistry, 23 (15), pp. 3443-3453.

Cooke, A. M., Gigg, R. and Potter, B. V. L., 1987. Synthesis of DL-Myo-inositol 1,4,5-triphosphate. Tetrahedron Letters, 28 (20), pp. 2305-2308.

Cooke, A. M., Gigg, R. and Potter, B. V. L., 1987. myo-Inositol 1,4,5-trisphosphorothioate : a novel analogue of a biological second messenger. Journal of the Chemical Society, Chemical Communications, 1987 (20), pp. 1525-1526.

Cooke, A. M., Nahorski, S. R. and Potter, B. V. L., 1989. myo-Inositol 1,4,5-trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5-phosphatase. FEBS Letters, 242 (2), pp. 373-377.

Cooke, A. M., Noble, N. J., Payne, S., Gigg, R. and Potter, B. V. L., 1989. Synthesis of myo-inositol 1,4-bisphosphate-5-phosphorothioate. Journal of the Chemical Society, Chemical Communications, 1989 (5), pp. 269-271.

Coopman, K., Smith, L. D., Wright, K. L. and Ward, S. G., 2007. Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis. International Immunopharmacology, 7 (3), pp. 360-371.

Cordery, S. F., Taverner, A., Ridzwan, I. E., Guy, R. H., Delgado-Charro, M. B., Husbands, S. M. and Bailey, C. P., 2013. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm. Addiction Biology

Cordiglieri, C., Odoardi, F., Zhang, B., Nebel, M., Kawakami, N., Klinkert, W. E. F., Lodygin, D., Luhder, F., Breunig, E., Schild, D., Ulaganathan, V. K., Dornmair, K., Dammermann, W., Potter, B. V. L., Guse, A. H. and Flugel, A., 2010. Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. Brain, 133 (7), pp. 1930-1943.

Cork, M. J., Varghese, J., Hadcraft, J., Lane, M., Ferguson, A., Moustafa, M., Guy, R. H. and Ward, S., 2007. Differences in the effect of topical corticosteroids and calcineurin inhibitors on the skin barrier - Implications for therapy. Journal Of Investigative Dermatology, 127, S45-S45.

Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., Macgowan, A. L., Tazi-Ahnini, R. and Ward, S. J., 2009. Epidermal barrier dysfunction in atopic dermatitis. Journal Of Investigative Dermatology, 129 (8), pp. 1892-1908.

Correa, V., Riley, A. M., Shuto, S., Horne, G., Nerou, E. P., Marwood, R. D., Potter, B. V. L. and Taylor, C. W., 2001. Structural determinants of adenophostin A activity at inositol trisphosphate receptors. Molecular Pharmacology, 59 (5), pp. 1206-1215.

Cottrell, G. and Turner, A. J., 2013. Aminopeptidase P1. In: Rawlings, N. D. and Salvesen, G., eds. Handbook of Proteolytic Enzymes. Vol. 2. 3rd ed. London: Academic Press, pp. 1525-1528.

Cottrell, G. S., Padilla, B. E., Amadesi, S., Poole, D. P., Murphy, J. E., Hardt, M., Roosterman, D., Steinhoff, M. and Bunnett, N. W., 2009. Endosomal Endothelin-converting Enzyme-1: A Regulator of β-Arrestin-Dependent ERK Signaling. Journal of Biological Chemistry, 284 (33), pp. 22411-22425.

Cozier, G. E., Leese, M. P., Lloyd, M. D., Baker, M. D., Thiyagarajan, N., Acharya, K. R. and Potter, B. V. L., 2010. Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors. Biochemistry, 49 (16), pp. 3464-3476.

Crabbe, T., Welham, M. and Ward, S., 2007. The PI3K inhibitor arsenal: choose your weapon! Trends in Biochemical Sciences, 32 (10), pp. 450-456.

Craddock, B. L., Hobbs, J., Edmead, C. E. and Welham, M. J., 2001. Phosphoinositide 3-kinase-dependent regulation of interleukin-3-induced proliferation: involvement of mitogen-activated protein kinases, SHP2 and Gab2. Journal of Biological Chemistry, 276 (26), pp. 24274-24283.

Craddock, N., Hurles, M. E., Cardin, N., Pearson, R. D., Plagnol, V., Robson, S., Vukcevic, D., Barnes, C., Conrad, D. F., Giannoulatou, E., Holmes, C., Marchini, J. L., Stirrups, K., Tobin, M. D., Wain, L. V., Yau, C., Aerts, J., Ahmad, T., Daniel Andrews, T., Arbury, H., Attwood, A., Auton, A., Ball, S. G., Balmforth, A. J., Barrett, J. C., Barroso, I., Barton, A., Bennett, A. J., Bhaskar, S., Blaszczyk, K., Bowes, J., Brand, O. J., Braund, P. S., Bredin, F., Breen, G., Brown, M. J., Bruce, I. N., Bull, J., Burren, O. S., Burton, J., Byrnes, J., Caesar, S., Clee, C. M., Coffey, A. J., Connell, J. M. C., Cooper, J. D., Dominiczak, A. F., Downes, K., Drummond, H. E., Dudakia, D., Dunham, A., Ebbs, B., Eccles, D., Edkins, S., Edwards, C., Elliot, A., Emery, P., Evans, D. M., Evans, G., Eyre, S., Farmer, A., Nicol Ferrier, I., Feuk, L., Fitzgerald, T., Flynn, E., Forbes, A., Forty, L., Franklyn, J. A., Freathy, R. M., Gibbs, P., Gilbert, P., Gokumen, O., Gordon-Smith, K., Gray, E., Green, E., Groves, C. J., Grozeva, D., Gwilliam, R., Hall, A., Hammond, N., Hardy, M., Harrison, P., Hassanali, N., Hebaishi, H., Hines, S., Hinks, A., Hitman, G. A., Hocking, L., Howard, E., Howard, P., Howson, J. M. M., Hughes, D., Hunt, S., Isaacs, J. D., Jain, M., Jewell, D. P., Johnson, T., Jolley, J. D., Jones, I. R., Jones, L. A., Kirov, G., Langford, C. F., Lango-Allen, H., Mark Lathrop, G., Lee, J., Lee, K. L., Lees, C., Lewis, K., Lindgren, C. M., Maisuria-Armer, M., Maller, J., Mansfield, J., Martin, P., Massey, D. C. O., McArdle, W. L., McGuffin, P., McLay, K. E., Mentzer, A., Mimmack, M. L., Morgan, A. E., Morris, A. P., Mowat, C., Myers, S., Newman, W., Nimmo, E. R., O’Donovan, M. C., Onipinla, A., Onyiah, I., Ovington, N. R., Owen, M. J., Palin, K., Parnell, K., Pernet, D., Perry, J. R. B., Phillips, A., Pinto, D., Prescott, N. J., Prokopenko, I., Quail, M. A., Rafelt, S., Rayner, N. W., Redon, R., Reid, D. M., Renwick, A., Ring, S. M., Robertson, N., Russell, E., St Clair, D., Sambrook, J. G., Sanderson, J. D., Schuilenburg, H., Scott, C. E., Scott, R., Seal, S., Shaw-Hawkins, S., Shields, B. M., Simmonds, M. J., Smyth, D. J., Somaskantharajah, E., Spanova, K., Steer, S., Stephens, J., Stevens, H. E., Stone, M. A., Su, Z., Symmons, D. P. M., Thompson, J. R., Thomson, W., Travers, M. E., Turnbull, C., Valsesia, A., Walker, M., Walker, N. M., Wallace, C., Warren-Perry, M., Watkins, N. A., Webster, J., Weedon, M. N., Wilson, A. G., Woodburn, M., Wordsworth, B. P., Young, A. H., Zeggini, E., Carter, N. P., Frayling, T. M., Lee, C., McVean, G., Munroe, P. B., Palotie, A., Sawcer, S. J., Scherer, S. W., Strachan, D. P., Tyler-Smith, C., Brown, M. A., Burton, P. R., Caulfield, M. J., Compston, A., Farrall, M., Gough, S. C. L., Hall, A. S., Hattersley, A. T., Hill, A. V. S., Mathew, C. G., Pembrey, M., Satsangi, J., Stratton, M. R., Worthington, J., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., Ouwehand, W. H., Parkes, M., Rahman, N., Todd, J. A., Samani, N. J. and Donnelly, P., 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464 (7289), pp. 713-722.

Cramer, H., Shaw, A., Wye, L. and Weiss, M., 2009. Over-the-counter advice seeking about complementary and alternative medicines (CAM) in community pharmacies and health shops: an ethnographic study. Health & Social Care in the Community, 18 (1), pp. 41-50.

Crane, G. J., Dora, K. A., Ings, N. T. and Garland, C. J., 2001. Potassium induced relaxation and repolarization in denuded rat isolated mesenteric arteries. Journal of Vascular Research, 38, (S1)-14.

Crane, G. J., Gallagher, N. T., Dora, K. A. and Garland, C. J., 2003. Small and intermediate calcium-dependent K + channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. The Journal of Physiology, 553, pp. 183-189.

Crane, G. J. and Garland, C. J., 2003. Inhibition of endothelium-dependent hyperpolarization in the rat isolated mesenteric artery with the thromboxane mimetic, U46619. Journal of Physiology, 547P, C109.

Crane, G. J. and Garland, C. J., 2004. Thromboxane receptor stimulation associated with loss of SK Ca activity and reduced EDHF responses in the rat isolated mesenteric artery. British Journal of Pharmacology, 142, pp. 43-50.

Crane, G. J., Walker, S. D., Dora, K. A. and Garland, C. J., 2003. Evidence for a differential cellular distribution of inward rectifier K channels in the rat isolated mesenteric artery. Journal of Vascular Research, 40 (2), pp. 159-168.

Creighton-Gutteridge, M. and Tyrrell, R. M., 2002. A novel iron chelator that does not induce HIF-1 activity. Free Radical Biology and Medicine, 33 (3), pp. 356-363.

Cresson, D., Fraley, M., Rashid, M. H., Lee, S. S. K., Gottschalk, R., Harrison, J., Wood, P. J., Brown, M. R. W. and Kornberg, A., 2007. A polyphosphate kinase 1 (ppk1) mutant of Pseudomonas aeruginosa exhibits multiple ultrastructural and functional defects. Proceedings of the National Academy of Sciences of the United States of America, 104 (9), pp. 3526-3531.

Cresswell, L., Yee, C. S., Farewell, V., Rahman, A., Teh, L. S., Griffiths, B., Bruce, I. N., Ahmad, Y., Prabu, A., Akil, M., McHugh, N. J., Toescu, V., D'Cruz, D., Khamashta, M. A., Maddison, P., Isenberg, D. A. and Gordon, C., 2009. Numerical scoring for the Classic BILAG index. Rheumatology, 48 (12), pp. 1548-1552.

Cronshaw, D. G., Kouroumalis, A., Parry, R., Webb, A., Brown, Z. and Ward, S. G., 2006. Evidence that phospholipase C-dependent, calcium-independent mechanisms are required for directional migration of T lymphocytes in response to the CCR4 ligands CCL17 and CCL22. Journal of Leukocyte Biology, 79, pp. 1369-1380.

Cronshaw, D. G., Owen, C., Brown, Z. and Ward, S. G., 2004. Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis. The Journal of Immunology, 172 (12), pp. 7761-7770.

Cuadrado, M.J., Bertolaccini, M.L., Seed, P.T., Tektonidou, M.G., Aguirre, A., Mico, L., Gordon, C., Ruiz-Irastorza, G., Egurbide, M.V., Gil, A., Espinosa, G., Houssiau, F., Rahman, A., Martin, H., Mchugh, N., Galindo, M., Akil, M., Amigo, M.C., Murru, V. and Khamashta, M.A., 2014. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis : A prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Rheumatology, 53 (2), ket313.

Cueva, J. P., Gallardo-Godoy, A., Juncosa, J. I., Vidi, P. A., Lill, M. A., Watts, V. J. and Nichols, D. E., 2011. Probing the Steric Space at the Floor of the D(1) Dopamine Receptor Orthosteric Binding Domain: 7 alpha-, 7 beta-, 8 alpha-, and 8 beta-Methyl Substituted Dihydrexidine Analogues. Journal of Medicinal Chemistry, 54 (15), pp. 5508-5521.

Cullis, P. M., Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1981. The stereochemistry of 2-substituted-2-oxo-4,5-diphenyl-1,3,2-dioxaphospholans and the related chiral [16O,17O,18O]phosphate monoesters. Journal of the Chemical Society, Chemical Communications, 5, pp. 245-246.

Cummins, J. H. and Potter, B. V. L., 1985. A simple method for the configurational analysis of a deoxynucleoside 5′- [16O,18O ,S] phosphorothioate. Journal of the Chemical Society, Chemical Communications, 1985 (13), pp. 851-853.

Cummins, J. H. and Potter, B. V. L., 1987. On the mechanism of action of bovine intestinal mucosa 5′-nucleotide phosphodiesterase : stereochemical evidence for a nucleotidyl-enzyme intermediate. European Journal of Biochemistry, 162 (1), pp. 123-128.

Cummins, J. H. and Potter, B. V. L., 1985. Stereochemical evidence for a phosphorylpyridinium intermediate in the iodine-mediated desulphurisation of a phosphorothioate diester. Journal of the Chemical Society, Chemical Communications, 1985 (12), pp. 800-802.

Cummins, J. H. and Potter, B. V. L., 1987. A general chemical method for the stereochemical analysis of nucleoside-5′ [ 16O, 18 O] phosphorothioates. Phosphorus Sulfur and Silicon and the Related Elements, 30 (3-4), pp. 589-592.

Cummins, J. H. and Potter, B. V. L., 1986. Stereochemical mechanism of the cleavage reaction catalysed by bovine intestinal mucosa 5′-nucleotide phosphodiesterase. In: Biochemical Society Transactions, 1986. Vol. 14. 6 ed. Biochemical Society, pp. 1289-1290.

Cunningham, M. O., Dhillon, A., Wood, S. J. and Jones, R. S. G., 2000. Reciprocal modulation of glutamate and gaba release may underlie the anticonvulsant effect of phenytoin. Neuroscience, 95 (2), pp. 343-351.

Cunningham, M. O. and Jones, R. S. G., 2001. Dendrotoxin sensitive potassium channels modulate GABA but not glutamate release in the rat entorhinal cortex in vitro. Neuroscience, 107 (3), pp. 395-404.

Cunningham, M. O. and Jones, R. S. G., 2000. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology, 39 (11), pp. 2139-2146.

Cunningham, M. O., Pervouchine, D. D., Racca, C., Kopell, N. J., Davies, C. H., Jones, R. S. G., Traub, R. D. and Whittington, M. A., 2006. Neuronal metabolism governs cortical network response state. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103 (14), pp. 5597-5601.

Cunningham, M. O., Woodhall, G. L. and Jones, R. S. G., 2003. Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology, 45, pp. 907-917.

Cunningham, M. O., Woodhall, G. L., Thompson, S. E., Dooley, D. J. and Jones, R. S. G., 2004. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. European Journal of Neuroscience, 20, pp. 1566-1576.

Cunningham, S. A., Else, A. J., Potter, B. V. L. and Eperon, I. C., 1991. Influences of separation and adjacent sequences on the use of alternative 5′ splice sites. Journal of Molecular Biology, 217 (2), pp. 265-281.

Cunninghame Graham, D. S., Wong, A. K., McHugh, N. J., Whittaker, J. C. and Vyse, T. J., 2006. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Human Molecular Genetics, 15 (21), pp. 3195-3205.

Curdy, C., Kalia, Y. N. and Guy, R. H., 2001. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. Journal of Pharmacy and Pharmacology, 53, pp. 769-777.

Curdy, C., Kalia, Y. N. and Guy, R. H., 2002. Post-iontophoresis recovery of human skin impedance in vivo. European Journal of Pharmaceutics and Biopharmaceutics, 53, pp. 15-21.

Curdy, C., Kalia, Y. N., Naik, A. and Guy, R. H., 2001. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. Journal of Controlled Release, 76, pp. 73-79.

Curdy, C., Naik, A., Kalia, Y. N., Alberti, I. and Guy, R. H., 2004. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. International Journal of Pharmaceutics, 271, pp. 251-256.

Curia, G., Longo, D., Biagini, G., Jones, R. S. G. and Avoli, M., 2008. The pilocarpine model of temporal lobe epilepsy. Journal of Neuroscience Methods, 172 (2), pp. 143-157.

Curnock, A. P., Logan, M. K. and Ward, S. G., 2002. Chemokine signalling: pivoting around multiple phosphinositide 3-kinases. Arthritis & Rheumatism, 105, pp. 125-136.

Curnock, A. P., Sotsios, Y., Wright, K. L. and Ward, S. G., 2003. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class 1A and 1B phosphoinositide 3-kinases. The Journal of Immunology, 170 (8), pp. 4021-4030.

Curnock, A. P. and Ward, S. G., 2003. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutrants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signalling. Journal of Immunological Methods, 273, pp. 29-41.

Cuzzocrea, S., Mazzon, E., Di Paola, R., Genovese, T., Patel, N. S. A., Muià, C., Threadgill, M. D., De Sarro, A. and Thiemermann, C., 2004. 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn-Schmiedeberg's Archives of Pharmacology, 370, pp. 464-473.

Cuzzocrea, S., McDonald, M. C., Mazzon, E., Dugo, L., Serraino, I., Threadgill, M. D., Caputi, A. P. and Thiemermann, C., 2002. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochemical Pharmacology, 63, pp. 293-304.

D

D'Hooge, F., Elfeky, S. A., Flower, S., Pascu, S. I., Jenkins, A. T. A., van den Elsen, J., James, T. and Fossey, J., 2012. Biotinylated boronic acid fluorophore conjugates: quencher elimination strategy for imaging and saccharide detection. RSC Advances, 2, pp. 3274-3280.

Da Silva, C. P., Potter, B. V. L., Mayr, G. W. and Guse, A. H., 1998. Quantification of intracellular levels of cyclic ADP-ribose by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 707 (1-2), pp. 43-50.

Dallosso, A. R., Hancock, A. L., Malik, S., Salpekar, A., King-Underwood, L., Pritchard-Jones, K., Peters, J., Moorwood, K., Ward, A., Malik, K. T. A. and Brown, K. W., 2007. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA, 13 (12), pp. 2287-2299.

Dallosso, A. R., Hancock, A. L., Szemes, M., Moorwood, K., Chilukamarri, L., Tsai, H. H., Sarkar, A., Barasch, J., Vuononvirta, R., Jones, C., Pritchard-Jones, K., Royer-Pokora, B., Lee, S. B., Owen, C., Malik, S., Feng, Y., Frank, M., Ward, A., Brown, K. W. and Malik, K., 2009. Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor. Plos Genetics, 5 (11), e1000745.

Damager, I., Buchini, S., Amaya, M. F., Buschiazzo, A., Alzari, P., Frasch, A. C., Watts, A. G. and Withers, S. G., 2008. Kinetic and mechanistic analysis of Trypanosoma cruzi trans-sialidase reveals a classical ping-pong mechanism with acid/base catalysis. Biochemistry, 47 (11), pp. 3507-3512.

Dammermann, W., Zhang, B., Nebel, M., Cordiglieric, C., Odoardi, F., Kirchberger, T., Kawakami, N., Dowden, J., Schmid, F., Dornmair, K., Hohenegger, M., Flugel, A., Guse, A. H. and Potter, B. V. L., 2009. NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist. Proceedings of the National Academy of Sciences of the United States of America, 106 (26), pp. 10678-10683.

Danoy, P., Pryce, K., Hadler, J., Bradbury, L. A., Farrar, C., Pointon, J., Ward, M., Weisman, M., Reveille, J. D., Wordsworth, B. P., Stone, M. A., Maksymowych, W. P., Rahman, P., Gladman, D., Inman, R. D. and Brown, M. A., 2010. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. Plos Genetics, 6 (12), e1001195.

Darley, D. J., Butler, D. S., Prideaux, S. J., Thornton, T. W., Wilson, A. D., Woodman, T. J., Threadgill, M. D. and Lloyd, M. D., 2009. Synthesis and use of isotope-labelled substrates for a mechanistic study on human α-methylacyl-CoA racemase 1A (AMACR; P504S). Organic and Biomolecular Chemistry, 7 (3), pp. 543-552.

Daugherty, A. L., McKee, M. L., FitzGerald, D. J. and Mrsny, R. J., 2000. Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node. Journal of Controlled Release, 65 (1-2), pp. 297-302.

Daugherty, A. L. and Mrsny, R. J., 2003. Emerging technologies that overcome biological barriers for therapeutic protein delivery. Expert Opinion on Biological Therapy, 3 (7), pp. 1071-1081.

Daugherty, A. L. and Mrsny, R. J., 2006. Formulation and delivery issues for monoclonal antibody therapeutics. Advanced Drug Delivery Reviews, 58 (5-6), pp. 686-706.

Daugherty, A. L. and Mrsny, R. J., 2010. Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection. Journal of Drug Targeting, 18 (1), pp. 27-35.

Daugherty, A. L., Rangell, L. K., Eckert, R., Zavala-Solorio, J., Peale, F. and Mrsny, R. J., 2011. Sustained release formulations of rhVEGF165 produce a durable response in a murine model of peripheral angiogenesis. European Journal of Pharmaceutics and Biopharmaceutics, 78 (2), pp. 289-297.

Davie, C. A., Feinstein, A., Kartsounis, L. D., Barker, G. J., McHugh, N. J., Walport, M. J., Ron, M. A., Moseley, I. F., McDonald, W. I. and Miller, D. H., 1995. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. The Journal of Comparative Neurology, 242 (8), pp. 522-528.

Davies, A. R. L., Hardick, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J. and Wonnacott, S., 1999. Characterisation of the binding of [3H]methyllycaconitine : a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology, 38 (5), pp. 679-690.

Davies, C. A., Blake, D. R., Winyard, P. G., Fuchs, J. and Packer, L., 2001. Radicals and inflammation: mediators and modulators. In: Environmental Stressors in Health and Disease. Marcel Dekker, pp. 17-52. (Oxidative Stress and Disease Series 7)

Davies, J. G., Brian John, M., Rees, J. and Staniforth, J., 1987. Solid Composition for Disinfecting Contact Lenses. A61L2/18-FI874192 (A), 24 September 1987.

Davies, J. G., Brian John, M. and Staniforth, J., 1988. Compositions for Treating Contact Lenses. A61L12/14-WO8808309 (A1), 03 November 1988.

Davies, J. G., Brian John, M., Rees, J. and Staniforth, J., 1990. Reinigung Und/Oder Desinfektion Von Kontaktlinsen. A61L2/18-AT57473 (T), 15 November 1990.

Dawson, H. E., Sutton, J. and Taylor, D. A., 2010. Recruitment of individuals with enduring mental health conditions for health services research. International Journal of Pharmacy Practice, 18 (Suppl 1), pp. 2-3.

Day, C. J., Price, R., Sandy, J. R. and Ireland, A. J., 2008. Inhalation of aerosols produced during the removal of fixed orthodontic appliances: A comparison of 4 enamel cleanup methods. American Journal of Orthodontics and Dentofacial Orthopedics, 133 (1).

Day, J. M., Foster, P. A., Tutill, H. J., Newman, S. P., Ho, Y. T., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2009. BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. British Journal of Cancer, 100 (3), pp. 476-486.

Day, J.M., Foster, P.A., Tutill, H.J., Schmidlin, F., Sharland, C.M., Hargrave, J.D., Vicker, N., Potter, B.V.L., Reed, M.J. and Purohit, A., 2013. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model. Endocrine-Related Cancer, 20 (1), pp. 53-64.

Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. International Journal of Cancer, 122 (9), pp. 1931-1940.

Day, J. M., Newman, S. P., Comninos, A., Solomon, C., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells. Steroid Biochemistry & Molecular Biology, 84 (2-3), pp. 317-325.

Day, J. M., Purohit, A., Tutill, H. J., Foster, P. A., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2009. The development of steroid sulfatase iInhibitors for hormone-dependent cancer therapy. In: Bradlow, H. L. and Carruba, G., eds. Steroid Enzymes and Cancer. Vol. 1155. Blackwell Publishing, pp. 80-87. (Annals of the New York Academy of Sciences)

Day, J. M., Tutill, H. J., Foster, P. A., Bailey, H. V., Heaton, W. B., Sharland, C. M., Vicker, N., Potter, B. V. L., Purohit, A. and Reed, M. J., 2009. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17β-hydroxysteroid dehydrogenase Type 3. Molecular and Cellular Endocrinology, 301 (1-2), pp. 251-258.

Day, J. M., Tutill, H. J., Newman, S. P., Purohit, A., Lawrence, H. R., Vicker, N., Potter, B. V. L. and Reed, M. J., 2006. 17β-hydroxysteroid dehydrogenase type 1 and type 2 : association between mRNA expression and activity in cell lines. Molecular and Cellular Endocrinology, 248 (1), pp. 246-249.

De Bank, P. A., Hou, Q., Warner, R. M., Wood, I. V., Ali, B. E., MacNeil, S., Kendall, D. A., Kellam, B., Makesheff, K. M. and Buttery, L. D. K., 2007. Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking. Biotechnology and Bioengineering, 97 (6), pp. 1617-1625.

De Bank, P. A., Kellam, B., Kendall, D. A. and Shakesheff, K. M., 2005. Altered cellular response to adsorbed matrix protein by chemoselective ligation of small molecules. Journal of Materials Chemistry, 15, pp. 2047-2055.

De Bank, P. A., Kellam, B., Kendall, D. A. and Shakesheff, K. M., 2003. Surface engineering of living myoblasts via selective periodate oxidation. Biotechnology and Bioengineering, 81 (7), pp. 800-808.

De Bank, P. A., Kendall, D. A. and Alexander, S. P. H., 2005. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. Biochemical Pharmacology, 69, pp. 1187-1193.

De Bank, P., Jones, M. and Ellis, M., 2009. Polymeric scaffolds for regenerative medicine. In: Mattiasson, B., Kumar, A. and Galaev, I. Y., eds. Macroporous Polymers: Production Properties and Biotechnological/Biomedical Applications. CRC Press, pp. 467-495.

De Kort, M., Correa, V., Valentijn, A. R. P. M., Van Der Marel, G. A., Potter, B. V. L., Taylor, C. W. and Van Boom, J. H., 2000. Synthesis of potent agonists of the D-myo -inositol 1,4,5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin A. Journal of Medicinal Chemistry, 43 (17), pp. 3295-3303.

DeLisle, S., Pittet, D., Potter, B. V. L., Lew, P. D. and Welsh, M. J., 1992. InsP3 and Ins(1,3,4,5)P4 act in synergy to stimulate influx of extracellular Ca2+ in Xenopus oocytes. American Journal of Physiology - Cell Physiology, 262 (6), C1456-C1463.

DeLisle, S., Krause, K.-H., Denning, G., Potter, B. V. L. and Welsh, M. J., 1990. Effect of inositol trisphosphate and calcium on oscillating elevations of intracellular calcium in Xenopus oocytes. Journal of Biological Chemistry, 265 (20), pp. 11726-11730.

DeLisle, S., Marksberry, E. W., Bonnett, C., Jenkins, D. J., Potter, B. V. L., Takahashi, M. and Tanzawa, K., 1997. Adenophostin A can stimulate Ca2+ influx without depleting the inositol 1,4,5-trisphosphate-sensitive Ca2+ stores in the Xenopus oocyte. Journal of Biological Chemistry, 272 (15), pp. 9956-9961.

Deave, T., Weiss, M. C. and Salisbury, C., 2003. Patient group directions for antibiotic supply in Walk-in Centres: how legal are they? British Journal of Community Nursing, 8 (5), pp. 209-213.

Delcros, J. G., Tomasi, S., Carrington, S., Martin, B., Renault, J., Blagbrough, I. S. and Uriac, P., 2002. Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. Journal of Medicinal Chemistry, 45 (23), pp. 5098-5111.

Delgado-Charro, M. B. and Guy, R. H., 2003. Iontophoresis: applications in drug delivery and noninvasive monitoring. In: Guy, R. H. and Hadgraft, J., eds. Transdermal Drug Delivery Systems, 2nd ed. Vol. 2nd Edition, Revised and Expanded. New York: Marcel Dekker, pp. 199-225.

Delgado-Charro, M. B. and Guy, R. H., 2001. Transdermal drug delivery. In: Hillery, A. M., Lloyd, A. W. and Swarbrick, J., eds. Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. London: Harwood Academic Publishers, pp. 207-236.

Delgado-Charro, M. B. and Guy, R. H., 2001. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. STP Pharma Sciences, 11 (6), pp. 404-414.

Delgado-Charro, M. B. and Guy, R. H., 2003. Transdermal reverse iontophoresis of valproate: a non-invasive method for therapeutic drug monitoring. Pharmaceutical Research, 20 (9), pp. 1508-1513.

Delgado-Charro, M. B., 2012. Iontophoretic drug delivery across the nail. Expert Opinion on Drug Delivery, 9 (1), pp. 91-103.

Delgado-Charro, M. B., 2011. Sampling substrates by skin permeabilization. In: Murthy, S. N., ed. Dermatokinetics of Therapeutic Agents. Boca Raton: Taylor and Francis, pp. 149-174.

Delgado-Charro, M. B., 2013. Forthcoming. Guy et al.; 'crackling' the skin code. Skin Pharmacology and Physiology

Delgado-Charro, M. B. and Guy, R. H., 2013. Forthcoming. Effective use of transdermal drug delivery in children. Advanced Drug Delivery Reviews

Delgado-Charro, M. B., 2009. Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling. Journal of Drug Delivery Science and Technology, 19 (2), pp. 75-88.

Della Rossa, A., Valentini, G., Bombardieri, S., Bencivelli, W., Silman, A. J., D'Angelo, S., Cerinic, M. M., Belch, J. F., Black, C. M., Becvar, R., Bruhlman, P., Cozzi, F., Czirják, L., Drosos, A. A., Dziankowska, B., Gabrielli, A., Giacomelli, R., Hayem, G., Inanc, M., McHugh, N. J., Nielsen, H., Scorza, R., Tirri, E., van den Hoogen, F. H., Vlachoyiannopoulos, P. G. and C, F., 2001. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Annals of the Rheumatic Diseases, 60 (6), pp. 585-591.

Dhami, A., 2009. Approaches to new DNA-repair inhibitors for applications in cancer therapy. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Dhami, A., Mahon, M. F., Lloyd, M. D. and Threadgill, M. D., 2009. 4-Substituted 5-nitroisoquinolin-1-ones from intramolecular Pd-catalysed reaction of N-(2-alkenyl)-2-halo-3-nitrobenzamides. Tetrahedron, 65 (24), pp. 4751-4765.

Dhillon, A. and Jones, R. S. G., 2000. Laminar differences in recurrent excitatory transmission in the rat entorhinal cortex in vitro. Neuroscience, 99 (3), pp. 413-422.

Dhillon, A. S., 2010. Engineering of combination particles for improved therapeutic efficacy. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Di Paola, R., Genovese, T., Caputi, A. P., Threadgill, M. D., Thiemermann, C. and Cuzzocrea, S., 2004. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion. European Journal of Pharmacology, 492, pp. 203-210.

Dias, M., Naik, A., Guy, R. H., Hadgraft, J. and Lane, M. E., 2008. In vivo infrared spectroscopy studies of alkanol effects on human skin. European Journal of Pharmaceutics and Biopharmaceutics, 69 (3), pp. 1171-1175.

Diaz del Consuelo, I., Falson, F., Guy, R. H. and Jacques, Y., 2007. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. Journal of Controlled Release, 122 (2), pp. 135-140.

Diaz del Consuelo, I., Falson, F., Guy, R. H. and Jacques, Y., 2005. Transport of fentanyl through pig buccal and esophageal epithelia in vitro . Influence of concentration and vehicle pH. Pharmaceutical Research, 22 (9), pp. 1525-1529.

Diaz del Consuelo, I., Pizzolato, G. P., Falson, F., Guy, R. H. and Jacques, Y., 2005. Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue. Journal of Pharmaceutical Sciences, 94 (12), pp. 2677-2688.

Diaz del Consuelo, I., Pizzolato, G. P., Jacques, Y., Guy, R. H. and Falson, F., 2005. Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Archives of Oral Biology, 50, pp. 981-987.

Dick, G. M., Rossow, C. F., Smirnov, S. V., Horowitz, B. and Sanders, K. M., 2001. Tamoxifen activates smooth muscle BK channels through the regulatory β1 subunit. Journal of Biological Chemistry, 276 (37), pp. 34594-34599.

Dieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S260.

Dieleman, J., Romio, S., De Vries, C., Sammon, C., Andrews, N., Hviid, A., Svanström, H., Mølgaard-Nielsen, D., Lapeyre-Mestre, M., Sommet, A., Saussier, C., Castot, A., Heijbel, H., Arnheim Dahlström, L., Hallgren, J., Sparen, P., Mosseveld, M., Schuemie, M., van der Maas, N., Jacobs, B. C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M. C., 2011. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ, 343, d3908.

Dieleman, J. P., Romio, S. S., De Vries, C. S., Sammon, C. J., Andrews, N., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Lapeyre-Mestre, M., Sommet, A., Saussier, C., Castot, A., Heijbel, H., Dahlstrom, L. A., Hallgren, J., Sparen, P., Mosseveld, M., Schuemie, M., van der Maas, N., Jacobs, B. C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines - A Multinational Case Control Study in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S258-S259.

Ding, Z., Rossi, A. M., Riley, A. M., Rahman, T., Potter, B. V. L. and Taylor, C. W., 2010. Binding of inositol 1,4,5-trisphosphate (IP3) and adenophostin A to the N-terminal region of the (IP3) receptor : thermodynamic analysis using fluorescence polarization with a novel (IP3) receptor ligand. Molecular Pharmacology, 77 (6), pp. 995-1004.

Dixon, M., Nathubhai, A., Andersen, O., van Aalten, D. and Eggleston, I. M., 2008. Synthesis of cyclic peptide chitinase inhibitors : Natural products,with chemotherapeutic potential. Journal of Peptide Science, 14 (8 (Suppl S)), p. 13.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2005. An efficient synthesis of argifin: a natural product chitinase inhibitor with chemotherapeutic potential. Bioorganic & Medicinal Chemistry Letters, 15 (21), pp. 4717-4721.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2006. First synthesis of argadin: A nanomolar inhibitor of family-18 chitinases. European Journal of Organic Chemistry, 22, pp. 5002-5006.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. SPPS of the natural product chitinase inhibitor argifin: library generation and biological evaluation. In: Del Valle, S., Escher, E. and Lubell, W. D., eds. Peptides for Youth. Vol. 611. New York: Springer, pp. 143-144. (Advances in Experimental Medicine and Biology)

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F., Nathubhai, A. and Eggleston, I. M., 2007. Cyclic peptide chitinase inhibitors: new leads for antifungal and anti-inflammatory drugs. Biopolymers, 88, p. 576.

Dixon, M. J., Bourre, L., MacRobert, A. J. and Eggleston, I. M., 2007. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid. Bioorganic & Medicinal Chemistry Letters, 17 (16), pp. 4518-4522.

Dixon, M. J., Nathubhai, A., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold. Organic and Biomolecular Chemistry, 7 (2), pp. 259-268.

Dixon, M. J., Nathubhai, A., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. Synthesis and Structure-based Dissection of Cyclic Peptide Chitinase Inhibitors: New Leads for Antifungal and Anti-inflammatory Drugs. In: DelValle, S., Escher, E. and Lubell, W. D., eds. Peptides for Youth - The Proceedings of the 20th American Peptide Symposium. Springer, pp. 525-526. (Advances in Experimental Medicine and Biology)

Dixon, M., Giuntini, F., Nathubhai, A., Andersen, O., van Aalten, D. and Eggleston, I., 2008. Synthetic approaches to cyclic peptide natural products as chitinase inhibitors. Journal of Peptide Science, 14 (8), p. 55.

Dixon, N. C., Hurst, T. L., Talbot, D. C. S., Tyrrell, R. M. and Thompson, D., 2009. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. Journal of Applied Physiology, 107 (1), pp. 63-68.

Dixon, N. C., Hurst, T. L., Talbot, D. C.s., Tyrrell, R. M. and Thompson, D., 2013. Effect of short-term reduced physical activity on cardiovascular risk factors in active lean and overweight middle-aged men. Metabolism, 62 (3), pp. 361-368.

Djabri, A., Guy, R. H. and Delgado-Charro, M. B., 2007. Transdermal reverse lontophoresis of lohexol as a tool for minimally-invasive monitoring of renal function. Therapeutic Drug Monitoring, 29 (4), pp. 532-533.

Djabri, A., 2009. Iontophoresis in paediatric medicine: Non-invasive delivery and monitoring applications. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Djabri, A., Guy, R. H. and Delgado-Charro, M. B., 2012. Transdermal iontophoresis of ranitidine: An opportunity in paediatric drug therapy. International Journal of Pharmaceutics, 435 (1), pp. 27-32.

Djabri, A., Guy, R. H. and Delgado-Charro, M. B., 2012. Passive and iontophoretic transdermal delivery of phenobarbital: implications in paediatric therapy. International Journal of Pharmaceutics, 435 (1), pp. 76-82.

Dobbin, E., Corrigan, P. M., Walsh, C. P., Welham, M. J., Freeburn, R. W. and Wheadon, H., 2008. Tel/PDGFR beta inhibits self-renewal and directs myelomonocytic differentiation of ES cells. Leukemia Research, 32 (10), pp. 1554-1564.

Dodd, C.N., Romio, S.A., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Crawford, N., Deceuninck, G., de Vries, C., De Wals, P., Gutierrez-Gimeno, M.V., Heijbel, H., Hughes, H., Hur, K., Hviid, A., Kelman, J., Kilpi, T., Chuang, S.K., Macartney, K., Rett, M., Lopez-Callada, V.R., Salmon, D., Gimenez Sanchez, F., Sanz, N., Silverman, B., Storsaeter, J., Thirugnanam, U., van der Maas, N., Yih, K., Zhang, T. and Izurieta, H., 2013. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31 (40), pp. 4448-4458.

Dohle, W., Leese, M. P., Jourdan, F. L., Major, M. R., Bai, R., Hamel, E., Ferrandis, E., Kasprzyk, P. G., Fiore, A., Newman, S. P., Purohit, A. and Potter, B. V. L., 2014. Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1-Substituted Tetrahydroisoquinolines. ChemMedChem, 9 (2), pp. 350-370.

Doisy, X., Blagbrough, I. S., Thomas, N. F. and Potter, B. V. L., 1998. Studies on the substituted 3-aminopropan-1-ol motif of lycoctonine class norditerpenoid alkaloids: A novel route to 3-hydroxymethylcyclohex-2-enone. Tetrahedron Letters, 39 (46), pp. 8525-8528.

Doisy, X., Blagbrough, I. S., Wonnacott, S. and Potter, B. V. L., 1998. Design, synthesis and biological evaluation of substituted benzoate analogues of the selective nicotinic acetylcholine receptor antagonist, methyllycaconitine. Pharmacy and Pharmacology Communications, 4 (7), pp. 313-317.

Dokoumetzidis, A., Kalantzi, L. and Fotaki, N., 2007. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opinion Drug Metabolism and Toxicology, 3 (4), pp. 491-505.

Dora, K. A., 2001. Cell-cell communication in the vessel wall. Vascular Medicine, 6, pp. 43-50.

Dora, K. A., 2005. Does arterial myogenic tone determine blood flow distribution in vivo? American Journal of Physiology-Heart and Circulatory Physiology, 289, H1323-H1325.

Dora, K. A., 2001. Intercellular calcium signalling: the artery wall. Cell & Developmental Biology, 12, pp. 27-35.

Dora, K. A., Gallagher, N. T., McNeish, A. and Garland, C. J., 2008. Modulation of endothelial cell K(Ca)3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circulation Research, 102 (10), pp. 1247-1255.

Dora, K. A. and Garland, C. J., 2001. Properties of smooth muscle hyperpolarization and relaxation to K + in the rat isolated mesenteric artery. American Journal of Physiology-Heart and Circulatory Physiology, 280, H2424-H2429.

Dora, K. A. and Garland, C. J., 2001. Properties of smooth muscle hyperpolarization and relaxation to potassium in the rat isolated mesenteric artery. Journal of Vascular Research, 38 ((S1)), P20.

Dora, K. A., Garland, C. J., Kwan, H. Y. and Yao, X., 2001. Endothelial cell protein kinase G inhibits release of EDHF through a PKG-sensitive cation channel. American Journal of Physiology-Heart and Circulatory Physiology, 280, H1272-H1277.

Dora, K. A., Garland, C. J. and Vanhoutte, P. M., 2001. Evidence for relaxation to endothelium-derived hyperpolarizing factor (EDHF) in isolated small mesenteric arteries of the mouse. In: EDHF 2000. London: Taylor & Francis, pp. 270-273.

Dora, K. A., Ings, N. T. and Garland, C. J., 2002. K Ca channel blockers reveal hyperpolarization and relaxation to K + in rat isolated mesenteric artery. American Journal of Physiology-Heart and Circulatory Physiology, 283, H606-H614.

Dora, K. A., Ings, N. T. and Garland, C. J., 2002. Modulation of responses to exogenous potassium by potassium channel activity in the rat isolated mesenteric artery. British Journal of Pharmacology, 135, 26P.

Dora, K. A., McEvoy, L., King, M., Ings, N. T., Garland, C. J. and Vanhoutte, P. M., 2003. The intensity of agonist-stimulation influences the mechanism for relaxation in the rat mesenteric artery. In: EDHF. Vol. 2002. London: Taylor & Francis, pp. 256-260.

Dora, K. A., Sandow, S. L., Gallagher, N. T., Takano, H., Rummery, N. M., Hill, C. E. and Garland, C. J., 2003. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. Journal of Vascular Research, 40, p. 480.

Dora, K. A., Sandow, S. L., Ings, N. T., Takano, H., Hill, C. E. and Garland, C. J., 2002. Myoendothelial gap junctions provide a pathway for EDHF in the mesenteric artery of the mouse. British Journal of Pharmacology, 135, 121P.

Dora, K. A., Takano, H., Spitaler, M. M., McSherry, I. N. and Garland, C. J., 2004. Role of endothelial cell K + channels in spreading dilatation. FASEB Journal, Abstract 437, p. 1.

Dora, K. A., Walker, S. D., Garland, C. J. and Vanhoutte, P. M., 2001. A central role for endothelial cell potassium channels in EDHF-mediated responses. In: EDHF 2000. London: Taylor & Francis, pp. 118-125.

Dora, K. A., Xia, J. and Duling, B. R., 2003. Endothelial cell signaling during conducted vasomotor responses. American Journal of Physiology-Heart and Circulatory Physiology, 285, H119-H126.

Dorenbos, R., Stein, T., Kabel, J., Bruand, C., Bolhuis, A., Bron, S., Quax, W. J. and van Dijl, J. M., 2002. Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. Journal of Biological Chemistry, 277 (19), pp. 16682-16888.

Dove, M.T., Calleja, M., Bruin, R., Wakelin, J., Tucker, M.G., Lewis, G.J., Hasan, S.M., Alexandrov, V.N., Keegan, M., Ballard, S., Tyer, R.P., Todorov, I., Wilson, P.B., Alfredsson, M., Price, G.D., Chapman, C., Emmerich, W., Wells, S.A., Marmier, A., Parker, S.C. and Du, Z., 2005. The eMinerals collaboratory : Tools and experience. Molecular Simulation, 31 (5), pp. 329-337.

Dowden, J. and Savovic, J., 2001. Olefin metathesis in non-degassed solvent using a recyclable, polymer supported alkylideneruthenium. Chemical Communications, 1, pp. 37-38.

Dowden, J. and Ward, S. G., 2001. Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation. Expert Opinion on Therapeutic Patents, 11 (2), pp. 295-306.

Dowden, J., Berridge, G., Moreau, C., Yamasaki, M., Churchill, G. C., Potter, B. V. L. and Galione, A., 2006. Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release. Chemistry & Biology, 13 (6), pp. 659-665.

Dowden, J., Brown, R. S., Moreau, C., Galione, A. and Potter, B. V. L., 2005. Chemical synthesis of the novel Ca 2+ messenger NAADP. Nucleosides, Nucleotides and Nucleic Acids, 24 ((5-7)), pp. 513-518.

Dowden, J., Hong, W., Parry, R. V., Pike, R. A. and Ward, S. G., 2010. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases. Bioorganic & Medicinal Chemistry Letters, 20 (7), pp. 2103-2105.

Dowden, J., Moreau, C., Brown, R. S., Berridge, G., Galione, A. and Potter, B. V. L., 2004. Chemical synthesis of the second messenger nicotinic acid adenine dinucleotide phosphate by total synthesis of nicotinamide adenine dinucleotide phosphate. Angewandte Chemie-International Edition, 43 (35), 4637 -4640.

Dowden, J., Pike, R. A., Parry, R. V., Hong, W., Muhsen, U. A. and Ward, S. G., 2011. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1. Organic and Biomolecular Chemistry, 9 (22), pp. 7814-7821.

Dowden, J. and Welham, M., 2007. Reagents and Methods for Cross-Linking Biological Molecules. C07D207/46-WO2007113575 (A2), 11 October 2007.

Drago, C., Caggiano, L. and Jackson, R. F. W., 2005. Vanadium-catalyzed sulfur oxidation/kinetic resolution in the synthesis of enantiomerically pure alkyl aryl sulfoxides. Angewandte Chemie-International Edition, 44, pp. 7221-7223.

Drago, C., Walker, E. J., Caggiano, L. and Jackson, R. F. W., 2009. Enantioselective oxidation of an alkyl aryl sulfide : Synthesis of (S)-(-)-methyl p-Bromophenyl sulfoxide. Organic Syntheses, 86, pp. 121-129.

Drew, C. J. G., O'Reilly, K. C., Lane, M. A. and Bailey, S. J., 2011. Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience, 172, pp. 66-73.

Dubus, A., Lloyd, M. D., Lee, H. J., Schofield, C. J., Baldwin, J. E. and Frere, J. M., 2001. Probing the penicillin sidechain selectivity of recombinant deacetoxycephalosporin C synthase. Cellular and Molecular Life Sciences (CMLS), 58, pp. 835-843.

Dujardin, N., Staes, E., Kalia, Y. N., Clarys, P., Guy, R. H. and Préat, V., 2002. In vivo assessment of skin electroporation using square wave pulses. Journal of Controlled Release, 79, pp. 219-227.

Duken, P., Lammers, A. A., Ozaki, S., Potter, B. V. L., Erneux, C. and Van Haastert, P. J. M., 1994. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase. European Journal of Biochemistry, 226 (2), pp. 561-566.

Duncan, L., Purohit, A., Howarth, N. M., Potter, B. V. L. and Reed, M. J., 1993. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate : a potential therapeutic agent in breast cancer. Cancer Research, 53, pp. 298-303.

Dunphy, J., Oliver, M., Rands, A. L., Lovell, C. R. and McHugh, N. J., 2000. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. British Journal of Dermatology, 142 (3), pp. 461-467.

Dutet, J. and Delgado-Charro, M. B., 2009. In vivo transungual iontophoresis: effect of DC current application on ionic transport and on transonychial water loss. Journal of Controlled Release, 140 (2), pp. 117-125.

Dutet, J. and Delgado-Charro, M.B., 2012. Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy. Pharmaceutical Research, 29 (12), pp. 3464-3474.

Dutet, J., 2009. Iontophoretic drug delivery to the nail. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Dutet, J. and Delgado-Charro, M. B., 2010. Electroosmotic transport of mannitol across human nail during constant current iontophoresis. Journal of Pharmacy and Pharmacology, 62 (6), pp. 721-729.

Dutet, J. and Delgado-Charro, M. B., 2010. Transungual iontophoresis of lithium and sodium: effect of pH and co-ion competition on cationic transport numbers. Journal of Controlled Release, 144 (2), pp. 168-174.

de Boer, A. H., Chan, H. K. and Price, R., 2012. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Advanced Drug Delivery Reviews, 64 (3), pp. 257-274.

de Jong-van den Berg, L. T. W., Egberts, A. C. G. and de Vries, C. S., 2001. Langs de valkuilen (5) Onderzoeksopzetten en risicomaten [Study design and risk estimates]. Pharmaceutisch Weekblad, 136 (34), pp. 1280-1283.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Farmaco-epidemiologie Langs de valkuilen (2) Methoden en meetsystemen. Pharmaceutisch Weekblad, 136 (28), pp. 1023-1025.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Farmaco-epidemiologie Langs de valkuilen (7) Statistisch verband en causaliteit. Pharmaceutisch Weekblad, 136 (39), pp. 1468-1470.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Langs de valkuilen (1) De associatie van blootstelling en uitkomst. Pharmaceutisch Weekblad, 136 (26), pp. 944-947.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Pregnancy and breatfeeding mothers. In: Taylor, K. and Harding, G., eds. Pharmacy Practice. London: Taylor & Francis, pp. 301-312.

de Jong-van den Berg, L. T. W., de Vries, C. S., Brouwers, J. J. M. and Veehof, L. J. G., 2001. Zwangerschap en geneesmiddelen [Pregnancy and medicines]. Huisarts en Wetenschap, 44 (5), pp. 198-203.

de Vries, C., Bromley, S. and Farmer, R., 2006. Myocardial infarction risk and hormone replacement: Differences between products. Maturitas, 53 (3), pp. 343-350.

de Vries, C., Nightingale, A. and Farmer, R., 2008. Epidemiology of systemic lupus erythematosus in the United Kingdom: Comment on the article by Somers et al. Arthritis & Rheumatism, 59 (2), p. 297.

de Vries, C. S., 2002. Cox II inhibitors versus non-steroidal anti-inflammatory drugs in rheumatoid and osteoarthritis patients: gastrointestinal effects. In: Foxcroft, D. R. and Muthu, V., eds. STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 2(8). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., 2000. Dokterende folklore [Doctoring folklore]. Pharmaceutisch Weekblad, 135 (20), p. 705.

de Vries, C. S., 2001. Effects of TNF-alpha antagonists in people with rheumatoid arthritis. In: Foxcroft, D. R. and Muthu, V., eds. STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 1(19). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., 2004. MMR scare. The Independent, 27 Feb 2004.

de Vries, C. S. and , B. L., 2003. Cochlear implants in adults. In: STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 3(10). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., Bromley, S. E., Thomas, H. and Farmer, R. D. T., 2005. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Safety, 28 (3), pp. 241-249.

de Vries, C. S., Herrings, R. M. C. and de Jong-van den Berg, L. T. W., 2001. Langs de valkuilen (4) Informatiebronnen voor farmacoepidemiologisch onderzoek. [Information sources for pharmacoepidemiology research]. Pharmaceutisch Weekblad, 136 (32), pp. 1190-1193.

de Vries, C. S. and Russell-Jones, D. L., 2009. Rosiglitazone or pioglitazone in type 2 diabetes? British Medical Journal, 339, b3076.

de Vries, C. S., Snowball, J., Russell-Jones, D. and Hutchison, A., 2008. Stillbirth and early neonatal death risk is reduced in those using analogue compared with those using human insulin. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), 034.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Farmaco-epidemiologie Langs de valkuilen (6) Fouten en vertekening in farmacoepidemiologisch onderzoek [Bias and confounding in pharmacoepidemiology research]. Pharmaceutisch Weekblad, 136 (37), pp. 1391-1393.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2003. Langs de valkuilen (13) De begrippen 'inceptie cohort', stratification, en causaliteit [Principles of inception cohorts, stratification, and causality]. Pharmaceutisch Weekblad, 138 (13), pp. 461-464.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2003. Langs de valkuilen (14): Experiment versus observatie [experiment versus observation]. Pharmaceutisch Weekblad, 138 (21), p. 753.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Langs de valkuilen (9) Handleiding kritisch lezen [A guide to critical appraisal]. Pharmaceutisch Weekblad, 136 (43), pp. 1614-1616.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Pharmacovigilance and pharmacoepidemiology. In: Taylor, K. and Harding, G., eds. Pharmacy Practice. London: Taylor & Francis, pp. 367-392.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2004. Spontane rapportage en farmacoepidemiologie [spontaneous reporting and pharmacoepidemiology]. In: Buurma, H., de Jong-van den Berg, L. T. W. and Leufkens, H. G. M., eds. Het Geneesmiddel, 4th ed. Maarssen: Elsevier.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2008. Spontane rapportage en farmacoepidemiologie [spontaneous reporting and pharmacoepidemiology]. In: Buurma, H., de Jong-van den Berg, L. T. W. and Leufkens, H. G. M., eds. Het Geneesmiddel, 5th ed. Maarssen: Elsevier.

de Vries, C. S., van Groontheest, A. C. and de Jong-van den Berg, L. T. W., 2001. Farmaco-epidimiologie Langs de valkuilen (3) Spontane meldingen. Pharmaceutisch Weekblad, 136 (30), pp. 1104-1106.

de Vries, F., de Vries, C. S., Cooper, C., Leufkens, B. and van Staa, T. -P., 2006. Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. International Journal of Epidemiology, 35 (5), pp. 1301-1308.

de Wit, M., Campbell, W., FitzGerald, O., Gladman, D. D., Helliwell, P. S., James, J., Lindsay, C., MacDonald, R., McHugh, N. J., Mease, P. J., Orbai, A.-M., Palominos, P., Parkinson, A., Tillett, W. and Goel, N., 2014. Patient Participation in Psoriasis and Psoriatic Arthritis Outcome Research : A Report from the GRAPPA 2013 Annual Meeting. The Journal of Rheumatology, 41 (6), pp. 1206-11.

E

Edge, S., Belu, A. M., Potter, U. J., Steele, D. F., Young, P. M., Price, R. and Staniforth, J. N., 2002. Chemical characterisation of sodium starch glycolate particles. International Journal of Pharmaceutics, 240, pp. 67-78.

Edge, S., Steele, D. F., Tobyn, M. J., Staniforth, J. N. and Chen, A., 2001. Directional bonding in compacted microcrystalline cellulose. Drug Development and Industrial Pharmacy, 27 (7), pp. 613-621.

Edginton, A. M. and Fotaki, N., 2010. Oral drug absorption in pediatric populations. In: Dressman, J. B. and Reppas, C., eds. Oral Drug Absorption: Prediction and Assessment, 2nd Edition. Vol. 193. New York: Informa Healthcare, pp. 108-126. (Drugs and the Pharmaceutical Sciences)

Edmead, C. E., Fox, B. C., Stace, C., Ktistakis, N. and Welham, M. J., 2006. The pleckstrin homology domain of Gab-2 is required for optimal interleukin-3 signalsome-mediated responses. Cellular Signalling, 18 (8), pp. 1147-1155.

Edmonds, S., Turnbull, C. and Blake, D. R., 2001. Effect of intensive exercise on patients with active RA. Annals of the Rheumatic Diseases, 60 (4), p. 429.

Edwards, H. J., Hargrave, J. D., Penrose, S. D. and Frost, C. G., 2010. Synthetic applications of rhodium catalysed conjugate addition. Chemical Society Reviews, 39 (6), pp. 2093-2105.

Edwards, T., Thomas, R. D. and McHugh, N. J., 1993. Anticardiolipin antibodies in ischaemic heart disease. Lancet, 342 (8877), p. 989.

Eilers, H., Cattaruzza, F., Nassini, R., Materazzi, S., Andre, E., Chu, C., Cottrell, G. S., Schumacher, M., Geppetti, P. and Bunnett, N. W., 2010. Pungent General Anesthetics Activate Transient Receptor Potential-A1 to Produce Hyperalgesia and Neurogenic Bronchoconstriction. Anesthesiology, 112 (6), pp. 1452-1463.

El Ouaaliti, M., Moore, S. F. and Mackenzie, A. B., 2010. The role of protein kinase C and phosphoinositide 3-kinase in P2X7 receptor-mediated oxidation and IL-1beta processing. Purinergic Signalling, 6 (1), p. 49.

El-Awady, E. S. E., Moss, S., Mottram, D. and O'Donnell, J., 2006. Student perspectives on pharmacy curriculum and instruction in Egyptian schools. American Journal of Pharmaceutical Education, 70 (1).

El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2008. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. British Journal of Pharmacology, 155 (8), pp. 1164-1173.

El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2008. Lipopolysaccharide-induced vascular hypocontractility to endothelin-1 in rats is dependent on non-voltage-gated calcium channels but not on calcium sensitization. Fundamental & Clinical Pharmacology, 22 (Suppl 2), p. 74.

El-Awady, M., 2008. Molecular pharmacology of altered cardiopulmonary function in inflammation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

El-Awady, M. S., Smirnov, S. V. and Watson, M. L., 2006. Mechanisms of LPS-induced changes in vascular reactivity to endothelin 1 in rat aortic and pulmonary vessels. pA2Online, 4 (2), 020P.

El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2009. Voltage-independent calcium channels mediate lipopolysaccharide-induced hyporeactivity to endothelin-1 in the rat aorta. American Journal of Physiology-Heart and Circulatory Physiology, 296 (5), H1408-H1415.

El-Bassossy, H., El-Maraghi, N., El-Fayomi, H. and Watson, M. L., 2006. Heme oxygenase-1 protects against tumour necrosis factor-? and interleukin-1? induced hyporesponsiveness to ach in the rat pulmonary artery. In: British Pharmacological Society 75th Anniversery Meeting, 2006-12-01, Oxford.

El-Bassossy, H. M., El-Fawal, R., Fahmy, A. and Watson, M. L., 2013. Arginase inhibition alleviates hypertension in the metabolic syndrome. British Journal of Pharmacology, 169 (3), pp. 693-703.

El-Bassossy, H. M., El-Maraghy, N. N., El-Fayoumi, H. M. and Watson, M. L., 2009. Haem oxygenase-1 induction protects against tumour necrosis factor α impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. British Journal of Pharmacology, 158 (6), pp. 1527-1535.

El-Hamamsy, M. H. R. I., Smith, A. W., Thompson, A. S. and Threadgill, M. D., 2007. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis. Bioorganic and Medicinal Chemistry, 15 (13), pp. 4552-4576.

El-Sabawi, D., Edge, S., Price, R. and Young, P. M., 2006. Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: Surface smoothing effects. Drug Development and Industrial Pharmacy, 32 Nov-Dec (10), pp. 1135-1138.

El-Sabawi, D., Price, R., Edge, S. and Young, P. M., 2006. Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Development and Industrial Pharmacy, 32 (2), pp. 243-251.

El-Wakeel, H., Taylor, G. J. and Tate, J. J. T., 2007. What do patients really want to know in an informed consent procedure? A questionnaire-based survey of patients in the Bath area. Journal of Medical Ethics, 32, pp. 612-616.

Elhissi, A. M. A., O'Neill, M. A. A., Roberts, S. A. and Taylor, K. M. G., 2006. A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. International Journal of Pharmaceutics, 320, pp. 124-130.

Elmasry, M. S., Blagbrough, I. S., Rowan, M. G., Saleh, H. M., Kheir, A. A. and Rogers, P. J., 2011. Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines. Journal of Pharmaceutical and Biomedical Analysis, 54 (4), pp. 646-652.

Elmasry, M. S., Saleh, H. M., Kheir, A. A., Blagbrough, I. and Rogers, P. J., 2009. Quantitative HPLC analysis of mebeverine HCI and other GIT medicines stored in a monitored dosage system for polypharmacy. International Journal of Pharmacy Practice, 17 (Supplement 1), A111-A112.

Engstrom, W., Ward, A. and Moorwood, K., 2010. The role of scaffold proteins in JNK signalling. Cell Proliferation, 43 (1), pp. 56-66.

Essapen, S., Thomas, H., Green, M., de Vries, C. S., Cook, M., Marks, C., Topham, C. and Modjtahedi, H., 2004. The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters. International Journal of Oncology, 24 (2), pp. 241-248.

Evans, D. I., Jones, R. S. G. and Woodhall, G. L., 2001. Differential actions of PKA and PKC in the regulation of glutamate release by group III mGluRs in the entorhinal cortex. Journal of Neurophysiology, 85 (2), 571 -579.

Evans, D. I., Jones, R. S. G. and Woodhall, G., 2000. Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex. Journal of Neurophysiology, 83 (5), pp. 2519-2525.

Evans, D. M., Spencer, C. C. A., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., Opperman, U., Dilthey, A., Pirinen, M., Stone, M. A., Appleton, L., Moutsianis, L., Leslie, S., Wordsworth, T., Kenna, T. J., Karaderi, T., Thomas, G. P., Ward, M. M., Weisman, M. H., Farrar, C., Bradbury, L. A., Danoy, P., Inman, R. D., Maksymowych, W., Gladman, D., Rahman, P., Morgan, A., Marzo-Ortega, H., Bowness, P., Gaffney, K., Gaston, J. S. H., Smith, M., Bruges-Armas, J., Couto, A. R., Sorrentino, R., Paladini, F., Ferreira, M. A., Xu, H. J., Liu, Y., Jiang, L., Lopez-Larrea, C., Diaz-Pena, R., Lopez-Vazquez, A., Zayats, T., Band, G., Bellenguez, C., Blackburn, H., Blackwell, J. M., Bramon, E., Bumpstead, S. J., Casas, J. P., Corvin, A., Craddock, N., Deloukas, P., Dronov, S., Duncanson, A., Edkins, S., Freeman, C., Gillman, M., Gray, E., Gwilliam, R., Hammond, N., Hunt, S. E., Jankowski, J., Jayakumar, A., Langford, C., Liddle, J., Markus, H. S., Mathew, C. G., McCann, O. T., McCarthy, M. I., Palmer, C. N. A., Peltonen, L., Plomin, R., Potter, S. C., Rautanen, A., Ravindrarajah, R., Ricketts, M., Samani, N., Sawcer, S. J., Strange, A., Trembath, R. C., Viswanathan, A. C., Waller, M., Weston, P., Whittaker, P., Widaa, S., Wood, N. W., McVean, G., Reveille, J. D., Wordsworth, B. P., Brown, M. A. and Donnelly, P., 2011. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics, 43 (8), pp. 761-767.

Evans, L. A., Adams, H., Barber, C. G., Caggiano, L. and Jackson, R. F. W., 2007. Stereoselective synthesis of 2,3-difunctionalised thioesters using nucleophilic epoxidation of 1-arylthio-1-nitroalkenes. Organic and Biomolecular Chemistry, 5, pp. 31356-3163.

F

Falasca, M., Chiozzotto, D., Godage, H. Y., Mazzoletti, M., Riley, A. M., Previdi, S., Potter, B. V. L., Broggini, M. and Maffucci, T., 2010. A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. British Journal of Cancer, 102 (1), pp. 104-114.

Falasca, M., Riley, A., Godage, H. and Potter, B., 2011. Novel Inositol Phosphate Derivatives. A61K31/661-WO2011064559 (A2), 03 June 2011.

Farghaly, H., Causton, B., Blagbrough, I. and Watson, M. L., 2008. The effect of PI3K inhibition on IL-13-induced arginase I expression in mice tracheal segments. Fundamental & Clinical Pharmacology, 22, p. 14.

Farghaly, H. S. M., Blagbrough, I. S., Medina-Tato, D. A. and Watson, M. L., 2008. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110δ-dependent mechanism. Molecular Pharmacology, 73 (5), pp. 1530-1537.

Farghaly, H., 2009. Pharmacological targets for gene therapy in lung inflammation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Fasehee, H., Westers, H., Bolhuis, A., Antelmann, H., Hecker, M., Quax, W. J., Mirlohi, A. F., van Dijl, J. M. and Ahmadian, G., 2011. Functional analysis of the sortase YhcS in Bacillus subtilis. Proteomics, 11 (19), pp. 3905-3913.

Feighery, L. M., Cochrane, S. W., Quinn, T., Baird, A. W., O’Toole, D., Owens, S.-E., O’Donoghue, D., Mrsny, R. J. and Brayden, D. J., 2008. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharmaceutical Research, 25 (6), pp. 1377-1386.

Felemez, M., Marwood, R. D., Potter, B. V. L. and Spiess, B., 1999. Inframolecular studies of the protonation of adenophostin A : comparison with 1-D-myo-inositol 1,4,5-trisphosphate. Biochemical and Biophysical Research Communications, 266 (2), pp. 334-340.

Felemez, M., Schlewer, G., Jenkins, D. J., Correa, V., Taylor, C. W., Potter, B. V. L. and Spiess, B., 1999. Inframolecular studies of the protonation of 1d-1,2,4/3,5-cyclopentanepentaol 1,3,4-trisphosphate, a ring-contracted analogue of 1d-myo-inositol 1,4,5-trisphosphate. Carbohydrate Research, 322 (1-2), pp. 95-101.

Ferbas, J., Belouski, S.S., Horner, M., Kaliyaperumal, A., Chen, L., Boyce, M., Colaço, C.B., Mchugh, N., Quick, V., Nicholl, R.J., Siu, G. and Chung, J., 2013. A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus. British Journal Of Clinical Pharmacology, 76 (2), pp. 188-202.

Ferguson, J. E., Potter, B. V. L. and Nuccitelli, R., 1990. The effect of myo-inositol 1, 4, 5-trisphosphorothioate on Cl-current pattern and intracellular Ca2+ in the Xenopus laevis oocyte. Biochemical and Biophysical Research Communications, 172 (1), pp. 229-236.

Fernandez, I., Price, R. D., Bolton, P. D., Mahon, M. F., Davidson, M. G. and Lopez-Ortiz, F., 2004. X-ray and multinuclear NMR study of the mixed aggregate [(Ph2P(O)N(CH2Ph)CH3) · LiOC6H2-2,6-{C(CH3)3}2-4-CH3) · C7H8]2: a model for the directed metalation of phosphinamides. Journal of Organometallic Chemistry, 689 (11), pp. 1890-1896.

Ferrari, F., Cocconi, D., Bettini, R., Giordano, F., Santi, P., Tobyn, M., Price, R., Young, P., Caramella, C. and Colombo, P., 2004. The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech, 5 (4), pp. 1-6.

Ferrer, S., Naughton, D. P., Parveen, I. and Threadgill, M. D., 2002. N- and O-Alkylation of isoquinolin-1-ones in the Mitsunobu reaction: development of potential drug delivery systems. Journal of the Chemical Society - Perkin Transcriptions 1

Ferrer, S., Naughton, D. P. and Threadgill, M. D., 2003. 1H NMR studies on the reductively triggered release of heterocyclic and steroid drugs from 4,7-dioxoindole-3-methyl prodrugs. Tetrahedron, 59 (19), pp. 3445-3454.

Ferrer, S., Naughton, D. P. and Threadgill, M. D., 2002. Labelled compounds of interest as antitumour agents - VIII. Synthesis of 2H-isotopomers of pentamethylmelamine and of a potential prodrug thereof. Journal of Labelled Compounds and Radiopharmaceuticals, 45, pp. 479-484.

Ferrer, S., Naughton, D. P. and Threadgill, M. D., 2003. Studies on the reductively triggered release of heterocyclic and steroid drugs from 5-nitrothien-2-ylmethyl prodrugs. Tetrahedron, 59, pp. 3437-3444.

Fijn, R., de Vries, C. S., Brouwers, J. R. B. J. and de Jong-van den Berg, L. T. W., 2000. Die Bedeutung von Arzneimittellisten im Krankenhaus [The impact of hospital drug formularies]. Krankenhauspharmazie, 21 (4), pp. 133-138.

Filipsson, S., Laaksonen, R., Duggan, C., Antoniou, S. and Coleman, V., 2007. Bridging therapy after heart valve replacement. Pharmacy World & Science, 29 (3), pp. 311-313.

Finnin, B. A., O'Neill, M. A. A., Gaisford, S., Beezer, A. E., Hadgraft, J. and Sears, P., 2006. Performance validation of step-isothermal calorimeters. Journal of Thermal Analysis and Calorimetry, 83 (2), pp. 331-334.

Finokaliotou, S., 2009. Synthetic and biological studies of antiparasitic natural product derivatives. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Firth, A. L., Gordienko, D. V., Yuill, K. H. and Smirnov, S. V., 2009. Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation. American Journal of Physiology-Lung Cellular and Molecular Physiology, 296 (3), L347-L360.

Firth, A. L., Gordienko, D. V., Yuill, K. H. and Smirnov, S. V., 2008. Cellular localization of mitochondria contributes to the regulation of Kv channel currents in the rat pulmonary, but not mesenteric arterial myocytes. In: Physiological Society Meeting, 2008-12-15 - 2008-12-17, Kings College London, London.

Firth, A. L., Yuill, K. H. and Smirnov, S. V., 2008. Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 295 (1), L61-L70.

Fischer, D. S., Chander, S. K., Woo, L. W. L., Fenton, J. C., Purohit, A., Reed, M. J. and Potter, B. V. L., 2003. Novel D-ring modified steroid derivatives as potent, non-estrogenic steroid sulfatase inhibitors with in vivo activity. Steroid Biochemistry & Molecular Biology, 84 (2-3), pp. 343-349.

Fischer, D. S., Woo, L. W. L., Mahon, M. F., Purohit, A., Reed, M. J. and Potter, B. V. L., 2003. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase. Bioorganic and Medicinal Chemistry, 11 (8), pp. 1685-1700.

Fisher, D. I., Safrany, S. T., Strike, P., McLennan, A. G. and Cartwright, J. L., 2002. Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-biphosphate. Journal of Biological Chemistry, 277 (49), pp. 47313-47317.

Fithian, D. C., Paxton, E. W., Stone, M. L., Silva, P., Davis, D. K., Elias, D. A. and White, L. M., 2004. Epidemiology and natural history of acute patellar dislocation. The American Journal of Sports Medicine, 32 Jul-Aug (5), pp. 1114-1121.

FitzGerald, D. and Mrsny, R. J., 2000. New approaches to antigen delivery. Critical Review of Therapeutic Drug Carrier Systems, 17 (3), pp. 165-248.

Flower, V., Pauling, J. D., Shipley, J. A. and McHugh, N. J., 2010. Raynaud's phenomenon and macrocytic anaemia. BMJ, 341, c6011.

Folkes, L., Graham, A. and Weiss, M. C., 2001. A qualitative study of the views of women aged 18-29 on over-the-counter availability of hormonal emergency contraception. Journal of Family Planning and Reproductive Health Care, 27 (4), pp. 189-192.

Fonseca, C., Lindahl, G. E., Ponticos, M., Sestini, P., Renzoni, E. A., Holmes, A. M., Spagnolo, P., Pantelidis, P., Leoni, P., McHugh, N. J., Stock, C. J., Shi-Wen, X., Denton, C. P., Black, C. M., Welsh, K. I., du Bois, R. M. and Abraham, D. J., 2007. A polymorphism in the CTGF promoter region associated with systemic sclerosis. The New England Journal of Medicine, 357 (12), pp. 1210-1220.

Fonseca, C., Renzoni, E., Sestini, P., Pantelidis, P., Lagan, A., Bunn, C., McHugh, N., Welsh, K. I., Du Bois, R. M., Denton, C. P., Black, C. and Abraham, D., 2006. Endothelin axis polymorphisms in patients with scleroderma. Arthritis & Rheumatism, 54 (9), pp. 3034-3042.

Forsey, R. W., Fisher, J., Thompson, J., Stone, M. H., Bell, C. and Ingham, E., 2006. The effect of hyaluronic acid and phospholipid based lubricants on friction within a human cartilage damage model. Biomaterials, 27 (26), pp. 4581-4590.

Fortt, S. M. and Potter, B. V. L., 1997. An approach to a carbocyclic analogue of cyclic adenosine 5′-diphosphate ribose. The synthesis and bisphosphorylation of N1-[(1S, 3R)-3-(Hydroxymethyl)cyclopent-1-yl]inosine. Tetrahedron Letters, 38 (30), pp. 5371-5374.

Fossey, J.S., D'Hooge, F., van den Elsen, J.M.H., Pereira Morais, M.P., Pascu, S.I., Bull, S.D., Marken, F., Jenkins, A.T.A., Jiang, Y.-B. and James, T.D., 2012. The development of boronic acids as sensors and separation tools. Chemical Record, 12 (5), pp. 464-478.

Foster, J.G., Blunt, M.D., Carter, E. and Ward, S.G., 2012. Inhibition of PI3K signaling Spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies. Pharmacological Reviews, 64 (4), pp. 1027-1054.

Foster, J. G., 2012. The Role of Phosphatidylinositol 3-Kinase in P2X7R Gated Signalling in T Lymphocytes. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Foster, J. G., Carter, E., Kilty, I., Mackenzie, A. B. and Ward, S. G., 2013. Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naïve human CD4+ T lymphocytes. The Journal of Immunology, 190 (4), pp. 1551-1559.

Foster, P. A., Chander, S. K., Newman, S. P., Woo, L. W. L., Sutcliffe, O. B., Bubert, C., Zhou, D. J., Chen, S. A., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. A new therapeutic strategy against hormone-dependent breast cancer : the preclinical development of a dual aromatase and sulfatase inhibitor. Clinical Cancer Research, 14 (20), pp. 6469-6477.

Foster, P. A., Chander, S. K., Parsons, M. F. C., Newman, S. P., Woo, L. W. L., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. Efficacy of three potent steroid sulfatase inhibitors : pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer. Breast Cancer Research and Treatment, 111 (1), pp. 129-138.

Foster, P. A., Ho, Y. T., Newman, S. P., Kasprzyk, P. G., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research and Treatment, 111 (2), pp. 251-260.

Foster, P. A., Ho, Y. T., Newman, S. P., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2009. STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells. Anticancer Research, 29 (10), pp. 3751-3757.

Foster, P. A., Newman, S. P., Chander, S. K., Stengel, C., Jhalli, R., Woo, L. L. W., Potter, B. V. L., Reed, M. J. and Purohit, A., 2006. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy. Clinical Cancer Research, 12 (18), pp. 5543-5549.

Foster, P. A., Newman, S. P., Leese, M. P., Bernetiere, S., Diolez, C., Camara, J., Hacher, B., Baronnet, M.-M., Ali, T., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. A new micronized formulation of 2-methoxyestradiol- bis -sulfamate (STX140) is therapeutically potent against breast cancer. Anticancer Research, 28 (2A), pp. 577-581.

Foster, P. A., Stengel, C., Ali, T., Leese, M. P., Potter, B. V. L., Reed, M. J., Purohit, A. and Newman, S. P., 2008. A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140. Anticancer Research, 28 (3A), pp. 1483-1491.

Foster, P. A., Woo, L. W. L., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer. Endocrinology, 149 (8), pp. 4035-4042.

Foster, P. S., Hogan, S. P., Hansbro, P. M., O'Brien, R., Potter, B. V. L., Ozaki, S. and Denborough, M. A., 1994. The metabolism of d-myo-inositol 1,4,5-trisphosphate and d-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle. European Journal of Biochemistry, 222 (3), pp. 955-964.

Foster, S. R., Pearce, A., Blake, A. J., Welham, M. J. and Dowden, J., 2007. Novel octavalent cross-linker displays efficient trapping of protein protein interactions. Chemical Communications

Fotaki, N. and Reppas, C., 2005. The flow through cell methodology in the evaluation of intralumenal drug release characteristics. Dissolution Technologies, 12 (2), pp. 17-21.

Fotaki, N., Symillides, M. and Reppas, C., 2005. Canine vs. in vitro data for predicting input profiles of L-sulpiride after oral administration. European Journal of Pharmaceutical Sciences, 26 (3-4), pp. 324-333.

Fotaki, N., Symillides, M. and Reppas, C., 2005. In vitro vs. canine date for predicting input profiles of isosorbide-5 mononitrate from oral extended release products on a confidence interval basis. European Journal of Pharmaceutical Sciences, 24, pp. 115-122.

Fotaki, N., 2010. Controlled release formulations of BSC class I compounds. AAPS Journal, 12 (S2).

Fotaki, N., Aivaliotis, A. and Reppas, C., 2005. The USP IV apparatus for the assessment of intraluminal drug release profile from extended relase products in the fasted state. In: 2nd International Symposium on Scientific and Regulatory Aspects of Dissolution and Bioequivalence, 2005, 2005-01-01, Athens.

Fotaki, N., Box, K., Comer, J., Mole, J., Taylor, R., Karki, S. and Price, R., 2013. Dissolution and precipitation studies of carbamazepine cocrystals with small scale assays. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N. and Brassine, C., 2013. Age related biorelevant dissolution testing for pediatric pellet formulations. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N., Gikas, E., Halabalaki, M. and Reppas, C., 2004. An improved GC-MS method for the quantification of isosorbide-5-mononitrate in plasma. European Journal of Pharmaceutical Sciences, 23 (Supplement), S39.

Fotaki, N., Karki, S., Price, R., Chapman, A. and Lenke, J., 2013. Forthcoming. Surface dissolution UV imaging for studying properties of pharmaceutical cocrystals for oral administration. AAPS Journal

Fotaki, N., Long, C., Tang, K. and Chokshi, H., 2013. Surface dissolution UV imaging for studying properties of a poorly soluble weak basic compound. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N., Long, C. M., Cuppok-Rosiaux, Y., Marchaud, D., Garbacz, G., Lange, S. and Klein, S., 2014. Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods. In: 41st Annual Meeting & Exposition of the Controlled Release Society (CRS), 2014, 2014-07-13 - 2014-07-16, Chicago.

Fotaki, N., Long, C. M., Tang, K. and Chokshi, H., 2014. Dissolution of amorphous solid dispersions : theory and practice. In: Shah, N. H., Sandhu, H. K., Choi, D. S., Chokshi, H. K. and Malick, W., eds. Amorphous Solid Dispersions. New York, U. S. A.: Springer US.

Fotaki, N., Martin, G.P. and Krämer, J., 2013. Dissolution highlights from the 2012 AAPS annual meeting in Chicago. Dissolution Technologies, 20 (2), pp. 57-59.

Fotaki, N., Obwoge, E. and Tang, K., 2007. Development of an in vitro-in vivo correlation (IVIVC) for a BCS Class II compound with pH-dependent solubility. AAPS Journal, 9 (S2).

Fotaki, N., Obwoge, E., Tang, K. and Chokshi, H., 2007. Development of an in vitro-in vivo correlation (IVIVC) for a BCS Class II compound with pH-dependent solubility. In: American Association of Pharmaceutical Scientists (ΑΑPS) Annual Meeting and Exposition, 2007-11-09 - 2007-11-15, San Diego.

Fotaki, N. and Reppas, C., 2002. Biorelevant release data vs canine data for the prediction of isosorbide-5-mononitrate absorption profile from extended release products in the fasted state. In: SOCRATES Intensive Programme of Innovative Therapeutics : from Molecules to Drugs, 2002, 2002-06-02 - 2002-06-11, Crotone.

Fotaki, N. and Reppas, C., 2002. In vitro release vs canine data for predicting the absorption profile of levosulpiride in the Fed State. AAPS Journal, 4 (S1).

Fotaki, N., Vertzoni, M., Dressman, J. B. and Reppas, C., 2000. Optimising the in vitro conditions to simulate the release process in stomach after meals. European Journal of Pharmaceutical Scientists, 11 (S1), S44.

Fotaki, N., Walwyn, C., Tang, K. and Chokshi, H., 2007. Flow through cell dissolution testing as a formulation screening and quality tool for the assessment of bioavailability. AAPS Journal, 9 (S2).

Fotaki, N., Walwyn, C., Tang, K. and Chokshi, H., 2007. Flow through cell dissolution testing as a formulation screening and quality tool for the assessment of bioavailability. In: American Association of Pharmaceutical Scientists (ΑΑPS) Annual Meeting and Exposition, 2007-11-09 - 2007-11-15, San Diego.

Fotaki, N., 2011. Flow-through cell apparatus (USP apparatus 4) : Operation and features. Dissolution Technologies, 18 (4), pp. 46-49.

Fotaki, N., 2009. Pros and cons of methods used for the prediction of oral drug absorption. Expert Review of Clinical Pharmacology, 2 (2), pp. 195-208.

Fotaki, N., Aivaliotis, A., Butler, J., Dressman, J., Fischbach, M., Hempenstall, J., Klein, S. and Reppas, C., 2009. A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. European Journal of Pharmaceutics and Biopharmaceutics, 73 (1), pp. 115-120.

Fotaki, N., Brown, W., Kochling, J., Chokshi, H., Miao, H., Tang, K. and Gray, V., 2013. Rationale for selection of dissolution media: three case studies. Dissolution Technologies, 20 (3), pp. 6-13.

Fotaki, N., Gray, V., Kesisoglou, F., Mayock, S., Mirza, T. and Salt, A., 2013. Survey results for in vitro-in vivo correlations (IVIVC) : Critical variables for success. Dissolution Technologies, 20 (2), pp. 48-50.

Fotaki, N. and Klein, S., 2013. Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data. Molecular Pharmaceutics, 10 (11), pp. 4016-4023.

Fotaki, N. and Reppas, C., 2001. Protein digestion effects the release process in media simulating the composition of meals administered in bioequivalence studies. AAPS Journal, 3 (S1).

Fotaki, N. and Vertzoni, M., 2010. Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations. The Open Drug Delivery Journal, 4 (1), pp. 2-13.

Fotaki, N., Warren, K., Irish, N. and Haden Tebb, A., 2009. Development of in vitro-in vivo correlations (IVIVCs) for controlled release formulations of BSC Class I compounds. In: 2nd PharmSciFair, 2009-06-08 - 2009-06-12, Nice.

Fox, B. C., Crew, T. E. and Welham, M. J., 2005. Phosphoinositide 3-kinases can act independently of p27 Kip1 to regulate optimal IL-3-dependent cell cycle progression and proliferation. Cellular Signalling, 17, pp. 473-487.

Fox, F. E., Rodham, K. J., Harris, M. F., Taylor, G. J., Sutton, J., Scott, J. and Robinson, B., 2009. Experiencing "the other side": a study of empathy and empowerment in general practitioners who have been patients. Qualitative Health Research, 19 (11), pp. 1580-1588.

Fox, F., Harris, M., Taylor, G. J., Rodham, K., Sutton, J., Robinson, B. and Scott, J., 2009. What happens when doctors are patients? qualitative study of GPs. British Journal of General Practice, 59 (568), pp. 811-818.

Fox, F. E., Taylor, G. J., Harris, M. F., Rodham, K. J., Sutton, J., Scott, J. and Robinson, B., 2010. "It's crucial they're treated as patients": ethical guidance and empirical evidence regarding treating doctor-patients. Journal of Medical Ethics, 36 (1), pp. 7-11.

Fraser, S.J., Oughton, J., Batten, W.A., Clark, A.S.S., Schmierer, D.M., Gordon, K.C. and Strachan, C.J., 2013. Forthcoming. Simultaneous qualitative and quantitative analysis of counterfeit and unregistered medicines using Raman spectroscopy. Journal of Raman Spectroscopy

Freeburn, R. W., Wright, K. L., Burgess, S. J., Astoul, E., Cantrell, D. A. and Ward, S. G., 2002. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. The Journal of Immunology, 169 (10), pp. 5441-5450.

Frixa, C., Mahon, M. F., Thompson, A. S. and Threadgill, M. D., 2003. Synthesis of meso -substituted porphyrins carrying carboranes and oligo(ethylene glycol) units for potential applications in boron neutron capture therapy. Organic and Biomolecular Chemistry, 1 (2), pp. 306-317.

Frixa, C., Mahon, M. F., Thompson, A. S. and Threadgill, M. D., 2002. Direct Cu(I)-catalysed coupling of a carborane to a meso-tetraphenylporphyrin. Tetrahedron Letters, 43 (8), pp. 1557-1559.

Frixa, C., Scobie, M., Black, S. J., Thompson, A. S. and Threadgill, M. D., 2002. Formation of a remarkably robust 2:1 complex between β-cyclodextrin and a phenyl-substituted icosahedral carborane. Chemical Communications, 27, pp. 2876-2877.

Furkert, D. P. and Husbands, S. M., 2007. First asymmetric synthesis of trans -3,4-dimethyl-4-arylpiperidines. Organic Letters, 9 (19), pp. 3769-3771.

Fusi, L., Purohit, A., Brosens, J., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2008. Inhibition of steroid sulfatase activity in endometriotic Implants by STX64 (667Coumate) : a potential new therapy. The Scientific World Journal, 8, pp. 1325-1327.

G

Gabra, B. H., Bailey, C. P., Kelly, E., Sanders, A. V., Henderson, G., Smith, F. L. and Dewey, W. L., 2007. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance. Brain Research, 1159, pp. 86-93.

Gabra, B. H., Bailey, C. P., Kelly, E., Smith, F. L., Henderson, G. and Dewey, W. L., 2008. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Research, 1217, pp. 70-77.

Gaisford, S., O'Neill, M., Thompson, L. and Cahn, K. L., 2006. Shelf-life prediction of intravenous busulfan by isothermal calorimetry. Hospital Pharmacist, 13, pp. 295-298.

Gaisford, S. and O'Neill, M. A. A., 2006. Pharmaceutical Isothermal Calorimetry. USA: Informa Healthcare.

Galione, A., Parrington, J. and Dowden, J., 2004. The NAADP receptor: commentary on Billington et al. British Journal of Pharmacology, 142, pp. 1203-1207.

Galione, A. and Potter, B., 1998. Cyclic Adenosine Diphosphate Ribose Analogues. C07H19/20-WO9843992 (A1), 08 October 1998.

Galione, A., White, A., Willmott, N., Turner, M., Potter, B. V. L. and Watson, S. P., 1993. cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclicADP-ribose synthesis. Nature, 365 (6445), pp. 456-459.

Gallagher, N. T., Garland, C. J. and Dora, K. A., 2006. Differential roles for IK Ca and SK Ca channels in EDHF-type responses in mouse mesenteric arteries. FASEB Journal, 20.

Gamble, J. F., Chiu, W. S. and Tobyn, M., 2011. Investigation into the impact of sub-populations of agglomerates on the particle size distribution and flow properties of conventional microcrystalline cellulose grades. Pharmaceutical Development and Technology, 16 (5), pp. 542-548.

Gao, F. J., Cui, S. X., Chen, M. H., Cheng, Y. N., Sun, L. R., Ward, S. G., Kokudo, N., Tang, W. and Qu, X. J., 2008. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences, 83 (23-24), pp. 815-820.

Garden, D. L. F., Massey, P. V., Caruana, D. A., Johnson, B., Warburton, E. C., Aggleton, J. P. and Bashir, Z. I., 2009. Anterior thalamic lesions stop synaptic plasticity in retrosplenial cortex slices: expanding the pathology of diencephalic amnesia. Brain, 132 (7), pp. 1847-1857.

Garfield, A. S., Cowley, M., Smith, F. M., Moorwood, K., Stewart-Cox, J. E., Gilroy, K., Baker, S., Xia, J., Dalley, J. W., Hurst, L. D., Wilkinson, L. S., Isles, A. R. and Ward, A., 2011. Distinct physiological and behavioural functions for parental alleles of imprinted Grb10. Nature, 469 (7331), pp. 534-538.

Garg, P., Martin, C. F., Elms, S. C., Gordon, F. J., Wall, S. M., Garland, C. J., Sutliff, R. L. and O'Neill, W. C., 2007. Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. American Journal of Physiology-Heart and Circulatory Physiology, 292 (5), H2100-H2105.

Garland, C. J., 2004. Endothelium-dependent hyperpolarizing factor: a significant influence on vascular dilatation in health and disease. Journal of Medical Sciences - Taipei, 24 (2), pp. 59-70.

Garland, C. J., 2003. Role of endothelial cell ion channels in the resistance artery function. Neurophysiology, 35 (3/4), pp. 189-196.

Garland, C. J., Yarova, P. L., Jiménez-Altayó, F. and Dora, K. A., 2011. Vascular hyperpolarization to β-adrenoceptor agonists evokes spreading dilatation in rat isolated mesenteric arteries. British Journal of Pharmacology, 164 (3), pp. 913-921.

Garnelis, T., Athanassopoulos, C. M., Papaioannou, D., Eggleston, I. M. and Fairlamb, A. H., 2004. Very short and efficient syntheses of the spermine alkaloid kukoamine A and analogs using isolable succinimidyl cinnamates. Chemistry Letters, 34 (2), pp. 264-265.

Garrett, S. W., Liu, C., Riley, A. M. and Potter, B. V. L., 1998. Rapid and practical synthesis of D-myo-inositol 1,4,5-trisphosphate. Journal of the Chemical Society, Perkin Transactions 1, 1998 (8), pp. 1367-1368.

Gawler, D. J., Potter, B. V. L., Gigg, R. and Nahorski, S. R., 1991. Interactions between inositol tris- and tetrakis-phosphates : effects on intracellular Ca2+ mobilization in SH-SY5Y cells. Biochemical Journal, 276 (1), pp. 163-167.

Gawler, D. J., Potter, B. V. L. and Nahorski, S. R., 1990. Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells. Biochemical Journal, 272 (2), pp. 519-524.

Geall, A. J., Al-Hadithi, D. and Blagbrough, I. S., 2002. Efficient calf thymus DNA condensation upon binding with novel bile acid polyamine amides. Bioconjugate Chemistry, 13, pp. 481-490.

Geall, A. J. and Blagbrough, I. S., 2000. Homologation of polyamines in the rapid synthesis of lipospermine conjugates and related lipoplexes. Tetrahedron, 56 (16), pp. 2449-2460.

Geall, A. J. and Blagbrough, I. S., 2000. Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy. Journal of Pharmaceutical and Biomedical Analysis, 22 (5), pp. 849-859.

Geall, A. J., Taylor, R. J., Earll, M. E., Eaton, M. A. W. and Blagbrough, I. S., 2000. Synthesis of cholesteryl polyamine carbamates: pK(a) studies and condensation of calf thymus DNA. Bioconjugate Chemistry, 11 (3), pp. 314-326.

Geinoz, S., Guy, R. H., Testa, B. and Carrupt, P. A., 2004. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharmaceutical Research, 21 (1), pp. 83-92.

Geinoz, S., Rey, S., Boss, G., Bunge, A. L., Guy, R. H., Carrupt, P. A., Reist, M. and Testa, B., 2002. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharmaceutical Research, 19 (11), pp. 1622-1629.

Gelfuso, G. M., Gratieri, T., Delgado-Charro, M. B., Guy, R. H. and Vianna Lopez, R. F., 2013. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. Journal of Pharmaceutical Sciences, 102 (5), pp. 1488-1494.

Genovese, T., Mazzon, E., Di Paola, R., Muià, C., Patel, N. S. A., Threadgill, M. D., Caputi, A. P., Thiemermann, C. and Cuzzocrea, S., 2005. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. Journal of Pharmacology and Experimental Therapeutics, 313 (2), pp. 529-538.

Genovese, T., Mazzon, E., Muià, C., Patel, N. S. A., Threadgill, M. D., Bramanti, P., De Sarro, A., Thiemermann, C. and Cuzzocrea, S., 2005. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. Journal of Pharmacology and Experimental Therapeutics, 312 (2), pp. 449-457.

Ghazaleh, H. A., Lalies, M. D., Husbands, S. M., Nutt, D. J. and Hudson, A. L., 2007. The effect of 1-(4,5-dihydro-1 H -imidazol-2-yl) on monoamine release ajnd turnover in the rat frontal cortex. Neuroscience Letters, 422, pp. 109-113.

Ghonaim, H. M., Li, S., Pourzand, C. and Blagbrough, I. S., 2006. Design of lipospermine non-viral gene delivery vectors for self-assembly DNA nanoparticle formulations. Journal of Pharmacy and Pharmacology, 58, A7-A7.

Ghonaim, H. M., Li, S., Pourzand, C. and Blagbrough, I. S., 2007. Efficient novel unsymmetrical lipopolyamine formulations for gene delivery. Journal of Pharmacy and Pharmacology, 59, A37-A37.

Ghonaim, H. M., Li, S., Pourzand, C. and Blagbrough, I. S., 2007. Formulation and delivery of fluorescent siRNA by lipospermine nanoparticle complex formation. Journal of Pharmacy and Pharmacology, 59, A36-A37.

Ghonaim, H. M., Li, S., Soltan, M. K., Pourzand, C. and Blagbrough, I. S., 2007. Chain length modulation in symmetrical lipopolyamines and the effect on nanoparticle formulations for gene delivery. Journal of Pharmacy and Pharmacology, 59, A36-A36.

Ghonaim, H. M. and Blagbrough, I. S., 2014. Synthesis and formulations of lipid aminoglycoside conjugates : nanoparticles for efficient gene and sirna delivery. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (2), pp. 153-157.

Ghonaim, H. M., 2008. Design and development of pharmaceutical dosage forms for gene and siRNA delivery. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Ghonaim, H. M., Ahmed, O. A. A., Pourzand, C. and Blagbrough, I. S., 2008. Varying the chain length in N4,N9-diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA formulation. Molecular Pharmaceutics, 5 (6), pp. 1111-1121.

Ghonaim, H. M., Cheng, Y. X., Pourzand, C. and Blagbrough, I., 2010. Self-assembled complex formulations of lipid-aminoglycoside conjugates : Nanoparticles for efficient gene and siRNA delivery. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1295-1296.

Ghonaim, H. M., Li, S. and Blagbrough, I. S., 2010. N1,N12 -Diacyl Spermines: SAR Studies on Non-viral Lipopolyamine Vectors for Plasmid DNA and siRNA Formulation. Pharmaceutical Research, 27 (1), pp. 17-29.

Ghonaim, H. M., Li, S. and Blagbrough, I. S., 2009. Very long chain N4,N9-diacyl spermines: non-viral lipopolyamine V vectors for efficient plasmid DNA and siRNA delivery. Pharmaceutical Research, 26 (1), pp. 19-31.

Ghonaim, H. M., Soltan, M. K. and Blagbrough, I. S., 2010. Heterocyclic N-4, N-9-diacyl spermines : Nanoparticle lipopolyamine vectors for efficient pDNA and siRNA delivery. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1276-1277.

Giardina, E., Hüffmeier, U., Ravindran, J., Behrens, F., Lepre, T., McHugh, N. J., Korendowych, E., Burkhardt, H., Novelli, G. and Reis, A., 2011. Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. Arthritis & Rheumatism, 63 (12), pp. 3801-3806.

Giller, T., 2009. Iontophoretic delivery of selected antiparkinsonian agents in vitro. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Giuntini, F., Bourre, L., MacRobert, A. J., Wilson, M. and Eggleston, I. M., 2008. Quantitative determination of 5-aminolaevulinic acid and its esters in cell lysates by HPLC-fluorescence. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 875 (2), pp. 562-566.

Giuntini, F., Bourre, L., Wilson, M., MacRobert, A. J. and Eggleston, I. M., 2008. A novel approach to improve cellular delivery of 5-aminolaevulinic acid : New ALA-containing peptide prodrugs for photodynamic therapy. Journal of Peptide Science, 14 (8 (Suppl S)), p. 156.

Giuntini, F., Bourre, L., MacRobert, A. J., Wilson, M. and Eggleston, I. M., 2009. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization. Journal of Medicinal Chemistry, 52 (13), pp. 4026-4037.

Gladman, D. D., Cook, R. J., Schentag, C., Feletar, M., Inman, R., Hitchon, C., Karsh, J., Klinkhoff, A., Maksymowych, W., Mosher, D., Nair, B. and Stone, M. A., 2003. The clinical assessment of patients with psoriatic arthritis (PsA): Results of a validation study of the Spondyloarthritis Research Consortium of Canada. Arthritis & Rheumatism, 48 (9), S168-S168.

Gladman, D. D., Cook, R. J., Schentag, C., Feletar, M., Inman, R. I., Hitchon, C., Karsh, J., Klinkhoff, A. V., Maksymowych, W. P., Mosher, D. P., Nair, B. and Stone, M. A., 2004. The clinical assessment of patients with psoriatic arthritis: Results of a reliability study of the spondyloarthritis research consortium of Canada. Journal of Rheumatology, 31 (6), pp. 1126-1131.

Gladman, D. D., Inman, R. D., Cook, R. J., Maksymowych, W. P., Braun, J., Davis, J. C., Landewe, R. B. M., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M. A., Taylor, W., Veale, D. J. and van der Heijde, D., 2007. International spondyloarthritis interobserver reliability exercise - The INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. Journal of Rheumatology, 34 (8), pp. 1740-1745.

Gladman, D. D., Inman, R. D., Cook, R. J., van der Heijde, D., Landewe, R. B. M., Braun, J., Davis, J. C., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M. A., Taylor, W., Veale, D. J. and Maksymowych, W. P., 2007. International spondyloarthritis interobserver reliability exercise - The INSPIRE study: I. Assessment of spinal measures. Journal of Rheumatology, 34 (8), pp. 1733-1739.

Gladman, D. D., Inman, R. D., Cook, R. R., Maksymowych, W., Van der Heijde, D., Landewe, R., Braun, J., Davis, J., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, R., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M., Taylor, W. and Veale, D. J., 2006. International spondyloarthritis inter-observer reliability exercise - The inspire study. Annals of the Rheumatic Diseases, 65, p. 217.

Gladman, D. D., Landewé, R., McHugh, N. J., Fitzgerald, O., Thaci, D., Coates, L., Mease, P. J., Qureshi, A. A., Krueger, G. G., Ritchlin, C. T., Kavanaugh, A. F. and Garg, A., 2010. Composite measures in psoriatic arthritis: GRAPPA 2008. Journal of Rheumatology, 37 (2), pp. 453-461.

Gliddon, A. E., Dore, C. J., Dunphy, J., Betteridge, Z., McHugh, N. J. and Maddison, P. J., 2011. Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis. Journal of Rheumatology, 38 (4), pp. 702-705.

Gliddon, A. E., Doré, C. J., Black, C. M., McHugh, N. J., Moots, R., Denton, C. P., Herrick, A., Barnes, T., Camilleri, J., Chakravarty, K., Emery, P., Griffiths, B., Hopkinson, N. D., Hickling, P., Lanyon, P., Laversuch, C., Lawson, T., Mallya, R., Nisar, M., Rhys-Dillon, C., Sheeran, T. and Maddison, P. J., 2007. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis & Rheumatism, 56 (11), pp. 3837-46.

Glouchankova, L., Krishna, U. M., Potter, B. V. L., Falck, J. R. and Bezprozvanny, I., 2000. Association of the inositol (1,4,5)-trisphosphate receptor ligand binding site with phosphatidylinositol (4,5)-bisphosphate and adenophostin A. Molecular Cell Biology Research Communications, 3 (3), pp. 153-158.

Godage, H. Y., Riley, A. M., Woodman, T. J. and Potter, B. V. L., 2006. Regioselective hydrolysis of myo-inositol 1,3,5-orthobenzoate via a 1,2-bridged 2'-phenyl-1,3'-dioxolan-2'-ylium ion provides a rapid route to the anticancer agent Ins(1,3,4,5,6,)P5. Chemical Communications, 2006 (28), pp. 2989-2991.

Godage, H. Y., Riley, A. M., Woodman, T. J., Thomas, M. P., Mahon, M. F. and Potter, B. V. L., 2013. Regioselective opening of myo-inositol orthoesters : mechanism and synthetic utility. Journal of Organic Chemistry, 78 (6), pp. 2275-2288.

Gomez, G. R., Fernandez, I., Ortiz, F. L., Price, R. D., Davidson, M. G., Mahon, M. F. and Howard, J. A. K., 2007. A tetrameric lithiated phosphazene containing a lithium atom bound exclusively to four sp(3)-hybridized carbanionic centers: A key intermediate for understanding structure-reactivity relationships of phosphazenyllithium compounds. Organometallics, 26 (3), pp. 514-518.

Goodyer, C. L. M., Chinje, E. C., Jaffar, M., Stratford, I. J. and Threadgill, M. D., 2003. Synthesis of N -Benzyl- and N -Phenyl-2-amino-4,5- dihydrothiazoles and thioureas and evaluation as modulators of the isoforms of nitric oxide synthase. Bioorganic and Medicinal Chemistry, 11 (19), pp. 4189-4206.

Goodyer, C. L. M., Chinje, E. C., Jaffar, M., Stratford, I. J. and Threadgill, M. D., 2003. Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase isoforms by homologues of thiocitrulline. Bioorganic & Medicinal Chemistry Letters, 13, pp. 3679-3680.

Gossec, L., Dougados, M., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pham, T., Braun, J., Sieper, J., Olivieri, I., van der Heijde, D., Collantes, E., Stone, M., Kvien, T. K. and Asas, [N. V.], 2008. Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Annals of the Rheumatic Diseases, 67 (6), pp. 782-788.

Gossec, L., Kvien, T. K., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pharm, T., Braun, J., Sieper, J., Oliveiri, I., Van der Heijde, D., Collantes, E., Stone, M. A. and Dougados, M., 2007. Dissemination and evaluation of the ASAS/EULAR recommendation for the management of ankylosing spondylitis: Results of a study among 1507 rheumatologists. Annals of the Rheumatic Diseases, 66, p. 65.

Gossec, L., Kvien, T., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pham, T., Braun, J., Sieper, J., Oliveiri, I., van der Heijde, D., Collantes, E., Stone, M. and Dougados, M., 2007. Dissémination et évaluation des recommandations ASAS/EULAR pour la prise en charge de la Spondylarthrite Ankylosante (SA): résultats d’une étude chez 1,507 rhumatologues. Revue du Rhumatisme, 74 (11-12), pp. 1155-1156.

Gossec, L., Smolen, J. S., Gaujoux-Viala, C., Ash, Z., Marzo-Ortega, H., van der Heijde, D., Fitzgerald, O., Aletaha, D., Balint, P., Boumpas, D., Braun, J., Breedveld, F. C., Burmester, G., Cañete, J. D., de Wit, M., Dagfinrud, H., de Vlam, K., Dougados, M., Helliwell, P., Kavanaugh, A., Kvien, T. K., Landewé, R., Luger, T., Maccarone, M., McGonagle, D., McHugh, N. J., McInnes, I. B., Ritchlin, C., Sieper, J., Tak, P. P., Valesini, G., Vencovsky, J., Winthrop, K. L., Zink, A. and Emery, P., 2012. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1), pp. 4-12.

Grammatopoulos, G., Pandit, H. G., da Assunção, R., Taylor, A., McLardy-Smith, P., De Smet, K. A., Murray, D. W. and Gill, H. S., 2014. Pelvic position and movement during hip replacement. The Bone & Joint Journal, 96-B (7), pp. 876-883.

Grangier, G., Trigg, W. J., Lewis, T., Rowan, M. G., Potter, B. V. L. and Blagbrough, I. S., 1998. Synthesis of C5-substituted AE-bicyclic analogues of lycoctonine, inuline and methyllycaconitine. Tetrahedron Letters, 39 (8), pp. 889-892.

Gray, V., Fotaki, N. and Martin, G. P., 2012. Dissolution highlights from the 2011 AAPS annual meeting in Washington, D. C. Dissolution Technologies, 19 (1), pp. 69-70.

Greedy, B. M., Bradbury, F., Thomas, M. P., Grivas, K., Cami-Kobeci, G., Archambeau, A., Bosse, K., Clark, M. J., Aceto, M., Lewis, J. W., Traynor, J. R. and Husbands, S. M., 2013. Orvinols with mixed kappa/mu opioid receptor agonist activity. Journal of Medicinal Chemistry, 56 (8), pp. 3207-3216.

Greenhill, S. D. and Jones, R. S. G., 2010. Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurons of the rat entorhinal cortex in vitro. Neuroscience, 167 (2), pp. 456-474.

Greenhill, S. and Jones, R. S. G., 2007. Simultaneous estimation of global background synaptic inhibition and excitation from membrane potential fluctuations in layer III layer III neurones of the rat entorhinal cortex in vitro. Neuroscience, 147 (4), pp. 884-892.

Greenhill, S. D., Morgan, N. H., Massey, P. V., Woodhall, G. L. and Jones, R. S. G., 2012. Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release. Neuropharmacology, 62 (2), pp. 807-814.

Greenhill, S. D., 2008. The role of synaptic noise in cortical excitability. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Gregory, R. B., Hughes, R., Riley, A. M., Potter, B. V. L., Wilcox, R. A. and Barritt, G. J., 2004. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca 2+ inflow and Ca 2+ release from intracellular stores in rat hepatocytes. Biochemical Journal, 381 (Pt 2), pp. 519-526.

Grey, E.B., Harcourt, D., O'Sullivan, D., Buchanan, H. and Kilpatrick, N.M., 2013. A qualitative study of patients' motivations and expectations for dental implants. British Dental Journal, 214 (1), E1.

Gribbon, C. and De Bank, P., 2008. Cell/microparticle aggregates-a novel method to engineer large ex vivo neo-tissue. European Cells and Materials, 16 (Supplement 3), p. 56.

Griffen, J., White, J., Kociok-Kohn, G., Lloyd, M., Wells, A., Arnot, T. and Lewis, S., 2013. New aminocyclitols with quaternary stereocentres via acylnitroso cycloaddition with an ipso,ortho-arene dihydrodiol. Tetrahedron, 69 (29), pp. 5989-5997.

Griffiths, A. D., Potter, B. V. L. and Eperon, I. C., 1987. Stereospecificity of nucleases towards phosphorothioate-substituted RNA : stereochemistry of transcription by T7 RNA polymerase. Nucleic Acids Research, 15 (10), pp. 4145-4162.

Griffiths, A. D., Potter, B. V. L. and Eperon, I. C., 1988. Substitution of pre-mRNA with phosphorothioate linkages reveals a new splicing-related reaction. Journal of Biological Chemistry, 263 (25), pp. 12295-12304.

Grint, T., Riley, A. M., Mills, S. J., Potter, B. V. L. and Safrany, S. T., 2012. Fibrinogen—a possible extracellular target for inositol phosphates. Messenger, 1 (2), pp. 160-166.

Groocock, J., Kitson, G., McGlen, S., Salek, M. and Rogers, P., 2011. The impact of the introduction of the GPhC Code of conduct for pharmacy students, and fitness to practise procedures on MPharm students in Great Britain. International Journal of Pharmacy Practice, 19 (Suppl 2), p. 10.

Grundt, P., Jales, A. R., Traynor, J. R., Lewis, J. W. and Husbands, S. M., 2003. 14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles. Journal of Medicinal Chemistry, 46, pp. 1563-1566.

Grundt, P., Martinez Bermejo, F., Lewis, J. W. and Husbands, S. M., 2003. Formic acid catalyzed rearrangement of thevinols(=4,5-Epoxy-3,6-dimethoxy- α ,17-dimethyl-6,14-ethenomorphinan-7-methanols) and their vinylogous analogues: effects of 5 β -methyl substitution. Helvetica Chimica Acta, 86, pp. 2287-2298.

Grundt, P., Martinez-Bermejo, F., Lewis, J. W. and Husbands, S. M., 2003. Opioid binding and in vitro profiles of a series of 4-hydroxy-3-methoxyindolomorphinans. Transformation of a δ-selective ligand into a high affinity k -selective ligand by introduction of a 5,14-substituted bridge. Journal of Medicinal Chemistry, 46, pp. 3174-3177.

Grundt, P., Martinez-Bermejo, F., Lewis, J. W. and Husbands, S. M., 2003. The 14-alkyl- and 14-alkenyl-5β-methylindolomorphinan series provide δ-selective partial opioid agonists. Helvetica Chimica Acta, 86, pp. 793-798.

Grundt, P., Williams, I. A., Lewis, J. W. and Husbands, S. M., 2004. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore. Journal of Medicinal Chemistry, 47 (21), pp. 5069-5075.

Grégoire, S., Ribaud, C., Benech, F., Meunier, J. R., Garrigues-Mazert, A. and Guy, R. H., 2009. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations. British Journal of Dermatology, 160 (1), pp. 80-91.

Gulmez, E., Lignot, S., Larrey, D., De Vries, C., Gutthann, S. P., Montastruc, J., Sturkenboom, M., Benichou, J., Velo, G., Caputi, A., Salvo, F., Hamoud, F., Micon, S., Lassalle, R., Jove, J., Pageaux, G., Horsmans, Y., Bernuau, J., Bissoli, F., Stricker, B., Thorburn, D., Gatta, A., Monteiro, E., Vafiadis, I., McCormick, A., Metselaar, H., Sen, E., Nightingale, A., Blin, P. and Moore, N., 2011. NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Principal Results of the 7-Country Case-Population Study (SALT). Drug Safety, 34 (10), p. 895.

Gulmez, E. S., Lignot, S., Larrey, D., De Vries, C., Perez-Gutthann, S., Montastruc, J. L., Sturkenboom, M., Benichou, J., Velo, G., Caputi, A., Salvo, F., Hamoud, F., Micon, S., Lassalle, R., Jove, J., Pageaux, G. P., Horsmans, Y., Bernuau, J., Bissoli, F., Stricker, B., Thorburn, D., Gatta, A., Monteiro, E., Vafiadis, I., McCormick, A., Metselaar, H., Sen, E., Nightingale, A., Blin, P. and Moore, N., 2011. NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Preliminary Results of the Study of Acute Liver Transplant (SALT) in 7 European Countries. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S305-S305.

Gulmez, S.E., Larrey, D., Pageaux, G.-P., Lignot, S., Lassalle, R., Jové, J., Gatta, A., McCormick, P.A., Metselaar, H.J., Monteiro, E., Thorburn, D., Bernal, W., Zouboulis-Vafiadis, I., De Vries, C., Perez-Gutthann, S., Sturkenboom, M., Bénichou, J., Montastruc, J.-L., Horsmans, Y., Salvo, F., Hamoud, F., Micon, S., Droz-Perroteau, C., Blin, P. and Moore, N., 2013. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen) : The multinational case-population SALT study. Drug Safety, 36 (2), pp. 135-144.

Gulmez, S.E., Larrey, D., Pageaux, G.-P., Lignot-Maleyran, S., De Vries, C., Sturkenboom, M., Perez-Gutthann, S., Bénichou, J., Bissoli, F., Horsmans, Y., Bernuau, J., Stricker, B., Thorburn, D., Blin, P. and Moore, N., 2013. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). European Journal of Clinical Pharmacology, 69 (3), pp. 605-616.

Gunawardena, H., Betteridge, Z. E. and McHugh, N. J., 2008. Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Current Opinion in Rheumatology, 20 (6), pp. 675-680.

Gunawardena, H., Wedderburn, L. R., North, J., Betteridge, Z., Dunphy, J., Chinoy, H., Davidson, J. E., Cooper, R. G., McHugh, N. J. and Juvenile Dermatomy Res Grp, U. K., 2008. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology, 47 (3), pp. 324-328.

Gunawardena, H., Betteridge, Z. E. and McHugh, N. J., 2009. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology, 48 (6), pp. 607-612.

Gunawardena, H., Harris, N. D., Carmichael, C. and McHugh, N. J., 2007. Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology, 46 (7), pp. 1079-1082.

Gunawardena, H., Harris, N. D., Carmichael, C. and McHugh, N. J., 2007. Microvascular responses following digital thermal hyperaemia and iontophoresis measured by laser Doppler imaging in idiopathic inflammatory myopathy. Rheumatology, 46 (9), pp. 1483-1486.

Gunawardena, H. and McHugh, N. J., 2008. Features and recommended treatment of systemic sclerosis. Prescriber, 19 (18), pp. 59-65.

Gunawardena, H., Wedderburn, L. R., Chinoy, H., Betteridge, Z. E., North, J., Ollier, W. E. R., Cooper, R. G., Oddis, C. V., Ramanan, A. V., Davidson, J. E. and McHugh, N. J., 2009. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis & Rheumatism, 60 (6), pp. 1807-1814.

Gunn, J., Pauling, J.D. and McHugh, N.J., 2014. Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease. Clinical Rheumatology, 33 (6), pp. 869-871.

Guse, A. H., da Silva, C. P., Potter, B. V. L. and Mayr, G. W., 1997. Ca2+-signalling in human T-lymphocytes : potential roles for cyclic ADP-ribose and 2'- phospho-cyclic ADP-ribose. In: Koch-Nolte, F. and Haag, F., eds. ADP Ribosylation in Animal Tissues. London, U. K.: Plenum, pp. 431-436. (Advances in Experimental Medicine and Biology; 419)

Guse, A. H., Berg, I., da Silva, C. P., Potter, B. V. L. and Mayr, G. W., 1997. Ca2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. Journal of Biological Chemistry, 272 (13), pp. 8546-8550.

Guse, A. H., Cakir-Kiefer, C., Fukuoka, M., Shuto, S., Weber, K., Bailey, V. C., Matsuda, A., Mayr, G. W., Oppenheimer, N., Schuber, F. and Potter, B. V. L., 2002. Novel hydrolysis-resistant analogues of cyclic ADP-ribose : modification of the "northern" ribose and calcium release activity. Biochemistry, 41 (21), pp. 6744-6751.

Guse, A. H., Da Silva, C. P., Berg, I., Skapenko, A. L., Weber, K., Heyer, P., Hohenegger, M., Ashamu, G. A., Schulze-koops, H., Potter, B. V. L. and Mayr, G. W., 1999. Regulation of calcium in T lymphocytes by the second messenger cyclic ADP-ribose. Nature, 398 (6722), pp. 70-73.

Guse, A. H., Silva, C. P., Weber, K., Armah, C. N., Ashamu, G. A., Schulze, C., Potter, B. V. L., Mayr, G. W. and Hilz, H., 1997. 1-(5-Phospho-beta-D-ribosyl)2'-phosphoadenosine 5'-phosphate cyclic anhydride induced Ca2+ release in human T-cell lines. European Journal of Biochemistry, 245 (2), pp. 411-417.

Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L. and Mayr, G. W., 1995. Characterization of cyclic adenosine diphosphate-induced Ca2-release in T-lymphocyte cell lines. The Journal of Immunology, 155 (7), pp. 3353-3359.

Guse, A. H., da Silva, C. P., Weber, K., Ashamu, G. A., Potter, B. V. L. and Mayr, G. W., 1996. Regulation of cADP-ribose-induced Ca2+ Release by Mg2+ and inorganic phosphate. Journal of Biological Chemistry, 271 (39), pp. 23946-23953.

Guy, R. H., 2003. 'Minimally invasive' technologies for transdermal delivery and clinical chemistry. In: Challenge in Drug Delivery for the New Millenium. Bulletin Technique Gattefossé 96. Vol. 96. , pp. 47-61. (Bulletin Technique Gattefossé)

Guy, R. H., 2007. Transdermal science and technology - an update. Drug Delivery System, 22 (4), pp. 442-449.

Guy, R. H., Delgado-Charro, M. B. and Kalia, Y. N., 2001. Iontophoretic transport across the skin. Skin Pharmacology and Applied Skin Physiology, 14 (Suppl 1), pp. 35-40.

Guy, R. H. and Hadgraft, J., 2003. Transdermal drug delivery. New York: Marcel Dekker.

Guy, R. H., 2010. Predicting the rate and extent of fragrance chemical absorption into and through the skin. Chemical Research in Toxicology, 23 (5), pp. 864-870.

Guy, R. H., 2010. Transdermal drug delivery. In: Schafer-Korting, M., ed. Drug Delivery. Vol. 197. 197 ed. Springer, pp. 399-410. (Handbook of Experimental Pharmacology)

Guy, R. H. and Szoka, F. C., 2011. Perturbation of solute transport at a liquid-liquid interface by polyethylene glycol (PEG): implications for PEG-induced biomembrane fusion. Physical Chemistry Chemical Physics, 13 (12), pp. 5346-5352.

Guédat, P., Schlewer, G., Krempp, E., Riley, A. M., Potter, B. V. L. and Spiess, B., 1997. Investigation of the inframolecular acid–base properties of d-myo-inositol 1,3,4,5-tetrakisphosphate and DL-myo-inositol 1,2,4,5-tetrakisphosphate. Chemical Communications, 1997 (6), pp. 625-626.

Gülmez, S. E., Lignot-Maleyran, S., De Vries, C. S., Sturkenboom, M., Micon, S., Hamoud, F., Blin, P. and Moore, N., 2012. Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiology and Drug Safety, 21 (8), pp. 851-856.

Güngör, S., Delgado-Charro, M. B., Ruiz-Perez, B., Schubert, W., Isom, P., Moslem, P., Patane, M. A. and Guy, R. H., 2010. Trans-scleral iontophoretic delivery of low molecular weight therapeutics. Journal of Controlled Release, 147 (2), pp. 225-231.

Güngör, S., Delgado-Charro, M. B., Masini-Etévé, V., Potts, R. O. and Guy, R. H., 2013. Transdermal flux predictions for selected selective oestrogen receptor modulators (SERMs) : Comparison with experimental results. Journal of Controlled Release, 172 (3), pp. 601-606.

H

Haddington, N., Hanning, L., Weiss, M. and Taylor, D. A., 2013. The use of a high-fidelity simulation manikin in teaching clinical skills to fourth year undergraduate pharmacy students. Pharmacy Education, 13 (1), pp. 54-60.

Hader, S., 2011. Synthesis and evaluation of fluorinated sialic acid derivatives as novel 'mechanism-based' neuraminidase inhibitors. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Hader, S. and Watts, A., 2013. The synthesis of a series of deoxygenated 2,3-difluoro-N-acetylneuraminic acid derivatives as potential sialidase inhibitors. Carbohydrate Research, 374, pp. 23-28.

Hadgraft, J. and Guy, R. H., 2004. Biotechnological aspects of transport across human skin. Biotechnology & Genetic Engineering Reviews, 21, pp. 183-193.

Hadgraft, J. and Guy, R. H., 2003. Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Guy, R. H. and Hadgraft, J., eds. Transdermal Drug Delivery, 2nd ed. Vol. 2nd Edition, Revised and Expanded. New York: Marcel Dekker, pp. 1-23.

Haigh, R. C., McCabe, C. S., Halligan, P. W. and Blake, D. R., 2003. Joint stiffness in a phantom limb: evidence of central nervous system involvement in rheumatoid arthritis. Rheumatology, 42, pp. 888-892.

Haigh, R. C., Shenker, N. G., Roberts, E. M., Blake, D. R. and Mapp, P. I., 2001. Mirror-imaging and contralateral sensitisation of the inflammatory response following capsaicin injection in man. Rheumatology, 41, S98.

Haigh, R. H. and Blake, D. R., 2001. Understanding pain. Clinical Medicine, 1 (Jan-Feb), pp. 44-48.

Hall, J., Rosenthal, M., Family, H., Sutton, J., Hall, K. and Tsuyuki, R. T., 2013. Personality traits of hospital pharmacists : Toward a better understanding of factors influencing pharmacy practice change. The Canadian Journal of Hospital Pharmacy, 66 (5), pp. 289-295.

Hamann, P.D.H., Cooper, R.G., McHugh, N.J. and Chinoy, H., 2013. Statin-induced necrotizing myositis - A discrete autoimmune entity within the "statin-induced myopathy spectrum". Autoimmunity Reviews, 12 (12), pp. 1177-1181.

Hamblin, M. R., Cummins, J. H. and Potter, B. V. L., 1986. Mung bean nuclease catalyses DNA cleavage with inversion of configuration at phosphorus. In: Biochemical Society Transactions, 1986. Vol. 14. 5 ed. Biochemical Society, pp. 899-900.

Hamblin, M. R., Cummins, J. H. and Potter, B. V. L., 1987. Mung bean (Phaseolus aureus) nuclease. Biochemical Journal, 241 (3), pp. 827-833.

Hamblin, M. R., Flora, J. S. and Potter, B. V. L., 1987. myo-Inositol phosphorothioates, phosphatase-resistant analogues of myo-inositol phosphates. Synthesis of DL-myo-inositol 1,4-bisphosphate and DL-myo-inositol 1,4-bisphosphorothioate. Biochemical Journal, 246 (3), pp. 771-774.

Hamblin, M. R., Gigg, R. and Potter, B. V. L., 1987. Bisphosphorylation of a vic-diol using a phosphite approach : synthesis of myo-inositol 4,5-bisphosphate. Journal of the Chemical Society, Chemical Communications, 1987 (8), pp. 626-627.

Hamblin, M. R. and Potter, B. V. L., 1985. E. coli Ada regulatory protein repairs the Sp diastereoisomer of alkylated DNA. FEBS Letters, 189 (2), pp. 315-317.

Hamblin, M. R., Potter, B. V. L. and Gigg, R., 1987. Synthesis of myo-inositol phosphates and analogues using a phosphite chemistry approach. In: Biochemical Society Transactions, 1987. Vol. 15. 3 ed. Biochemical Society, pp. 1289-1290.

Hamilton, C. J., Fairlamb, A. H. and Eggleston, I. M., 2002. Regiocontrolled synthesis of the macrocyclic polyamine alkaloid ( + )-lunarine, a time-dependent inhibitor of trypanothione reductase. Journal of the Chemical Society - Perkin Transcriptions 1, 8, pp. 1115-1123.

Hamilton, C. J., Saravanamuthu, A., Eggleston, I. M. and Fairlamb, A. H., 2003. Ellman's reagent-mediated regeneration of trypanothione in situ: substrate economoic microplate and time-dependent inhibition assays for trypanothione reductase. Biochemical Journal, 369, pp. 529-537.

Hamilton, C. J., Saravanamuthu, A., Fairlamb, A. H. and Eggleston, I. M., 2003. Benzofuranyl 3,5-bis-polyamine derivatives as time-dependent inhibitors of trypanothione reductase. Bioorganic and Medicinal Chemistry, 11, pp. 3683-3693.

Hamilton, C. J., Saravanamuthu, A., Poupat, C., Fairlamb, A. H. and Eggleston, I. M., 2006. Time-dependent inhibitors of trypanothione reductase. Analogues of the spermidine alkaloid lunarine and related natural products. Bioorganic and Medicinal Chemistry, 14, pp. 2266-2278.

Hamilton, C. S., Yasuhara, A., Baldwin, J. E., Lloyd, M. D. and Rutledge, P. J., 2001. Contrasting fates for 6-α-methylpenicillin N upon oxidation by deacetoxycephalosporin C synthase (DAOCS) and deacetoxy/deacetylcephalosporin C synthase (DAOC/DACS). Bioorganic & Medicinal Chemistry Letters, 11, pp. 2511-2514.

Hanning, L. M., Parmar, N. R. and Morris, E. J., 2013. Experiences using the Confluence wiki as an e-portfolio in a Pharmacist Prescribing Programme. In: Monash Pharmacy Education Symposium 2013, 2013-07-08 - 2013-07-10, Prato.

Hansbro, P.M., Foster, P. S., Liu, C. S., Potter, B. V. L. and Denborough, M. A., 1994. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism. Biochemical and Biophysical Research Communications, 200 (1), pp. 8-15.

Haque, S., Gordon, C., Isenberg, D., Rahman, A., Lanyon, P., Bell, A., Emery, P., McHugh, N. J., Teh, L. S., Scott, D. G. I., Akil, M., Naz, S., Andrews, J., Griffiths, B., Harris, H., Youssef, H., McLaren, J., Toescu, V., Devakumar, V., Teir, J. and Bruce, I. N., 2010. Risk factors for clinical coronary heart disease in systemic lupus erythematosus : The Lupus and Atherosclerosis Evaluation of Risk (LASER) study. Journal of Rheumatology, 37 (2), pp. 322-329.

Hardick, D. J., Blagbrough, I. S., Cooper, G., Potter, B. V. L., Critchley, T. and Wonnacott, S., 1996. Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal α-bungarotoxin binding sites : importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding. Journal of Medicinal Chemistry, 39 (24), pp. 4860-4866.

Hardick, D. J., Blagbrough, I. S. and Potter, B. V. L., 1996. Isotopic enrichment by asymmetric deuteriation : an investigation of the synthesis of deuteriated (S)-(−)-methylsuccinic acids from itaconic acid. Journal of the American Chemical Society, 118 (25), pp. 5897-5903.

Hardick, D. J., Blagbrough, I. S., Wonnacott, S. and Potter, B. V. L., 1994. Regioselective anthranoylation of demethylated aconitine : novel analogues of aconitine inuline and methyllycaconitine. Tetrahedron Letters, 35 (20), pp. 3371-3374.

Hardick, D. J., Cooper, G., Scott-Ward, T., Blagbrough, I. S., Potter, B. V. L. and Wonnacott, S., 1995. Conversion of the sodium channel activator aconitine into a potent α7-selective nicotinic ligand. FEBS Letters, 365 (1), pp. 79-82.

Hargrave, J. D., Allen, J. C., Kociok-Kohn, G., Bish, G. and Frost, C. G., 2010. Catalytic enantioselective Dieckmann-type annulation: Synthesis of pyrrolidines with quaternary stereogenic centers. Angewandte Chemie-International Edition, 49 (10), pp. 1825-1829.

Hargrave, J.D., Allen, J.C. and Frost, C.G., 2010. Alternatives to organoboron reagents in rhodium-catalyzed conjugate additions. Chemistry - An Asian Journal, 5 (3), pp. 386-396.

Hargrave, J.D., Frost, C.G. and Bish, G., 2006. Switching stereoselectivity in rhodium-catalysed 1,4-additions : The asymmetric synthesis of 2-substituted pyrrolizidinones. Chemical Communications, 2006 (42), pp. 4389-4391.

Hargrave, J.D., Herbert, J., Bish, G. and Frost, C.G., 2006. Rhodium-catalysed addition of organotrialkoxysilanes to α-substituted acrylic esters. Organic and Biomolecular Chemistry, 4 (17), pp. 3235-3241.

Hargrave, J. D., Bish, G., Kociok-Kohn, G. and Frost, C. G., 2010. Rhodium-catalysed conjugate addition of arylboronic acids to enantiopure dehydroamino acid derivatives. Organic and Biomolecular Chemistry, 8 (22), pp. 5120-5125.

Harootunian, A. T., Kao, J. P. Y., Paranjape, S., Adams, S.R., Potter, B. V. L. and Tsien, R. Y., 1991. Cytosolic Ca2+ oscillations in REF52 fibroblasts : Ca2+-stimulated IP3 production or voltage-dependent Ca2+ channels as key positive feedback elements. Cell Calcium, 12 (2-3), pp. 153-164.

Harrington, L. S., Carrier, M. J., Gallagher, N., Gilroy, D., Garland, C. J. and Mitchell, J. A., 2007. Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels. American Journal of Physiology-Heart and Circulatory Physiology, 293 (3), H1682-H1688.

Harris, H., 2008. Rapid preformulation screening of drug candidates for dry powder inhaler preparation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Harris, S. J., Foster, J. G. and Ward, S. G., 2009. PI3K isoforms as drug targets in inflammatory diseases : Lessons from pharmacological and genetic strategies. Current Opinion in Investigational Drugs, 10 (11), pp. 1151-1162.

Harris, S. J., Parry, R. V., Westwick, J. and Ward, S. G., 2008. Phosphoinositide lipid phosphatases: Natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. Journal of Biological Chemistry, 283 (5), pp. 2465-2469.

Harris, S. J., 2010. Characterisation of SHIP-1 as a Regulator of T Lymphocyte Function. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Harris, S. J., Parry, R. V., Foster, J. G., Blunt, M. D., Wang, A., Marelli-Berg, F., Westwick, J. and Ward, S. G., 2011. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility. The Journal of Immunology, 186 (8), pp. 4936-4945.

Harris, S. J., Ciuclan, L., Finan, P. M., Wymann, M. P., Walker, C., Westwick, J., Ward, S. G. and Thomas, M. J., 2012. Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels. European Journal of Immunology, 42 (12), pp. 3394-3404.

Harvey, G., Black, C., Maddison, P. and McHugh, N., 1997. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Journal of Rheumatology, 24 (3), pp. 477-484.

Harvey, G. R., Butts, S., Rands, A. L., Patel, Y. and McHugh, N. J., 1999. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clinical And Experimental Immunology, 117 (2), pp. 395-402.

Harvey, G. R. and McHugh, N. J., 1999. Serologic abnormalities in systemic sclerosis. Current Opinion in Rheumatology, 11 (6), pp. 495-502.

Harvey, G. R., Rands, A. L. and McHugh, N. J., 1996. Anti-RNA polymerase antibodies in systemic sclerosis (SSc) : association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II. Clinical And Experimental Immunology, 105 (3), pp. 468-474.

Hasdemir, B., Murphy, J. E., Cottrell, G. S. and Bunnett, N. W., 2009. Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2. Journal of Biological Chemistry, 284 (41), pp. 28453-28466.

Hasnat, M.A., Safwan, J.A., Islam, M.S., Rahman, Z., Karim, M.R., Pirzada, T.J., Samed, A.J. and Rahman, M.M., 2014. Electrochemical decolorization of Methylene blue at Pt electrode in KCl solution for environmental remediation. Journal of Industrial and Engineering Chemistry

Hassell, K., Atella, V., Schafheutle, E., Weiss, M. C. and Noyce, P., 2003. Cost to the patient or cost to the healthcare system? Which one matters most for GP prescribing decisions? A UK-Italy comparison. European Journal of Public Health, 13 (1), pp. 18-23.

Hathout, R. M. and Woodman, T. J., 2012. Applications of NMR in the characterization of pharmaceutical microemulsions. Journal of Controlled Release, 161 (1), pp. 62-72.

Hathout, R. M., Woodman, T. J., Mansour, S., Mortada, N. D., Geneidi, A. S. and Guy, R. H., 2010. Microemulsion formulations for the transdermal delivery of testosterone. European Journal of Pharmaceutical Sciences, 40 (3), pp. 188-196.

Hathout, R. M., Mansour, S., Geneidi, A. S. and Mortada, N. D., 2011. Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. Journal of Colloid and Interface Science, 354 (1), pp. 124-130.

Hathout, R. M., Mansour, S., Mortada, N. D., Geneidi, A. S. and Guy, R. H., 2010. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Molecular Pharmaceutics, 7 (4), pp. 1266-1273.

Hay, F. R., O'Neill, M. A. A., Beezer, A. E. and Gaisford, S., 2006. Isothermal micro-calorimetry: a tool to predict seed longevity? Seed Science Research, 16, pp. 89-96.

Hayes, J. D., Kelleher, M. O. and Eggleston, I. M., 2008. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. European Journal of Nutrition, 47, pp. 73-88.

Hayes, J. D., Kelleher, M. O., Eggleston, I. M., Akesson, B. and Merke, P., 2007. Anticarcinogenic effects of glucosinalate breakdown products. In: Dietary vitamins, polyphenols, selenium and probiotics: biomarkers of exposure and mechanisms of anticarcinogenic action. Nofer Institute of Occupational Medicine, pp. 140-160.

Heid, I. M., Jackson, A. U., Randall, J. C., Winkler, T. W., Qi, L., Steinthorsdottir, V., Thorleifsson, G., Zillikens, M. C., Speliotes, E. K., Mägi, R., Workalemahu, T., White, C. C., Bouatia-Naji, N., Harris, T. B., Berndt, S. I., Ingelsson, E., Willer, C. J., Weedon, M. N., Luan, J.'a., Vedantam, S., Esko, T., Kilpeläinen, T. O., Kutalik, Z., Li, S., Monda, K. L., Dixon, A. L., Holmes, C. C., Kaplan, L. M., Liang, L., Min, J. L., Moffatt, M. F., Molony, C., Nicholson, G., Schadt, E. E., Zondervan, K. T., Feitosa, M. F., Ferreira, T., Allen, H. L., Weyant, R. J., Wheeler, E., Wood, A. R., Estrada, K., Goddard, M. E., Lettre, G., Mangino, M., Nyholt, D. R., Purcell, S., Smith, A. V., Visscher, P. M., Yang, J., McCarroll, S. A., Nemesh, J., Voight, B. F., Absher, D., Amin, N., Aspelund, T., Coin, L., Glazer, N. L., Hayward, C., Heard-Costa, N. L., Hottenga, J.-J., Johansson, Å., Johnson, T., Kaakinen, M., Kapur, K., Ketkar, S., Knowles, J. W., Kraft, P., Kraja, A. T., Lamina, C., Leitzmann, M. F., McKnight, B., Morris, A. P., Ong, K. K., Perry, J. R. B., Peters, M. J., Polasek, O., Prokopenko, I., Rayner, N. W., Ripatti, S., Rivadeneira, F., Robertson, N. R., Sanna, S., Sovio, U., Surakka, I., Teumer, A., van Wingerden, S., Vitart, V., Zhao, J. H., Cavalcanti-Proença, C., Chines, P. S., Fisher, E., Kulzer, J. R., Lecoeur, C., Narisu, N., Sandholt, C., Scott, L. J., Silander, K., Stark, K., Tammesoo, M.-L., Teslovich, T. M., Timpson, N. J., Watanabe, R. M., Welch, R., Chasman, D. I., Cooper, M. N., Jansson, J.-O., Kettunen, J., Lawrence, R. W., Pellikka, N., Perola, M., Vandenput, L., Alavere, H., Almgren, P., Atwood, L. D., Bennett, A. J., Biffar, R., Bonnycastle, L. L., Bornstein, S. R., Buchanan, T. A., Campbell, H., Day, I. N. M., Dei, M., Dörr, M., Elliott, P., Erdos, M. R., Eriksson, J. G., Freimer, N. B., Fu, M., Gaget, S., Geus, E. J. C., Gjesing, A. P., Grallert, H., Gräßler, J., Groves, C. J., Guiducci, C., Hartikainen, A.-L., Hassanali, N., Havulinna, A. S., Herzig, K.-H., Hicks, A. A., Hui, J., Igl, W., Jousilahti, P., Jula, A., Kajantie, E., Kinnunen, L., Kolcic, I., Koskinen, S., Kovacs, P., Kroemer, H. K., Krzelj, V., Kuusisto, J., Kvaloy, K., Laitinen, J., Lantieri, O., Lathrop, G. M., Lokki, M.-L., Luben, R. N., Ludwig, B., McArdle, W. L., McCarthy, A., Morken, M. A., Nelis, M., Neville, M. J., Paré, G., Parker, A. N., Peden, J. F., Pichler, I., Pietiläinen, K. H., Platou, C. G. P., Pouta, A., Ridderstråle, M., Samani, N. J., Saramies, J., Sinisalo, J., Smit, J. H., Strawbridge, R. J., Stringham, H. M., Swift, A. J., Teder-Laving, M., Thomson, B., Usala, G., van Meurs, J. B. J., van Ommen, G.-J., Vatin, V., Volpato, C. B., Wallaschofski, H., Walters, G. B., Widen, E., Wild, S. H., Willemsen, G., Witte, D. R., Zgaga, L., Zitting, P., Beilby, J. P., James, A. L., Kähönen, M., Lehtimäki, T., Nieminen, M. S., Ohlsson, C., Palmer, L. J., Raitakari, O., Ridker, P. M., Stumvoll, M., Tönjes, A., Viikari, J., Balkau, B., Ben-Shlomo, Y., Bergman, R. N., Boeing, H., Smith, G. D., Ebrahim, S., Froguel, P., Hansen, T., Hengstenberg, C., Hveem, K., Isomaa, B., Jørgensen, T., Karpe, F., Khaw, K.-T., Laakso, M., Lawlor, D. A., Marre, M., Meitinger, T., Metspalu, A., Midthjell, K., Pedersen, O., Salomaa, V., Schwarz, P. E. H., Tuomi, T., Tuomilehto, J., Valle, T. T., Wareham, N. J., Arnold, A. M., Beckmann, J. S., Bergmann, S., Boerwinkle, E., Boomsma, D. I., Caulfield, M. J., Collins, F. S., Eiriksdottir, G., Gudnason, V., Gyllensten, U., Hamsten, A., Hattersley, A. T., Hofman, A., Hu, F. B., Illig, T., Iribarren, C., Jarvelin, M.-R., Kao, W. H. L., Kaprio, J., Launer, L. J., Munroe, P. B., Oostra, B., Penninx, B. W., Pramstaller, P. P., Psaty, B. M., Quertermous, T., Rissanen, A., Rudan, I., Shuldiner, A. R., Soranzo, N., Spector, T. D., Syvanen, A.-C., Uda, M., Uitterlinden, A., Völzke, H., Vollenweider, P., Wilson, J. F., Witteman, J. C., Wright, A. F., Abecasis, G. R., Boehnke, M., Borecki, I. B., Deloukas, P., Frayling, T. M., Groop, L. C., Haritunians, T., Hunter, D. J., Kaplan, R. C., North, K. E., O'Connell, J. R., Peltonen, L., Schlessinger, D., Strachan, D. P., Hirschhorn, J. N., Assimes, T. L., Wichmann, H.-E., Thorsteinsdottir, U., van Duijn, C. M., Stefansson, K., Cupples, L. A., Loos, R. J. F., Barroso, I., McCarthy, M. I., Fox, C. S., Mohlke, K. L. and Lindgren, C. M., 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nature Genetics, 42 (11), pp. 949-960.

Hejaz, H. A. M., Purohit, A., Mahon, M. F., Reed, M. J. and Potter, B. V. L., 1999. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O -sulfamoyl-1,3,5(10)-estratriene : x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene. Journal of Medicinal Chemistry, 42 (16), pp. 3188-3192.

Hejaz, H. A. M., Woo, L. W. L., Purohit, A., Reed, M. J. and Potter, B. V. L., 2004. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Bioorganic and Medicinal Chemistry, 12 (10), pp. 2759-2772.

Hendryk, S., Czuba, Z. P., Jędrzejowska-Szypułka, H., Szliszka, E., Phillips, V. A., Threadgill, M. D. and Król, W., 2008. Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischaemia and after reperfusion. Journal of Physiology and Pharmacology, 59 (4), pp. 811-822.

Herkenne, C., Alberti, I., Naik, A., Kalia, Y. N., Mathy, F. X., Préat, V. and Guy, R. H., 2008. In vivo methods for the assessment of topical drug bioavailability. Pharmaceutical Research, 25 (1), pp. 87-103.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2007. Dermatopharmacokinetic prediction of topical drug bioavailability in vivo. Journal Of Investigative Dermatology, 127 (4), pp. 887-894.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2008. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. Journal of Pharmaceutical Sciences, 97 (1), pp. 185-197.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2007. Ibuprofen transport into and through skin from topical formulations: in vitro - in vivo comparison. Journal Of Investigative Dermatology, 127 (1), pp. 135-142.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2006. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharmaceutical Research, 23 (8), pp. 1850-1856.

Herrick, A. L., Lunt, M., Whidby, N., Ennis, H., Silman, A., McHugh, N. J. and Denton, C. P., 2010. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. Journal of Rheumatology, 37 (1), pp. 116-124.

Herrick, A. L., Roberts, C., Tracey, A., Silman, A., Anderson, M., Goodfield, M., McHugh, N. J., Muir, L. and Denton, C. P., 2009. Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis & Rheumatism, 60 (3), pp. 878-882.

Hertle, R., Mrsny, R. and Fitzgerald, D. J., 2001. Dual-function vaccine for Pseudomonas aeruginosa : characterization of chimeric exotoxin A-Pilin protein. Infection and Immunity, 69 (11), pp. 6962-6969.

Hewinson, J., Moore, S. F., Glover, C., Watts, A. and Mackenzie, A. B., 2008. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 β processing in human monocytes. The Journal of Immunology, 180 (12), pp. 8410-8420.

Hickman, M., Lingford-Hughes, A., Bailey, C., Macleod, J., Nutt, D. and Henderson, G., 2008. Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction, 103 (7), pp. 1060-1062.

Hidalgo Aragones, M. I., Purohit, A., Parish, D., Sahm, U. G., Pouton, C. W., Potter, B. V., L. and Reed, M. J., 1996. Pharmacokinetics of oestrone-3-O-sulphamate. Steroid Biochemistry & Molecular Biology, 58 (5-6), pp. 611-617.

Higgins, L. G., Kelleher, M. O., Eggleston, I. M., Itoh, K., Yamamoto, M. and Hayes, J. D., 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicology and Applied Pharmacology, 237 (3), pp. 267-280.

Hill, C. E., Phillips, J. K. and Sandow, S. L., 2001. Heterogeneous control of blood flow amongst different vascular beds. Medicinal Research Reviews, 21, pp. 1-60.

Hill, C. E., Rummery, N. M., Hickey, H. and Sandow, S. L., 2002. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clinical and Experimental Pharmacology and Physiology, 29, pp. 620-625.

Hinch, M., Jacques, O., Drago, C., Caggiano, L., Jackson, R. F. W., Dexter, C., Anson, M. S. and MacDonald, S. J. F., 2006. Effective asymmetric oxidation of enones and alkyl aryl sulfides. Journal of Molecular Catalysis A: Chemical, 251 (1-2), pp. 123-128.

Hirata, M., Takeuchi, H., Riley, A. M., Mills, S. J., Watanabe, Y. and Potter, B. V. L., 1997. Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate. Biochemical Journal, 328 (1), pp. 93-98.

Hirst, P. H., Riley, A. M., Mills, S. J., Spiers, I. D., Poyner, D. R., Freeman, S., Potter, B. V. L. and Smith, A. W., 1999. Inositol polyphosphate-mediated iron transport in Pseudomonas aeruginosa. Journal of Applied Microbiology, 86 (3), pp. 537-543.

Ho, M. W. Y., Yang, X., Carew, M. A., Zhang, T., Hua, L., Kwon, Y.-U., Chung, S.-K., Adelt, S., Vogel, G., Riley, A. M., Potter, B. V. L. and Shears, S. B., 2002. Regulation of Ins(3,4,5,6)P 4 signaling by a reversible kinase/phosphatase. Current Biology, 12 (6), pp. 477-482.

Ho, Y. T., Newman, S. P., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-methyl oestrogens and their sukphamaoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis. Steroid Biochemistry & Molecular Biology, 86, pp. 189-196.

Ho, Y. T., Newman, S. P., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis. Steroid Biochemistry & Molecular Biology, 86 (2), pp. 189-196.

Ho, Y. T., Purohit, A., Vicker, N., Newman, S. P., Robinson, J. J., Leese, M. P., Ganeshapillai, D., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2003. Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates. Biochemical and Biophysical Research Communications, 305 (4), pp. 909-914.

Hobbs, C. M., 2010. The Functional Expression of N-Methyl-D-Aspartate Glutamate-Type Receptors by Megakaryocytes and Platelets. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Hobert, M. E., Sands, K. A., Mrsny, R. J. and Madara, J. L., 2002. Cdc42 and Rac1 regulate late events in Salmonella typhimurium -induced Interleukin-8 secretion from polarizedepithelial cells. Journal of Biological Chemistry, 277 (52), pp. 51025-51032.

Hobson, R. J., Scott, J. and Sutton, J., 2010. Pharmacists and nurses as independent prescribers: Exploring the patient's perspective. Family Practice, 27 (1), pp. 110-120.

Hobson, R. J. and Sewell, G. J., 2003. A national survey of pharmacist transcribing of discharge prescriptions. International Journal of Pharmacy Practice, 11, pp. 89-95.

Hobson, R. J. and Sewell, G. J., 2006. A survey of nurse prescribing implementation in primary and secondary care in England. In: 12th Health Services Research & Pharmacy Practice Conference, 2006-01-01, University of Bath.

Hobson, R. J. and Sewell, G. J., 2002. Factors influencing provision of pharmacist discharge prescription transcription services and authorisation requirements of pharmacist-written prescriptions. International Journal of Pharmacy Practice, 10, R62.

Hobson, R. J. and Sewell, G. J., 2004. Responsibility, accountability and factors influencing provision of pharmacist transcription of discharge prescriptions. International Journal of Pharmacy Practice, 12, pp. 163-168.

Hobson, R. J. and Sewell, G. J., 2006. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharmacy World & Science, 28 (2), pp. 76-90.

Hobson, R. J. and Sewell, G. J., 2006. Supplementary prescribing by pharmacists in England. American Journal of Health-Systems Pharmacy, 63, pp. 244-253.

Hobson, R. J. and Sewell, G. J., 2002. UK survey of discharge prescriptions, transcribing and development of the hospital pharmacist-prescribing role. International Journal of Pharmacy Practice, 10, R10.

Hobson, R. J., 2008. Investigation into early implementation of non medical prescribing in the UK. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Hodgkin, M., Craxton, A., Parry, J. B., Hughes, P. J., Potter, B. V. L., Michell, R. H. and Kirk, C. J., 1994. Bovine testis and human erythrocytes contain different subtypes of membrane-associated Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphomonoesterases. Biochemical Journal, 297 (3), pp. 637-645.

Hohenegger, M., Berg, I., Weigl, L., Mayr, G. W., Potter, B. V. L. and Guse, A. H., 1999. Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes. British Journal of Pharmacology, 128 (6), pp. 1235-1240.

Holbourn, K. P., Lloyd, M. D., Thompson, A. S., Threadgill, M. D. and Acharya, K. R., 2011. Cloning, purification, crystallization and preliminary crystallographic analysis of the human histone deacetylase sirtuin 1. Acta Crystallographica Section F-Structural Biology and Crystallization Communications, 67 (4), pp. 461-463.

Holmström, A.-R., Airaksinen, M., Weiss, M., Laaksonen, R., Wuliji, T. and Chan, X.H., 2012. National and local medication error reporting systems: a survey of practices in 16 countries. Journal of Patient Safety, 8 (4), pp. 165-176.

Holt, R. J., Zhang, Y. M., Binia, A., Dixon, A. L., Vandiedonck, C., Cookson, W. O., Knight, J. C. and Moffatt, M. F., 2011. Allele-specific transcription of the asthma-associated PHD finger protein 11 gene (PHF11) modulated by octamer-binding transcription factor 1 (Oct-1). Journal of Allergy and Clinical Immunology, 127 (4), 1054-U322.

Hooton, J. C., Jones, M. D. and Price, R., 2006. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. Journal of Pharmaceutical Sciences, 95 (6), pp. 1288-1297.

Hopkins, A. M., Li, D. X., Mrsny, R. J., Walsh, S. V. and Nusrat, A., 2000. Modulation of tight junction function by G protein-coupled events. Advanced Drug Delivery Reviews, 41 (3), pp. 329-340.

Hopton, S. R. and Thompson, A. S., 2011. Manipulative interplay of two adozelesin molecules with d(ATTAAT)2 achieving ligand-stacked Watson-Crick and Hoogsteen base-paired duplex adducts. Biochemistry, 50 (19), pp. 4143-4154.

Hopton, S. R. and Thompson, A. S., 2011. Nuclear magnetic resonance solution structures of inter- and intrastrand adducts of DNA cross-linker SJG-136. Biochemistry, 50 (21), pp. 4720-4732.

Horne, G., Maechling, C., Fleig, A., Hirata, M., Penner, R., Spiess, B. and Potter, B. V. L., 2004. D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of D-myo-inositol 1,3,4,5-tetrakisphosphate : biological activity and pH-dependent conformational properties. Biochemical and Biophysical Research Communications, 320 (4), pp. 1262-1270.

Horne, G., Mills, S. J. and Potter, B. V. L., 2004. First derivatives of myo-inositol 1,4,6-trisphosphate modified at positions 2 and 3 : structural an analogues of D- myo -inositol 1,4,5-trisphosphate. Carbohydrate Research, 339, pp. 51-65.

Horne, G. and Potter, B. V. L., 2001. Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-tetrakisphosphate. Chemistry - A European Journal, 7 (1), pp. 80-87.

Hou, Q., De Bank, P. A. and Shakesheff, K. M., 2004. Injectable scaffolds for tissue regeneration. Journal of Materials Chemistry, 14, p. 1915.

Houston, D. R., Eggleston, I. M., Synstad, B., Eijsink, V. G. H. and van Aalten, D. M. F., 2002. The cyclic dipeptide CI-4 [ cyclo- (L-Arg-D-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate. Biochemical Journal, 368 (27), pp. 23-27.

Houston, D. R., Synstad, B., Eijsink, V. G. H., Stark, M. J. R., Eggleston, I. M. and van Aalten, D. M. F., 2004. Structure-based exploration of cyclic dipeptide chitinase inhibitors. Journal of Medicinal Chemistry, 47, pp. 5713-5720.

Howarth, N. M., Cooper, G., Purohit, A., Duncan, L., Reed, M. J. and Potter, B. V. L., 1993. Phosphonates and thiophosphonates as sulfate surrogates : synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Bioorganic & Medicinal Chemistry Letters, 3 (2), pp. 313-318.

Howarth, N. M., Purohit, A., Reed, M. J. and Potter, B. V. L., 1994. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. Journal of Medicinal Chemistry, 37 (2), pp. 219-221.

Howarth, N. M., Purohit, A., Reed, M. J. and Potter, B. V. L., 1997. Estrone sulfonates as inhibitors of estrone sulfatase. Steroids, 62 (4), pp. 346-350.

Howarth, N. M., Purohit, A., Robinson, J. J., Vicker, N., Reed, M. J. and Potter, B. V. L., 2002. Estrone 3-sulfate mimics, inhibitors of estrone sulfatase activity : homology model construction and docking studies. Biochemistry, 41 (50), pp. 14801-14814.

Howson, S. E., Bolhuis, A., Brabec, V., Clarkson, G. J., Malina, J., Rodger, A. and Scott, P., 2012. Optically pure, water-stable metallo-helical ‘flexicate’ assemblies with antibiotic activity. Nature Chemistry, 4 (1), pp. 31-36.

Hoyles, R. K., Ellis, R. W., Wellsbury, J., Lees, B., Newlands, P., Goh, N. S. L., Roberts, C., Desai, S., Herrick, A. L., McHugh, N. J., Foley, N. M., Pearson, S. B., Emery, P., Veale, D. J., Denton, C. P., Wells, A. U., Black, C. M. and du Bois, R. M., 2006. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis & Rheumatism, 54 (12), pp. 3962-3970.

Hsieh, J. C., Tham, D. M., Feng, W., Huang, F., Embaie, S., Liu, K., Dean, D., Hertle, R., Fitzgerald, D. J. and Mrsny, R. J., 2005. Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells. Infection and Immunity, 73 (11), pp. 7705-7717.

Hu, Z., Pantoș, G. D., Kuganathan, N., Arrowsmith, R., Jacobs, R. M. J., Kociok-Köhn, G., O'Byrne, J., Jurkschat, K., Burgos, P., Tyrrell, R. M., Botchway, S. W., Sanders, J. K. M. and Pascu, S. I., 2012. Interactions between amino acid-tagged naphthalenediimide and single walled carbon nanotubes for the design and construction of new bioimaging probes. Advanced Functional Materials, 22 (3), pp. 503-518.

Hudson, A. L., Nutt, D. J. and Husbands, S. M., 2001. Imidazoline receptors and their role in depression. Pharmaceutical News, 8 (3), pp. 18-24.

Hudson, A. L., Tyacke, R. J., Lalies, M. D., Davies, N., Finn, D. P., Martí, O., Robinson, E., Husbands, S. M., Minchin, M. C. W., Kimura, A. and Nutt, D. J., 2003. Novel ligands for the investigation of imidazoline receptors and their binding proteins. Annals of the New York Academy of Sciences, 1009, pp. 302-308.

Huffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., Bruce, I. N., Ryan, A. W., Behrens, F., Lascorz, J., Bohm, B., Traupe, H., Lohmann, J., Gieger, C., Wichmann, H. E., Herold, C., Steffens, M., Klareskog, L., Wienker, T. F., FitzGerald, O., Alenius, G. M., McHugh, N. J., Novelli, G., Burkhardt, H., Barton, A. and Reis, A., 2010. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nature Genetics, 42 (11), pp. 996-999.

Hull, L. C., Llorente, J., Gabra, B. H., Smith, F. L., Kelly, E., Bailey, C., Henderson, G. and Dewey, W. L., 2010. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. Journal of Pharmacology and Experimental Therapeutics, 332 (3), pp. 1127-1135.

Hull, L.C., Gabra, B.H., Bailey, C.P., Henderson, G. and Dewey, W.L., 2013. Reversal of morphine analgesic tolerance by ethanol in the mouse. Journal of Pharmacology and Experimental Therapeutics, 345 (3), pp. 512-519.

Hurley, B. P., Siccardi, D., Mrsny, R. J. and McCormick, B. A., 2004. Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A 3 1. The Journal of Immunology, 173 (9), pp. 5712-5720.

Husbands, S. M., 2004. Kappa-opioid receptor ligands. Expert Opinion on Therapeutic Patents, 14 (12), pp. 1725-1741.

Husbands, S. M., Glennon, R. A., Gorgerat, S., Gough, R., Tyacke, R., Crosby, J., Nutt, D. J., Lewis, J. W. and Hudson, A. L., 2001. β-carboline binding to imidazoline receptors. Drug and Alcohol Dependence, 64, pp. 203-208.

Husbands, S. M. and Lewis, J. W., 2003. Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse. Mini-Reviews in Medicinal Chemistry, 3, pp. 137-144.

Husbands, S. M., Neilan, C. L., Broadbear, J., Grundt, P., Breeden, S., Aceto, M. D., Woods, J. H., Lewis, J. W. and Traynor, J. R., 2005. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. European Journal of Pharmacology, 509, pp. 117-125.

Husbands, S. M., 2013. Buprenorphine and related orvinols. In: Ko, M.-C. and Husbands, S. M., eds. Research and Development of Opioid-Related Ligands. Washington, DC: American Chemical Society, pp. 127-144. (ACS Symposium Series; 1131)

Hutcheon, G. W. and Bolhuis, A., 2003. The archael twin-arginine translocation pathway. Biochemical Society Transactions, 31 (3), pp. 686-689.

Hutcheon, G. W., Vasisht, N. and Bolhuis, A., 2005. Characterisation of a highly stable α-amylase from the halophilic archaeon Haloarcula hispanica. Extremophiles, 9, pp. 487-495.

Hutchison, A., Russell-Jones, D., Hordern, V. and de Vries, C. S., 2008. Reduced risk of hypoglycaemia in analogue compared with human insulin : An observational study in the UK. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), p. 271.

Hutchison, A., Russell-Jones, D. and de Vries, C. S., 2009. Predictors of drug choice in newly diagnosed type 2 diabetes. Diabetologia, 52 (Supplement 1), p. 314.

Huws, S. A., Morley, R. J., Jones, M. V., Brown, M. R. W. and Smith, A. W., 2008. Interactions of some common pathogenic bacteria with Acanthamoeba polyphaga. FEMS Microbiology Letters, 282 (2), pp. 258-265.

Huws, S. A., Smith, A. W., Enright, M. C., Wood, P. J. and Brown, M. R. W., 2006. Amoebae promote persistence of epidemic strains of MRSA. Environmental Microbiology, 8 (6), pp. 1130-1133.

Hyyryläinen, H. L., Bolhuis, A., Darmon, E., Muukkonen, L., Koski, P., Vitikainen, M., Sarvas, M., Prágai, Z., Bron, S., van Dijl, J. M. and Kontinen, V. P., 2001. A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress. Molecular Microbiology, 41 (5), pp. 1159-1172.

Hébert, H.L., Bowes, J., Smith, R.L., McHugh, N.J., Barker, J.N.W.N., Griffiths, C.E.M., Barton, A. and Warren, R.B., 2013. Forthcoming. Polymorphisms in IL-1B Distinguish between Psoriasis of Early and Late Onset. Journal Of Investigative Dermatology

I

Iarova, P. L., Garland, C. J. and Dora, K. A., 2010. Activation of β-adrenoceptors evokes local and spreading dilatation in rat isolated mesenteric arteries. In: 60th Annual British Microcirculation Meeting, 2010-01-01, Peninsula Medical School, Exeter.

Iarova, P. L., Smirnov, S. V., Dora, K. A. and Garland, C. J., 2013. β1-adrenoceptor stimulation suppresses endothelial IKCa-channel hyperpolarization and associated dilatation in resistance arteries. British Journal of Pharmacology, 169 (4), pp. 875-886.

Iarova, P. L., 2011. Mechanisms underlying the endothelium-dependent modulation of vascular tone. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Ibrahim, A. and Scott, J., 2013. Community pharmacists in Khartoum State, Sudan: their current roles and perspectives on pharmaceutical care implementation. International Journal of Clinical Pharmacy, 35 (2), pp. 236-243.

Iiott, N.E., Heward, J.A., Roux, B., Tsitsiou, E., Fenwick, P.S., Lenzi, L., Goodhead, I., Hertz-Fowler, C., Heger, A., Hall, N., Donnelly, L.E., Sims, D. and Lindsay, M.A., 2014. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide- induced inflammatory response in human monocytes. Nature Communications, 5.

Ingram, S. W., Safrany, S. T. and Barnes, L. D., 2003. Disruption and overexpression of the Schizosaccharomyces pombe aps1 gene and the effects on growth rate, morphology, and intracellular diadenosine 5', 5'''- P 1 , P 5 -pentaphosphate and diphosphoinositol polyphosphate concentrations. Biochemical Journal, 369, pp. 519-528.

Inman, R. and Stone, M., 2007. Reactive Arthritis: Etiology and Pathogenesis. In: Hochberg, M., Silman, A., Smolen, J., Weinblatt, M. and Weisman, M., eds. Rheumatology, 4th Edition. .

Irarrazabal, C. E., Burg, M. B., Ward, S. G. and Ferraris, J. D., 2006. Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: role in osmoprotective transcriptional regulation. Proceedings of the National Academy of Sciences of the United States of America, 103 (23), pp. 8882-8887.

Ireland, A. J., Moreno, T. and Price, R., 2003. Airborne particles produced during enamel cleanup after removal of orthodontic appliances. American Journal of Orthodontics and Dentofacial Orthopedics, 124, pp. 683-686.

Ireland, A. J., Wilson, A. A., Blythe, L., Johnston, N. J., Price, R. and Sandy, J. R., 2011. Particulate production during orthodontic production laboratory procedures. Journal of Exposure Science and Environmental Epidemiology, 21 (5), pp. 536-540.

Ireson, C. R., Chander, S. K., Purohit, A., Parish, D. C., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2004. Pharmacokinetics of the nonsteroidal sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats. British Journal of Cancer, 91 (7), pp. 1399-1404.

Ireson, C. R., Chander, S. K., Purohit, A., Perera, S., Newman, S. P., Parish, D., Leese, M. P., Smith, A. C., Potter, B. V. L. and Reed, R. J., 2004. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer, 90 (4), pp. 932-937.

Ireson, C. R., Parish, D., Purohit, A., Woo, L. W. L., Potter, B. V. L., Chander, S. K. and Reed, M. J., 2003. Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. Journal of Steroid Biochemistry and Molecular Biology, 84 (2), pp. 337-342.

Isenberg, D. A., Rahman, A., Allen, E., Farewell, V., Akil, M., Bruce, I. N., D'Cruz, D., Griffiths, B., Khamashta, M., Maddison, P., McHugh, N., Snaith, M., Teh, L. S., Yee, C. S., Zoma, A. and Gordon, C., 2005. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology, 44 (7), pp. 902-906.

Isenman, D. E., Leung, E., Mackay, J. D., Bagby, S. and van den Elsen, J. M. H., 2008. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement eeceptor 2 (CR2) share overlapping contact residues on C3d: Implications for the controversy regarding the CR2/C3d cocrystal structure. Molecular Immunology, 45 (16), pp. 4095-4096.

Isenman, D. E., Leung, E., Mackay, J. D., Bagby, S. and van den Elsen, J. M. H., 2010. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure. The Journal of Immunology, 184 (4), pp. 1946-1955.

J

Jackson, T., Woo, L. W. L., Trusselle, M. N., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Non-steroidal aromatase inhibitors based ona biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling. ChemMedChem, 3, pp. 603-618.

Jackson, T. R., Springall, J. S., Rogalle, D., Masurnoto, N., Li, H. C., D'Hooge, F., Perera, S. P., Jenkins, A. T. A., James, T. D., Fossey, J. S. and van den Elsen, J. M. H., 2008. Boronate affinity saccharide electrophoresis : A novel carbohydrate analysis tool. Electrophoresis, 29 (20), pp. 4185-4191.

Jackson, T., Woo, L. W. L., Trusselle, M. N., Chander, S. K., Purohit, A., Reed, M. J. and Potter, B. V. L., 2007. Dual aromatase-sulfatase inhibitors based on the anastrozole template : synthesis, in vitro SAR, molecular modelling and in vivo activity. Organic and Biomolecular Chemistry, 5, pp. 2940-2952.

Jackson, T., Woo, L. W. L., Trusselle, M. N., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Non-steroidal aromatase inhibitors based on a biphenyl scaffold : synthesis, in vitro SAR, and molecular modelling. ChemMedChem, 3 (4), pp. 603-618.

Jadon, D., Tillett, W., Wallis, D., Cavill, C., Bowes, J., Waldron, N., Dixon, A., Sengupta, R., Barton, A., Korendowych, E. and McHugh, N. J., 2013. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology, 52 (2), pp. 261-6.

Jakubovics, N. S., Smith, A. W. and Jenkinson, H. F., 2002. Oxidative stress tolerance is managanese (Mn 2+ ) regulated in Streptococcus gordonii. Microbiology, 148, pp. 3255-3263.

James, K. L., Barlow, D., Bithell, A., Burfield, R., Hiom, S., Lord, S., Pollard, M., Roberts, D., Way, C., Sutton, C. and Whittlesea, C., 2011. Measuring dispensary workload: a comparison of the event recording and direct time techniques. International Journal of Pharmacy Practice, 19 (4), pp. 264-275.

James, K. L., Barlow, D., Burfield, R., Hiom, S., Roberts, D. and Whittlesea, C., 2008. A study of unprevented dispensing incidents in Welsh NHS hospitals. International Journal of Pharmacy Practice, 16 (3), pp. 175-188.

James, K. L., Barlow, D., Burfield, R., Hiom, S., Roberts, D. and Whittlesea, C., 2011. Unprevented or prevented dispensing incidents: which outcome to use in dispensing error research? International Journal of Pharmacy Practice, 19 (1), pp. 36-50.

James, K. L., Barlow, D., McArtney, R., Hiom, S., Roberts, D. and Whittlesea, C., 2009. Incidence, type and causes of dispensing errors : A review of the literature. International Journal of Pharmacy Practice, 17 (1), pp. 9-30.

James, K. L., Davies, J. G., Kinchin, I., Patel, J. P. and Whittlesea, C., 2010. Understanding vs. competency: the case of accuracy checking dispensed medicines in pharmacy. Advances in Health Sciences Education, 15 (5), pp. 735-747.

James, K. L., Barlow, D., Bithell, A., Hiom, S., Lord, S., Oakley, P., Pollard, M., Roberts, D., Way, C. and Whittlesea, C., 2013. The impact of automation on pharmacy staff experience of workplace stressors. International Journal of Pharmacy Practice, 21 (2), pp. 105-116.

James, K. L., Barlow, D., Bithell, A., Hiom, S., Lord, S., Pollard, M., Roberts, D., Way, C. and Whittlesea, C., 2013. The impact of automation on workload and dispensing errors in a hospital pharmacy. International Journal of Pharmacy Practice, 21 (2), pp. 92-104.

James, K. L., Barlow, D., Hiom, S., Roberts, D. and Whittlesea, C., 2008. Development and use of the critical incident technique in evaluating causes of dispensing incidents. International Journal of Pharmacy Practice, 16 (4), pp. 239-249.

Janciene, R., Stumbreviciute, Z., Podeniene, D., Puodziunaite, B. D., Black, S. and Husbands, S. M., 2006. Synthesis of novel 1-substituted [1,3]thiazolo[3,2- a ]-[1,5]benzodiazepine derivatives from 1,5-benzodiazepine-2-thiones and α-halogen carbonyl compounds. Journal of Heterocyclic Chemistry, 43, pp. 979-984.

Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1981. Analysis of the chirality of [16O,17O,18O] phosphate esters by 31P nuclear magnetic resonance spectroscopy. Journal of the Chemical Society, Perkin Transactions 1

Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1980. A stereochemical investigation of the cyclisation of D-glucose-6[(R)-16O,17O,18O]phosphate and adenosine-5′[(R)-16O,17O,18O]phosphate. Journal of the Chemical Society, Chemical Communications, 1980 (23), pp. 1142-1145.

Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1981. The stereochemical course of phosphoryl transfer catalysed by Bacillus stearothermophilus and rabbit skeletal-muscle phosphofructokinase with a chiral [160,170,18O] phosphate ester. Biochemical Journal, 199 (2), pp. 427-432.

Jenkins, D. J., Riley, A. M. and Potter, B. V. L., 1998. Carbohydrates as sources of chiral inositol polyphosphates and their mimics. In: Chapleur, Y., ed. Carbohydrate Mimics, Concepts and Methods. Chichester, U. K.: Wiley-VCH, pp. 171-208.

Jenkins, D. J., Dubreuil, D. and Potter, B. V. L., 1996. Synthesis of D-2-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate from D-glucose. Journal of the Chemical Society - Perkin Transcriptions 1, 1996 (12), pp. 1365-1372.

Jenkins, D. J., Marwood, R. D. and Potter, B. V. L., 1997. A disaccharide polyphosphate mimic of 1D-myo-inositol 1,4,5-trisphosphate. Chemical Communications, 1997 (5), pp. 449-450.

Jenkins, D. J. and Potter, B. V. L., 1995. (2-Hydroxyethyl)-∝-D-glucopyranoside-2',3,4-trisphosphate : synthesis of a second messenger mimic related to adenophostin A. Journal of the Chemical Society, Chemical Communications, 1995 (11), pp. 1169-1170.

Jenkins, D. J. and Potter, B. V. L., 1996. A Ca2+-mobilising carbohydrate-based polyphosphate : synthesis of 2-hydroxyethyl α-d-glucopyranoside 2′,3,4-trisphosphate. Carbohydrate Research, 287 (2), pp. 169-182.

Jenkins, D. J. and Potter, B. V. L., 1994. On the selectivity of stannylene-mediated alkylation and esterification of methyl 4,6-O-benzylidene α-D-glucopyranoside. Carbohydrate Research, 265 (1), pp. 145-149.

Jenkins, D. J. and Potter, B. V. L., 1998. Total synthesis, from D-xylose, of chiral, ring-contracted 1D-myo-inositol 1,4,5-trisphosphate and 1,3,4,5-tetrakisphosphate analogues with C-2 excised. Journal of the Chemical Society, Perkin Transactions 1, 1998 (1), pp. 41-50.

Jenkins, D. J., Riley, A. M. and Potter, B. V. L., 1996. Chiral cyclopentane-based mimics of D-myo -inositol 1,4,5-trisphosphate from D- glucose. Journal of Organic Chemistry, 61 (22), pp. 7719-7726.

Jenkinson, T., Armas, J., Evison, G., Cohen, M., Lovell, C. and McHugh, N. J., 1994. The cervical spine in psoriatic arthritis : a clinical and radiological study. British Journal of Rheumatology, 33 (3), pp. 255-259.

Jiang, L. H., Rassendren, F., Mackenzie, A. B., Zhang, Y. H., Surprenant, A. and North, R. A., 2005. N -methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X 7 receptors. American Journal of Physiology - Cell Physiology, 289, C1295-C1302.

Jiang, X., Tsitsiou, E., Herrick, S. E. and Lindsay, M. A., 2010. MicroRNAs and the regulation of fibrosis. FEBS Journal, 277 (9), pp. 2015-2021.

Jin, L., Weisman, M., Zhang, G., Ward, M., Luo, J., Bruckel, J., Inman, R., Khan, M. A., Schumacher, H. R., Maksymowych, W. P., Mahowald, M., Martin, T., Rosenbaum, J. T., Yu, D. T. Y., Stone, M., Watson, J., Dickman, E., Davis, J. and Reveille, J. D., 2005. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity. Rheumatology, 44 (1), pp. 55-60.

Jin, L., Zhang, G., Akey, J. M., Luo, J. C., Lee, J., Weisman, M. H., Bruckel, J., Inman, R. D., Stone, M. A., Khan, M. A., Schumacher, H. R., Maksymowych, W. P., Mahowald, M. L., Sawitzke, A. D., Vasey, F. B., Yu, D. T. Y. and Reveille, J. D., 2004. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis & Rheumatism, 50 (9), pp. 3047-3048.

Jirojanakul, P., Skevington, S. M. and Hudson, J., 2003. Predicting young children's quality of life. Social Science & Medicine, 57 (7), pp. 1277-1288.

Jo, J., Ball, S. M., Seok, H., Oh, S. B., Massey, P. V., Molnar, E., Bashir, Z. I. and Cho, K., 2006. Experience-dependent modification of mechanisms of long-term depression. Nature Neuroscience, 9, pp. 170-172.

Johnson, E. A., Oldfield, S., Braksator, E., Gonzalez-Cuello, A., Couch, D., Hall, K. J., Mundell, S. J., Bailey, C. P., Kelly, E. and Henderson, G., 2006. Agonist-selective mechanisms of μ-opioid receptor desensitization in human embryonic kidney 293 cells. Molecular Pharmacology, 70 (2), pp. 676-685.

Jones, C., Junk, P. C., Black, S. J. and Lewis, J., 2001. The molecular structure of [InBr(Salen)(OSMe2)]. Main Group Metal Chemistry, 24 (2), pp. 123-124.

Jones, M. D., Harris, H., Hooton, J. C., Shur, J., King, G. S., Mathoulin, C. A., Nichol, K., Smith, T. L., Dawson, M. L., Ferrie, A. R. and Price, R., 2008. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. European Journal of Pharmaceutics and Biopharmaceutics, 69 (2), pp. 496-507.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2006. Dehydration of trehalose dihydrate at low relative humidity and ambient temperature. International Journal of Pharmaceutics, 313 (1-2), pp. 87-98.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2006. The use of AFM to investigate how fines improve DPI performance. Journal of Pharmacy and Pharmacology, 58, A42-A43.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2008. An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces. Pharmaceutical Research, 25 (2), pp. 337-348.

Jones, M. D. and Price, R., 2006. The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharmaceutical Research, 23 (8), pp. 1665-1674.

Jones, M. D., Young, P. M., Traini, D., Shur, J., Edge, S. and Price, R., 2008. The use of atomic force microscopy to study the conditioning of micronised budesonide. International Journal of Pharmaceutics, 357 (1-2), pp. 314-317.

Jones, M. D., 2006. An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Jones, R. S. G. and Woodhall, G. L., 2005. Background synaptic activity in rat entorhinal cortical neurones: differential control of transmitter release by presynaptic receptors. The Journal of Physiology, 562 (1), pp. 107-120.

Jones, S. M., Armas, J. B., Cohen, M. G., Lovell, C. R., Evison, G. and McHugh, N. J., 1994. Psoriatic arthritis : outcome of disease subsets and relationship of joint disease to nail and skin disease. British Journal of Rheumatology, 33 (9), pp. 834-839.

Jones, S. M., Dixey, J., Hall, N. D. and McHugh, N. J., 1997. Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis. British Journal of Rheumatology, 36 (7), pp. 748-757.

Jones, S. M., Harris, C. P., Lloyd, J., Stirling, C. A., Reckless, J. P. and McHugh, N. J., 2000. Lipoproteins and their subfractions in psoriatic arthritis : identification of an atherogenic profile with active joint disease. Annals of the Rheumatic Diseases, 59 (11), pp. 904-909.

Jones, S. M., Mathew, C. M., Dixey, J., Lovell, C. R. and McHugh, N. J., 1996. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. British Journal of Dermatology, 135 (5), pp. 678-686.

Jones, S. M. and McHugh, N. J., 1994. Subgroups in psoriatic arthritis. British Journal of Rheumatology, 33 (8), p. 789.

Jones, S. M., McKay, K. M. and McHugh, N. J., 1997. Bilateral hip replacements in a man with cystic fibrosis and episodic arthritis. British Journal of Rheumatology, 36 (2), pp. 298-299.

Jones, V. T., Lowe, G. and Potter, B. V. L., 1980. Evidence against a step-wise mechanism for the fumarase-catalysed dehydration of (2S)-malate. European Journal of Biochemistry, 108 (2), pp. 433-437.

Jongbloed, J. D. H., Bolhuis, A., Braun, P. G., Darmon, E., Dorenbos, R., Tjalsma, H., Westers, H., Zanen, G. E., Quax, W. J., Bron, S. and van Dijl, J. M., 2000. Functional analysis of the secretome of Bacillus subtilis. In: Biotechnology: Practice in Non-Food, 2000-10-22 - 2000-10-25, Muenster.

Jourdan, F., Bubert, C., Leese, M. P., Smith, A., Ferrandis, E., Regis-Lydi, S., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates : synthesis, in vitro evaluation and computational modelling. Organic and Biomolecular Chemistry, 6 (22), pp. 4108-4119.

Jourdan, F., Leese, M. P., Dohle, W., Ferrandis, E., Newman, S. P., Chander, S., Purohit, A. and Potter, B. V. L., 2011. Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents. Journal of Medicinal Chemistry, 54 (13), pp. 4863-4879.

Jourdan, F., Leese, M. P., Dohle, W., Hamel, E., Ferrandis, E., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate. Journal of Medicinal Chemistry, 53 (7), pp. 2942-2951.

Ju, M., Scott-ward, T. S., Liu, J., Khuituan, P., Li, H., Cai, Z., Husbands, S. M. and Sheppard, D. N., 2014. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics. British Journal of Pharmacology, 171 (1), pp. 265-278.

Judd, K. E., Mahon, M. F. and Caggiano, L., 2009. Efficient synthesis of tetrahydro-β-carbolin-1-one and dihydroisoquinolin-1-one derivatives as versatile intermediates. Synthesis, 2009 (16), pp. 2809-2817.

Judd, K., 2011. Synthesis and evaluation of narciclasine analogues. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Judd, K. E. and Caggiano, L., 2011. Bi(OTf)3-catalysed prenylation of electron-rich aryl ethers and phenols with isoprene: a direct route to prenylated derivatives. Organic and Biomolecular Chemistry, 9 (14), pp. 5201-5210.

K

Kabasakal, Y., Elvins, D. M., Ring, E. F. and McHugh, N. J., 1996. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Annals of the Rheumatic Diseases, 55 (8), pp. 507-512.

Kaerger, J. S., Edge, S. and Price, R., 2004. Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. European Journal of Pharmaceutical Sciences, 22 (2-3), pp. 173-179.

Kaerger, J. S. and Price, R., 2004. Processing of spherical crystalline particles via a novel solution atomization and crystallization by sonication (SAXS) technique. Pharmaceutical Research, 21 (2), pp. 372-381.

Kaestner, S. A. and Sewell, G. J., 2007. Chemotherapy dosing. Part I: scientific basis for current practice and use of body surface area. Clinical Oncology, 19 (1), pp. 23-37.

Kaestner, S. A. and Sewell, G. J., 2007. Chemotherapy dosing part II: alternative approaches and future prospects. Clinical Oncology, 19 (2), pp. 99-107.

Kaestner, S. and Sewell, G. J., 2007. A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'. Journal of Oncology Pharmacy Practice, 13 (2), pp. 119-126.

Kaestner, S. and Sewell, G. J., 2007. Dose-banding of carboplatin: rationale and proposed banding scheme. Journal of Oncology Pharmacy Practice, 13 (2), pp. 109-117.

Kaestner, S., Walker, V., Roberts, S., Perren, T. and Sewell, G. J., 2004. Clinical and pharmacokinetic (PK) study on 'dose-banded' and individual-dose chemotherapy: an interim report. Journal of Oncology Pharmacy Practice, 10 (2), p. 100.

Kalia, Y. N., Alberti, I., Naik, A. and Guy, R. H., 2001. Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacology and Applied Skin Physiology, 14 (Suppl 1), pp. 82-86.

Kalia, Y. N. and Guy, R. H., 2001. Modeling transdermal drug release. Advanced Drug Delivery Reviews, 48, pp. 159-172.

Kalia, Y. N., Naik, A., Garrison, J. and Guy, R. H., 2004. Iontophoretic drug delivery. Advanced Drug Delivery Reviews, 56, pp. 619-658.

Kankaanranta, H., Ilmarinen, P., Zhang, X., Adcock, I.M., Lahti, A., Barnes, P.J., Giembycz, M.A., Lindsay, M. A. and Moilanen, E., 2014. Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1. PLoS ONE, 9 (2), e90298.

Katz, J. L., Libby, T. A., Kopajtic, T., Husbands, S. M. and Newman, A. H., 2003. Behavioral effects of rimcazole analogues alone and in combination with cocaine. European Journal of Pharmacology, 468, pp. 109-119.

Kay, G. R., Staniforth, J. N., Newnes, L. B. and MacGregor, S. A., 1996. Powder comminution and blending characteristics of a novel jet multi-operational processor. European Journal of Pharmaceutical Scientists, 4 (Supplement 1), S184.

Kealey, S., Turner, E.M., Husbands, S.M., Salinas, C.A., Jakobsen, S., Tyacke, R.J., Nutt, D.J., Parker, C.A. and Gee, A.D., 2013. Imaging imidazoline-I binding sites in porcine brain using C-BU99008. The Journal of Nuclear Medicine, 54 (1), pp. 139-144.

Kealey, S., Gee, A. D., Husbands, S. M., Bennacef, I. and Passchier, J., 2011. (11)C Urea synthesis via palladium(II)-mediated oxidative carbonylation of amines. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S108.

Kealey, S., Husbands, S., Casey, E. M., Salinas, C. A., Parker, C. A., Jakobsen, S., Tyacke, R. J., Nutt, D. J. and Gee, A. D., 2010. Synthesis and in vivo evaluation of 11C BU99008 as a ligand for the imidazoline 12 binding site. NeuroImage, 52 (Supplement 1), S127-S128.

Kealey, S., Husbands, S. M., Casey, E., Salinas, C. A., Parker, C. A., Jakobsen, S., Tyacke, R. J., Nutt, D. J. and Gee, A. D., 2011. Synthesis and in vivo evaluation of (11)C BU99008 as a ligand for the imidazoline I(2) binding site. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S304.

Kealey, S., Husbands, S. M., Bennacef, I., Gee, A. D. and Passchier, J., 2014. Palladium-mediated oxidative carbonylation reactions for the synthesis of 11C-radiolabelled ureas. Journal of Labelled Compounds & Radiopharmaceuticals, 57 (4), pp. 202-208.

Kealey, S., Jennings, L. E., Miller, P. W., Gee, A. D., Plisson, C., White, A. J. P., Husbands, S. and Long, N. J., 2011. Copper(I) tris(pyrazolyl)borate complexes for use in positron emission tomograhpy. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (7), p. 392.

Kealey, S., Plisson, C., Collier, T. L., Long, N. J., Husbands, S. M. and Gee, A. D., 2011. Solution (11)C carbonylation chemistry for the synthesis of a PET tracer - (11)C MK0233. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S107.

Kealey, S., Plisson, C., Collier, T. L., Long, N. J., Husbands, S. M., Martarello, L. and Gee, A. D., 2011. Microfluidic reactions using C-11 carbon monoxide solutions for the synthesis of a positron emission tomography radiotracer. Organic and Biomolecular Chemistry, 9 (9), pp. 3313-3319.

Kee, C. H., Ariffin, A., Awang, K., Takeya, K., Morita, H., Hussain, S. I., Chan, K. M., Wood, P. J., Threadgill, M. D., Lim, C. G., Ng, S., Weber, J. F. F. and Thomas, N. F., 2010. Challenges associated with the synthesis of unusual o-carboxamido stilbenes by the Heck protocol: Intriguing substituent effects, their toxicological and chemopreventive implications. Organic and Biomolecular Chemistry, 8 (24), pp. 5646-5660.

Kellam, B., De Bank, P. A. and Shakesheff, K. M., 2003. Chemical modification of mammalian cell surfaces. Chemical Society Reviews, 32, pp. 327-337.

Kelleher, M. O., McMahon, M., Eggleston, I. M., Dixon, M. J., Taguchi, K., Yamamoto, M. and Hayes, J. D., 2009. 1-Cyano-2,3-epithiopropane is a novel plant-derived chemopreventive agent which induces cytoprotective genes that afford resistance against the genotoxicα,β-unsaturated aldehyde acrolein. Carcinogenesis, 30 (10), pp. 1754-1762.

Keller, G. A., Li, W. and Mrsny, R. J., 2000. Targeting macromolecular therapeutics to specific cell organelles. In: Park, K. and Mrsny, R. J., eds. Controlled Drug Delivery: Designing Technologies for the Future. Vol. 752. Washington, DC: ACS Books, pp. 168-183. (ACS Symposium Series)

Kelly, E., Bailey, C. P. and Henderson, G., 2008. Agonist-selective mechanisms of GPCR desensitization. British Journal of Pharmacology, 153 (S1), S379-S388.

Kershaw, N. J., Mukherji, M., MacKinnon, C. H., Claridge, T. W. D., Odell, B., Wierzbicki, A. S., Lloyd, M. D. and Schofield, C. J., 2001. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. Bioorganic & Medicinal Chemistry Letters, 11, pp. 2545-2548.

Khan, M., Akey, J., Bruckel, J., Weisman, M., Inman, R., Stone, M., Maksymowych, W., Schumacher Jr, H., Mahowald, M., Sawitzke, A., Vasey, F., Yu, D., Newman, P., McClain, J., Jin, L. and Reveille, J., 2002. HLA-DRB1*0101 and DRB1*1501 but not HLA-B60(B*4001) Contribution to susceptability to Ankylosing Spondylitis (AS. Arthritis and Rheumatism, 46 (9), S1138.

Khan, S. A., Rossi, A. M., Riley, A. M., Potter, B. V.L. and Taylor, C. W., 2013. Subtype-selective regulation of IP3 receptors by thimerosal via cysteine residues within the IP3-binding core and suppressor domain. Biochemical Journal, 451 (2), pp. 177-184.

Khossravi, M., Kao, Y. H., Mrsny, R. J. and Sweeney, T. D., 2002. Analysis methods of polysorbate 20: a new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20. Pharmaceutical Research, 19 (5), pp. 634-639.

Khroyan, T. V., Polgar, W. E., Cami-Kobeci, G., Husbands, S. M., Zaveri, N. T. and Toll, L., 2011. The first universal opioid ligand, (2S)-2- (5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydro xy-6-methoxymorphinan-7-yl -3,3-dimethylpentan-2-ol (BU08028): Characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward. Journal of Pharmacology and Experimental Therapeutics, 336 (3), pp. 952-961.

Khroyan, T. V., Wu, J., Polgar, W. E., Cami-Kobeci, G., Fotaki, N., Husbands, S. M. and Toll, L., 2014. Forthcoming. BU08073 a buprenorphine analog with partial agonist activity at mu receptors in vitro but long-lasting opioid antagonist activity in vivo in mice. British Journal of Pharmacology

Kim, J.-H., Resende, R., Wennekes, T., Chen, H.-M., Bance, N., Buchini, S., Watts, A. G., Pilling, P., Streltsov, V. A., Petric, M., Liggins, R., Barrett, S., Mckimm-Breschkin, J. L., Niikura, M. and Withers, S. G., 2013. Mechanism-based covalent neuraminidase inhibitors with broad spectrum influenza antiviral activity. Science, 340 (6128), pp. 71-75.

Kim, T. H., Stone, M., Payne, U., Zhang, X., King, L., Ionescu, M., Lobanok, T., Poole, A. R. and Inman, R. D., 2004. Biomarkers differentiate axial and peripheral disease in Ankylosing Spondylitis, and reflect response to infliximab. Arthritis & Rheumatism, 50 (9), S620-S620.

Kim, T. H., Stone, M., Rahman, P., Payne, U. and Inman, R. D., 2004. Analysis of IL-1 complex polymorphisms in Korean and Toronto ankylosing spondylitis patients. Arthritis & Rheumatism, 50 (9), S214-S214.

Kim, T. H., Stone, M. A., Rahman, P., Yoo, D. H., Park, Y. W., Payne, U., Hallett, D. and Inman, R. D., 2005. Interleukin 1 and nuclear factor-kappa B polymorphisms in ankylosing spondylitis in Canada and Korea. Journal of Rheumatology, 32 (10), pp. 1907-1910.

Kim, T., Stone, M., Payne, U., Zhang, X., Ionescu, M., Lobanok, T., King, L., Poole, A. and Inman, R., 2005. Cartilage Biomarkers in Ankylosing Spondylitis: Relationship to clinical variables and treatment response. Arthritis & Rheumatism, 52 (3), pp. 885-891.

Kimura, A., Tyacke, R. J., Robinson, J. J., Husbands, S. M., Minchin, M. C. W., Nutt, D. J. and Hudson, A. L., 2009. Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site. Brain Research, 1279, pp. 21-28.

Kingham, E., 2009. Investigation of phosphoinositide 3-kinase dependent signalling in the regulation of embryonic stem cell fate. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kingham, E. and Welham, M., 2009. Distinct roles for isoforms of the catalytic subunit of class-IA PI3K in the regulation of behaviour of murine embryonic stem cells. Journal of Cell Science, 122 (13), pp. 2311-2321.

Kingsley, G. H., Kowalczyk, A., Taylor, H., Ibrahim, F., Packham, J. C., McHugh, N. J., Mulherin, D. M., Kitas, G. D., Chakravarty, K., Tom, B. D. M., O'Keeffe, A. G., Maddison, P. J. and Scott, D. L., 2012. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology, 51 (8), pp. 1368-1377.

Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Forthcoming. An Investigation into the Effect of Fine Lactose Particles on the Fluidization Behaviour and Aerosolization Performance of Carrier-Based Dry Powder Inhaler Formulations. AAPS PharmSciTech

Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Forthcoming. Defining the Critical Material Attributes of Lactose Monohydrate in Carrier Based Dry Powder Inhaler Formulations Using Artificial Neural Networks. AAPS PharmSciTech

Kinnunen, H., 2012. Active sites, agglomerates or increased cohesion? Investigations into the mechanism of how lactose fines improve dry powder inhaler performance. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kinnunen, H., Shur, J., Hebbink, G., Muresan, A. S. and Price, R., 2010. Lactose fluidisation properties and their relationship to dry powder inhaler performance. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1342-1343.

Kinnunen, H. M. and Mrsny, R. J., 2014. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site. Journal of Controlled Release, 182 (1), pp. 22-32.

Kirchberger, T., Moreau, C., Wagner, G. K., Fliegert, R., Siebrands, C. C., Nebel, M., Schmid, F., Harneit, A., Odoardi, F., Flugel, A., Potter, B. V. L. and Guse, A. H., 2009. 8-Bromo-cyclic inosine diphosphoribose : towards a selective cyclic ADP-ribose agonist. Biochemical Journal, 422 (1), pp. 139-149.

Kissin, M. W., Snook, K. L., Layer, G. T., Jackson, P., de Vries, C. S., Shousha, S., Sinnett, H. D., Singhal, H., Nigar, E., Cunnick, G. and Chia, Y., 2009. Intraoperative molecular sentinel lymph node analysis with OSNA : Multicentre prospective UK evaluation. Cancer Research, 69 (2 Suppl), 106S.

Klein, M., Mann, H., Pleštilova, L., Betteridge, Z., McHugh, N., Remáková, M., Novota, P. and Vencovsky, J., 2014. Arthritis in Idiopathic Inflammatory Myopathy : Clinical Features and Autoantibody Associations. The Journal of Rheumatology

Klocke, R., Bradley, N., Mapp, P. I., Bruckdorfer, K. R. and Blake, D. R., 2001. Nitrotyrosine proteins in synovial fluid and plasma in rheumatoid arthritis - correlation with other disease parameters. British Journal of Rheumatology, 41 (S1), p. 33.

Klocke, R., Cockcroft, J. R., Taylor, G. J., Hall, I. R. and Blake, D. R., 2003. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Annals of the Rheumatic Diseases, 62 (5), pp. 414-418.

Klocke, R., Glew, D., Cox, N. and Blake, D. R., 2001. Sonographic erosions of the rheumatoid little toe. Annals of the Rheumatic Diseases, 60 (9), pp. 896-897.

Kluettgens, B. U., Sewell, G. J. and Nunn, A. J., 2003. Current clinical practice in neonatal and paediatric parenteral nutrition in Europe. European Journal of Hospital Pharmacy, 9, pp. 122-126.

Kluettgens, B. U., Sewell, G. J. and Nunn, A. J., 2002. Current paediatric parenteral nutrition practice in Europe. International Journal of Pharmacy Practice, 10 ((Suppl)), R77.

Knez, L., Laaksonen, R. and Duggan, C., 2010. Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiology and Oncology, 44 (4), pp. 249-256.

Knez, L., Laaksonen, R., Duggan, C. and Nijjar, R., 2008. Evaluation of clinical interventions made by pharmacists in cancer services. The Pharmaceutical Journal, 280 (7492), pp. 277-280.

Ko, M. C. and Husbands, S. M., 2009. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. Journal of Pharmacology and Experimental Therapeutics, 328 (1), pp. 193-200.

Koffarnus, M. N., Greedy, B., Husbands, S. M., Grundt, P., Newman, A. H. and Woods, J. H., 2009. The discriminative stimulus effects of dopamine D2-and D3-preferring agonists in rats. Psychopharmacology, 203 (2), pp. 317-327.

Koh, W. H., Dunphy, J., Dixey, J., Calin, A., McHugh, N. J. and Maddison, P. J., 1995. Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. British Journal of Rheumatology, 34 (7), pp. 695-696.

Koh, W. H., Dunphy, J., Whyte, J., Dixey, J. and McHugh, N. J., 1995. Characterisation of anticytoplasmic antibodies and their clinical associations. Annals of the Rheumatic Diseases, 54 (4), pp. 269-273.

Kolios, G., Valatas, V. and Ward, S. G., 2004. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology, 113, pp. 427-437.

Kommander, D., Fairservice, A., Deak, M., Gular, G. S., Prescott, A. R., Downes, C. P., Safrany, S. T., Alessi, D. R. and van Aalten, D. M. F., 2004. Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO Journal, 23, pp. 3918-3928.

Koob, Z., Perez, A., Bascompta, E., Soulard, C., Caroline, C., Hillairet de Boisferon, M., Woo, L. W. L., Potter, B. V. L., Reed, M. J., Ali, T., Bichat, F. and Prevost, G., 2011. Forthcoming. The steroid sulfatase inhibitor BN-83495 inhibits the growth of DMBA induced mammary tumors in rats alone or in combination with estradiol receptor blockers. Breast Cancer Research and Treatment

Korendowych, E., Owen, P., Ravindran, J., Carmichael, C. and McHugh, N., 2005. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology, 44 (8), pp. 1056-1060.

Korendowych, E., Dixey, J., Cox, B., Jones, S. and McHugh, N., 2003. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. Journal of Rheumatology, 30 (1), pp. 96-101.

Korendowych, E. and McHugh, N., 2005. Genetic factors in psoriatic arthritis. Current Rheumatology Reports, 7 (4), pp. 306-312.

Korniejewska, A., McKnight, A. J., Johnson, Z., Watson, M. L. and Ward, S. G., 2011. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology, 132 (4), pp. 503-515.

Korniejewska, A., 2009. Characterisation of the Chemokine Receptor CXCR3 and its Atypical Variants in Human T Lymphocytes. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Korniejewska, A., Watson, M. L. and Ward, S. G., 2010. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes. In: Marelli-Berg, F. M. and Nourshargh, S., eds. T-Cell Trafficking. Vol. 606. Humana Press, pp. 125-147. (Methods in Molecular Biology)

Korniejewska, A., Watson, M. L. and Ward, S. G., 2006. Exploring the role for protein arginine methylation in chemokine signalling and migration of human T-lymphocytes. In: Gordon Research Conference on Chemotactic Cytokines, 2006-09-17 - 2006-09-22, Aussois.

Kouroumalis, A., Nibbs, R. J., Aptel, H., Wright, K. L., Kolios, G. and Ward, S. G., 2005. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate Gα i -independent signaling and actin responses in human intestinal myofibroblasts. The Journal of Immunology, 175 (8), pp. 5403-5411.

Kramer, M., Chaudhuri, J. B., De Bank, P. A. and Ellis, M. J., 2011. Aligned neurite outgrowth on electrospun PLGA nanofibres. European Cells and Materials, 22 (Supplement 2), p. 59.

Kramer, M., Chaudhuri, J. B., Ellis, M. J. and De Bank, P. A., 2011. Promotion of neurite outgrowth via incorporation of poly-L-lysine into aligned PLGA nanofibre scaffolds. European Cells and Materials, 22 (Supplement 3), p. 53.

Krause-Heuer, A.M., Leverett, P., Aldrich-Wright, J.R. and Bolhuis, A., 2012. Copper(ii) and palladium(ii) complexes with cytotoxic and antibacterial activity. Australian Journal of Chemistry, 65 (7), pp. 860-873.

Kroes, R., Renwick, A. G., Feron, V., Galli, C. L., Gibney, M., Greim, H., Guy, R. H., Lhugeonot, J. C. and van de Sandt, J. J. M., 2007. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food and Chemical Toxicology, 45 (12), pp. 2533-2562.

Kruck, M., Munoz, M.P., Bishop, H.L., Butts, C.P., Lloyd-Jones, G.C., Frost, C.G., Chapman, C.J. and Kociok-Kohn, G., 2008. BINOL-3,3′-triflone N,N-dimethyl phosphoramidites : Through-space 19F31P spin-spin coupling with a remarkable dependency on temperature and solvent internal pressure. Chemistry - A European Journal, 14 (26), pp. 7808-7812.

Kubavat, H. A., 2011. The influence of crystallization on the mechanical and interfacial properties of active pharmaceutical ingredients. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kubavat, H. A., Shur, J., Ruecroft, G., Hipkiss, D. and Price, R., 2012. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation. International Journal of Pharmaceutics, 430 (1-2), pp. 26-33.

Kubavat, H. A., Shur, J., Ruecroft, G., Hipkiss, D. and Price, R., 2012. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations. Pharmaceutical Research, 29 (4), pp. 994-1006.

Kudoh, T., Fukuoka, M., Ichikawa, S., Murayama, T., Ogawa, Y., Hashii, M., Higashida, H., Kunerth, S., Weber, K., Guse, A. H., Potter, B. V. L., Matsuda, A. and Shuto, S., 2005. Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca2 + -mobilizing second messenger. Structure-activity relationship of the N1-ribose moiety. Journal of the American Chemical Society, 127 (24), pp. 8846-8855.

Kudoh, T., Murayama, T., Hashii, M., Higashida, H., Sakurai, T., Maechling, C., Spiess, B., Weber, K., Guse, A. H. and Potter, B. V. L., 2008. Design and synthesis of 4″,6″-unsaturated cyclic ADP-carbocyclic-ribose, a Ca2+-mobilizing agent selectively active in T cells. Tetrahedron, 64 (41), pp. 9754-9765.

Kudoh, T., Weber, K., Guse, A. H., Potter, B. V. L., Hashii, M., Higashida, H., Arisawa, M., Matsuda, A. and Shuto, S., 2008. Design and synthesis of 4",6"-unsaturated cyclic ADP-carbocyclic ribose as a Ca 2+-mobilizing agent. Tetrahedron Letters, 49 (25), pp. 3976-3979.

Kumar, V., Ridzwan, I.E., Grivas, K., Lewis, J.W., Clark, M.J., Meurice, C., Jimenez-Gomez, C., Pogozheva, I., Mosberg, H., Traynor, J.R. and Husbands, S.M., 2014. Selectively promiscuous opioid ligands : Discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity. Journal of Medicinal Chemistry, 57 (10), pp. 4049-4057.

Kumpfmueller, B., 2011. Control of embryonic stem cell fate: the role of phosphoinositide 3-kinase signalling and Zscan4. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kunerth, S., Langhorst, M. F., Schwarzmann, N., Gu, X., Huang, L., Yang, Z., Zhang, L., Mills, S. J., Zhang, L.-h., Potter, B. V. L. and Guse, A. H., 2004. Amplification and propagation of pacemaker Ca 2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cells. Journal of Cell Science, 117, pp. 2141-2149.

Kurz, X., Leufkens, B., Blackburn, S., Moride, Y., Simmons, V. and De Vries, C., 2011. Increasing Scientific Standards, Transparency and Independence in Pharmacoepidemiological Research: Is the Concept of ENCePP Studies a Way Forward? Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S150.

Kusmartseva, O., Kattige, A. S., Price, R. and Smith, P. R., 2004. In-line assessment of pulmonary drug delivery using light obscuration. Biosensors and Bioelectronics, 20, pp. 468-474.

Kvam, E., Hejmadi, V., Ryter, S., Pourzand, C. and Tyrrell, R. M., 2000. Heme oxygenase activity causes transient hypersensitivity to oxidative ultraviolet A radiation that depends on release of iron from heme. Free Radical Biology and Medicine, 28 (8), pp. 1191-1196.

Kwan, D. C., Thomas, J. R. and Bolhuis, A., 2008. Bioenergetic requirements of a Tat-dependent substrate in the halophilic archaeon Haloarcula hispanica. FEBS Journal, 275 (24), pp. 6159-6167.

Kwan, D., 2009. Investigation into the twin-arginine translocation pathway of halophilic and thermophilic archaea. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kwan, D. and Bolhuis, A., 2010. Analysis of the twin-arginine motif of a haloarchaeal Tat substrate. FEMS Microbiology Letters, 308 (2), pp. 138-143.

Kwong, J. S. W., Lloyd, M. D. and Threadgill, M. D., 2006. Design and synthesis of a novel transition state mimic for poly(ADP-ribose) polymerase 1 (PARP-1) inhibition. In: Conférences Européenes du Groupement des Pharmacochimistes de L'Arc Atlantique (GP2A), 2006-09-07 - 2006-09-08, Bath.

Kwong, J. S. W., Lloyd, M. D. and Threadgill, M. D., 2006. Design, synthetic approaches and characterisation of a novel cyclic sulfoximine NAD+ (nicotinamide adenine dinucleotide) analogue. In: American Chemical Society (ACS) 232nd National Meeting, 2006-09-10 - 2006-09-14, San Francisco.

Kwong, J. S. W., Lloyd, M. D. and Threadgill, M. D., 2006. Synthesis of cyclic sulfoximine mimics of 2-deoxyribosides as enzyme inhibitors in cancer. Journal of Pharmacy and Pharmacology, 58, A58-A58.

Kwong, J. S. W., Mahon, M. F., Lloyd, M. D. and Threadgill, M. D., 2007. Synthesis and conformational and configurational studies of diastereoisomeric O-protected 4-(arylsulfonimidoyl)butane-1,2,3-triols. Tetrahedron, 63 (51), pp. 12601-12607.

Kyle, S., Chandler, D., Griffiths, C. E. M., Helliwell, P., Lewis, J., McInnes, I., Oliver, S., Symmons, D., McHugh, N. and , B. S. f. R. S. G. A. W. G. (S.), 2005. Guideline for anti-TNF-α therapy in psoriatic arthritis. Rheumatology, 44 (3), pp. 390-397.

L

Laaksonen, R., Bates, I. and Duggan, C., 2007. Training, clinical medication review performance and self-assessed competence: investigating influences. Pharmacy Education, 7 (3), pp. 257-265.

Laaksonen, R., Duggan, C. and Bates, I., 2002. Desire for information about drugs: relationships with patients' characteristics and adverse effects. Pharmacy World & Science, 24 (5), pp. 205-210.

Laaksonen, R., Duggan, C. and Bates, I., 2007. Performance in clinical therapeutics training of community pharmacists. Pharmacy Education, 7 (2), pp. 167-175.

Laaksonen, R., Duggan, C. and Bates, I., 2001. Relationships between patients' desire for information and adverse drug reactions. In: HSRPP Conference, 2003-01-01, Belfast.

Laaksonen, R., Duggan, C., Bates, I. and Mackie, C., 2003. Community pharmacists' job and career satisfaction. In: HSRPP Conference, 2003-01-01, Belfast.

Laaksonen, R., Duggan, C., Bates, I. and Mackie, C., 2005. Job and career satisfaction. In: HSRPP Conference, 2005, 2005-01-01, Reading.

Laaksonen, R. and Mills, E., 2005. The influence of clinical training on self-assessed competence of community pharmacists. In: LLLP Conferences, 2005-01-01, Saskatoon.

Laaksonen, R., Mills, E., Bates, I., Duggan, C., Davies, G. and Mackie, C., 2006. The influence of clinical training on self-assessed competence in community pharmacists. In: HSRPP Conference, 2006, 2006-01-01, Bath.

Laaksonen, R., Mills, E., Davies, G., Duggan, C., Bates, I. and Mackie, C., 2006. The self-assessed competence of community pharmacists and participation in clinical training. Dosis, 22 (3), pp. 205-216.

Laaksonen, R., Mills, E. R., Duggan, C., Davies, J. G., Bates, I. and Mackie C A, [N. V.], 2007. The effect of training and service provision on the self-assessed competence of community pharmacists. International Journal of Pharmacy Practice, 15 (2), pp. 141-147.

Laaksonen, R., 2008. Involving pharmacy students in quality assurance processes. In: Higher Education Academy Annual Conference, 2008-07-01 - 2008-07-03, Harrogate.

Laaksonen, R., 2009. Involving undergraduate students ingiving feedback. International Journal of Pharmacy Practice, 17 (S1), A10.

Laaksonen, R., 2009. Iso-Britanniassa proviisori arvioi, neuvoo ja palvelee. Proviisori, 2, pp. 28-29.

Laaksonen, R., 2009. Pharmacists and life-long learning in the United Kingdom. Dosis, 25, pp. 94-98.

Laaksonen, R., Duggan, C. and Bates, I., 2009. Overcoming barriers to engagement in continuing professional development in community pharmacy : A longitudinal study. The Pharmaceutical Journal, 282 (7535), pp. 44-48.

Laaksonen, R., Duggan, C. and Bates, I., 2010. Performance of community pharmacists in providing clinical medication reviews. Annals of Pharmacotherapy, 44 (7), pp. 1181-1190.

Laaksonen, R., Duggan, C., Bates, I. and Mackie, C., 2004. Job and career satisfaction. In: 1st Nordic Social Pharmacy and Health Services Research (NSPHSR) Conference, 2004-01-01, Uppsala.

Laaksonen, R., Gunasekaran, I., Holland, R., Leung, J., Patel, A. and Shah, S., 2010. Forthcoming. Satisfaction of recent pharmacy undergraduate students. Pharmacy Education

Laaksonen, R., Jansen, O., Jones, J. and Panesar, G., 2010. Engaging pharmacy students in giving feedback on teaching and assessment. Pharmacy Practice, 8 (Suppl 1), p. 40.

Lairson, L. L., Watts, A. G., Wakarchuk, W. W. and Withers, S. G., 2006. Using substrate engineering to harness enzymatic promiscuity and expand biological catalysis. Nature Chemical Biology, 2 (12), pp. 724-728.

Lamming, R., Hajee, D., Horrill, M., Kay, G., Staniforth, J. N., Tobyn, M., Li, M., MacGregor, S. and Newnes, L., 2002. Lessons from co-development of a Single Vessel Processor: methodologies for managing innovation in customer-supplier networks. International Journal of Technology Management, 23 (1-3), pp. 21-39.

Lampe, D., Liu, C., Mahon, M. F. and Potter, B. V. L., 1996. Synthesis of L-scyllo-inositol 1,2,4-trisphosphate, scyllo-inositol 1,2,4,5-tetrakisphosphate and phosphorothioate and DL-2-deoxy-2-fluoro-myo-inositol 1,4,5-trisphosphate: optical resolution of DL-1-O-allyl-3,6-di-O-benzyl-4,5-O-isopropylidene-scyllo-inositol. Journal of the Chemical Society - Perkin Transcriptions 1, 1996 (14), pp. 1717-1727.

Lampe, D., Liu, C. and Potter, B. V. L., 1994. Synthesis of selective non-Ca2+ Mobilizing Inhibitors of D-myo-Inositol 1,4,5-trisphosphate 5-phosphatase. Journal of Medicinal Chemistry, 37 (7), pp. 907-912.

Lampe, D., Mills, S. J. and Potter, B. V. L., 1992. Total synthesis of the second messenger analogue D-myo-inositol 1-phosphorothioate 4,5-bisphosphate: optical resolution of DL-1-O-allyl-2,3,6-tri-O-benzyl-myo-inositol and fluorescent labelling of myo-inositol 1,4,5-trisphosphate. Journal of the Chemical Society - Perkin Transcriptions 1, 1992 (21), pp. 2899-2906.

Lampe, D. and Potter, B. V. L., 1993. Synthesis of 2-fluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate and scyllo-inositol 1,2,4-trisphosphate, novel analogues of the second messenger myo-inositol 1,4,5-trisphosphate. Tetrahedron Letters, 34 (14), pp. 2365-2368.

Lampe, D. and Potter, B. V. L., 1990. Synthesis of myo-inositol 1-phosphorothioate 4,5-bisphosphate : preparation of a fluorescently labelled myo-inositol 1,4,5-trisphosphate analogue. Journal of the Chemical Society, Chemical Communications, 1990 (21), pp. 1500-1501.

Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.

Lango Allen, H., Estrada, K., Lettre, G., Berndt, S. I., Weedon, M. N., Rivadeneira, F., Willer, C. J., Jackson, A. U., Vedantam, S., Raychaudhuri, S., Ferreira, T., Wood, A. R., Weyant, R. J., Segrè, A. V., Speliotes, E. K., Wheeler, E., Soranzo, N., Park, J.-H., Yang, J., Gudbjartsson, D., Heard-Costa, N. L., Randall, J. C., Qi, L., Vernon Smith, A., Mägi, R., Pastinen, T., Liang, L., Heid, I. M., Luan, J.’a., Thorleifsson, G., Winkler, T. W., Goddard, M. E., Sin Lo, K., Palmer, C., Workalemahu, T., Aulchenko, Y. S., Johansson, Å., Carola Zillikens, M., Feitosa, M. F., Esko, T., Johnson, T., Ketkar, S., Kraft, P., Mangino, M., Prokopenko, I., Absher, D., Albrecht, E., Ernst, F., Glazer, N. L., Hayward, C., Hottenga, J.-J., Jacobs, K. B., Knowles, J. W., Kutalik, Z., Monda, K. L., Polasek, O., Preuss, M., Rayner, N. W., Robertson, N. R., Steinthorsdottir, V., Tyrer, J. P., Voight, B. F., Wiklund, F., Xu, J., Hua Zhao, J., Nyholt, D. R., Pellikka, N., Perola, M., Perry, J. R. B., Surakka, I., Tammesoo, M.-L., Altmaier, E. L., Amin, N., Aspelund, T., Bhangale, T., Boucher, G., Chasman, D. I., Chen, C., Coin, L., Cooper, M. N., Dixon, A. L., Gibson, Q., Grundberg, E., Hao, K., Juhani Junttila, M., Kaplan, L. M., Kettunen, J., König, I. R., Kwan, T., Lawrence, R. W., Levinson, D. F., Lorentzon, M., McKnight, B., Morris, A. P., Müller, M., Suh Ngwa, J., Purcell, S., Rafelt, S., Salem, R. M., Salvi, E., Sanna, S., Shi, J., Sovio, U., Thompson, J. R., Turchin, M. C., Vandenput, L., Verlaan, D. J., Vitart, V., White, C. C., Ziegler, A., Almgren, P., Balmforth, A. J., Campbell, H., Citterio, L., De Grandi, A., Dominiczak, A., Duan, J., Elliott, P., Elosua, R., Eriksson, J. G., Freimer, N. B., Geus, E. J. C., Glorioso, N., Haiqing, S., Hartikainen, A.-L., Havulinna, A. S., Hicks, A. A., Hui, J., Igl, W., Illig, T., Jula, A., Kajantie, E., Kilpeläinen, T. O., Koiranen, M., Kolcic, I., Koskinen, S., Kovacs, P., Laitinen, J., Liu, J., Lokki, M.-L., Marusic, A., Maschio, A., Meitinger, T., Mulas, A., Paré, G., Parker, A. N., Peden, J. F., Petersmann, A., Pichler, I., Pietiläinen, K. H., Pouta, A., Ridderstråle, M., Rotter, J. I., Sambrook, J. G., Sanders, A. R., Oliver Schmidt, C., Sinisalo, J., Smit, J. H., Stringham, H. M., Bragi Walters, G., Widen, E., Wild, S. H., Willemsen, G., Zagato, L., Zgaga, L., Zitting, P., Alavere, H., Farrall, M., McArdle, W. L., Nelis, M., Peters, M. J., Ripatti, S., van Meurs, J. B. J., Aben, K. K., Ardlie, K. G., Beckmann, J. S., Beilby, J. P., Bergman, R. N., Bergmann, S., Collins, F. S., Cusi, D., den Heijer, M., Eiriksdottir, G., Gejman, P. V., Hall, A. S., Hamsten, A., Huikuri, H. V., Iribarren, C., Kähönen, M., Kaprio, J., Kathiresan, S., Kiemeney, L., Kocher, T., Launer, L. J., Lehtimäki, T., Melander, O., Mosley Jr, T. H., Musk, A. W., Nieminen, M. S., O’Donnell, C. J., Ohlsson, C., Oostra, B., Palmer, L. J., Raitakari, O., Ridker, P. M., Rioux, J. D., Rissanen, A., Rivolta, C., Schunkert, H., Shuldiner, A. R., Siscovick, D. S., Stumvoll, M., Tönjes, A., Tuomilehto, J., van Ommen, G.-J., Viikari, J., Heath, A. C., Martin, N. G., Montgomery, G. W., Province, M. A., Kayser, M., Arnold, A. M., Atwood, L. D., Boerwinkle, E., Chanock, S. J., Deloukas, P., Gieger, C., Grönberg, H., Hall, P., Hattersley, A. T., Hengstenberg, C., Hoffman, W., Mark Lathrop, G., Salomaa, V., Schreiber, S., Uda, M., Waterworth, D., Wright, A. F., Assimes, T. L., Barroso, I., Hofman, A., Mohlke, K. L., Boomsma, D. I., Caulfield, M. J., Adrienne Cupples, L., Erdmann, J., Fox, C. S., Gudnason, V., Gyllensten, U., Harris, T. B., Hayes, R. B., Jarvelin, M.-R., Mooser, V., Munroe, P. B., Ouwehand, W. H., Penninx, B. W., Pramstaller, P. P., Quertermous, T., Rudan, I., Samani, N. J., Spector, T. D., Völzke, H., Watkins, H., Wilson, J. F., Groop, L. C., Haritunians, T., Hu, F. B., Kaplan, R. C., Metspalu, A., North, K. E., Schlessinger, D., Wareham, N. J., Hunter, D. J., O’Connell, J. R., Strachan, D. P., Wichmann, H. -E., Borecki, I. B., van Duijn, C. M., Schadt, E. E., Thorsteinsdottir, U., Peltonen, L., Uitterlinden, A. G., Visscher, P. M., Chatterjee, N., Loos, R. J. F., Boehnke, M., McCarthy, M. I., Ingelsson, E., Lindgren, C. M., Abecasis, G. R., Stefansson, K., Frayling, T. M. and Hirschhorn, J. N., 2010. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467 (7317), p. 832.

Larner-Svensson, H. M., Williams, A. E., Tsitsiou, E., Perry, M. M., Jiang, X., Chung, K. F. and Lindsay, M., 2010. Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respiratory Research, 11 (1), 68.

Lasheen, D. S., Ismail, M. A. H., Abou El Ella, D. A., Ismail, N. S. M., Eid, S., Vleck, S., Glenn, J. S., Watts, A. G. and Abouzid, K. A. M., 2013. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity. Bioorganic and Medicinal Chemistry, 21 (10), pp. 2742-2755.

Laude, A. J., Tovey, S. C., Dedos, S. G., Potter, B. V. L., Lummis, S. C. R. and Taylor, C. W., 2005. Rapid functional assays of recombinant IP3 receptors. Cell Calcium, 38 (1), pp. 45-51.

Lavelle, M. J., Smith, A. W., Ward, S. G. and Watson, M. L., 2001. Phosphoinositide 3-kinase and PTEN activity in airway epithelial cells. Pediatric Pulmonology, S22, pp. 196-197.

Lawrence, H. R., Vicker, N., Allan, G. M., Smith, A., Mahon, M. F., Tutill, H. J., Purohit, A., Reed, M. J. and Potter, B. V. L., 2005. Novel and potent 17 β -hydroxysteroid dehydrogenase type 1 inhibitors. Journal of Medicinal Chemistry, 48 (8), pp. 2759-2762.

Leboulanger, B., Aubry, J. M., Bondolfi, G., Guy, R. H. and Delgado-Charro, M. B., 2004. Lithium monitoring by reverse iontophoresis in vivo. Clinical Chemistry, 50 (11), pp. 2091-2100.

Leboulanger, B., Aubry, J. M., Bondolfi, G., Guy, R. H. and Delgado-Charro, M. B., 2003. Reverse iontophoretic monitoring of lithium in vivo. Therapeutic Drug Monitoring, 25 (4), p. 499.

Leboulanger, B., Fathi, M., Guy, R. H. and Delgado-Charro, M. B., 2004. Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Pharmaceutical Research, 21 (7), pp. 1214-1222.

Leboulanger, B., Guy, R. H. and Delgado-Charro, M. B., 2004. Non-invasive monitoring of phenytoin by reverse iontophoresis. European Journal of Pharmaceutical Sciences, 22, pp. 427-433.

Leboulanger, B., Guy, R. H. and Delgado-Charro, M. B., 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiological Measurement, 25, R35-R50.

Leboulanger, B., Guy, R. H. and Delgado-Charro, M. B., 2003. Reverse iontophoretic monitoring of free phenytoin. Therapeutic Drug Monitoring, 25 (4), p. 499.

Lecour, S., Smith, R. M., Woodward, B., Opie, L. H., Rochette, L. and Sack, M. N., 2002. Identification of a novel role for sphingolipid in TNFα and ischemic preconditioning mediated cardioprotection. Journal of Molecular and Cellular Cardiology, 34, pp. 509-518.

Lee, A., White, N. and van der Walle, C. F., 2003. The intestinal zonula occludens toxin (ZOT) receptor recognises non-native ZOT conformers and localises to the intercellular contacts. FEBS Letters, 555 (3), pp. 638-642.

Lee, H. J., Dai, Y. F., Shiau, C. Y., Schofield, C. J. and Lloyd, M. D., 2003. The kinetic properties of various R258 mutants of deacetoxycephalosporin C synthase. European Journal of Biochemistry, 270, pp. 1301-1307.

Lee, H. J., Lloyd, M. D., Harlos, K., Clifton, I. J., Baldwin, J. E. and Schofield, C. J., 2001. Alteration of the 2-oxoacid cosubstrate selectivity in deacetoxycephalosporin C synthase: the role of arginine-258. Journal of Biological Chemistry, 276, pp. 18290-18295.

Lee, H. J., Lloyd, M. D., Harlos, K., Clifton, I. J., Baldwin, J. E. and Schofield, C. J., 2001. Kinetic and crystallographic studies on deacetoxycephalosporin C synthase. Journal of Molecular Biology, 308, pp. 937-948.

Lee, H. J., Schofield, C. J. and Lloyd, M. D., 2002. Active site mutations of recombinant deacetoxycephalosporin C synthase. Biochemical and Biophysical Research Communications, 292, pp. 66-70.

Lee, J., Reveille, J. D., Luo, L., Bruckel, J., Weisman, M., Khan, M. A., Inman, R., Schumacher, H. R., Maksymowych, W. P., Martin, T. M., Rosenbaum, M. A., Yu, D. T. Y., Stone, M. and Jin, L., 2003. Fine mapping of a candidate susceptibility region on chromosome 11 in ankylosing spondylitis. American Journal of Human Genetics, 73 (5), p. 533.

Leese, M. P., Hejaz, H. A. M., Mahon, M. F., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2005. A-ring-substituted estrogen-3- 0 -sulfamates: potent multitargeted anticancer agents. Journal of Medicinal Chemistry, 48, pp. 5243-5256.

Leese, M. P., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2004. 2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents. Bioorganic & Medicinal Chemistry Letters, 14, pp. 3135-3138.

Leese, M. P., Jourdan, F., Ferrandis, E., Regis-Lydi, S., Kasprzyk, P. G., Stengel, C., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents. EJC Supplements, 8 (7), p. 141.

Leese, M. P., Hejaz, H. A. M., Mahon, M. F., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2005. A-Ring-Substituted Estrogen-3- O -sulfamates : potent multitargeted anticancer agents. Journal of Medicinal Chemistry, 48 (16), pp. 5243-5256.

Leese, M. P., Jourdan, F., Dohle, W., Kimberley, M. R., Thomas, M. P., Bai, R., Hamel, E., Ferrandis, E. and Potter, B. V. L., 2012. Steroidomimetic tetrahydroisoquinolines for the design of new microtubule disruptors. ACS Medicinal Chemistry Letters, 3 (1), pp. 5-9.

Leese, M. P., Jourdan, F., Kimberley, M. R., Cozier, G. E., Thiyagarajan, N., Stengel, C., Regis-Lydi, S., Foster, P. A., Newman, S. P., Acharya, K. R., Ferrandis, E., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Chimeric microtubule disruptors. Chemical Communications, 46 (17), pp. 2907-2909.

Leese, M. P., Jourdan, F. L., Gaukroger, K., Mahon, M. F., Newman, S. P., Foster, P. A., Stengel, C., Regis-Lydi, S., Ferrandis, E., Di Fiore, A., De Simone, G., Supuran, C. T., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. Journal of Medicinal Chemistry, 51 (5), pp. 1295-1308.

Leese, M. P., Jourdan, F. L., Major, M. R., Dohle, W., Hamel, E., Ferrandis, E., Fiore, A., Kasprzyk, P. G. and Potter, B. V. L., 2014. Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors. ChemMedChem, 9 (1), pp. 85-108.

Leese, M. P., Jourdan, F. L., Major, M. R., Dohle, W., Thomas, M. P., Hamel, E., Ferrandis, E., Mahon, M. F., Newman, S. P., Purohit, A. and Potter, B. V. L., 2014. Forthcoming. Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones. ChemMedChem

Leese, M. P., Leblond, B., Smith, A., Newman, S. P., Di Fiore, A., De Simone, G., Supuran, C. T., Purohit, A., Reed, M. J. and Potter, B. V. L., 2006. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents : synthesis, in vitro SAR, protein crystallography, and in vivo activity. Journal of Medicinal Chemistry, 49 (26), pp. 7683-7696.

Leese, M. P., Leblond, B., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2005. Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3- 0 -sulfamates. Steroid Biochemistry & Molecular Biology, 94 (1), pp. 239-251.

Leese, M. P., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2004. 2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents. Bioorganic & Medicinal Chemistry Letters, 14 (12), pp. 3135-3138.

Leichtnam, M. L., Rolland, H., Wüthrich, P. and Guy, R. H., 2006. Enhancement of transdermal testosterone delivery by supersaturation. Journal of Pharmaceutical Sciences, 95 (11), pp. 2373-2379.

Leichtnam, M. L., Rolland, H., Wüthrich, P. and Guy, R. H., 2006. Formulation and evaluation of a testosterone transdermal spray. Journal of Pharmaceutical Sciences, 95 (8), pp. 1693-1702.

Leichtnam, M. L., Rolland, H., Wüthrich, P. and Guy, R. H., 2006. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations. Journal of Controlled Release, 113, pp. 57-62.

Leichtnam, M. L., Rolland, H., Wüthrich, P. and Guy, R. H., 2007. Impact of antinucleants on transdermal delivery of testosterone from a spray. Journal of Pharmaceutical Sciences, 96 (1), pp. 84-92.

Leichtnam, M. L., Rolland, H., Wüthrich, P. and Guy, R. H., 2006. Testosterone hormone replacement therapy: state-of-the-art and emerging technologies. Pharmaceutical Research, 23 (6), pp. 1117-1132.

Lendrem, D., Mitchell, S., McMeekin, P., Bowman, S., Price, E., Pease, C.T., Emery, P., Andrews, J., Lanyon, P., Hunter, J., Gupta, M., Bombardieri, M., Sutcliffe, N., Pitzalis, C., McLaren, J., Cooper, A., Regan, M., Giles, I., Isenberg, D., Vadivelu, S., Coady, D., Dasgupta, B., McHugh, N., Young-Min, S., Moots, R., Gendi, N., Akil, M., Griffiths, B. and Ng, W.-F., 2013. Health-related utility values of patients with primary Sjögren's syndrome and its predictors. Annals of the Rheumatic Diseases

Leslie, N. R., McLennan, A. G. and Safrany, S. T., 2002. Cloning and characterisation of hAps1 and hAps2, human diadenosine polyphosphate-metabolising Nudix hydrolases. BMC Biochemistry, 3.

Letchford, J., Cardwell, A., Lee, M., Beresford, J. N., Welham, M. J. and Perry, M. J., 2004. The generation of antibodies against adult human mesenchymal stem cells by phage display. Journal of Bone and Mineral Research, 19 (6), p. 1045.

Letchford, J., Cardwell, A., Stewart, K., Perry, M. J. and Beresford, J. N., 2003. A novel approach to the generation of antibodies against adult human mesenchymal stem cells. Journal of Bone and Mineral Research, 18 (7), p. 1368.

Letchford, J., Cardwell, A. M., Stewart, K., Coogans, K. K. S., Cox, J. P. L., Lee, M., Beresford, J. N., Perry, M. J. and Welham, M. J., 2006. Isolation of C15: A novel antibody generated against mesenchymal stem cell-enriched adult human marrow. Journal of Immunological Methods, 308 (1-2), pp. 124-137.

Letchford, J., Jefferiss, C. M., Walsh, S., Stewart, K. and Beresford, J. N., 2001. Optimisation of selection procedures for the isolation of phage antibodies from STRO-1 + cell populations. Journal of Bone and Mineral Research, 16, p. 1184.

Levitan, I., Payne, R., Potter, B. V. L. and Hillman, P., 1994. Facilitation of the responses to injections of inositol 1,4,5-trisphosphate analogs in Limulus ventral photoreceptors. Biophysical Journal, 67 (3), pp. 1161-1172.

Lewis, J. W. and Husbands, S. M., 2004. The orvinols and related opioids - high affinity ligands with diverse efficacy profiles. Current Pharmaceutical Design, 10, pp. 717-732.

Li, D. X. and Mrsny, R. J., 2000. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. The Journal of Cell Biology (JCB), 148 (4), pp. 791-800.

Li, H., Li, L., Deng, L., Singh, G., Tyrrell, R. M. and Zhong, J. L., 2010. A role for Nrf2 in UVA-mediated heme oxygenase induction and protection from membrane damage in human skin fibroblasts. Proceedings of SPIE - The International Society for Optical Engineering, 7845, 78450X.

Li, M., Threadgill, M. D., Wang, Y. L., Cai, L. and Lin, X., 2009. Poly(ADP-Ribose) Polymerase Inhibition Down-Regulates Expression of Metastasis-Related Genes in CT26 Colon Carcinoma Cells. Pathobiology, 76 (3), pp. 108-116.

Li, S. and Blagbrough, I. S., 2006. Design and synthesis of a series of novel non-viral cationic lipid vectors for plasmid DNA formulation. Journal of Pharmacy and Pharmacology, 58, A7-A8.

Li, Y., Husbands, S. M., Mahon, M. F., Traynor, J. R. and Rowan, M. G., 2007. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the k -opioid receptor. Chemistry & Biodiversity, 4 (7), pp. 1586-1593.

Liang, T. W., Demarco, R. A., Mrsny, R. J., Gurney, A., Gray, A., Hooley, J., Aaron, H. L., Huang, A., Klassen, T., Tumas, D. B. and Fong, S., 2000. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. American Journal of Physiology - Cell Physiology, 279 (6), C1733-C1743.

Liddell, W. G., Carmichael, C. R. and McHugh, N. J., 2005. Joint and soft tissue injections : a survey of general practitioners. Rheumatology, 44 (8), pp. 1043-1046.

Lind, R. J., Hardick, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Davies, A. R. L., Clough, M. S., Earley, F. G. P., Reynolds, S. E. and Wonnacott, S., 2001. [3H]-methyllycaconitine : a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors. Insect Biochemistry and Molecular Biology, 31 (6-7), pp. 533-542.

Lindsay, M. A., 2008. microRNAs and the immune response. Trends in Immunology, 29 (7), pp. 343-351.

Lipp, R., Mrsny, R. and Park, K., 2010. Seventh international nanomedicine and drug delivery symposium (NanoDDS'09). Journal of Controlled Release, 146 (2), p. 163.

Lipscomb, S. J., Lee, H. J., Mukherji, M., Baldwin, J. E., Schofield, C. J. and Lloyd, M. D., 2002. The role of arginine residues in substrate binding and catalysis by deacetoxycephalosporin C synthase. European Journal of Biochemistry, 269, pp. 2735-2739.

Liu, C., Huang, Y., Mather, S., Garland, C. J. and Dora, K. A., 2004. Extracellular ATP facilitates flow-induced [Ca2+] increase and vasodilation in rat small mesenteric artery. FASEB Journal, Abstract 440, p. 10.

Liu, C., Mather, S., Huang, Y., Garland, C. J. and Yao, X., 2004. Extracellular ATP facilitates flow-induced vasodilation in rat small mesenteric arteries. American Journal of Physiology-Heart and Circulatory Physiology, 286, H1688-H1695.

Liu, C., Ngai, C. Y., Huang, Y., Ko, W. H., Wu, M., He, G. W., Garland, C. J., Dora, K. A. and Yao, X., 2006. Depletion of intracellular Ca 2+ stores enhances flow-induced vascular dilatation in rat small mesenteric artery. British Journal of Pharmacology, 147, pp. 506-515.

Liu, C., Al-Hafidh, J., Westwick, J. and Potter, B. V. L., 1994. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor. Bioorganic and Medicinal Chemistry, 2 (4), pp. 253-257.

Liu, C., Davis, R. J., Nahorski, S. R., Ballereau, S., Spiess, B. and Potter, B. V. L., 1999. Synthesis, calcium mobilizing, and physicochemical properties of d-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the d-myo-inositol 1,4,5-trisphosphate receptor. Journal of Medicinal Chemistry, 42 (11), pp. 1991-1998.

Liu, C., Nahorski, S. R. and Potter, B. V. L., 1992. Synthesis from quebrachitol of 1L-chiro-inositol 2,3,5-trisphosphate, an inhibitor of the enzymes of 1D-myo-inositol 1,4,5-trisphosphate metabolism. Carbohydrate Research, 234, pp. 107-115.

Liu, C., Nahorski, S. R. and Potter, B. V. L., 1991. Total synthesis from L-quebrachitol of the D-myo-inositol 1,4,5-trisphosphate analogue, L-chiro-inositol 2,3,5-trisphosphate, a potent inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase inhibitor. Journal of the Chemical Society, Chemical Communications, 1991 (15), pp. 1014-1016.

Liu, C. and Potter, B. V. L., 1994. Synthesis of myo-inositol 1,4,5-trisphosphate 3-phosphorothioate as an inhibitor of myo-inositol 1,3,4,5-tetrakisphosphate 3-phosphatase. Tetrahedron Letters, 35 (10), pp. 1605-1608.

Liu, C. and Potter, B. V. L., 1997. Synthesis of 3-Position-Modified Analogues of myo -inositol 1,4,5-trisphosphate, tools for investigation of the polyphosphoinositide pathway of cellular signaling. Journal of Organic Chemistry, 62 (24), pp. 8335-8340.

Liu, C. and Potter, B. V.L., 1994. Synthesis of (±)-3-O-alkylated Myo-inositol 1,4,5-trisphosphate analogues as potent receptor ligands and enzyme inhibitors. Tetrahedron Letters, 35 (45), pp. 8457-8460.

Liu, C., Riley, A. M., Yang, X., Shears, S. B. and Potter, B. V. L., 2001. Synthesis and biological activity of D-and L-chiro-inositol 2,3,4,5-tetrakisphosphate : design of a novel and potent inhibitor of ins(3,4,5,6)P4 1-kinase/ins(1,3,4)P3 5/6-kinase. Journal of Medicinal Chemistry, 44 (18), pp. 2984-2989.

Liu, C., Safrany, S. T., Nahorski, S. R. and Potter, B. V. L., 1992. Synthesis of L-chiro-inositol 1,4,6-trisphosphorothioate, a potent and selective inhibitor of myo-inositol 1,4,5-trisphosphate 5-phosphatase. Bioorganic & Medicinal Chemistry Letters, 2 (12), pp. 1523-1528.

Liu, C., Thomas, N. F. and Potter, B. V. L., 1993. Synthesis of racemic myo-inositol 1,4,5-trisphosphate 3-O-methylenecarboxylate, a Ca2+-mobilising myo-lnositol 1,3,4,5-tetrakisphosphate analogue. Journal of the Chemical Society, Chemical Communications, 1993 (22), pp. 1687-1689.

Liu, K., Hearne, K., Mrsny, A., Staka, C. and Mrsny, R. J., 2012. A strategy to improve selectivity and targeting to epithelial-derived cancer cells. Journal of Controlled Release, 164 (2), pp. 205-212.

Liu, Q., Graeff, R., Kriksunov, I. A., Jiang, H., Zhang, B., Oppenheimer, N., Lin, H. N., Potter, B. V. L., Lee, H. C. and Hao, Q., 2009. Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD Hydrolase. Journal of Biological Chemistry, 284 (40), pp. 27637-27645.

Liu, Q., Kriksunov, I. A., Moreau, C., Graeff, R., Potter, B. V. L., Lee, H. C. and Hao, Q., 2007. Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog. Journal of Biological Chemistry, 282 (34), pp. 24825-24832.

Liu, Y., Cortinovis, D. and Stone, M. A., 2004. Recent advances in the treatment of the spondyloarthropathies. Current Opinion in Rheumatology, 16 (4), pp. 357-365.

Liu, Y., Cortinovis, D. and Stone, M., 2004. Current therapies in Spondyloarthropathies. Op Rheum, 16 (4), pp. 357-365.

Llorente, J., Withey, S., Rivero, G., Cunningham, M., Cooke, A., Saxena, K., McPherson, J., Oldfield, S., Dewey, W.L., Bailey, C.P., Kelly, E. and Henderson, G., 2013. Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons. Molecular Pharmacology, 84 (2), pp. 252-260.

Llorente, J., Lowe, J. D., Sanderson, H. S., Tsisanova, E., Kelly, E., Henderson, G. and Bailey, C. P., 2012. μ-Opioid receptor desensitization: homologous or heterologous? European Journal of Neuroscience, 36 (12), pp. 3636-3642.

Lloyd, M. D., Boardman, K. D. E., Smith, A., van den Brink, D. M., Wanders, R. J. A. and Threadgill, M. D., 2007. Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome. Journal of Enzyme Inhibition and Medicinal Chemistry, 22 (5), pp. 584-590.

Lloyd, M. D., Boardman, K. D. E. and Threadgill, M. D., 2006. Expression and characterisation of human adehyde dehydrogenase 10: implications for Söjgren-Larsson syndrome. In: Conférences Européenes du Groupement des Pharmacochimistes de L'Arc Atlantique (GP2A), 2006-09-07 - 2006-09-08, Bath.

Lloyd, M. D., Darley, D. J., Wierzbicki, A. S. and Threadgill, M. D., 2008. α-Methylacyl-CoA racemase - an 'obscure' metabolic enzyme takes centre stage. FEBS Journal, 275, pp. 1089-1102.

Lloyd, M. D., Lipscomb, S. J., Hewitson, K. S., Hensgens, C. M. H., Baldwin, J. E. and Schofield, C. J., 2004. Controlling the substrate selectivity of deacetoxy/deacetylcephalosporin C synthase. Journal of Biological Chemistry, 279 (15), pp. 15420-15426.

Lloyd, M. D., Mukherji, M., Kershaw, N. J., Chien, W., Wierzbicki, A. S., Schofield, C. J., Roels, F., Baes, M. and De Bie, S., 2005. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism. In: Peroxisomal disorders and regulation of genes. Ghent: Kluwer Academic/Plenum Publishers, pp. 303-304. (Advances in Experimental Medicine and Biology)

Lloyd, M. D., Jevglevskis, M., Lee, G. L., Wood, P. J., Threadgill, M. D. and Woodman, T. J., 2013. α-Methylacyl-CoA racemase (AMACR): Metabolic enzyme, drug metabolizer and cancer marker P504S. Progress in Lipid Research, 52 (2), pp. 220-230.

Lloyd, M. D., Pederick, R. L., Natesh, R., Woo, L. W. L., Purohit, A., Reed, M. J., Acharya, R. and Potter, B. V. L., 2005. Crystal structure of human carbonic anhydrase II at 1.95 Å resolution in complex with 667-coumate, a novel anti-cancer agent. Biochemical Journal, 385 (Pt 3), pp. 715-720.

Lloyd, M. D., Thiyagarajan, N., Ho, Y. T., Woo, L. W. L., Sutcliffe, O. B., Purohit, A., Reed, M. J., Acharya, K. R. and Potter, B. V. L., 2005. First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors. Biochemistry, 44 (18), pp. 6858-6866.

Lockyer, P. J., Bottomley, J. R., Reynolds, J. S., McNulty, T. J., Venkateswarlu, K., Potter, B. V. L., Dempsey, C. E. and Cullen, P. J., 1997. Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors GAP1IP4BP and GAP1m result from the GAP1IP4BP PH domain directing plasma membrane targeting. Current Biology, 7 (12), pp. 1007-1010.

Loghmani-Khouzani, H., Poorheravi, M. R., Sadeghi, M. M. M., Caggiano, L. and Jackson, R. F. W., 2008. α-Fluorination of β-ketosulfones by Selectfluor™ F–TEDA–BF4. Tetrahedron, 64 (30-31), pp. 7419-7425.

Loi, V., Fotaki, N., Reppas, C. and Wheatley, T., 2001. Release of phenylpropanolamine HCI from ethylcellulose-coated pellets in biorelevant media. Pharmaceutical Technology, 25 (3), pp. 44-50.

Loi, V., Fotaki, N., Reppas, C., Wheatley, T. and Dressman, J., 2000. Release of phenylpropanolamine pellets in media simulating the gastrointestinal tract. In: 3rd Panhellenic Congress of Clinical Chemistry, 2000, 2000-01-01, Athens.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. Forthcoming. Development of PBPK model for an amorphous oral formulation of a poorly soluble drug : Importance of in vitro solubility and dissolution data. AAPS Journal

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2011. Dissolution testing for amorphous formulations : Effect of media and hydrodynamics. AAPS Journal, 13 (S2).

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. In vitro dissolution characterization of an amorphous formulation of a BCS class II compound. In: UK-PharmSci Meeting, 2012, 2012-09-12 - 2012-09-14, Nottingham.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. In vitro-in vivo correlations for an amorphous formulation of a poorly soluble compound. In: FIP Conference, 2012-10-03 - 2012-10-08, Amsterdam.

Long, C. M., Tang, K., Chokski, H. and Fotaki, N., 2012. Investigation on the physiological relevant amount of surfactant in simulated gastric fluids for in vitro solubility and dissolution studies. In: PharmaTech 2012, 2012-11-20 - 2012-11-21, Kuala Lumpur.

Long, N., Kealey, S., Jennings, L., Miller, P., Gee, A., Plisson, C., White, A. and Husbands, S. M., 2011. Copper(I) tris(pyrazolyl)borate complexes for use in positron emission tomography. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S98.

Lopez, R. F. V., Bentley, M. V. L. B., Delgado-Charro, M. B. and Guy, R. H., 2001. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharmaceutical Research, 18 (3), pp. 311-315.

Lopez, R. F. V., Bentley, M. V. L. B., Delgado-Charro, M. B. and Guy, R. H., 2003. Optimization of aminolevulinic acid delivery by iontophoresis. Journal of Controlled Release, 88, pp. 65-70.

Lopez, R. F. V., Bentley, M. V. L. B., Delgado-Charro, M. B., Salomon, D., van den Bergh, H., Lange, N. and Guy, R. H., 2003. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochemistry and Photobiology, 77 (3), pp. 304-308.

Lopez, R. F. V., Lange, N., Guy, R. H. and Bentley, M. V. L. B., 2004. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Advanced Drug Delivery Reviews, 56, pp. 77-94.

Lord, A. M., Lloyd, M. D. and Threadgill, M. D., 2006. Quinoline-8-carboxamides as novel PARP-1 inhibitors. In: Conférences Européenes du Groupement des Pharmacochimistes de L'Arc Atlantique (GP2A), 2006-09-07 - 2006-09-08, Bath.

Lord, A.-M., Mahon, M. F., Lloyd, M. D. and Threadgill, M. D., 2009. Design, synthesis, and evaluation in vitro of quinoline-8-carboxamides, a new class of poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) inhibitor. Journal of Medicinal Chemistry, 52 (3), pp. 868-877.

Low, Y. L., Jakubovics, N. S., Flatman, J. C., Jenkinson, H. F. and Smith, A. W., 2003. Manganese-dependent regulation of the endocarditis-associated virulence factor EfaA of Enterococcus faecalis. Journal of Medical Microbiology, 52, pp. 113-119.

Lowe, G., Cullis, P. M., Jarvest, R. L., Potter, B. V. L. and Sproat, B. S., 1981. The stereochemistry of phosphoryl transfer. Philosophical Transactions of the Royal Society B, 293, pp. 75-92.

Lowe, G. and Potter, B. V. L., 1981. A stereochemical investigation of phosphoryl transfer catalysed by phosphoglucomutase by the use of a-D-glucose 1 -[(S)-160,170,180] phosphate. Biochemical Journal, 199 (3), pp. 693-698.

Lowe, G., Cullis, P. M., Jarvest, R. L. and Potter, B. V. L., 1981. Chiral [16O, 17O, 18O] phosphate monoesters for determining the stereochemical course of phosphokinases. In: Phosphorus Chemistry. Vol. 171. ACS Publications, pp. 103-107. (ACS Symposium Series)

Lowe, G. and Potter, B., 1980. Bacteriostatic activity of fluoro-analogues of 5-(2-hydroxyethyl)-4-methylthiazole, a metabolic intermediate in the biosynthesis of thiamine. Journal of the Chemical Society: Perkin Transactions 1, 1980, pp. 2026-2028.

Lowe, G. and Potter, B. V. L., 1984. Measurement of the 31P–31P geminal coupling constant in pyrophosphate using the scalar relaxation between 17O and 31P nuclei. Journal of the Chemical Society, Chemical Communications, 1984 (13), pp. 877-879.

Lowe, G. and Potter, B. V. L., 1989. Synthesis of inorganic P1-[(S)-16O, 17O, 18O]pyrophosphate. Journal of Labelled Compounds & Radiopharmaceuticals, 27 (1), pp. 63-73.

Lowe, G. and Potter, B. V. L., 1980. Synthesis, absolute configuration, and circular dichroism of the enantiomers of fluorosuccinic acid. Journal of the Chemical Society: Perkin Transactions 1, 1980, pp. 2029-2032.

Lowe, G. and Potter, B. V. L., 1982. The stereochemical course of phosphoryl transfer catalysed by glucose 6-phosphotase. Biochemical Journal, 201 (3), pp. 421-423.

Lowe, G. and Potter, B. V. L., 1981. The stereochemical course of yeast hexokinase-catalysed phosphoryl transfer by using adenosine 5'[gamma(S)-16O,17O,18O]triphosphate as substrate. Biochemical Journal, 199 (1), pp. 227-233.

Lowe, G., Potter, B. V. L., Sproat, B. S. and Hull, W. E., 1979. The effect of 17O and the magnitude of the 18O-isotope shift in 31P nuclear magnetic resonance spectroscopy. Journal of the Chemical Society, Chemical Communications, 17, pp. 733-735.

Lowe, J. D. and Bailey, C. P., 2011. Lack of agonist-induced desensitization of mu-opioid receptors located at nerve terminals. Pharmacological Reports, 63 (1), p. 235.

Lund, A. J. S., Hurst, T. L., Tyrrell, R. M. and Thompson, D., 2011. Markers of chronic inflammation with short-term changes in physical activity. Medicine and Science in Sports and Exercise, 43 (4), pp. 578-583.

Luzardo-Alvarez, A., Delgado-Charro, M. B. and Blanco-Méndez, J., 2003. In vivo iontophoretic administration of ropinirole hydrochloride. Journal of Pharmaceutical Sciences, 92 (12), pp. 2441-2448.

Luzardo-Alvarez, A., Delgado-Charro, M. B. and Blanco-Méndez, J., 2001. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharmaceutical Research, 18 (12), pp. 1714-1720.

M

MacCarthy-Morrogh, L., Townsend, P. A., Purohit, A., Hejaz, H. A. M., Potter, B. V. L., Reed, M. J. and Packham, G., 2000. Differential effects of estrone and estrone-3-0-sulfamate derivatives on mitotic arrest, apoptosis and microtubule assembly in human breast cancer cells. Cancer Research, 60 (19), pp. 5441-5450.

MacGregor, S. A., Newnes, L. B., Staniforth, J. N., Lamming, R. C., Tobyn, M. J., Li, M., Kay, G. R., Horrill, M. D. and Hajee, D. W., 1996. Pharmaceutical process modelling. In: International Conference on Process Modelling, 1996-01-01, Cottbus.

Mackenzie, A. B., Chirakkal, H. and North, R. A., 2003. A proton gated chloride channel expressed by human alveolar macrophages abstract 2003. World Congress in Inflammation, Vancouver

Mackenzie, A. B., Chirakkal, H. and North, R. A., 2003. Kv1.3 potassium channels in human alveolar macrophages. American Journal of Physiology-Lung Cellular and Molecular Physiology, 285, L862-L868.

Mackenzie, A. B., Chirakkal, H. and North, R. A., 2002. Properties of Kv1.3 potassium channels in human lung macrophages. The Journal of Physiology, 544 (Suppl. S), 10P-11P.

Mackenzie, A. B., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A. and Surprenant, A., 2001. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity, 8, pp. 825-835.

Mackenzie, A. B., Young, M. T., Adolfini, E. and Surprenant, A., 2005. Pseudoapoptosis induced by brief activation of ATP-gated P2X 7. Journal of Biological Chemistry, 280 (40), pp. 33968-33976.

Mackenzie, A. and Watts, A., 2009. Detection and Functionalisation of S-Nitrosylated Polypeptides. G01N33/68-WO2009024791 (A1), 26 February 2009.

Mackenzie, A., Welham, M. and Thompson, B., 2010. Expression of ATP-gated P2X7 receptors in mouse embryonic stem cells. Purinergic Signalling, 6 (Supplement 1), p. 129.

Mackie, C. A., Mohammed, A., Corlett, S., Laaksonen, R., Bates, I., Duggan, C., Morrow, S., Patel, H. and Krishek, B., 2005. A randomised controlled trial of medication review by accredited community pharmacists. International Journal of Pharmacy Practice, 13, R17.

Mackridge, A. J. and Scott, J., 2009. Experiences, attitudes and training needs of pharmacy support staff providing services to drug users in Great Britain: A qualitative study. Journal of Substance Use, 14 (6), pp. 375-384.

Madani, H., Thompson, A. S. and Threadgill, M. D., 2002. An expedient synthesis of 7-0-functionalised pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones. Tetrahedron, 58 (40), pp. 8107-8111.

Maddison, P. J., Stephens, C., Briggs, D., Welsh, K. I., Harvey, G., Whyte, J., McHugh, N. and Black, C. M., 1993. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. Medicine, 72 (2), pp. 103-112.

Maffucci, T., Piccolo, E., Cumashi, A., Lezzi, M., Riley, A. M., Saiardi, A., Godage, H. Y., Rossi, C., Broggini, M., Iacobelli, S., Potter, B. V. L., Innocenti, P. and Falasca, M., 2005. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Research, 65 (18), pp. 8339-8349.

Maidment, I., Taylor, D. A. and Branford, D., 2007. Talking about medicines” — agreeing on the way forward. Hospital Pharmacist, 14, p. 74.

Mak, Y. T., Hampson, G., Beresford, J. N. and Spector, T. D., 2004. Variations in genome-wide gene expression in identical twins - a study of primary osteoblast-like culture from female twins discordant for osteoporosis. Bmc Genetics, 5.

Maksymowych, W. P., Dhillon, S., Inman, R. D., Salonen, D., Stone, M., Spady, B., Williams, M. and Lambert, R. G., 2004. The spondyloarthritis research consortium of Canada (SPARCC) magnetic resonance imaging (MRI) index: A new scoring system for the evaluation of sacroiliac joint inflammation in spondyloarthritis. Annals of the Rheumatic Diseases, 63, pp. 409-410.

Maksymowych, W. P., Dhillon, S. S., Inman, R. D., Salonen, D., Stone, M., Spady, B., Krishnananthan, R., Williams, M. and Lambert, R. G. W., 2004. The spondyloarthritis research consortium of canada (SPARCC) magnetic resonance imaging (MRI) index: A new scoring system for the evaluation of spinal inflammation in spondyloarthritis. Annals of the Rheumatic Diseases, 63, p. 414.

Maksymowych, W. P., Inman, R. D., Gladman, D., Thomson, G., Stone, M., Karsh, J., Russell, A. S. and Sparcc, [N. V.], 2003. Canadian rheumatology association consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis. Journal of Rheumatology, 30 (6), pp. 1356-1363.

Maksymowych, W. P., Inman, R. D., Salonen, D., Dhillon, S., Williams, M., Stone, M., Conner-Spady, B. and Lambert, R. G., 2004. Performance of the spondyloarthritis research consortium of Canada (SPARCC) MRI index for scoring sacroiliac and spinal inflammation at two Canadian sites. Arthritis & Rheumatism, 50 (9), S217-S218.

Maksymowych, W. P., Inman, R. D., Salonen, D., Dhillon, S. S., Krishnananthan, R., Stone, M., Conner-Spady, B., Palsat, J. and Lambert, R. G. W., 2005. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism, 53 (4), pp. 502-509.

Maksymowych, W. P., Inman, R. D., Salonen, D., Dhillon, S. S., Williams, M., Stone, M., Conner-Spady, B., Palsat, J. and Lambert, R. G. W., 2005. Spondyloarthritis research consortium of Canada magnetic resonance Imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis & Rheumatism, 53 (5), pp. 703-709.

Malini, B., Purohit, A., Ganeshapillai, D., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2000. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates. Steroid Biochemistry & Molecular Biology, 75 (4-5), pp. 253-258.

Manfredi, G., Moorwood, K., Stewart-Cox, J., Withington, I. and Ward, A., 2010. DKK1 and GPCRX, two new transgenic mouse models for innovative Alzheimer's disease drug discovery. Genetics Research, 92 (1), pp. 74-75.

Mangels, D., Mathers, J., Bolhuis, A. and Robinson, C., 2005. The core TatABC complex of the twin-arginine translocase in Escherichia coli : TatC drives assembly whereas TatA is essential for stability. Journal of Molecular Biology, 345, pp. 415-423.

Mapp, P., Woodward, B., Yu, Q. and Williams, K. I., 2002. Changes in pulmonary vascular reactivity in rats during and after chronic hypoxia. British Journal of Pharmacology, 135, 77P.

Marchant, J. S., Beecroft, M. D., Riley, A. M., Jenkins, D. J., Marwood, R. D., Taylor, C. W. and Potter, B. V. L., 1997. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo -inositol 1,4,5-trisphosphate receptors. Biochemistry, 36 (42), pp. 12780-12790.

Markovitch, D., Tyrrell, R. M. and Thompson, D., 2008. Anticipation of subsequent demanding exercise increases the expression of haem oxygenase-1 mRNA in human lymphocytes. Stress - The International Journal on the Biology of Stress, 11 (1), pp. 79-82.

Markovitch, D., Tyrrell, R. M. and Thompson, D., 2008. Acute moderate-intensity exercise in middle-aged men has neither an anti- nor pro-inflammatory effect. Journal of Applied Physiology, 105 (1), pp. 260-265.

Markovitch, D., Tyrrell, R. M. and Thompson, D., 2005. Heme oxygenase-1 expression in human lymphocytes and resistance to oxidative stress following exercise. FASEB Journal, 19 (4), A131-A131.

Markovitch, D., Tyrrell, R. M. and Thompson, D., 2007. The effect of prior exercise on ex vivo induction of heme oxygenase-1 in human lymphocytes. Free Radical Research, 41 (10), pp. 1125-1134.

Markovitch, D., Tyrrell, R. M., Tauler, P., Frystyk, J., Stokes, K. and Thompson, D., 2009. Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes. Nutrition, 25 (6), pp. 668-675.

Marro, D., Delgado-Charro, M. B. and Guy, R. H., 2001. Peptides and proteins - transdermal absorption. In: Swarbrick, J. and Boylan, J. C., eds. Encyclopaedia of Pharmaceutical Technology, 2nd ed. Vol. 2nd Edition. New York: Marcel Dekker, pp. 2125-2140.

Marro, D., Guy, R. H. and Delgado-Charro, M. B., 2001. Characterization of the iontophoretic permselectivity properties of human and pig skin. Journal of Controlled Release, 70 (1-2), pp. 213-217.

Marro, D., Kalia, Y. N., Delgado-Charro, M. B. and Guy, R. H., 2001. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharmaceutical Research, 18 (12), pp. 1701-1708.

Marro, D., Kalia, Y. N., Delgado-Charro, M. B. and Guy, R. H., 2001. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species. Pharmaceutical Research, 18 (12), pp. 1709-1713.

Martin, G. P., Fotaki, N., Salt, A. D. and Gray, V. A., 2011. 2010 Pharmaceutical Sciences World Congress Provides Dissolution Programming with an International Flavor. Dissolution Technologies, 18 (2), pp. 38-42.

Martin-Fernandez, C., Bales, J., Hodgkinson, C., Welman, A., Welham, M. J., Dive, C. and Morrow, C. J., 2009. Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs. Molecular Cancer Research, 7 (6), pp. 955-965.

Marwood, R. D., Correa, V., Taylor, C. W. and Potter, B. V. L., 2000. Synthesis of adenophostin A. Tetrahedron: Asymmetry, 11 (2), pp. 397-403.

Marwood, R. D., Riley, A. M., Correa, V., Taylor, C. W. and Potter, B. V. L., 1999. Simplification of adenophostin A defines a minimal structure for potent glucopyranoside-based mimics of 1,4,5-trisphosphate. Bioorganic & Medicinal Chemistry Letters, 9 (3), pp. 453-458.

Marwood, R. D., Riley, A. M., Jenkins, D. J. and Potter, B. V. L., 2000. Synthesis of adenophostin A and congeners modified at glucose. Journal of the Chemical Society, Perkin Transactions 1

Marwood, R. D., Shuto, S., Jenkins, D. J. and Potter, B. V. L., 2000. Convergent synthesis of adenophostin A analogues via a base replacement strategy. Chemical Communications, 2000 (3), pp. 219-220.

Massey, P. V. and Bashir, Z. I., 2007. Long-term depression: multiple forms and implications for brain function. Trends in Neurosciences, 30 (4), pp. 176-184.

Massey, P. V., Bhabra, G., Cho, K., Brown, M. W. and Bashir, Z. I., 2001. Activation of muscarinic receptors induces protein synthesis-dependent long-lasting depression in the perirhinal cortex. European Journal of Neuroscience, 14 (1), pp. 145-152.

Massey, P. V., Johnson, B. E., Moult, P. R., Auberson, Y. P., Brown, M. W., Molnar, E., Collingridge, G. L. and Bashir, Z. I., 2004. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. Journal of Neuroscience, 24 (36), pp. 7821-7828.

Massey, P. V., Phythian, D., Narduzzo, K., Warburton, E. C., Brown, M. W. and Bashir, Z. I., 2008. Learning-specific changes in long-term depression in adult perirhinal cortex. Journal of Neuroscience, 28 (30), pp. 7548-7554.

Massey, P. V., Warburton, E. C., Wynick, D., Brown, M. W. and Bashir, Z. I., 2003. Galanin regulates spatial memory but not visual recognition memory or synaptic plasticity in perirhinal cortex. Neuropharmacology, 44 (1), pp. 40-48.

Mather, S., Dora, K. A. and Garland, C. J., 2004. A technique to incorporate cell impermeant compounds into the endothelium of pressurized mesenteric arteries. British Journal of Pharmacology, 2, 112P.

Mather, S., Dora, K. A. and Garland, C. J., 2003. Endothelial cell Ca 2+ release and EDHF mediated dilatation in pressurised rat mesenteric arteries. ANZMS Meeting

Mather, S., Dora, K. A. and Garland, C. J., 2004. Selective block of intracellular calcium release and EDHF dilatation in rat isolated resistance arteries. The Journal of Physiology, 555P, C10.

Mather, S., Dora, K. A., Sandow, S. L., Winter, P. and Garland, C. J., 2005. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circulation Research, 97, pp. 399-407.

Matsumoto, R. R., Hewett, K. L., Pouw, B., Husbands, S. M., Cao, J. J. and Newman, A. H., 2001. Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters. Neuropharmacology, 42, pp. 878-886.

Matthews, L. J. R., De Haes, P., Donck, L. V. and Bouwknecht, J. A., 2011. Depression and immune responses: validation of LPS-induced anhedonia in sucrose preference test in male rats. Journal of Psychopharmacology, 25 (8), A46.

Matthews, S. E., Pouton, C. W. and Threadgill, M. D., 2001. Formation of hybrid polymethylene-poly(oxyethylene) macrocycles. Tetrahedron Letters, 42, pp. 1355-1357.

Mayes, N., 2011. Patient and health care professional views of re-designing services in primary care. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Maynard, O. M., Munafo, M. R., Roberts, N., Bauld, L. and Leonards, U., 2011. Effects of plain packaging on eye movements towards health warnings and brand information in non-smokers, weekly smokers and daily smokers. Journal of Psychopharmacology, 25 (8), A35.

McCabe, C. S., Haigh, R. C., Halligan, P. W. and Blake, D. R., 2003. Referred sensations in patients with complex regional pain syndrome type I. Rheumatology, 42, pp. 1067-1073.

McCabe, C. S., Haigh, R. C., Ring, E. F. R., Halligan, P. W., Wall, P. D. and Blake, D. R., 2003. A controlled pilot study of the utility of mirror visual feedback in the treatment of Complex Regional Pain Syndrome (Type 1). Rheumatology, 42 (1), pp. 97-101.

McCabe, C. S., Haigh, R. C., Shenker, N. G., Lewis, J. and Blake, D. R., 2003. Phantoms in rheumatology. In: Novartis Foundation Symposium, 2003-01-01.

McCarren, M., Potter, B. V. L. and Miller, R. J., 1989. A metabolically stable analog of 1,4,5-inositol trisphosphate activates a novel K+ conductance in pyramidal cells of the rat hippocampal slice. Neuron, 3 (4), pp. 461-471.

McCormick, B. A. and Mrsny, R. J., 2006. NF-kB-independent responses activated by bacterial-epithelial interactions: the role ofarachidonic acid metabolites. In: McCormick, B. A., ed. Bacterial-Epithelial Cell Cross-Talk: Molecular Mechanisms in Pathognesis. Cambridge, MA: Cambridge Publishing, pp. 269-300.

McDonald, M. C., Mota-Filipe, H., Wright, J. A., Abdelrahman, M., Threadgill, M. D., Thompson, A. S. and Thiemermann, C., 2000. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. British Journal of Pharmacology, 130 (4), pp. 843-850.

McDonough, M. J., Stick, R. V., Tilbrook, D. M. G. and Watts, A. G., 2004. An investigation into the synthesis of some molecules related to methyl acarviosin. Australian Journal of Chemistry, 57 (3), pp. 233-241.

McEvoy, L. A. F. and Dora, K. A., 2002. Intercellular calcium signalling via gap junctions in response to mechanosensitive signals in rat aortic endothelial cells. British Journal of Pharmacology, 135, 119P.

McGrogan, A., Snowball, J. and De Vries, C., 2012. Major malformations in babies whose mothers had pre-existing diabetes during pregnancy. Pharmacoepidemiology and Drug Safety, 21 (S3), 838.

McGrogan, A., Franssen, C. F. M. and de Vries, C. S., 2011. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrology Dialysis Transplantation, 26 (2), pp. 414-430.

McGrogan, A., Madle, G. C., Seaman, H. E. and de Vries, C. S., 2009. The epidemiology of Guillain-Barré Syndrome worldwide. Neuroepidemiology, 32 (2), pp. 150-163.

McGrogan, A., Seaman, H. E., Wright, J. W. and de Vries, C. S., 2008. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clinical Endocrinology, 69 (5), pp. 687-696.

McGrogan, A., Sneddon, S. and de Vries, C. S., 2010. The incidence of Myasthenia Gravis: a systematic literature review. Neuroepidemiology, 34 (3), pp. 171-183.

McGrogan, A., Snowball, J. and De Vries, C., 2010. Pregnancy loss in patients with type 1 or type 2 diabetes during pregnancy. Pharmacoepidemiology and Drug Safety, 19 (S1), 498.

McGrogan, A., Snowball, J. and De Vries, C., 2010. Treatment of diabetes before and during pregnancy. Pharmacoepidemiology and Drug Safety, 19 (S1), 156.

McGrogan, A., Snowball, J. and de Vries, C. S., 2009. Statins and pregnancy outcomes : A cohort study in the GPRD. Pharmacoepidemiology and Drug Safety, 18 (Supplement 1), S75-S76.

McHugh, N., James, I. and Maddison, P., 1990. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. Journal of Rheumatology, 17 (10), pp. 1320-1328.

McHugh, N. J., 1999. Minocycline-induced lupus and autoimmune phenomena. Lupus, 8 (417), pp. 417-418.

McHugh, N. J., 1990. Pregnancy loss, menopause, and the onset of rheumatoid arthritis. Annals of the Rheumatic Diseases, 49 (10), pp. 817-818.

McHugh, N. J., 2002. Systemic lupus erythematosus and dysregulated apoptosis-what is the evidence? Rheumatology, 41 (3), pp. 242-245.

McHugh, N. J., 1994. Systemic sclerosis : HLA antigens, autoantibodies and the brain. British Journal of Rheumatology, 33 (4), pp. 305-306.

McHugh, N. J., Balachrishnan, C. and Jones, S. M., 2003. Progression of peripheral joint disease in psoriatic arthritis : a 5-yr prospective study. Rheumatology, 42 (6), pp. 778-783.

McHugh, N. J., Csuka, M., Watson, H., Belcher, G., Amadi, A., Ring, E. F., Black, C. M. and Maddison, P. J., 1988. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Annals of the Rheumatic Diseases, 47 (1), pp. 43-47.

McHugh, N. J., Distler, O., Giacomelli, R. and Riemekasten, G., 2003. Non organ based laboratory markers in systemic sclerosis. Clinical and Experimental Rheumatology, 21 (3 Suppl 29), S32-38.

McHugh, N. J., Elvins, D. M. and Ring, E. F., 1993. Elevated anticardiolipin antibodies in a patient with vibration-white-finger, valvular heart disease and psoriatic arthritis. Clinical Rheumatology, 12 (1), pp. 70-73.

McHugh, N. J., Harvey, G. R., Whyte, J. and Dorsey, J. K., 1995. Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis. Three further cases. Arthritis & Rheumatism, 38 (12), pp. 1845-1850.

McHugh, N. J., James, I. E., Fairburn, K. and Maddison, P. J., 1990. Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clinical And Experimental Immunology, 81 (2), pp. 244-9.

McHugh, N. J., James, I. E. and Maddison, P. J., 1988. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease. Clinical And Experimental Immunology, 72 (3), pp. 457-64.

McHugh, N. J., James, I. E. and Plant, G. T., 1990. Anticardiolipin and antineutrophil antibodies in giant cell arteritis. Journal of Rheumatology, 17 (7), pp. 916-922.

McHugh, N. J. and Laurent, M. R., 1989. The effect of pregnancy on the onset of psoriatic arthritis. British Journal of Rheumatology, 28 (1), pp. 50-2.

McHugh, N. J., Laurent, M. R., Treadwell, B. L., Tweed, J. M. and Dagger, J., 1987. Psoriatic arthritis : clinical subgroups and histocompatibility antigens. Annals of the Rheumatic Diseases, 46 (3), pp. 184-8.

McHugh, N. J. and Maddison, P. J., 1989. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis & Rheumatism, 32 (12), pp. 1623-1624.

McHugh, N. J., Maddison, P. J., MacCleod, T. I., Dean, S. G., James, I. E., Goulding, N. J. and Tan, R. S., 1988. Papular lesions and cutaneous lupus erythematosus : A comparative clinical and histological study using monoclonal antibodies. The Journal of Rheumatology, 15 (7), pp. 1097-1103.

McHugh, N. J., Maymo, J., Skinner, R. P., James, I. and Maddison, P. J., 1988. Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 47 (2), pp. 110-115.

McHugh, N. J., Moye, D. A., James, I. E., Sampson, M. and Maddison, P. J., 1991. Lupus anticoagulant : clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 50 (8), pp. 548-52.

McHugh, N. J., Owen, P., Cox, B., Dunphy, J. and Welsh, K., 2006. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Annals of the Rheumatic Diseases, 65 (4), pp. 488-494.

McHugh, N. J., Reilly, P. A. and McHugh, L. A., 1989. Pregnancy outcome and autoantibodies in connective tissue disease. The Journal of Rheumatology, 16 (1), pp. 42-6.

McHugh, N. J. and Tweed, J. M., 1984. Sea urchin spine synovitis. The New Zealand Medical Journal, 97 (765), p. 700.

McHugh, N. J., Whyte, J., Artlett, C., Briggs, D. C., Stephens, C. O., Olsen, N. J., Gusseva, N. G., Maddison, P. J., Black, C. M. and Welsh, K., 1994. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives : a serological and HLA study. Clinical And Experimental Immunology, 96 (2), pp. 267-274.

McHugh, N. J., Whyte, J., Harvey, G. and Haustein, U. F., 1994. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis & Rheumatism, 37 (8), pp. 1198-1205.

McHugh, N. J., Campbell, G. J., Landreth, J. J. and Laurent, M. R., 1987. Polyarthritis and angioimmunoblastic lymphadenopathy. Annals of the Rheumatic Diseases, 46 (7), pp. 555-558.

McHugh, N. J., 2009. Traditional schemes for treatment of psoriatic arthritis. Journal of Rheumatology, 83 (Suppl), pp. 49-51.

McHugh, N. J. and Soriano, E. R., 2007. Conventional therapy of psoriatic arthritis: evidence-based review. Reumatismo, 59 (Suppl 1), pp. 81-84.

McIntyre, B. G., Martinez Bermejo, F., Srivastava, S. K., Husbands, S. M., Lewis, J. W., Crosby, J. and Simpson, T. J., 2001. Solid phase synthesis of 4-hydroxycinnamic acid and its derivatives for potential use in combinatorial chemistry: a novel route for the synthesis of 4-hydroxycinnamoyl coenzyme A and NMDA receptor antagonists. Combinatorial Chemistry and High Throughput Screening, 4, pp. 111-114.

McLaggan, D., Adjimatera, N., Sepcic, K., Jaspars, M., MacEwan, D. J., Blagbrough, I. S. and Scott, R. H., 2006. Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNA. BMC Biotechnology, 6 (6).

McLoughlin, M. J., Mays, T. J. and Price, R., 2005. Growth spiral activity and step velocities on a crystal surface. Physical Review Letters, 95 (11), 115504-1-115504-4.

McNeilage, L. J., Whittingham, S., McHugh, N. and Barnett, A. J., 1986. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis. The Journal of Immunology, 137 (8), pp. 2541-7.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2005. A role for thromboxaneA 2 in constiction to an inhibitor of NO synthase in rat middle cerebral artery. British Journal of Pharmacology, 3 (4), 174P.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2004. Ca-dependent K + -channels and endothelium dependent hyperpolarization in rat isolated cerebral arteries. British Journal of Pharmacology, 2 (2), 80P.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2004. EDHF in rat mid-cerebral arteries - a possible role for K +. British Journal of Pharmacology, 2 (2), 94P.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2004. K + may act as an EDHF in rat middle cerebral artery. FASEB Journal, Abstract 643, p. 19.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2006. NO can suppress mnyogenic tone in rat middle cerebral arteries by activating BK Ca. FASEB Journal, 20.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2005. NO suppresses myogenic tone in rat middle cerebral artery by activating BK Ca channels. British Journal of Pharmacology, 3 (4), 012P.

McNeish, A. J., Dora, K. A. and Garland, C. J., 2005. Possible role for K+ in endothelium-derived hyperpolarizing factor-linked dilatation in rat middle cerebral artery. Stroke, 36, pp. 1526-1532.

McNeish, A. J. and Garland, C. J., 2007. Thromboxane A 2 inhibition of SK Ca after NO synthase block in rat middle cerebral artery. British Journal of Pharmacology, 151, pp. 441-449.

McNeish, A. J., Kansui, Y., Garland, C. and Dora, K., 2007. Nitric Oxide does not suppress myogenic tone by activating ryanodine sensitive stores in rat middle cerebral artery. FASEB Journal, 21 (6), A1168-A1168.

McNeish, A. J., Nelli, S., Wilson, W. S., Dowell, F. J. and Martin, W., 2003. Differential effects of ascorbate on endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and coronary artery. British Journal of Pharmacology, 138 (6), pp. 1172-1180.

McNeish, A. J., Sandow, S. L., Neylon, C. B., Chen, M. X., Dora, K. A. and Garland, C. J., 2006. Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery. Stroke, 7, pp. 1277-1282.

McNeish, A. J., Wilson, W. S. and Martin, W., 2002. Ascorbate blocks endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and rat mesentery. British Journal of Pharmacology, 135 (7), pp. 1801-1809.

McNeish, A. J., Wilson, W. S. and Martin, W., 2001. Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye. British Journal of Pharmacology, 134 (4), pp. 912-920.

McNeish, A.J., Jimenez-Altayo, F., Cottrell, G.S. and Garland, C.J., 2012. Statins and Selective Inhibition of Rho Kinase Protect Small Conductance Calcium-Activated Potassium Channel Function (K 2.3) in Cerebral Arteries. PLoS ONE, 7 (10), 46735.

McNeish, A. J., Altayo, F. J. and Garland, C. J., 2010. Evidence both L-type and non-L-type voltage-dependent calcium channels contribute to cerebral artery vasospasm following loss of NO in the rat. Vascular Pharmacology, 53 (3-4), pp. 151-159.

McNulty, C., Logan, M., Donald, I. P., Ennis, D., Taylor, D. A., Baldwin, R. N., Bannerjee, M. and Cartwright, K. A., 1997. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy, 40 (5), pp. 707-711.

McPherson, J., Rivero, G., Baptist, M., Llorente, J., Al-Sabah, S., Krasel, C., Dewey, W. L., Bailey, C. P., Rosethorne, E. M., Charlton, S. J., Henderson, G. and Kelly, E., 2010. μ-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Molecular Pharmacology, 78 (4), pp. 756-766.

McRae, L. A., 2007. Flk-1 signalling during ES cell differentiation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

McSherry, I. N., Garland, C. J., Campbell, W., Falck, J., Hill, M. and Dora, K. A., 2005. EDHG-like responses in rat cremaster muscle arterioles involve IK Ca and SK Ca channels, and CYP-450 metabolites. Asian Congress for Microcirculation, Tokyo, Japan

McSherry, I. N., Garland, C. J. and Dora, K. A., 2003. Blockade of IK Ca and SK Ca channels inhibits EDHF-mediated vasodilatation, but not endothelial cell calcium changes, in isolated rat mesenteric arteries. ANZMS Meeting

McSherry, I. N., Garland, C. J. and Dora, K. A., 2004. Control of endothelial cell calcium handling in rat mesenteric arteries. British Journal of Pharmacology, 2 (2), 113P.

McSherry, I. N., Garland, C. J. and Dora, K. A., 2004. IK Ca and SK Ca endothelial cell hyperpolarization underlies vasodilation to EDHF but does not modify calcium entry in rat isolated mesenteric arteries. The Journal of Physiology, 555P, C12.

McSherry, I. N., Sandow, S. L., Campbell, W. B., Falck, J. R., Hill, M. A. and Dora, K. A., 2006. A role for heterocellular coupling and EETs in dilation of rat cremaster arteries. Microcirculation, 13, pp. 119-130.

McSherry, I. N., Sandow, S. L., Garland, C. J., Campbell, W. B., Falck, J. R., Hill, M. A. and Dora, K. A., 2005. EDHF-like responses in rat cremaster muscle arterioles. FASEB Journal, Late-breaking abstra.

McSherry, I. N., Spitaler, M. M., Takano, H. and Dora, K. A., 2005. Endothelial cell Ca 2+ increases are independent of membrane potential in pressurized rat mesenteric arteries. Cell Calcium, 38, pp. 23-33.

Mecklenburg, S., Collins, C. A., Doring, M., Burkholz, T., Abbas, M., Fry, F. H., Pourzand, C. and Jacob, C., 2008. The design of multifunctional antioxidants against the damaging ingredients of oxidative stress. Phosphorus Sulfur and Silicon and the Related Elements, 183 (4), pp. 863-888.

Medina-Tato, D. A., Ward, S. G. and Watson, M. L., 2007. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology, 121, pp. 448-461.

Medina-Tato, D. A., Ward, S. G. and Watson, M. L., 2006. Cross-regulation between class IA phosphatidyl inositol 3-kinase p110 beta and p110 delta isoforms. Inflammation Research, 55 (Suppl 2), S124-S124.

Medina-Tato, D. A., Watson, M. L. and Ward, S. G., 2006. Leukocyte navigation mechanisms as targets in airway diseases. Drug Discovery Today, 11 (19-20), pp. 866-879.

Mehier-Humbert, S., Bettinger, T., Yan, F. and Guy, R. H., 2005. Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. Journal of Controlled Release, 104, pp. 203-211.

Mehier-Humbert, S. and Guy, R. H., 2005. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Advanced Drug Delivery Reviews, 57, pp. 733-753.

Mehier-Humbert, S., Yan, F., Frinking, P., Schneider, M., Guy, R. H. and Bettinger, T., 2007. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjugate Chemistry, 18, pp. 652-662.

Mehier-Humbert, S., Yan, F., Guy, R. H. and Bettinger, T., 2005. Plasma membrane poration induced by ultrasound: implication for drug delivery. Journal of Controlled Release, 104, pp. 213-222.

Mehier-Humbert, S., Bettinger, T., Yan, F. and Guy, R. H., 2009. Influence of polymer adjuvants on the ultrasound-mediated transfection of cells in culture. European Journal of Pharmaceutics and Biopharmaceutics, 72 (3), pp. 567-573.

Mehta, R., Bolton, C., Gamble, K., Heer, K., Kalher, D. and Scott, J., 2001. Continuation of treatment of drug misusers across care boundaries in the South West. International Journal of Pharmacy Practice, 9 (Suppl), R30.

Meima, R., Eschevins, C., Fillinger, S., Bolhuis, A., Hamoen, L. W., Dorenbos, R., Quax, W. J., van Dijl, J. M., Provvedi, R., Chen, I., Dubnau, D. and Bron, S., 2002. The bdbDC operon of bacillus subtilis encodes thiol-disulfide oxidoreductases required for competence development. Journal of Biological Chemistry, 277 (9), pp. 6994-7001.

Meneghello, G., Parker, D. J., Ainsworth, B. J., Perera, S. P., Chaudhuri, J. B., Ellis, M. J. and De Bank, P. A., 2009. Fabrication and characterization of poly(lactic-co-glycolic acid)/polyvinyl alcohol blended hollow fibre membranes for tissue engineering applications. Journal of Membrane Science, 344 (1-2), pp. 55-61.

Meneghello, G., 2010. Development of a Novel PVA-PLGA Hollow Fibre Bioreactor for Tissue Engineering. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Meneghello, G., Ainsworth, B., De Bank, P., Ellis, M. J. and Chaudhuri, J., 2008. Effect of polyvinyl alcohol and sodium hypochlorite on porosity and mechanical properties of PLGA hollow fibre membrane scaffolds. European Cells and Materials, 16 (Supplement 3), p. 82.

Menniti, F. S., Bird, G. S. J., Takemura, H., Thastrup, O., Potter, B. V. L. and Putney Jr., J. W., 1991. Mobilization of calcium by inositol trisphosphates from permeabilized rat parotid acinar cells : evidence for translocation of calcium from uptake to release sites within the inositol 1,4,5-trisphosphate- and thapsigargin-sensitive calcium pool. Journal of Biological Chemistry, 266 (21), pp. 13646-13653.

Merclin, N., Bender, J., Sparr, E., Guy, R. H., Ehrsson, H. and Engström, S., 2004. Transdermal delivery from a lipid sponge phase - iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. Journal of Controlled Release, 100 (2), pp. 191-198.

Meredith, K., Bolhuis, A. and O’Neill, M. A. A., 2009. Enterococcal surface protein Esp affects antibiotic sensitivity in Enterococcus faecium. International Journal of Antimicrobial Agents, 34 (4), pp. 392-393.

Merino, G., Kalia, Y. N., Delgado-Charro, M. B., Potts, R. O. and Guy, R. H., 2003. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. Journal of Controlled Release, 88, pp. 85-94.

Merino, G., Kalia, Y. N. and Guy, R. H., 2003. Ultrasound-enhanced transdermal transport. Journal of Pharmaceutical Sciences, 92 (6), pp. 1125-1137.

Metwally, A., 2012. Pharmaceutical formulations of bionanoparticles for siRNA delivery. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Metwally, A. A. and Blagbrough, I. S., 2011. Self-assembled lipoplexes of short interfering RNA (siRNA) using spermine-based fatty acid amide guanidines: effect on gene silencing efficiency. Pharmaceutics, 3 (3), pp. 406-424.

Metwally, A. A. and Blagbrough, I. S., 2011. Self-assembled siRNA lipoplexes of LinOS-cholesterol mixtures : Enhanced siRNA uptake and gene silencing in HeLa cells. Human Gene Therapy, 22 (10), A81.

Metwally, A. A. and Blagbrough, I. S., 2011. Synthesis and evaluation of N4,N9-fatty acid conjugates of N1,N12-diamidino-spermine as non-viral siRNA delivery vectors. Human Gene Therapy, 22 (10), A85.

Metwally, A. A., Pourzand, C. and Blagbrough, I. A., 2011. Efficient gene silencing by self-assembled complexes of siRNA and symmetrical fatty acid amides of spermine. Pharmaceutics, 3 (2), pp. 125-140.

Metwally, A. A., Pourzand, C. and Blagbrough, I. S., 2010. Efficient siRNA delivery and effective gene silencing by lipoplexes. Drug Discovery Today, 15 (23-24), p. 1090.

Metwally, A. A., Pourzand, C. and Blagbrough, I. S., 2010. Efficient siRNA delivery and gene silencing by unsymmetrical fatty acid amides of spermine. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1220-1221.

Metwally, A. A., Reelfs, O., Pourzand, C. and Blagbrough, I. S., 2011. Asymmetrical N4,N9-diacyl spermines: SAR and their efficiency as siRNA delivery vectors compared with symmetrical mixtures. Human Gene Therapy, 22 (10), A84-A85.

Metwally, A. A., Reelfs, O., Pourzand, C. and Blagbrough, I. S., 2012. Efficient silencing of EGFP reporter gene with siRNA delivered by asymmetrical N4,N9-diacyl spermines. Molecular Pharmaceutics, 9 (7), pp. 1862-1876.

Metwally, A. A., Blagbrough, I. S. and Mantell, J. M., 2012. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol. Molecular Pharmaceutics, 9 (11), pp. 3384-3395.

Migaud, M. E., Pederick, R. L., Bailey, V. C. and Potter, B. V. L., 1999. Probing Aplysia californica adenosine 5‘-diphosphate ribosyl cyclase for substrate binding requirements : design of potent inhibitors. Biochemistry, 38 (28), pp. 9105-9114.

Miller, A. L., Plane, F., Jeremy, J. Y., McKinnon, H. J. and Jackson, C. L., 2003. Delayed recovery of receptor-mediated functional responses to acetylcholine in mouse isolated carotid arteries following endothelial denudation in vivo. Journal of Vascular Research, 40 Sep-Oct (5), pp. 449-59.

Mills, E. and Laaksonen, R., 2005. Methods for identifying pharmacists' learning needs. In: LLLP Conferences, 2005-01-01, Saskatoon.

Mills, E., Laaksonen, R., Bates, I., Davies, G. and Duggan, C., 2005. Self-assessment of competence in a community pharmacy setting. Pharmacy Education, 5 (3/4), pp. 189-199.

Mills, S. J. and Potter, B. V. L., 1997. Synthesis of the enantiomers of myo-inositol 1,2,4,5-tetrakisphosphate, a regioisomer of myo-inositol 1,3,4,5-tetrakisphosphate. Journal of the Chemical Society, Perkin Transactions 1, 1997 (9), pp. 1279-1286.

Mills, S. J., Riley, A. M., Murphy, C. T., Bullock, A. J., Westwick, J. and Potter, B. V. L., 1995. Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,4-trisphosphorothioate: new synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor. Bioorganic & Medicinal Chemistry Letters, 5 (3), pp. 203-208.

Mills, S. J., Safrany, S. T., Wilcox, R. A., Nahorski, S. R. and Potter, B. V. L., 1993. Synthesis of myo-inositol 1,2,4,5-tetrakisphosphate, a Ca2+-mobilising tetrakisphosphate with a potency similar to myo-inositol 1,4,5-trisphosphate. Bioorganic & Medicinal Chemistry Letters, 3 (8), pp. 1505-1510.

Mills, S. J., Al-hafidh, J., Westwick, J. and Potter, B. V.L., 1993. Myo-inositol 1,4,6-trisphosphate: A new synthetic Ca2+-mobilising inositol phosphate. Bioorganic & Medicinal Chemistry Letters, 3 (12), pp. 2599-2604.

Mills, S. J., Backers, K., Erneux, C. and Potter, B. V. L., 2003. Synthesis of D- and L-myo-inisitol 1,2,4,6-tetrakisphosphate regioisomers of myo -inisitol 1,3,4,5 tetrakisphosphate : activity against Ins(1,4,5)P3 binding proteins. Organic & Biomolecular Chemistry, 2003 (1), pp. 3546-3556.

Mills, S. J., Dozol, H., Vandeput, F., Backers, K., Woodman, T., Erneux, C., Spiess, B. and Potter, B. V. L., 2006. 3-hydroxybenzene 1,2,4-trisphosphate, a novel second messenger mimic and unusual substrate for type-I myo-inositol 1,4,5-trisphosphate 5-phosphatase : synthesis and physicochemistry. ChemBiochem, 7 (11), pp. 1696-1706.

Mills, S. J., Komander, D., Trusselle, M. N., Safrany, S. T., van Aalten, D. M. F. and Potter, B. V. L., 2007. Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Bα. ACS Chemical Biology, 2 (4), pp. 242-246.

Mills, S. J., Liu, C. and Potter, B. V. L., 2002. Synthesis of D-and L-myo -inositol 2,4,5-trisphosphate and trisphosphorothioate : structural analogues of D-myo-inositol 1,4,5-trisphosphate. Carbohydrate Research, 337 (20), pp. 1795-1801.

Mills, S. J., Persson, C., Cozier, G., Thomas, M. P., Trésaugues, L., Erneux, C., Riley, A. M., Nordlund, P. and Potter, B. V. L., 2012. A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. ACS Chemical Biology, 7 (5), pp. 822-828.

Mills, S. J. and Potter, B. V. L., 1996. Synthesis of D- and L- myo-inositol 1,4,6-trisphosphate, regioisomers of a ubiquitous second messenger. Journal of Organic Chemistry, 61 (25), pp. 8980-8987.

Mills, S. J. and Potter, B. V. L., 2003. Synthesis of potent Ins(1,4,5)P3 5-phosphatase inhibitors by modification of myo -inositol 1,3,4,6-tetrakisphosphate. Bioorganic and Medicinal Chemistry, 11 (19), pp. 4245-4253.

Mills, S. J., Riley, A. M., Liu, C., Mahon, M. F. and Potter, B. V. L., 2003. A definitive synthesis of D-myo-inositol 1,4,5,6-tetrakisphosphate and its enantiomer D-myo-inositol 3,4,5,6-tetrakisphosphate from a novel butane-2,3-diacetal-protected inositol. Chemistry - A European Journal, 9 (24), pp. 6207-6214.

Mills, S. J., Vandeput, F., Trusselle, M. N., Safrany, S. T., Erneux, C. and Potter, B. V. L., 2008. Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5‐trisphosphate 5‐phosphatase and interaction with the PH domain of protein kinase Bα. ChemBiochem, 9 (11), pp. 1757-1766.

Minaur, N. J., Jefferiss, C. M., Bhalla, A. K. and Beresford, J. N., 2002. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage. Rheumatology, 41 (7), pp. 735-740.

Minaur, N. J., Kounali, D., Vedi, S., Compston, J. E., Beresford, J. N. and Bhalla, A. K., 2002. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology, 41 (7), pp. 741-749.

Mitchell, P. J., 2005. Antidepressant treatment and rodent aggressive behaviour. European Journal of Pharmacology, 526, pp. 147-162.

Mitchell, P. J., Fairhall, S. J., Fletcher, A. and Redfern, P. H., 2003. Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats. Neuropharmacology, 44, pp. 911-925.

Mitchell, P. J., Hogg, S. and Sanchez, C., 2004. Agonistic behaviour of resident rats after acute and chronic treatment with S(+)- and R(-)-citalopram. International Journal of Neuropsychopharmacology, 7 (Suppl. 1), S187-S187.

Mitchell, P. J. and Redfern, P. H., 2005. Animal models of depressive illness: the importance of chronic drug treatment. Current Pharmaceutical Design, 11, pp. 171-203.

Mitragotri, S., Anissimov, Y. G., Bunge, A. L., Frasch, H. F., Guy, R. H., Hadgraft, J., Kasting, G. B., Lane, M. E. and Roberts, M. S., 2011. Mathematical models of skin permeability: An overview. International Journal of Pharmaceutics, 418 (1), pp. 115-129.

Mochizuki, T., Kondo, Y., Abe, H., Taylor, C. W., Potter, B. V. L., Matsuda, A. and Shuto, S., 2006. Design and synthesis of 5‘-deoxy-5‘-phenyladenophostin A, a highly potent IP3 receptor ligand 1. Organic Letters, 8 (7), pp. 1455-1458.

Mochizuki, T., Kondo, Y., Abe, H., Tovey, S. C., Dedos, S. G., Taylor, C. W., Paul, M., Potter, B. V. L., Matsuda, A. and Shuto, S., 2006. Synthesis of Adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands. Journal of Medicinal Chemistry, 49 (19), pp. 5750-5758.

Mohamed, A. I., El-Assal, M. I. A., Kassem, M. A., Blagbrough, I. S. and Ahmed, O. A. A., 2013. Role of PLGA-nanoparticles formulation to improve drug radioprotective activity in gamma-irradiated mice. Latin American Journal of Pharmacy, 32 (6), pp. 809-816.

Mohammadpoor-Baltork, I., Hill, M., Caggiano, L. and Jackson, R. F. W., 2006. Oxidative kinetic resolution of alky aryl sulfoxides. Synlett, 20, pp. 3540-3544.

Mohammed, D., Yang, Q., Guy, R.H., Matts, P.J., Hadgraft, J. and Lane, M.E., 2012. Comparison of gravimetric and spectroscopic approaches to quantify stratum corneum removed by tape-stripping. European Journal of Pharmaceutics and Biopharmaceutics, 82 (1), pp. 171-174.

Molloy, C. B., Connelly, P., Sengupta, R., Papachristos, A., Inrig, T., Pomeroy, E., Rockman, J., Kay, H. I., Taylor, G. and Stone, M. A., 2007. The role of lipoproteins and sensitivity CRP as potential biomarkers of disease activity in spondyloarthopathy. Arthritis & Rheumatism, 56 (12), p. 4299.

Molloy, C. B., Sengupta, R., Connelly, P., Papachristos, A., Inrig, T., Rockman, J., Kay, H., Pomeroy, E. and Stone, M. A., 2007. Lipid bioprofiles and correlation with disease activity measures in the' spondyloarthropathies. Annals of the Rheumatic Diseases, 66, p. 405.

Moore, S. F. and Mackenzie, A. B., 2007. Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cellular Signalling, 19 (4), pp. 855-866.

Moore, S. F. and Mackenzie, A. B., 2009. NADPH oxidase NOX2 mediates rapid vellular oxidation following ATP stimulation of endotoxin-primed macrophages. The Journal of Immunology, 183 (5), pp. 3302-3308.

Moore, S. F. and Mackenzie, A. B., 2008. Species and agonist dependent zinc modulation of endogenous and recombinant ATP-gated P2X7 receptors. Biochemical Pharmacology, 76 (12), pp. 1740-1747.

Moore, S., 2008. The role of fast ATP-Gated P2X receptors in inflammation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Morales, J.O., Su, R. and McConville, J.T., 2013. The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films. AAPS PharmSciTech, 14 (2), pp. 475-484.

Moreau, C., Frost, C.G. and Murrer, B., 1999. Catalytic asymmetric hydrosilylation of ketones using mixed-ligand ruthenium complexes. Tetrahedron Letters, 40 (30), pp. 5617-5620.

Moreau, C., Hague, C., Weller, A.S. and Frost, C.G., 2001. Rhodium-catalysed aryl transfer to aldehydes : Counterion effects with nitrogen containing ligands. Tetrahedron Letters, 42 (39), pp. 6957-6960.

Moreau, C., Liu, Q., Graeff, R., Wagner, G.K., Thomas, M.P., Swarbrick, J.M., Shuto, S., Lee, H.C., Hao, Q. and Potter, B.V.L., 2013. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5′-Diphosphate Ribose Template. PLoS ONE, 8 (6), e66247.

Moreau, C., Ashamu, G. A., Bailey, V. C., Galione, A., Guse, A. H. and Potter, B. V. L., 2011. Synthesis of cyclic adenosine 5 '-diphosphate ribose analogues : a C2 ' endo/syn "southern" ribose conformation underlies activity at the sea urchin cADPR receptor. Organic and Biomolecular Chemistry, 9 (1), pp. 278-290.

Moreau, C., Kirchberger, T., Swarbrick, J. M., Bartlett, S. J., Fliegert, R., Yorgan, T., Bauche, A., Harneit, A., Guse, A. H. and Potter, B. V. L., 2013. Structure–ativity relationship of adenosine 5′-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel : rational design of antagonists. Journal of Medicinal Chemistry, 56 (24), pp. 10079-10102.

Moreau, C., Kirchberger, T., Zhang, B., Thomas, M. P., Weber, K., Guse, A. H. and Potter, B. V. L., 2012. Aberrant cyclization affords a C-6 modified cyclic adenosine 5′-diphosphoribose analogue with biological activity in Jurkat T cells. Journal of Medicinal Chemistry, 55 (4), pp. 1478-1489.

Moreau, C., Wagner, G. K., Weber, K., Guse, A. H. and Potter, B. V. L., 2006. Structural determinants for N1/N7 cyclization of nicotinamide hypoxanthine 5‘-dinucleotide (NHD+ ) derivatives by ADP-ribosyl cyclase from Aplysia Californica : Ca 2+ -mobilizing activity of 8-substituted cyclic inosine 5‘-diphosphoribose analogues in T-lymphocytes. Journal of Medicinal Chemistry, 49 (17), pp. 5162-5176.

Moreau, C., Woodman, T. J. and Potter, B. V. L., 2006. Unusual entry to the novel 8-halo-N-ribosyl hypoxanthine system by degradation of a cyclic adenosine-5'-diphosphate ribose analogue. Chemical Communications, 2006 (10), pp. 1127-1129.

Moreno, E., Nolasco, L. a., Caggiano, L. and Jackson, R. F. W., 2006. Synthesis of orthogonally protected biaryl amino acid derivatives. Organic and Biomolecular Chemistry, 4, pp. 3639-3647.

Morris, C. J., Cantrill, J. A. and Weiss, M. C., 2001. GP survey response rate: a miscellany of influencing factors. Family Practice, 18, pp. 454-456.

Morris, C. J., Cantrill, J. A. and Weiss, M. C., 2003. Minor ailment consultations: a mismatch of perceptions between GPs and pharmacists. Primary Care Research & Development, 4, pp. 365-370.

Morris, C. J. and Weiss, M. C., 2001. GPs' attitudes to minor ailments. Family Practice, 18 (6), pp. 581-585.

Morris, S. A., Nerou, E. P., Riley, A. M., Potter, B. V. L. and Taylor, C. W., 2002. Determinants of adenophostin A binding to inositol trisphosphate receptors. Biochemical Journal, 367 (Pt 1), pp. 113-120.

Mort, C. J. W., Migaud, M. E., Galione, A. and Potter, B. V. L., 2004. Aplysia californica mediated cyclisation of novel 3'-modified NAD analogues : a role for hydrogen bonding in the recognition of cyclic adenosine 5'-diphosphate ribose. Bioorganic and Medicinal Chemistry, 12 (2), pp. 475-487.

Moschos, S. A., Spinks, K., Williams, A. E. and Lindsay, M. A., 2008. Targeting the lung using siRNA and antisense based oligonucleotides. Current Pharmaceutical Design, 14 (34), pp. 3620-3627.

Moser, K., Kriwet, K., Froehlich, C., Kalia, Y. N. and Guy, R. H., 2001. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharmaceutical Research, 18 (7), pp. 1006-1011.

Moser, K., Kriwet, K., Froehlich, C., Naik, A., Kalia, Y. N. and Guy, R. H., 2001. Permeation enhancement of a highly lipophilic drug using supersaturated systems. Journal of Pharmaceutical Sciences, 90 (5), pp. 607-616.

Moser, K., Kriwet, K., Kalia, Y. N. and Guy, R. H., 2001. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. Journal of Controlled Release, 73, pp. 245-253.

Moser, K., Kriwet, K., Kalia, Y. N. and Guy, R. H., 2001. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. International Journal of Pharmaceutics, 224, pp. 169-176.

Moser, K., Kriwet, K., Naik, A., Kalia, Y. N. and Guy, R. H., 2001. Passive skin penetration enhancement and its quantification in vitro. European Journal of Pharmaceutics and Biopharmaceutics, 52, pp. 103-112.

Moskalenko, A. V., Yarova, P. L., Gordeev, S. N. and Smirnov, S. V., 2010. Single protein molecule mapping with magnetic atomic force microscopy. Biophysical Journal, 98 (3), pp. 478-487.

Moss, R. J., Wadsworth, K. J., Chapman, C.J. and Frost, C.G., 2004. Rhodium catalysed tandem conjugate addition-protonation : An enantioselective synthesis of 2-substituted succinic esters. Chemical Communications, 10 (17), pp. 1984-1985.

Moss, S. H., 2005. Dissolution testing. Commercial and Academic Services, Bath.

Moss, S. H., 2006. Lipidex. Bath: Commercial and Academic Services.

Moss, S. H., 2006. MiDatabank. Bath: Commercial and Academic Services, Bath.

Moss, S. H., 2007. Sunlight and you. Bath University: Commercial and Academic Services, Bath.

Mountjoy, P. D., Bailey, S. J. and Rutter, G. A., 2007. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia, 50, pp. 168-177.

Moynihan, H., Jales, A. R., Greedy, B. M., Rennison, D., Broadbear, J. H., Purington, L., Traynor, J. R., Woods, J. H., Lewis, J. W. and Husbands, S. M., 2009. 14β-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. Journal of Medicinal Chemistry, 52 (6), pp. 1553-1557.

Mrsny, R. J., 2006. Active targeting strategies in cancer with a focus on potential nanotechnology applications. In: Amiji, M. M., ed. Nanotechnology in Cancer Therapeutics. Boca Raton, Florida: CRC Press, pp. 19-42.

Mrsny, R. J., 2004. Learning from nature: examples of rapid, repetitive, responsive biological events. In: Yui, N., Mrsny, R. J. and Park, K., eds. Multi-Reflexive Polymers and Hydrogels: Understanding and Designing Fast-Responsive Polymeric Systems. Boca Raton, Florida: CRC Press, pp. 3-15.

Mrsny, R. J., 2005. Modification of epithelial tight junction integrity to enhance transmucosal absorption. Critical Review of Therapeutic Drug Carrier Systems, 22 (4), pp. 331-418.

Mrsny, R. J., 2004. Strategies for targeting protein therapeutics to selected tissues and cells. Expert Opinion on Biological Therapy, 4 (1), pp. 65-73.

Mrsny, R. J., 2004. Tissue and cell specific targeting. In: Amiji, M. M., ed. Gene Delivery: Principles and Applications. Boca Raton, Florida: CRC Press, pp. 5-27.

Mrsny, R. J., Daugherty, A. L., McKee, M. L. and Fitzgerald, D. J., 2002. Bacterial toxins as tools for mucosal vaccination. Drug Discovery Today, 7 (4), pp. 247-258.

Mrsny, R. J., Gewirtz, A. T., Siccardi, D., Savidge, T., Hurley, B. P., Madara, J. L. and McCormick, B. A., 2004. Identification of hepoxilin A 3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proceedings of the National Academy of Sciences of the United States of America, 101 (19), pp. 7421-7426.

Mrsny, R. J. and Nusrat, A., 2005. Adhesion proteins in cellular tight junctions: critical components in the modulation of paracellular permeability. Advanced Drug Delivery Reviews, 57 (6), pp. 809-810.

Mrsny, R. J., 2009. Lessons from nature: "Pathogen-Mimetic" systems for mucosal Nano-medicines. Advanced Drug Delivery Reviews, 61 (2), pp. 172-192.

Mrsny, R. J., 2009. Metabolic processes at injection sites affecting pharmacokinetics, pharmacodynamics and metabolism of protein and peptide therapeutics. In: Mrsny, R. J. and Daugherty, A. L., eds. Proteins and Peptides: Pharmacokinetic, Pharmacodynamic, and Metabolic Outcomes. New York: Informa Healthcare, pp. 80-105.

Mrsny, R. J., Brown, G. T., Gerner-Smidt, K., Buret, A. G., Meddings, J. B., Quan, C., Koval, M. and Nusrat, A., 2008. A key claudin extracellular loop domain is critical for epithelial barrier integrity. American Journal Of Pathology, 172 (4), pp. 905-915.

Mrsny, R. J., 2012. Oral drug delivery research in Europe. Journal of Controlled Release, 161 (2), pp. 247-253.

Mu, X. H., Tobyn, M. J. and Staniforth, J. N., 2003. Development and evaluation of bio-dissolution systems capable of detecting the food effect on a polysaccharide-based matrix system. Journal of Controlled Release, 93 (3), pp. 309-318.

Mudry, B., Carrupt, P. A., Guy, R. H. and Delgado-Charro, M. B., 2007. Quantitative structure-permeation relationship for iontophoretic transport across the skin. Journal of Controlled Release, 122 (2), pp. 165-172.

Mudry, B., Guy, R. H. and Delgado-Charro, M. B., 2006. Electromigration of ions across the skin: determination and prediction of transport numbers. Journal of Pharmaceutical Sciences, 95 (3), pp. 561-569.

Mudry, B., Guy, R. H. and Delgado-Charro, M. B., 2006. Iontophoresis in transdermal delivery. In: Touitou, E. and Barry, B. W., eds. Enhancement in drug delivery. Boco Raton: CRC Press, pp. 279-302.

Mudry, B., Guy, R. H. and Delgado-Charro, M. B., 2006. Prediction of iontophoretic transport across the skin. Journal of Controlled Release, 111, pp. 362-367.

Mudry, B., Guy, R. H. and Delgado-Charro, M. B., 2006. Transport numbers in transdermal iontophoresis. Biophysical Journal, 90, pp. 2822-2830.

Mukherji, M., Chien, W., Kershaw, N. J., Clifton, I. J., Schofield, C. J., Wierzbicki, A. S. and Lloyd, M. D., 2001. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Human Molecular Genetics, 10 (18), pp. 1971-1982.

Mukherji, M., Kershaw, N. J., MacKinnon, C. H., Clifton, I. J., Wierzbicki, A. S., Schofield, C. J. and Lloyd, M. D., 2001. 'Chemical co-substrate rescue' of phytanoyl-CoA 2-hydroxylase mutants causing Refsum's Disease. Chemical Communications, 2001, pp. 972-973.

Mukherji, M., Kershaw, N. J., Schofield, C. J., Wierzbicki, A. S. and Lloyd, M. D., 2002. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal α oxidation of phytanic acid. Chemistry & Biology, 9, pp. 597-605.

Mukherji, M., Schofield, C. J., Wierzbicki, A. S., Jansen, G. A., Wanders, R. J. A. and Lloyd, M. D., 2003. The chemical biology of branched-chain lipid metabolism. Progress in Lipid Research, 42, pp. 359-376.

Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah-Muthu, S. S., Colhoun, H. M., Lawrenson, R. A. and de Vries, C. S., 2008. Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database. Diabetologia, 51 (9), pp. 1639-1645.

Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah-Muthu, S. S., Colhoun, H. M., Lawrenson, R. A. and de Vries, C. S., 2006. Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia, 49 (12), pp. 2859-2865.

Mundell, S. J., Matharu, A. -L., Pula, G., Holman, D., Roberts, P. J. and Kelly, E., 2002. Metabotropic Glutamate Receptor 1 Internalization Induced by Muscarinic Acetylcholine Receptor Activation: Differential Dependency of Internalization of Splice Variants on Nonvisual Arrestins. Molecular Pharmacology, 61 (5), pp. 1114-1123.

Mundell, S. J., Pula, G., More, J. C. A., Jane, D. E., Roberts, P. J. and Kelly, E., 2004. Activation of Cyclic AMP-Dependent Protein Kinase Inhibits the Desensitization and Internalization of Metabotropic Glutamate Receptors 1a and 1b. Molecular Pharmacology, 65 (6), pp. 1507-1516.

Mundell, S. J., Matharu, A.-L., Pula, G., Roberts, P. J. and Kelly, E., 2001. Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent. Journal of Neurochemistry, 78 (3), pp. 546-551.

Mundell, S. J., Pula, G., Carswell, K., Roberts, P. J. and Kelly, E., 2003. Agonist-induced internalization of metabotropic glutamate receptor 1A: structural determinants for protein kinase C- and G protein-coupled receptor kinase-mediated internalization. Journal of Neurochemistry, 84 (2), pp. 294-304.

Mundell, S. J., Pula, G., McIlhinney, R. A. J., Roberts, P. J. and Kelly, E., 2004. Desensitization and Internalization of Metabotropic Glutamate Receptor 1a Following Activation of Heterologous Gq/11-Coupled Receptors. Biochemistry, 43 (23), pp. 7541-7551.

Murphy, C. T., Bullock, A., Lindley, C. J., Mills, S. J., Riley, A., Potter, B. V. L. and Westwick, J., 1996. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors. Molecular Pharmacology, 50 (5), pp. 1223-1230.

Murphy, C. T., Riley, A. M., Lindley, C. J., Jenkins, D. J., Westwick, J. and Potter, B. V. L., 1997. Structural analogues of D-myo-inositol 1,4,5-trisphosphate and adenophostin A : recognition by cerebellar and platelet inositol 1,4,5-trisphosphate receptors. Molecular Pharmacology, 52 (4), pp. 741-748.

Murphy, C. T., Riley, A. M., Mills, S. J., Lindley, C. J., Potter, B. V. L. and Westwick, J., 2000. Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,6-trisphosphorothioate : partial agonists with very low intrinsic activity at the platelet myo-Inositol 1,4,5-trisphosphate receptor. Molecular Pharmacology, 57 (3), pp. 595-601.

Murphy, J. E., Padilla, B. E., Hasdemir, B., Cottrell, G. S. and Bunnett, N. W., 2009. Endosomes: A legitimate platform for the signaling train. Proceedings of the National Academy of Sciences of the United States of America, 106 (42), pp. 17615-17622.

Murphy, J. E., Roosterman, D., Cottrell, G. S., Padilla, B. E., Feld, M., Brand, E., Cedron, W. J., Bunnett, N. W. and Steinhoff, M., 2011. Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor. American Journal of Physiology - Cell Physiology, 301 (4), C780-C791.

Murray, M. L., 2004. Treating major depression in children and adolescents: Research is needed into safer and more effective drugs. BMJ, 328 (7438), pp. 524-525.

Murray, M. L., de Vries, C. S. and Wong, I. C. K., 2004. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Archives of Disease in Childhood, 89 (12), pp. 1098-1102.

Müller, A., Severi, E., Mulligan, C., Watts, A. G., Kelly, D. J., Wilson, K. S., Wilkinson, A. J. and Thomas, G. H., 2006. Conservation of structure and mechanism in primary and secondary transporters exemplified by SiaP, a sialic acid-binding virulence factor from Haemophilus Influenzae. Journal of Biological Chemistry, 281 (31), pp. 22212-22222.

N

N'Dri-Stempfer, B., Navidi, W. C., Guy, R. H. and Bunge, A. L., 2008. Optimizing metrics for the assessment of bioequivalence between topical drug products. Pharmaceutical Research, 25 (7), pp. 1621-1630.

Nahorski, S. R., Batty, I. H., Willcocks, A. L., Strupish, J. and Potter, B. V. L., 1989. Metabolism and intracellular receptors for inositol 1, 4, 5-trisphosphate in brain. In: Freysz, L., Hawthorne, J. N. and Toffano, G., eds. Neurochemical Aspects of Phospholipid Metabolism. Springer-Verlag, pp. 95-98. (Fidia Research Series; 20)

Nahorski, S. R., Batty, I. H., Willcocks, A. L., Strupish, J. and Potter, B. V. L., 1989. Receptor-mediated phosphoinositide metabolism in brain. In: Segawa, T., Endo, M., Ui, M. and Kurihara, K., eds. Physiology and Pharmacology of Transmembrane Signalling. Amsterdam, the Netherlands: Elsevier Science B.V., pp. 217-221.

Nahorski, S. R. and Potter, B. V. L., 1992. Interaction of inositol polyphosphate analogues with intracellular receptors. In: Krogsgaard-Larsen, P., Brogger Christensen, S. and Kofod, H., eds. New Leads and Targets in Drug Research. Copenhagen, Denmark: Munksgaard, pp. 211-223.

Nahorski, S. R. and Potter, B. V. L., 1989. Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. Trends in Pharmacological Sciences, 10 (4), pp. 139-144.

Nathubhai, A., 2010. Molecular probes for mammalian chitinases. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Nathubhai, A., Patterson, R., Woodman, T. J., Sharp, H. E. C., Chui, M. T. Y., Chung, H. H. K., Lau, S. W. S., Zheng, J., Lloyd, M. D., Thompson, A. S. and Threadgill, M. D., 2011. N3-Alkylation during formation of quinazolin-4-ones from condensation of anthranilamides and orthoamides. Organic and Biomolecular Chemistry, 9 (17), pp. 6089-6099.

Nathubhai, A., Wood, P. J., Lloyd, M. D., Thompson, A. S. and Threadgill, M. D., 2013. Design and discovery of 2‑arylquinazolin-4-ones as potent and selective inhibitors of tankyrases. ACS Medicinal Chemistry Letters, 4 (12), pp. 1173-1177.

Naughton, D. P., Ferrer, S. and Threadgill, M. D., 2002. Drug targeting using bioreductive delivery systems. Proceedings of the Indian National Science Academy (PINSA), B68 (4), pp. 371-378.

Neal, A. P. and Blagbrough, I. S., 2001. Design and synthesis of fluorescent cholesterol and lithocholic acid polyamine conjugates. Abstracts of Papers of the American Chemical Society, 221, U58-U58.

Neal, A. P. and Blagbrough, I. S., 2001. Fluorescent steroidal lipopolyamine conjugates for monitoring gene delivery. Abstracts of Papers of the American Chemical Society, 221, U62-U62.

Neal, A. P. and Blagbrough, I. S., 2002. Hydrdboration of cholesterol carbamates: Novel fluorescent lipopolyamines. Abstracts of Papers of the American Chemical Society, 224, U34-U34.

Nebel, M., Schworer, A., Siebrands, C. C., Limbrock, A.-C., Swarbrick, J. M., Hohenegger, M., Geisler, A., Herich, L., Schlegel, S., Carrier, L., Eschenhagen, T., Potter, B. V. L., Ehmke, H. and Guse, A. H., 2012. Forthcoming. Antagonism of NAADP mediated calcium signaling ameliorates arrythmias in the heart. Circulation

Nebel, M., Schwoerer, A. P., Warszta, D., Siebrands, C. C., Limbrock, A.-C., Swarbrick, J. M., Fliegert, R., Weber, K., Bruhn, S., Hohenegger, M., Geisler, A., Herich, L., Schlegel, S., Carrier, L., Eschenhagen, T., Potter, B. V. L., Ehmke, H. and Guse, A. H., 2013. Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling and arrhythmias in the heart evoked by β-adrenergic stimulation. Journal of Biological Chemistry, 288 (22), pp. 16017-16030.

Neilan, C. L., Husbands, S. M., Breeden, S., Ko, M. C., Aceto, M. D., Lewis, J. W., Woods, J. H. and Traynor, J. R., 2004. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. European Journal of Pharmacology, 499, pp. 107-116.

Nerou, E. P., Riley, A. M., Potter, B. V. L. and Taylor, C. W., 2001. Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor. Journal of Biological Chemistry, 355 (Pt 1), pp. 59-69.

Newman, S. P. and Potter, B. V. L., 2002. Steroid sulfatase. In: Wiley Encyclopedia of Molecular Medicine [5 vol. set]. John Wiley & Sons, Inc., pp. 3012-3013.

Newman, S. P., Day, J. M., Potter, B. V. L., Reed, M. J. and Purohit, A., 2011. Forthcoming. The effects of paclitaxel and STX140 on early-and late-stage breast cancer in tte clinically relevant C3(1)/SV40 mouse model. European Journal of Cancer

Newman, S. P., Foster, P. A., Ho, Y. T., Day, J. M., Raobaikady, B., Kasprzyk, P. G., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2007. The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers. British Journal of Cancer, 97 (12), pp. 1673-1682.

Newman, S. P., Purohit, A., Ghilchik, M. W., Potter, B. V. L. and Reed, M. J., 2000. Regulation of steroid sulphatase expression and activity in breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 75 (4-5), pp. 259-264.

Newman, S. P., Purohit, A., Potter, B. V. L. and Reed, M. J., 2002. Steroid sulfatase. In: Encyclopedia of Molecular MEdicine. Vol. 5. John Wiley & Sons, Inc., pp. 3012-3013.

Newman, S. P., Foster, P. A., Stengel, C., Day, J. M., Ho, Y. T., Judde, J.-G., Lassalle, M., Prevost, G., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Clinical Cancer Research, 14 (2), pp. 597-606.

Newman, S. P., Ireson, C. R., Tutill, H. J., Day, J. M., Parsons, M. F.C., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2006. The role of 17β-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Research, 66 (1), pp. 324-330.

Newman, S. P., Leese, M. P., Purohit, A., James, D. R. C., Rennie, C. E., Potter, B. V. L. and Reed, M. J., 2004. Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates. International Journal of Cancer, 109 (4), pp. 533-540.

Newnes, L. B., MacGregor, S. A., Staniforth, J. N., Kay, G. R. and Marinescu, I. D., 1996. Powder processing from the 1980's to the 1990's. In: Marinescu, I. D., ed. Manufacturing Engineering : 2000 and Beyond, 1996-07-01, Connecticut.

Newnes, L. B., MacGregor, S. A., Staniforth, J. N., Kay, G. R. and Mayorga, R. V., 1995. A generic solution to the automation of powder production. In: Mayorga, R. V., ed. 3rd IASTED International Conf. Robotics & Manufacturing, 1995-06-01, Mexico.

Newnes, L. B., Staniforth, J. N. and MacGregor, S. A., 1994. A single vessel solution to the automation of pharmaceutical production. In: Proc. Third International Conference on Automation, Robotics and Computer Vision, 1994-11-01, Singapore.

Newnes, L. B., Staniforth, J. N., MacGregor, S. A. and Kay, G. R., 1995. Automation of powder production within the food and pharmaceutical industries. In: International Conference on Computer Aided Production Engineering, 1995-09-01, London.

Newnes, L. B., Staniforth, J. N., MacGregor, S. A., Kay, G. R., Stockton, D. and Wainwright, C., 1995. Flexible processing of powder production within the pharmaceutical industries. In: Stockton, D. and Wainwright, C., eds. Advances in Manufacturing Technology IX, 1995-09-01, De Montfort University.

Newstead, S. L., Potter, J. A., Wilson, J. C., Xu, G., Chien, C. -H., Watts, A. G., Withers, S. G. and Taylor, G. L., 2008. The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates. Journal of Biological Chemistry, 283 (14), pp. 9080-9088.

Newton, J.L., Frith, J., Powell, D., Hackett, K., Wilton, K., Bowman, S., Price, E., Pease, C., Andrews, J., Emery, P., Hunter, J., Gupta, M., Vadivelu, S., Giles, I., Isenberg, D., Lanyon, P., Jones, A., Regan, M., Cooper, A., Moots, R., Sutcliffe, N., Bombardieri, M., Pitzalis, C., McLaren, J., Young-Min, S., Dasgupta, B., Griffiths, B., Lendrem, D., Mitchell, S., Ng, W.-F., Bacabac, E.C., Moots, R., Chadravarty, K., Lamabadusuriya, S., Bombardieri, M., Pitzalis, C., Sutcliffe, N., Gendi, N., Adeniba, R., Hamburger, J., Richards, A., Rauz, S., Brailsford, S., Logan, J., Mulherin, D., Andrews, J., Emery, P., McManus, A., Pease, C., Booth, A., Regan, M., Dimitroulas, T., Kadiki, L., Kaur, D., Kitas, G., Lloyd, M., Moore, L., Gordon, E., Lawson, C., Gupta, M., Hunter, J., Stirton, L., Ortiz, G., Price, E., Clunie, G., Rose, G., Cuckow, S., Knight, S., Symmons, D., Jones, B., Carr, A., Edgar, S., Carrozzo, M., Figuereido, F., Foggo, H., Gillespie, C., Lendrem, D., Macleod, I., Mitchell, S., Tarn, J., Jones, A., Lanyon, P., Muir, A., White, P., Young-Min, S., Pugmire, S., Vadivelu, S., Cooper, A., Watkins, M., Field, A., Kaye, S., Mewar, D., Medcalf, P., Tomlinson, P., Whiteside, D., McHugh, N., Pauling, J., James, J., Olaitan, N., Akil, M., McDermott, J., Godia, O., Coady, D., Kidd, E., Palmer, L., Dasgupta, B., Katsande, V., Long, P., Chandra, U., MacKay, K., Fedele, S., Ferenkeh-Koroma, A., Isenberg, D., Marconnell, H., Porter, S., Allcoat, P. and McLaren, J., 2012. Forthcoming. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome. Annals of the Rheumatic Diseases

Nicholls, R. E., Zhang, X. L., Bailey, C. P., Conklin, B. R., Kandel, E. R. and Stanton, P. K., 2006. MGluR2 acts through inhibitory Gα subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103 (16), pp. 6380-6385.

Nicoli, S., Bunge, A. L., Delgado-Charro, M. B. and Guy, R. H., 2009. Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum. Pharmaceutical Research, 26 (4), pp. 865-871.

Nieland, N. P. R., Moynihan, H. A., Carrington, S., Broadbear, J., Woods, J. H., Traynor, J. R., Husbands, S. M. and Lewis, J. W., 2006. Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphines and codeinones. Journal of Medicinal Chemistry, 49, pp. 5333-5338.

Nieland, N. P. R., Rennison, D., Broadbear, J. H., Purington, L., Woods, J. H., Traynor, J. R., Lewis, J. W. and Husbands, S. M., 2009. 14β-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and Related Opioids. Further Examples of Pseudoirreversible μ Opioid Receptor Antagonists. Journal of Medicinal Chemistry, 52 (21), pp. 6926-6930.

Nightingale, A. L., Farmer, R. D. T. and de Vries, C. S., 2007. Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiology and Drug Safety, 16 (2), pp. 144-151.

Nightingale, A. L., Farmer, R. D. T. and de Vries, C. S., 2006. Incidence of clinically diagnosed systemic lupus erythematosus 1992–1998 using the UK General Practice Research Database. Pharmacoepidemiology and Drug Safety, 15 (9), pp. 656-661.

Nightingale, A. L., Hutchison, A. and De Vries, C., 2011. Differences in Oral Candidiasis Risk between Different Inhaled Corticosteroids. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S141.

Nixon, S., Sieg, A., Delgado-Charro, M. and Guy, R., 2007. Reverse iontophoresis of L-lactate: in vitro and in vivo studies. Journal of Pharmaceutical Sciences, 96 (12), pp. 3457-3465.

Noble, N. J., Cooke, A. M. and Potter, B. V.L., 1992. Synthesis of (±)-myo-inositol 1,4,5-trisphosphate and the novel analogue (±)-myo-inositol 1,4-bisphosphate 5-phosphorothioate. Carbohydrate Research, 234, pp. 177-187.

Noble, N. J., Dubreuil, D. and Potter, B. V. L., 1992. Total synthesis of myo-inositol 1-phosphate4,5-pyrophosphate, a novel second messenger analogue, via myo-inositol 1-phosphate 4,5-bisphosphorothioate. Bioorganic & Medicinal Chemistry Letters, 2 (5), pp. 471-476.

Noble, N. J. and Potter, B. V. L., 1989. Desulphurisation of vicinal bisphosphorothioates : a novel synthetic route to substituted cyclic pyrophosphates. Journal of the Chemical Society, Chemical Communications, 1989 (17), pp. 1194-1195.

Nogueiras-Nieto, L., Gómez-Amoza, J. L., Delgado-Charro, M. B. and Otero-Espinar, F. J., 2011. Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery. Journal of Controlled Release, 156 (3), pp. 337-344.

Nogueiras-Nieto, L., Delgado-Charro, M. B. and Otero-Espinar, F.J., 2013. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine. European Journal of Pharmaceutics and Biopharmaceutics, 83 (3), pp. 370-377.

Nolasco, L., Perez Gonzalez, M., Caggiano, L. and Jackson, R. F. W., 2009. Application of Negishi Cross-Coupling to the Synthesis of the Cyclic Tripeptides OF4949-III and K-13. Journal of Organic Chemistry, 74 (21), pp. 8280-8289.

Nunn, D. L., Potter, B. V. L. and Taylor, C. W., 1990. Molecular target sizes of inositol 1,4,5-trisphosphate receptors in liver and cerebellum. Biochemical Journal, 265 (2), pp. 393-398.

Nusrat, A., Brown, G. T., Tom, J., Drake, A., Bui, T. T., Quan, C. and Mrsny, R. J., 2005. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Molecular Biology of the Cell, 16 (4), pp. 1725-1734.

Nusrat, A., Chen, J. A., Foley, C. S., Liang, T. W., Tom, J., Cromwell, M., Quan, C. and Mrsny, R. J., 2000. The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. Journal of Biological Chemistry, 275 (38), pp. 29816-29822.

Nusrat, A. and Mrsny, R. J., 2005. Tight junctions; more than a permeability barrier. Advanced Drug Delivery Reviews, 57.

N’Dri-Stempfer, B., Navidi, W. C., Guy, R. H. and Bunge, A. L., 2009. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharmaceutical Research, 26 (2), pp. 316-328.

O

O'Donovan, L. and De Bank, P. A., 2011. A novel caged carbonyl for biomaterial modification and cell patterning. European Cells and Materials, 22 (Supplement 3), p. 52.

O'Donovan, L. and De Bank, P. A., 2012. A photocleavable linker for the chemoselective functionalization of biomaterials. Journal of Materials Chemistry, 22 (41), pp. 21878-21884.

O'Neill, L. A. J., Brown, Z. and Ward, S. G., 2003. Toll-like receptors in the spotlight. Nature Immunology, 4, p. 299.

O'Neill, M. A. A., 2004. Microcalorimetry. In: Yearbook of Science and Technology 2004. The McGraw-Hill Companies, Inc.

O'Neill, M. A. A., 2004. New calculational techniques for the elucidation of the thermodynamic and kinetic parameters from isothermal calorimetric data: application to second order (and higher orders) reactions studied by flow calorimetry. Thermochimica Acta, 417, pp. 185-186.

O'Neill, M. A. A., 2005. Recent developments for the analysis of data obtained from isothermal calorimetry. Current Pharmaceutical Biotechnology, 6, pp. 205-214.

O'Neill, M. A. A., Beezer, A. E., Deal, R. M., Morris, A. C., Mitchell, J. C., Orchard, J. A. and Connor, J. A., 2003. Survey of the effect of fill volume on the values for the enthalpy and rate constant derived from isothermal microcalorimetry: applications of a newly developed test reaction. Thermochimica Acta, 397, pp. 163-169.

O'Neill, M. A. A., Beezer, A. E., Mitchell, J. C., Orchard, J. and Connor, J. A., 2004. Determination of Michaelis-Menten parameters obtained from isothermal flow calorimetric data. Thermochimica Acta, 417, pp. 187-192.

O'Neill, M. A. A., Beezer, A. E., Morris, A. C., Urakami, K., Willson, R. J. and Connor, J. A., 2003. Solid-state reactions from isothermal heat conduction microcalorimetry. Journal of Thermal Analysis and Calorimetry, 73, pp. 709-714.

O'Neill, M. A. A., Beezer, A. E., Tetteh, J., Gaisford, S. and Dhuna, M., 2007. Application of chemometric analysis to complexity in isothermal calorimetric data. Journal of Physical Chemistry B, 111, pp. 8145-8149.

O'Neill, M. A. A., Beezer, A. E., Vine, G. J., Kemp, R. B., Olomolaiye, D., Volpe, P. L. O. and Oliveira, D., 2004. Practical and theoretical consideration of flow-through microcalorimetry: determination of "thermal volume" and its flow rate dependence. Thermochimica Acta, 413, pp. 193-199.

O'Neill, M. A. A., Gaisford, S., Beezer, A. E., Skaria, C. V. and Sears, P., 2006. A comparison of the performance of calorimeters: application of a test and reference reaction. Journal of Thermal Analysis and Calorimetry, 84 (2), pp. 301-306.

O'Neill, M. A. A. and Letcher, T. M., 2004. Isothermal flow calorimetry; principles and applications for industry. In: Chemical Thermodynamics for Industry. RSC.

O'Neill, M. A. A., Vine, G. J., Beezer, A. E., Bishop, A. H., Hadgraft, J., Labetoulle, C., Walker, M. and Bowler, P. G., 2003. Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. International Journal of Pharmaceutics, 263, pp. 61-68.

O'Neill, M., Beezer, A. E., Labetoulle, C., Nicolaides, L., Mitchell, J. C., Orchard, J. A., Connor, J. A., Kemp, R. B. and Olomolaiye, D., 2003. The base catalysed hydrolysis of methyl paraben: a test reaction for flow microcalorimeters used for determination of both kinetic and thermodynamic parameters. Thermochimica Acta, 399, pp. 63-71.

O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.

O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.

O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.

O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.

O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.

Oates, J., Barrett, C., Barnett, J., Byrne, K., Bolhuis, A. and Robinson, C., 2005. The twin-arginine translocation apparatus incorporates a distinct form of TatABC complex, spectrum of modular TatA complexes and minor TatAB complex. Journal of Molecular Biology, 346 (1), pp. 295-305.

Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K. L., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., Mechoulam, R., Zimmer, A. and Bab, I., 2006. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proceedings of the National Academy of Sciences of the United States of America, 103 (3), pp. 696-701.

Oldfield, S., Braksator, E., Rodriguez-Martin, I., Bailey, C. P., Donaldson, L. F., Henderson, G. and Kelly, E., 2008. C-terminal splice variants of the μ-opioid receptor: existence, distribution and functional characteristics. Journal of Neurochemistry, 104 (4), pp. 937-945.

Olesen, C., de Vries, C. S., Thrane, N., MacDonald, T. M., Larsen, H. and Sorensen, H. T., 2001. Effect of diuretics on fetal growth: A drug effect or confounding by indication? Pooled Danish and Scottish cohort data. British Journal Of Clinical Pharmacology, 51 (2), pp. 153-157.

Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.

Olsen, J., Czeizel, A., Sørensen, H. T., Nielsen, G. L., de Jong van den Berg, L. T. W., Irgens, L. M., Olesen, C., Pedersen, L., Larsen, H., Lie, R. T., de Vries, C. S. and Bergman, U., 2002. How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper. Drug Safety, 25 (1), pp. 21-32.

Orchiston, E. A., Bennett, D., Leslie, N. R., Clarke, R. G., Winward, L., Downes, C. P. and Safrany, S. T., 2004. PTEN M-CBR3, a versatile and selective regulator of Ins(1,3,4,5,6)-Pentakisphosphate (Ins(1,3,4,5,6)P 5 ). Journal of Biological Chemistry, 279, pp. 1116-1122.

Orlando, L., Sanchez Ripoll, Y., Foster, J., Bone, H., Giachino, C. and Welham, M. J., 2012. Differential coupling of self-renewal signaling pathways in murine induced pluripotent stem cells. PLoS ONE, 7 (1), e30234.

Ostroumova, M. A., Lovell, C. R., McHugh, N. J. and Mann, R. J., 2006. Clinical Image : skin hyperpigmentation over inflamed joints. Arthritis & Rheumatism, 54 (8), p. 2604.

Oswald, C. L., Carrillo-Marquez, T., Caggiano, L. and Jackson, R. F. W., 2008. Negishi cross-coupling reactions of alpha-amino acid-derived organozinc reagents and aromatic bromides. Tetrahedron, 64 (4), pp. 681-687.

Owens, S. E., Graham, W. V., Siccardi, D., Turner, J. R. and Mrsny, R. J., 2005. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase. Pharmaceutical Research, 22 (5), pp. 703-709.

P

Pacheco-Tena, C., Burgos-Vargas, R., Aubin, J. E., Stone, M., Perez-Tamayo, R., Pineda, C. and Inman, R. D., 2002. Characterization of the osteoblast phenotype in spondyloarthropathy: Lessons from the ankylosing tarsitis environment. Arthritis & Rheumatism, 46 (9), S436-S436.

Pacheco-Tena, C., Zhang, X., Stone, M., Burgos-Vargas, R. and Inman, R. D., 2002. Innate immunity in host-microbial interactions: Beyond B27 in the spondyloarthropathies. Current Opinion in Rheumatology, 14 (4), pp. 373-382.

Paling, N. R. D. and Welham, M. J., 2002. Role of the tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling. Biochemical Journal, 368, pp. 885-894.

Paling, N. R. D. and Welham, M. J., 2005. Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoieses. Blood, 105 (11), pp. 4290-4297.

Paling, N. R. D., Wheadon, H., Bone, H. K. and Welham, M. J., 2004. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. Journal of Biological Chemistry, 279 (46), pp. 48063-48070.

Palysaeva, N.V., Kumpan, K., Struchkova, M.I., Dalinger, I.L., Kormanov, A.V., Aleksandrova, N.S., Chernyshev, V.M., Pyreu, D.F., Suponitsky, K.Y. and Sheremetev, A.B., 2014. A direct approach to a 6-hetarylamino[1,2,4]triazolo[4,3-b][1,2,4,5] tetrazine library. Organic Letters, 16 (2), pp. 406-409.

Panopoulou, A., Vermaak, E. and McHugh, N., 2013. A surprise behind a case of winter vomiting virus. BMJ Case Reports

Papadopoulos, C., Ross, J., Stewart, D., Dack, C., James, K. and Bowers, L., 2012. The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatrica Scandinavica, 125 (6), pp. 425-439.

Parekh, A. B., Riley, A. M. and Potter, B. V. L., 2002. Adenophostin A and ribophostin, but not inositol 1,4,5-triphosphate or manno -adenophostin, activate the Ca2+ release-activated Ca2+ current, /CRAC , in weak intracellular Ca2+ buffer. Biochemical Journal, 361, pp. 133-141.

Park, K., Yui, N. and Mrsny, R. J., 2004. A perspective on current and future synthetic reflexive systems. In: Yui, N., Mrsny, R. and Park, K., eds. Multi-Reflexive Polymers and Hydrogels: Understanding and Designing Fast-Responsive Polymeric Systems. Boca Raton, Florida: CRC Press, pp. 427-437.

Parker, C. A., Anderson, N. J., Robinson, E. S. J., Price, R., Tyacke, R. J., Husbands, S. M., Dillon, M. P., Eglen, R. M., Hudson, A. L., Nutt, D. J., Crump, M. P. and Crosby, J., 2004. Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry, 43, pp. 16385-16392.

Parker, C.A., Nabulsi, N., Holden, D., Lin, S.-F., Cass, T., Labaree, D., Kealey, S., Gee, A.D., Husbands, S.M., Quelch, D., Carson, R.E., Nutt, D.J., Huang, Y. and Tyacke, R.J., 2014. Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline Binding Sites in Rhesus Brain. The Journal of Nuclear Medicine, 55 (5), pp. 838-844.

Parry, R. V., Riley, J. L. and Ward, S. G., 2007. Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation. Trends in Immunology, 28 (4), pp. 161-168.

Parry, R. V. and Ward, S. G., 2005. T-lymphocyte activation. Encyclopedia of Life Sciences, 2005.

Parry, R. V., Whittaker, G. C., Sims, M., Edmead, C., Welham, M. J. and Ward, S. G., 2006. Ligation of CD28 stimulates the formation of a multimeric signaling complex involving Grb-2-Associated binder 2 (Gab2), Src homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the Gab2 pleckstrin homology domain. The Journal of Immunology, 176, pp. 594-602.

Parry, R. V., Harris, S. J. and Ward, S. G., 2010. Fine tuning T lymphocytes: A role for the lipid phosphatase SHIP-1. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics, 1804 (3), pp. 592-597.

Parry, R. V. and Ward, S. G., 2010. Protein arginine methylation: a new handle on T lymphocytes? Trends in Immunology, 31 (4), pp. 164-169.

Parsons, M. F. C., Foster, P. A., Chander, S. K., Jhalli, R., Newman, S. P., Leese, M. P., Potter, B. V. L., Purohit, A. and Reed, M. J., 2008. The in vivo properties of STX243 : A potent angiogenesis inhibitor in breast cancer. British Journal of Cancer, 99 (9), pp. 1433-1441.

Parveen, I., Threadgill, M. D., Hauck, B., Donnison, I. and Winters, A., 2011. Isolation, identification and quantitation of hydroxycinnamic acid conjugates, potential platform chemicals, in the leaves and stems of Miscanthus x giganteus using LC-ESI-MS(n). Phytochemistry, 72 (18), pp. 2376-2384.

Parveen, I., Winters, A., Threadgill, M. D., Hauck, B. and Morris, P., 2008. Extraction, structural characterisation and evaluation of hydroxycinnamate esters of orchard grass (Dactylis glomerata) as substrates for polyphenol oxidase. Phytochemistry, 69 (16), pp. 2799-2806.

Parveen, I., Wilson, T., Threadgill, M.D., Luyten, J., Roberts, R.E., Robson, P.R.H., Donnison, I.S., Hauck, B. and Winters, A.L., 2014. Screening for potential co-products in a Miscanthus sinensis mapping family by liquid chromatography with mass spectrometry detection. Phytochemistry

Parveen, I., Threadgill, M. D., Moorby, J. M. and Winters, A., 2010. Oxidative phenols in forage crops containing polyphenol oxidase enzymes. Journal of Agricultural and Food Chemistry, 58 (3), pp. 1371-1382.

Parveen, I., Wilson, T., Donnison, I., Cookson, A.R., Hauck, B. and Threadgill, M., 2013. Potential sources of high value chemicals from leaves, stems and flowers of Miscanthus sinensis 'Goliath' and Miscanthus sacchariflorus. Phytochemistry, 92, pp. 160-167.

Pascu, S. I., Waghorn, P. A., Arrowsmith, R. L., Bayly, S. R., Dilworth, J. R., Christlieb, M., Tyrrell, R. M., Zhong, J. L., Kowalczyk, R. M., Collison, D., Churchill, G. C. and Aigbirhio, F. I., 2010. Fluorescent copper(II) bis(thiosemicarbazonates) : Fromsynthesis to radiolabelling, in vitro cytotoxicity andconfocal fluorescence microscopy. Journal of Labelled Compounds & Radiopharmaceuticals, 53 (7-8), pp. 527-528.

Patel, K. M., Watson, M. L. and Ward, S. G., 2005. Differential sensitivity of class II phosphoinositide 3-kinase (PI3K) isoforms to broad spectrum P13K inhibitors. Pa2 Online, 2, 76P.

Patel, K. M., Whittaker, P., Watson, M. L. and Ward, S. G., 2003. Disparate effects of PPAR g ligands on PI3K and MAPK signalling pathways. Inflammation Research, Supplement 2, S174.

Patel, K. M., Wright, K. L., Whittaker, P., Chakravarty, P., Watson, M. L. and Ward, S. G., 2005. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPARγ agonists: evidence for disparate functional effects which are independent of NF-κB and PPARγ. Drug Discovery Today, 17, pp. 1098-1110.

Patel, N., Craddock, B. L., Staniforth, J. N., Tobyn, M. J. and Welham, M. J., 2001. Spray-dried insulin particles retain biological activity in rapid in-vitro assay. Journal of Pharmacy and Pharmacology, 53, pp. 1415-1418.

Patel, S., Veale, D., FitzGerald, O. and McHugh, N. J., 2001. Psoriatic arthritis--emerging concepts. Rheumatology, 40 (3), pp. 243-246.

Patel, Y. I. and McHugh, N. J., 2000. Apoptosis-new clues to the pathogenesis of Sjögren's syndrome? Rheumatology, 39 (2), pp. 119-121.

Patel, Y. I., St John, A. and McHugh, N. J.<